
<html lang="en"     class="pb-page"  data-request-id="8f22581c-06a3-47b9-8399-c988e58237ea"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2008.51.issue-2;article:article:10.1021/jm701018h;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="4,5-Diarylisoxazole Hsp90 Chaperone Inhibitors: Potential Therapeutic Agents for the Treatment of Cancer" /></meta><meta name="dc.Creator" content="Paul A.  Brough" /></meta><meta name="dc.Creator" content="Wynne  Aherne" /></meta><meta name="dc.Creator" content="Xavier  Barril" /></meta><meta name="dc.Creator" content="Jenifer  Borgognoni" /></meta><meta name="dc.Creator" content="Kathy  Boxall" /></meta><meta name="dc.Creator" content="Julie E.  Cansfield" /></meta><meta name="dc.Creator" content="Kwai-Ming J.  Cheung" /></meta><meta name="dc.Creator" content="Ian  Collins" /></meta><meta name="dc.Creator" content="Nicholas G. M.  Davies" /></meta><meta name="dc.Creator" content="Martin J.  Drysdale" /></meta><meta name="dc.Creator" content="Brian  Dymock" /></meta><meta name="dc.Creator" content="Suzanne A.  Eccles" /></meta><meta name="dc.Creator" content="Harry  Finch" /></meta><meta name="dc.Creator" content="Alexandra  Fink" /></meta><meta name="dc.Creator" content="Angela  Hayes" /></meta><meta name="dc.Creator" content="Robert  Howes" /></meta><meta name="dc.Creator" content="Roderick E.  Hubbard" /></meta><meta name="dc.Creator" content="Karen  James" /></meta><meta name="dc.Creator" content="Allan M.  Jordan" /></meta><meta name="dc.Creator" content="Andrea  Lockie" /></meta><meta name="dc.Creator" content="Vanessa  Martins" /></meta><meta name="dc.Creator" content="Andrew  Massey" /></meta><meta name="dc.Creator" content="Thomas P.  Matthews" /></meta><meta name="dc.Creator" content="Edward  McDonald" /></meta><meta name="dc.Creator" content="Christopher J.  Northfield" /></meta><meta name="dc.Creator" content="Laurence H.  Pearl" /></meta><meta name="dc.Creator" content="Chrisostomos  Prodromou" /></meta><meta name="dc.Creator" content="Stuart  Ray" /></meta><meta name="dc.Creator" content="Florence I.  Raynaud" /></meta><meta name="dc.Creator" content="Stephen D.  Roughley" /></meta><meta name="dc.Creator" content="Swee Y.  Sharp" /></meta><meta name="dc.Creator" content="Allan  Surgenor" /></meta><meta name="dc.Creator" content="D. Lee  Walmsley" /></meta><meta name="dc.Creator" content="Paul  Webb" /></meta><meta name="dc.Creator" content="Mike  Wood" /></meta><meta name="dc.Creator" content="Paul  Workman" /></meta><meta name="dc.Creator" content="Lisa  Wright" /></meta><meta name="dc.Description" content="Inhibitors of the Hsp90 molecular chaperone are showing considerable promise as potential chemotherapeutic agents for cancer. Here, we describe the structure-based design, synthesis, structure−acti..." /></meta><meta name="Description" content="Inhibitors of the Hsp90 molecular chaperone are showing considerable promise as potential chemotherapeutic agents for cancer. Here, we describe the structure-based design, synthesis, structure−acti..." /></meta><meta name="dc.Publisher" content=" American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 20, 2007" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm701018h" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2008 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm701018h" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm701018h" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm701018h" /></link>
        
    
    

<title>4,5-Diarylisoxazole Hsp90 Chaperone Inhibitors: Potential Therapeutic Agents for the Treatment of Cancer | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm701018h" /></meta><meta property="og:title" content="4,5-Diarylisoxazole Hsp90 Chaperone Inhibitors: Potential Therapeutic Agents for the Treatment of Cancer" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0023.jpeg" /></meta><meta property="og:description" content=" Inhibitors of the Hsp90 molecular chaperone are showing considerable promise as potential chemotherapeutic agents for cancer. Here, we describe the structure-based design, synthesis, structure−activity relationships and pharmacokinetics of potent small-molecule inhibitors of Hsp90 based on the 4,5-diarylisoxazole scaffold. Analogues from this series have high affinity for Hsp90, as measured in a fluorescence polarization (FP) competitive binding assay, and are active in cancer cell lines where they inhibit proliferation and exhibit a characteristic profile of depletion of oncogenic proteins and concomitant elevation of Hsp72. Compound 40f (VER-52296/NVP-AUY922) is potent in the Hsp90 FP binding assay (IC50 = 21 nM) and inhibits proliferation of various human cancer cell lines in vitro, with GI50 averaging 9 nM. Compound 40f is retained in tumors in vivo when administered i.p., as evaluated by cassette dosing in tumor-bearing mice. In a human colon cancer xenograft model, 40f inhibits tumor growth by ∼50%." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm701018h"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm701018h">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm701018h&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm701018h&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm701018h&amp;href=/doi/10.1021/jm701018h" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2008</span><span class="cit-fg-volume">, 51</span><span class="cit-fg-issue">, 2</span><span class="cit-fg-pageRange">, 196-218</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/51/2" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm070461w" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm070524a" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">4,5-Diarylisoxazole Hsp90 Chaperone Inhibitors: Potential Therapeutic Agents for the Treatment of Cancer</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul+A.++Brough">Paul A. Brough</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wynne++Aherne">Wynne Aherne</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xavier++Barril">Xavier Barril</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jenifer++Borgognoni">Jenifer Borgognoni</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kathy++Boxall">Kathy Boxall</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Julie+E.++Cansfield">Julie E. Cansfield</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kwai-Ming+J.++Cheung">Kwai-Ming J. Cheung</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ian++Collins">Ian Collins</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nicholas+G.+M.++Davies">Nicholas G. M. Davies</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Martin+J.++Drysdale">Martin J. Drysdale</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brian++Dymock">Brian Dymock</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Suzanne+A.++Eccles">Suzanne A. Eccles</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Harry++Finch">Harry Finch</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alexandra++Fink">Alexandra Fink</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Angela++Hayes">Angela Hayes</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert++Howes">Robert Howes</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Roderick+E.++Hubbard">Roderick E. Hubbard</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Karen++James">Karen James</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Allan+M.++Jordan">Allan M. Jordan</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrea++Lockie">Andrea Lockie</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vanessa++Martins">Vanessa Martins</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrew++Massey">Andrew Massey</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thomas+P.++Matthews">Thomas P. Matthews</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Edward++McDonald">Edward McDonald</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+J.++Northfield">Christopher J. Northfield</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Laurence+H.++Pearl">Laurence H. Pearl</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chrisostomos++Prodromou">Chrisostomos Prodromou</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stuart++Ray">Stuart Ray</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Florence+I.++Raynaud">Florence I. Raynaud</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stephen+D.++Roughley">Stephen D. Roughley</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Swee+Y.++Sharp">Swee Y. Sharp</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Allan++Surgenor">Allan Surgenor</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=D.+Lee++Walmsley">D. Lee Walmsley</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Webb">Paul Webb</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mike++Wood">Mike Wood</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Workman">Paul Workman</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lisa++Wright">Lisa Wright</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">Vernalis Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K., and Cancer Research U.K. Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span></div><div class="corresp-info"><strong>*</strong> To whom correspondence should be addressed. E-mail: <a href="/cdn-cgi/l/email-protection#8fffa1edfde0fae8e7cfaff9eafde1eee3e6fca1ece0e2"><span class="__cf_email__" data-cfemail="baca94d8c8d5cfddd2fa">[email protected]</span> vernalis.com</a>. Phone: 44 (0)1223 895372 . Fax: 44 (0)1223 895556.</div><div class="corresp-fn" id="afn1">†Vernalis Ltd.</div><div class="corresp-fn" id="afn2">‡The Institute of Cancer Research.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm701018h&amp;href=/doi/10.1021%2Fjm701018h" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2008</span></span><span class="cit-volume">, 51</span><span class="cit-issue">, 2</span><span class="cit-pageRange">, 196–218</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 20, 2007</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>15 August 2007</li><li><span class="item_label"><b>Published</b> online</span>20 November 2007</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 1 January 2008</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm701018h" title="DOI URL">https://doi.org/10.1021/jm701018h</a></div><div class="article_header-article-copyright"><strong>Copyright © 2008 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D196%26pageCount%3D23%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DPaul%2BA.%2BBrough%252C%2BWynne%2BAherne%252C%2BXavier%2BBarril%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D51%26issueNum%3D2%26contentID%3Djm701018h%26title%3D4%252C5-Diarylisoxazole%2BHsp90%2BChaperone%2BInhibitors%253A%2BPotential%2BTherapeutic%2BAgents%2Bfor%2Bthe%2BTreatment%2Bof%2BCancer%26numPages%3D23%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D218%26publicationDate%3DJanuary%2B2008">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm701018h"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">7864</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">309</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm701018h" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;4,5-Diarylisoxazole Hsp90 Chaperone Inhibitors: Potential Therapeutic Agents for the Treatment of Cancer&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;A. Brough&quot;},{&quot;first_name&quot;:&quot;Wynne&quot;,&quot;last_name&quot;:&quot;Aherne&quot;},{&quot;first_name&quot;:&quot;Xavier&quot;,&quot;last_name&quot;:&quot;Barril&quot;},{&quot;first_name&quot;:&quot;Jenifer&quot;,&quot;last_name&quot;:&quot;Borgognoni&quot;},{&quot;first_name&quot;:&quot;Kathy&quot;,&quot;last_name&quot;:&quot;Boxall&quot;},{&quot;first_name&quot;:&quot;Julie&quot;,&quot;last_name&quot;:&quot;E. Cansfield&quot;},{&quot;first_name&quot;:&quot;Kwai-Ming&quot;,&quot;last_name&quot;:&quot;J. Cheung&quot;},{&quot;first_name&quot;:&quot;Ian&quot;,&quot;last_name&quot;:&quot;Collins&quot;},{&quot;first_name&quot;:&quot;Nicholas&quot;,&quot;last_name&quot;:&quot;G. M. Davies&quot;},{&quot;first_name&quot;:&quot;Martin&quot;,&quot;last_name&quot;:&quot;J. Drysdale&quot;},{&quot;first_name&quot;:&quot;Brian&quot;,&quot;last_name&quot;:&quot;Dymock&quot;},{&quot;first_name&quot;:&quot;Suzanne&quot;,&quot;last_name&quot;:&quot;A. Eccles&quot;},{&quot;first_name&quot;:&quot;Harry&quot;,&quot;last_name&quot;:&quot;Finch&quot;},{&quot;first_name&quot;:&quot;Alexandra&quot;,&quot;last_name&quot;:&quot;Fink&quot;},{&quot;first_name&quot;:&quot;Angela&quot;,&quot;last_name&quot;:&quot;Hayes&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;Howes&quot;},{&quot;first_name&quot;:&quot;Roderick&quot;,&quot;last_name&quot;:&quot;E. Hubbard&quot;},{&quot;first_name&quot;:&quot;Karen&quot;,&quot;last_name&quot;:&quot;James&quot;},{&quot;first_name&quot;:&quot;Allan&quot;,&quot;last_name&quot;:&quot;M. Jordan&quot;},{&quot;first_name&quot;:&quot;Andrea&quot;,&quot;last_name&quot;:&quot;Lockie&quot;},{&quot;first_name&quot;:&quot;Vanessa&quot;,&quot;last_name&quot;:&quot;Martins&quot;},{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;Massey&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;P. Matthews&quot;},{&quot;first_name&quot;:&quot;Edward&quot;,&quot;last_name&quot;:&quot;McDonald&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;J. Northfield&quot;},{&quot;first_name&quot;:&quot;Laurence&quot;,&quot;last_name&quot;:&quot;H. Pearl&quot;},{&quot;first_name&quot;:&quot;Chrisostomos&quot;,&quot;last_name&quot;:&quot;Prodromou&quot;},{&quot;first_name&quot;:&quot;Stuart&quot;,&quot;last_name&quot;:&quot;Ray&quot;},{&quot;first_name&quot;:&quot;Florence&quot;,&quot;last_name&quot;:&quot;I. Raynaud&quot;},{&quot;first_name&quot;:&quot;Stephen&quot;,&quot;last_name&quot;:&quot;D. Roughley&quot;},{&quot;first_name&quot;:&quot;Swee&quot;,&quot;last_name&quot;:&quot;Y. Sharp&quot;},{&quot;first_name&quot;:&quot;Allan&quot;,&quot;last_name&quot;:&quot;Surgenor&quot;},{&quot;first_name&quot;:&quot;D.&quot;,&quot;last_name&quot;:&quot;Lee Walmsley&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Webb&quot;},{&quot;first_name&quot;:&quot;Mike&quot;,&quot;last_name&quot;:&quot;Wood&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Workman&quot;},{&quot;first_name&quot;:&quot;Lisa&quot;,&quot;last_name&quot;:&quot;Wright&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2007&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;20&quot;,&quot;issue&quot;:&quot;2&quot;,&quot;volume&quot;:&quot;51&quot;,&quot;pages&quot;:&quot;196-218&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm701018h&quot;},&quot;abstract&quot;:&quot;Inhibitors of the Hsp90 molecular chaperone are showing considerable promise as potential chemotherapeutic agents for cancer. Here, we describe the structure-based design, synthesis, structure−activity relationships and pharmacokinetics of potent small-molecule inhibitors of Hsp90 based on the 4,5-diarylisoxazole scaffold. Analogues from this series have high affinity for Hsp90, as measured in a fluorescence polarization (FP) competitive binding assay, and are active in cancer cell lines where they inhibit proliferation and exhibit a characteristic profile of depletion of oncogenic proteins and concomitant elevation of Hsp72. Compound 40f (VER-52296/NVP-AUY922) is potent in the Hsp90 FP binding assay (IC50 = 21 nM) and inhibits proliferation of various human cancer cell lines in vitro, with GI50 averaging 9 nM. Compound 40f is retained in tumors in vivo when administered i.p., as evaluated by cassette dosing in tumor-bearing mice. In a human colon cancer xenograft model, 40f inhibits tumor growth by ∼50%.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm701018h&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm701018h" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm701018h&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm701018h" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm701018h&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm701018h" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm701018h&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm701018h&amp;href=/doi/10.1021/jm701018h" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm701018h" /></input><a href="/doi/pdf/10.1021/jm701018h" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm701018h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm701018h%26sid%3Dliteratum%253Aachs%26pmid%3D18020435%26genre%3Darticle%26aulast%3DBrough%26date%3D2008%26atitle%3D4%252C5-Diarylisoxazole%2BHsp90%2BChaperone%2BInhibitors%253A%2BPotential%2BTherapeutic%2BAgents%2Bfor%2Bthe%2BTreatment%2Bof%2BCancer%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D51%26issue%3D2%26spage%3D196%26epage%3D218%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292153" title="Tumors">Tumors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/51/2" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_null" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/medium/jm-2007-01018h_0023.gif" alt="" id="_i2" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701018h&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Inhibitors of the Hsp90 molecular chaperone are showing considerable promise as potential chemotherapeutic agents for cancer. Here, we describe the structure-based design, synthesis, structure−activity relationships and pharmacokinetics of potent small-molecule inhibitors of Hsp90 based on the 4,5-diarylisoxazole scaffold. Analogues from this series have high affinity for Hsp90, as measured in a fluorescence polarization (FP) competitive binding assay, and are active in cancer cell lines where they inhibit proliferation and exhibit a characteristic profile of depletion of oncogenic proteins and concomitant elevation of Hsp72. Compound <b>40f</b> (VER-52296/NVP-AUY922) is potent in the Hsp90 FP binding assay (IC<sub>50</sub> = 21 nM) and inhibits proliferation of various human cancer cell lines in vitro, with GI<sub>50</sub> averaging 9 nM. Compound <b>40f</b> is retained in tumors in vivo when administered i.p., as evaluated by cassette dosing in tumor-bearing mice. In a human colon cancer xenograft model, <b>40f</b> inhibits tumor growth by ∼50%.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52542" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52542" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Molecular chaperones are proteins which play a key role in the conformational maturation, stability and function of other “client”protein substrates within the cell.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> Many of the client proteins of heat shock protein 90 (Hsp90)<a onclick="showRef(event, 'ref3 ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5 ref6">(3-6)</a> are involved in signal transduction, cell cycle regulation and apoptosis, including kinases, transcription factors and hormone receptors. The dysregulation of pathways involving these proteins are commonly associated with cancer pathology,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> and Hsp90 thus plays a key role in assisting survival, proliferation, invasion, metastasis and angiogenesis, which represent the hallmark traits of malignancy. However, Hsp90 is ubiquitously expressed in normal cells, comprising 1–2% of the total cellular protein, and has important functions in normal cell homeostasis. Consequently, Hsp90 was not pursued as a drug target until the discovery and characterization of natural product inhibitors of Hsp90 function such as geldanamycin<a onclick="showRef(event, 'ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10">(8-10)</a> (GM) and radicicol<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11, 12)</a> (RD) (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>, <b>1a</b> and <b>2</b>). In the cell, Hsp90 function is complex, involving homodimerization and binding to client proteins, co-chaperones and other accessory proteins operating in a chaperone cycle.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> The chaperone cycle is driven by hydrolysis of ATP to ADP and by ATP/ADP exchange,<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14, 15)</a> and it was shown that both GM and RD are able to inhibit Hsp90 function by binding to an ATP binding pocket in the N-terminal domain of Hsp90.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> The subsequent loss of chaperone function causes client proteins to be degraded by the ubiquitin−proteasome pathway. The prevalence of a high-affinity form of Hsp90 in tumor cells, the “addiction”of cancer cells to oncogenic client proteins and their greater dependency on Hsp90 have been proposed as rationales for selectivity of Hsp90 inhibitors for cancer versus normal cells.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Further validation of Hsp90 as a protein target for drug discovery comes from pharmacological and clinical studies with the GM analogue 17-allylaminogeldanamycin (17-AAG, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>, <b>1b</b>).<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> This first-in-class Hsp90 inhibitor to enter clinical trials has generated encouraging results in Phase-I trials.<a onclick="showRef(event, 'ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref21">(19-21)</a> Further clinical trials have been initiated with 17-AAG used as a single agent and in drug combinations in various cancer types. Hsp90 inhibitors are now the focus of significant research and development efforts,<a onclick="showRef(event, 'ref22 ref23 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref22 ref23 ref24 ref25">(22-25)</a> and their ability to interfere with multiple oncogenic pathways has raised hopes that they will show broad antitumor activity and be less susceptible to acquired drug resistance. However, despite the high cellular activity and clinical progression of 17-AAG, this compound has several potential limitations, including poor solubility, (thereby demanding special formulation), limited bioavailability, hepatotoxicity and extensive metabolism by polymorphic enzymes.<a onclick="showRef(event, 'ref26 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref26 ref27 ref28">(26-28)</a> Some of these issues have been addressed with the development of the water-soluble ansamycin 17-dimethylaminoethylgeldanamycin (17-DMAG Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>, <b>1c</b>)<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> and the prodrug of 17-AAG, IPI-504<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30, 31)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), which are reported to be in Phase-I/Ib and Phase-I/II clinical trials, respectively. However, these issues and the inherent chemical complexity of these ansamycin inhibitors have led to significant efforts to identify novel small-molecule inhibitors of Hsp90.<a onclick="showRef(event, 'ref22 ref32 ref33 ref34 ref35 ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref22 ref32 ref33 ref34 ref35 ref36 ref37">(22, 32-37)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/medium/jm-2007-01018h_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Natural product derived Hsp90 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701018h&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Research from several groups has focused on the purine scaffold and has generated potent inhibitors such as <b>3</b> and <b>4</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>), which are active in cellular and animal models of cancer.<a onclick="showRef(event, 'ref38 ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref38 ref39 ref40">(38-40)</a> We recently disclosed the identification of 4,5-diarylpyrazoles such as <b>5</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>) as a new class of Hsp90 inhibitors,<a onclick="showRef(event, 'ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref41 ref42">(41, 42)</a> and the structure-based elaboration of this hit resulted in the amide-substituted pyrazole <b>6</b>.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Compound <b>6</b> binds to the ATP binding site of Hsp90 with an IC<sub>50</sub> of 25 nM in a FP assay and has antiproliferative activity against HCT116 colon cancer cells, with a GI<sub>50</sub> of 260 nM. This activity compares favorably with the GI<sub>50</sub> value for 17-AAG of 160 nM in the same tumor cell line. Further medicinal chemistry efforts in this area have identified 4-substituted pyrazole amides such as <b>7</b><a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> and piperazines <b>8</b>.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> These are not as active in the FP assay as compound <b>6</b> and, consequently, exhibit reduced activity in tumor cell lines. Here, we report on further medicinal chemistry studies which identified diarylisoxazoles with a greater than 20-fold increase in their ability to inhibit cancer cell proliferation compared with that of previously reported diarylpyrazole compounds. Pharmacokinetic analyses performed by cassette dosing in tumor-bearing animals were used to select compounds showing the highest ratio between tumor levels and cellular GI<sub>50</sub>. The drug discovery potential of lead compounds was further evaluated by monitoring target modulation in vitro and assessing the ability to inhibit tumor growth in the HCT116 human colon carcinoma murine xenograft model.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/medium/jm-2007-01018h_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Purine class Hsp90 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701018h&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/medium/jm-2007-01018h_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Pyrazole class Hsp90 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701018h&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36218" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36218" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Our strategy to optimize the in vivo activity in our series was focused on the structure−activity relationships (SAR) in three distinct areas of the molecule and was guided by structural information of ligands (such as <b>6</b>) bound to the ATP binding site of Hsp90α.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> The binding mode anchor of this family of compounds is the resorcinol moiety, also present in radicicol.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> The resorcinol binds deep into the pocket, where the 4′-hydroxyl displaces one of the four water molecules that mediate substrate binding in the adenine binding region. Both phenolic hydroxyl groups and the N atoms of the pyrazole ring form a very tight network of hydrogen bonds with the carboxylate of the key residue Asp93 and surrounding polar groups or water molecules. The high complementarities and tight packing between Hsp90 and the inhibitor in this area leave room only for small modifications of the inhibitor’s core, but a wide range of substituents can be placed off of the pyrazole ring and the 5′ position of the resorcinol. Accordingly, and bearing in mind the experience gained in our previous work,<a onclick="showRef(event, 'ref43 ref44 ref45 ref47'); return false;" href="javascript:void(0);" class="ref ref43 ref44 ref45 ref47">(43-45, 47)</a> the areas that we focused on were (i) incorporation of a solubilizing group on the 4-arylpyrazole substituents, (ii) modification of the central pyrazole heterocycle, and (iii) the optimization of the 5′ substituent on the resorcinol ring. Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> shows compound <b>6</b> bound to the Hsp90 ATP binding site and illustrates the importance of the key interaction of the resorcinol with Asp93 and the hydrogen bond from the 5-amide substituent to Gly97.<a onclick="showRef(event, 'ref43 ref48'); return false;" href="javascript:void(0);" class="ref ref43 ref48">(43, 48)</a> Further inspection of this structure, and others of the same structural class, indicated that the meta and para positions of the aryl group appended to the 4 position of the pyrazole were pointing toward solvent and should therefore be suitable sites for the incorporation of a solubilizing group. Thus, we initiated the synthesis of pyrazole Hsp90 inhibitors (<b>19</b> and <b>20</b>), incorporating CH<sub>2</sub>-amine moieties as the solubilizing functionality. Several routes to these targets were utilized (Schemes <a class="ref internalNav" href="#sch1" aria-label="1">1</a> and <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). Key intermediates were the <i>p</i>- and <i>m</i>-formylphenyl compounds (<b>17</b> and <b>18</b>), serving as precursors to reductive amination reactions (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>), or the <i>p</i>-aminomethyl derivative <b>22</b>, as a versatile reagent for reductive amination, alkylation, conjugate addition and amide-forming reactions. The route used for the synthesis of <b>19e</b> and <b>20a</b>−<b>i</b> is shown in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Acetophenone <b>10</b> was made by regioselective Friedel−Crafts acylation of commercially available 4-chlororesorcinol <b>9</b>. Both phenolic hydroxyls were protected with benzyl groups, generating <b>11</b> prior to the subsequent reaction of an intermediate sodium enolate with diethyl oxalate, which afforded keto−enol ester <b>12</b>. Construction of the pyrazole heterocycle <b>13</b> was achieved by reaction of <b>12</b> with hydrazine hydrate in acetic acid or hydrazine hydrochloride in ethanol. Iodination at the 4-position of the pyrazole was achieved with <i>N</i>-iodosuccinimide, and it was found that the reaction yield was significantly improved with the addition of a catalytic amount of ceric ammonium nitrate. Conversion of the ethyl ester moiety of <b>14</b> to the ethylamide of <b>16</b> was achieved by ester saponification, activation of resulting acid <b>15</b>, and subsequent reaction with ethylamine. Compound <b>16</b> underwent a palladium-catalyzed Suzuki cross-coupling reaction with <i>p</i>- or <i>m</i>-formylphenylboronic acid to generate <b>17</b> and <b>18</b>, respectively. Reductive amination with various amines, followed by hydrogenation to remove the benzyl groups, furnished the desired amines <b>19e</b> and <b>20 a</b>−<b>i</b>.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/medium/jm-2007-01018h_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. X-ray structure of <b>6</b> bound to the ATP binding site of human Hsp90α. Red spheres represent structurally conserved water molecules.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701018h&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/medium/jm-2007-01018h_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0005.jpeg" id="gs1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Pyrazole Hsp90 Inhibitors <b>19e</b> and <b>20a</b>−<b>i</b></div><p class="last"><sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701018h&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) AcOH, BF<sub>3</sub>·OEt<sub>2</sub>, 58%; (b) BnBr, MeCN, K<sub>2</sub>CO<sub>3</sub>, 90%; (c) (CO<sub>2</sub>Et)<sub>2</sub>, NaOEt, EtOH, 94%; (d) H<sub>2</sub>NNH<sub>2</sub>, AcOH, 87%, or H<sub>2</sub>NNH<sub>2</sub>·HCl, EtOH, Δ, 81%; (e) NIS, CAN (1 mol %), MeCN, Δ, 98%; (f) 2 M NaOH, dioxane; 92%; (g) (COCl)<sub>2</sub>, DMF, DCM; (h) EtNH<sub>2</sub>·HCl, NEt<sub>3</sub>, 99%; (i) 4-formylphenylboronic acid, Pd(dppf)Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, THF, H<sub>2</sub>O, microwave, 68%; (j) 3-formylphenylboronic acid, Pd(dppf)Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, THF, H<sub>2</sub>O, microwave, 71%; (k) R1R2NH, NaCNBH<sub>3</sub>, AcOH, MeOH; (l) H<sub>2</sub>, Pd/C, AcOH.</p></p></figure><figure id="sch2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/medium/jm-2007-01018h_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0006.jpeg" id="gs2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Pyrazole Hsp90 Inhibitors <b>19a</b>−<b>d</b> and <b>19f</b>−<b>g</b></div><p class="last"><sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701018h&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 4-aminomethylphenyl boronic acid, H<sub>2</sub>O, THF, Pd(dppf)Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, Boc<sub>2</sub>O, Et<sub>3</sub>N, DMF, Δ, 26%; (b) (i) TFA; (ii) NaHCO<sub>3,</sub> 95%; (c) (i) vinylmethylsulfone or divinylsulfone; (ii) BCl<sub>3</sub>, DCM; (d) (i) acetaldehyde, NaBH(OAc)<sub>3</sub>, DCE then NaBH<sub>4</sub>, EtOH; (ii) cyclohexadiene, Pd/C, MeOH, 16%; (e) (i) HATU, DMF, DIPEA, 1-methylpiperidine-3-carboxylic acid or 2-carboxymethylpyrrolidine-1-carboxylic acid, rt; (ii) BCl<sub>3</sub>, DCM; (f) (i) 2-bromoethanol, EtOH, DIPEA; (ii) BCl<sub>3</sub>, DCM, 13%.</p></p></figure><div class="NLM_p">Compounds <b>19a</b>−<b>d</b> and <b>19f</b>,<b>g</b> were made using alternative procedures (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>) from the key intermediate aminomethyl derivative <b>22</b>. Compound <b>16</b> was cross-coupled with 4-aminomethylboronic acid and protected in situ as the <i>t</i>-butyloxycarbamate derivative to aid in product isolation. Trifluoroacetic-acid-mediated deprotection afforded the amine <b>22</b>, which was functionalized via four distinct synthetic methodologies. Diethylamine <b>19a</b> was prepared by reductive amination with acetaldehyde and subsequent debenzylation by transfer hydrogenolysis with cyclohexadiene and palladium on carbon. Sulfones <b>19c</b> and <b>19d</b> were prepared by vinylogous attack of the amine on methylvinylsulfone and divinylsulfone, respectively. Amides <b>19b</b> and <b>19f</b> were formed by a HATU<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a>-mediated coupling procedure, and <b>19g</b> utilized <i>bis</i> nucleophilic displacement on 2-bromoethanol. With the exception of <b>19a</b>, final products were obtained by boron trichloride-mediated deprotection of the dibenzyl resorcinol.</div><div class="NLM_p">The synthesis of the isoxazoles is analogous to that used for the pyrazole series (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). Keto−enol ester <b>12</b> was reacted with hydroxylamine hydrochloride to give the isoxazole <b>23</b>, and the subsequent conversion to final compounds utilized methods similar to those used for the corresponding pyrazoles, as outlined in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. The amide functionality however was introduced directly from the ester prior to halogenation. <i>N</i>-bromosuccinimide (NBS)/ceric ammonium nitrate (CAN) proved superior for bromination compared to an earlier method which used bromine in acetic acid. However, compared to pyrazole bromination, a relative increase in the amount of CAN was necessary to effect good yields in this case. Debenzylation of <b>28</b> and <b>29</b> was accomplished with boron trichloride in preference to hydrogenation. This change was due to concerns that hydrogenation may cleave the isoxazole ring and the observation of partial (ca. 5%) 5′-chlorine reduction in several reactions using catalytic hydrogenation. Some compounds of this class were made by a modified sequence, in which <b>25</b> was cross-coupled with boronate esters having the amino functionality already present. A modification of this route was also used for making the isoxazole analogue (<b>33</b>) of VER-49009 (<b>6</b>) using the intermediate <b>32</b> (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>).</div><figure id="sch3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/medium/jm-2007-01018h_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0007.jpeg" id="gs3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Isoxazole Hsp90 Inhibitors</div><p class="last"><sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701018h&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) H<sub>2</sub>NOH·HCl, EtOH, 86%; (b) EtNH<sub>2</sub>, MeOH, Δ, 89%; (c) NBS, CAN, MeCN, Δ, 4.5 h, 74%; (d) 4-formylphenylboronic acid, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, NaHCO<sub>3</sub>, DMF, H<sub>2</sub>O, 73%; (e) 3-formylphenylboronic acid, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, NaHCO<sub>3</sub>, DMF, H<sub>2</sub>O; (f) R1R2NH, NaCNBH<sub>3</sub>, AcOH, MeOH; (g) boronate ester, DME, NaHCO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>; (h) BCl<sub>3</sub>, DCM, 0 °C.</p></p></figure><figure id="sch4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/medium/jm-2007-01018h_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0008.jpeg" id="gs4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Preparation of <b>33</b> (the Isoxazole Analogue of Pyrazole <b>6</b>)</div><p class="last"><sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701018h&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 4-methoxyphenylboronic acid, NaHCO<sub>3</sub>, H<sub>2</sub>O, DMF, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, 63%; (b) BCl<sub>3</sub>, DCM, 0 °C, 65%.</p></p></figure><div class="NLM_p">The final area of interest for SAR studies described here was the 5′ position on the resorcinol ring. Substituents at C-5′ have the potential to induce a conformational change in the protein by forming a helix between residues 104 and 111.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> This structural change creates a lipophilic pocket in the ATP binding site of the Hsp90 protein, and we were keen to explore the influence of substituents at this position on the potency and physicochemical properties of the Hsp90 ligands. All of the 5′ analogues were made from key intermediates <b>34</b> by the method outlined in Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>. Differing synthetic methodologies were utilized for the synthesis of variably substituted 5′-resorcinol derivatives of <b>34</b>. For 5′-aryl and 5′-phenethyl substituents, the 5′-bromo intermediate <b>51</b> (Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>) was used as a substrate for Suzuki or Heck Pd-catalyzed coupling reactions. Styrene derivatives such as <b>34a</b> from Heck or Suzuki reactions of styrenes or vinylogous boronic acids were reduced prior to further manipulation. Compound <b>35c</b> (Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>) was subsequently used to make the 5′-phenyl derivative <b>45</b> (Scheme <a class="ref internalNav" href="#sch7" aria-label="7">7</a>), which was used for compound profiling comparisons. For the isobutyl-substituted intermediate <b>34e</b>, the route outlined in Scheme <a class="ref internalNav" href="#sch8" aria-label="8">8</a> was used. Starting from resorcinol, a Friedel−Crafts acylation afforded acetophenone derivative <b>53</b>, which was reduced<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> to the <i>sec</i>-butyl compound <b>54</b> prior to a second Friedel−Crafts acylation and benzyl protection. Construction of the key isoxazole <b>34e</b> proceeded as described above. An acetophenone derivative was also used in the route to the isopropyl-substituted intermediate <b>34f</b> (Scheme <a class="ref internalNav" href="#sch9" aria-label="9">9</a>). In this case however, a Wittig reaction was followed by hydrogenation to generate the 5′-isopropyl substituent (<b>47</b>–<b>59</b>, Scheme <a class="ref internalNav" href="#sch9" aria-label="9">9</a>). The reduction of the styrene functionality in <b>58</b> caused concomitant debenzylation. However, the resorcinol <b>59</b> acylated in better yield than the corresponding benzyl-protected substrate; therefore, reprotection was delayed until the subsequent step. The 5′-ethyl-substituted compounds (such as <b>34d</b>) were made from 4-ethylresorcinol by the same route as that used for the 5-chlororesorcinol outlined in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a> (see also Scheme <a class="ref internalNav" href="#sch10" aria-label="10">10</a>). For the introduction of a 5′-<i>tert</i>-butyl group, Friedel−Crafts alkylation methodology was applied (Scheme <a class="ref internalNav" href="#sch10" aria-label="10">10</a>), utilizing the <i>tert</i>-butyl cation generated from <i>tert</i>-butanol to afford acetophenone <b>65g</b>. Conversion to <b>34g</b> was accomplished in a similar fashion as that described previously for compound <b>24</b> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>).</div><figure id="sch5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/medium/jm-2007-01018h_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0009.jpeg" id="gs5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Conversion of Key Intermediate <b>34</b> to Isoxazole Hsp90 Inhibitors</div><p class="last"><sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701018h&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NBS or NIS, CAN, MeCN, Δ; (b) 4-formylphenylboronic acid, NaHCO<sub>3</sub>, H<sub>2</sub>O, DMF, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>; (c) R1R2NH, NaCNBH<sub>3</sub>, AcOH, MeOH; (d) BCl<sub>3</sub>, DCM, 0 °C.</p></p></figure><figure id="sch6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/medium/jm-2007-01018h_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0010.jpeg" id="gs6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Key Isoxazole Intermediates <b>34a</b>−<b>c</b> and <b>34 h</b>−<b>j</b></div><p class="last"><sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701018h&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) BnBr, K<sub>2</sub>CO<sub>3</sub>, MeCN, 97%; (b) NBS, DMF, rt, 97%; (c) (CO<sub>2</sub>Et)<sub>2</sub>, NaOEt, EtOH, 96%; (d) hydroxylamine hydrochloride, EtOH, Δ, 92%; (e) EtNH<sub>2</sub>, MeOH, Δ, 80%; (f) <i>trans</i>-2-phenylvinylboronic acid, DMF, H<sub>2</sub>O, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, NaHCO<sub>3</sub>, Δ, 71%; (g) PhB(OH)<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, H<sub>2</sub>O, THF, Pd(dppf)Cl<sub>2</sub>, Δ, 68%; (h) <i>trans</i>-2-(4-fluorophenyl)vinylboronic acid, DMF, H<sub>2</sub>O, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, NaHCO<sub>3</sub>, 69%; (i) 1,4-dioxane, Pd(C), H<sub>2</sub>; (j) (i) 3-fluorostyrene, Pd(<i>o</i>-Tol<sub>3</sub>P)<sub>2</sub>Cl<sub>2</sub>, <i>n</i>-BuOH; <i>i</i>-Pr<sub>2</sub>NH, (ii) TsNH<sub>2</sub>NH<sub>2</sub>, NaOAc, 1,2-DME, Δ, 92%.</p></p></figure><figure id="sch7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/medium/jm-2007-01018h_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0011.jpeg" id="gs7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of Isoxazole <b>45</b></div><p class="last"><sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701018h&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 4-fluorophenylboronic acid, NaHCO<sub>3</sub>, H<sub>2</sub>O, DMF, Pd(dppf)Cl<sub>2</sub>, 76%; (b) BCl<sub>3</sub>, DCM, 0 °C, 65%.</p></p></figure><figure id="sch8" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/medium/jm-2007-01018h_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0012.jpeg" id="gs8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Synthesis of Isoxazole Intermediate <b>34e</b></div><p class="last"><sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701018h&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) isobutyric acid, BF<sub>3</sub>·OEt<sub>2</sub> quant; (b) (i) ethylchloroformate, NEt<sub>3</sub>, THF; (ii) NaBH<sub>4</sub>, THF/H<sub>2</sub>O; (iii) 10% aq NaOH, 98%; (c) (i) AcOH, BF<sub>3</sub>·OEt<sub>2</sub>; (ii) BnBr, K<sub>2</sub>CO<sub>3</sub>, MeCN, 25%; (d) (CO<sub>2</sub>Et)<sub>2</sub>, NaOEt, EtOH, Δ, 58%; (e) hydroxylamine hydrochloride, EtOH, Δ, 74%; (f) EtNH<sub>2</sub>, MeOH, Δ, quant.</p></p></figure><figure id="sch9" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/medium/jm-2007-01018h_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0013.jpeg" id="gs9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. Synthesis of Isoxazole Intermediate <b>34f</b></div><p class="last"><sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701018h&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Ph<sub>3</sub>PMeBr, <i>n</i>-BuLi, THF, 80%; (b) H<sub>2</sub>, Pd/C, EtOH, 70%; (c) AcOH, BF<sub>3</sub>·OEt<sub>2</sub>, 88%; (d) BnBr, K<sub>2</sub>CO<sub>3</sub>, DMF, 88%; (e) (CO<sub>2</sub>Et)<sub>2</sub>, NaOEt, NaH, toluene, Δ, 86%; (f) hydroxylamine hydrochloride, EtOH, Δ, 91%; (g) EtNH<sub>2</sub>, MeOH, Δ, 85%.</p></p></figure><figure id="sch10" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/medium/jm-2007-01018h_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0014.jpeg" id="gs10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 10. Synthesis of Key Isoxazole Intermediates <b>34d</b> and <b>34g</b></div><p class="last"><sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701018h&amp;id=sch10"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) H<sub>2</sub>SO<sub>4</sub>, 2-methylpropan-2-ol, TFA, 75 °C, 92%; (b) AcOH, BF<sub>3</sub>·OEt<sub>2</sub>, 90 °C; (c) BnBr, K<sub>2</sub>CO<sub>3</sub>; (d) (CO<sub>2</sub>Et)<sub>2</sub>; NaOEt, EtOH; (e) H<sub>2</sub>NOH·HCl, EtOH, Δ; (f) EtNH<sub>2</sub>, MeOH, Δ.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01265" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01265" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Using the routes outlined in Schemes <a class="ref internalNav" href="#sch1" aria-label="1">1</a> and <a class="ref internalNav" href="#sch2" aria-label="2">2</a>, we synthesized a number of pyrazoles incorporating solubilizing groups on the 4-aryl group (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). For substituents in the para position of the 4-aryl group, in some cases, both enzyme potency and cellular GI<sub>50</sub> values (<b>19e</b> and <b>19f</b>) were similar to those of VER-49009 (<b>6</b>). However, in most instances, these diverse analogues were less potent than <b>6</b>. For compounds with aminomethyl groups at the meta position (<b>20a</b>−<b>i</b>), none of the examples matched the binding affinity of compound <b>6</b> in the FP assay or in the cell growth inhibition assay with HCT116 cells. Thus, although the crystal structure of <b>6</b> suggested that there was space to introduce solubilizing groups off of the 4-aryl substituent, it appeared that the regiochemistry and nature of the solubilizing group had an effect on how well this substitution was tolerated in these pyrazole analogues.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Binding (FP Assay) and Cell Growth Inhibition (SRB Assay) Data for Previously Reported Hsp90 Inhibitors<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead valign="bottom"><tr valign="top"><th align="center" valign="bottom">compound</th><th align="center" valign="bottom" char=".">FP IC<sub>50</sub><a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a>(µM)</th><th align="center" valign="bottom" char=".">GI<sub>50</sub><a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a>HCT116 (µM)</th></tr></thead><tbody><tr valign="top"><td align="left"><b>17</b>−AAG <b>(1b)</b></td><td align="char" char=".">1.27</td><td align="char" char=".">0.16</td></tr><tr valign="top"><td align="left" valign="top"><b>5</b></td><td align="char" valign="top" char=".">0.28</td><td align="char" valign="top" char=".">5.8</td></tr><tr valign="top"><td align="left" valign="top"><b>6</b></td><td align="char" valign="top" char=".">0.025</td><td align="char" valign="top" char=".">0.26</td></tr><tr valign="top"><td align="left" valign="top"><b>7</b></td><td align="char" valign="top" char=".">0.258</td><td align="char" valign="top" char=".">11.6</td></tr><tr valign="top"><td align="left" valign="top"><b>8</b></td><td align="char" valign="top" char=".">0.600</td><td align="char" valign="top" char=".">6.5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">Values are reported as the mean of at least two independent determinations.</p></div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Binding (FP Assay) and Cell Growth Inhibition (SRB Assay) Data for Aminomethyl-Functionalized Diarylpyrazoles<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table single-image frame_topbot"><colgroup><col /></col></colgroup><tbody><tr valign="top"><td><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/medium/jm-2007-01018h_0015.gif" alt="" id="gr15" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">Values are reported as the mean of at least two independent determinations. </p></div></div></div><div class="NLM_p">Examination of the binding for the pyrazole ring in ligands such as <b>6</b> demonstrated that the polar interactions deep inside of the binding site are very well matched between the protein and ligand. With this in mind, it was clear to us that very little steric change would be tolerated in this region. The nitrogen adjacent to the resorcinol (N1) is involved in hydrogen bonding with the key Asp93/water network at the base of the pocket as an H-bond acceptor. We felt that an alternative hydrogen-bond acceptor such as oxygen might be advantageous. Pyrazoles can exist in tautomeric forms, and when N1 is protonated, this represents a form which is unlikely to bind well to Hsp90. Further, the interaction between N2 and the amide backbone carbonyl of Gly97 is not in the ideal geometry. Therefore, fixing the position designated N1 as a 100% H-bond acceptor was considered to be a preferred feature, with the N2 position being less critical. We desired to achieve such a subtle change while keeping the other carbon positions already substituted with key functionality in a defined orientation for binding. Isoxazoles and pyrazoles differ in that the former does not bear hydrogen on a heteroatom and can therefore not be substituted. As a consequence, the isoxazole is also smaller in size and should still be accommodated in the binding site. In addition, there is no possibility of the existence of isomeric forms that can exist with the pyrazole. Evaluation of the binding of the isoxazole analogue <b>33</b> (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>) of the pyrazole <b>6</b> to Hsp90 protein gave an IC<sub>50</sub> value of 28 nM, similar to that of compound <b>6</b> (25 nM). This shows that the change is tolerated, with the matched pyrazole/isoxazole <b>6</b>/<b>33</b> exhibiting equipotent binding in the FP assay. However, the advantage of the isoxazole over the pyrazole scaffold became apparent when we looked at the activity of <b>6</b> versus <b>33</b> in cell growth inhibition assays across a range of human cancer cell lines (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). These data demonstrated a trend for higher potency (with respect to cell growth inhibition) for the isoxazole <b>33.</b> The interactions of pyrazole <b>6</b> and isoxazole <b>33</b> with Hsp90 were studied previously by isothermal calorimetry,<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> which showed that the isoxazole−Hsp90 complex is marginally more stable than the corresponding pyrazole complex and that the difference is predominantly due to the enthalpy difference. Kinetic analysis by surface plasmon resonance (SPR) has shown that, although these compounds have similar <i>K</i><sub>on</sub> values (6.4 × 10<sup>5</sup> and 8.2 × 10<sup>5</sup> M<sup>−1</sup> s<sup>−1</sup>) for <b>33</b> and <b>6</b>, respectively, the <i>K</i><sub>off</sub> for isoxazole <b>33</b> of 4.05 × 10<sup>−4</sup> s<sup>−1</sup> is 10-fold slower than that of 5.64 × 10<sup>−3</sup> s<sup>−1</sup> for pyrazole <b>6</b>. These combined data can help account for the increased cellular potency of the isoxazole and also help rationalize the measured four-fold higher concentrations of <b>33</b> compared to <b>6</b> recently shown in HCT116 cells. This was also sufficient for the isoxazole <b>33</b> to demonstrate the first signs of in vivo efficacy in a xenograft tumor model, as reported previously.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Binding (FP Assay) and Cell Growth Inhibition (SRB Assay) Data in Various Human Cancer Cell Lines for Compounds <b>6</b> and <b>33</b><a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead valign="bottom"><tr valign="bottom"><th align="center" valign="bottom" char=".">compound number</th><th align="center" valign="bottom" char=".">human Hsp90β FP IC<sub>50</sub> (µM)</th><th align="center" valign="bottom" char=".">HCT116 (colon) GI<sub>50</sub> (µM)</th><th align="center" valign="bottom" char=".">DU145 (prostate) GI<sub>50</sub> (µM)</th><th align="center" valign="bottom" char=".">PC3M (prostate) GI<sub>50</sub> (µM)</th><th align="center" valign="bottom" char=".">SKMel28(melanoma) GI<sub>50</sub> (µM)</th><th align="center" valign="bottom" char=".">SF268 (glioma) GI<sub>50</sub> (µM)</th><th align="center" valign="bottom" char=".">U87MG (glioma) GI<sub>50</sub> (µM)</th></tr></thead><tbody><tr valign="top"><td align="char" valign="top" char="."><b>6</b></td><td align="char" valign="top" char=".">0.025</td><td align="char" valign="top" char=".">0.36</td><td align="char" valign="top" char=".">1.2</td><td align="char" valign="top" char=".">2.2</td><td align="char" valign="top" char=".">0.48</td><td align="char" valign="top" char=".">0.32</td><td align="char" valign="top" char=".">1.2</td></tr><tr valign="top"><td align="char" valign="top" char="."><b>33</b></td><td align="char" valign="top" char=".">0.028</td><td align="char" valign="top" char=".">0.12</td><td align="char" valign="top" char=".">0.23</td><td align="char" valign="top" char=".">0.22</td><td align="char" valign="top" char=".">0.045</td><td align="char" valign="top" char=".">0.034</td><td align="char" valign="top" char=".">0.028</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>a</sup><p class="last">Values are reported as the mean of at least two independent determinations.</p></div></div></div><div class="NLM_p">The pyrazole to isoxazole scaffold change was next combined with solubilizing group incorporation on the 4-aryl ring. Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. shows data for a series of diarylisoxazoles, substituted with a range of amine-bearing substituents predominantly on the para position of the 4-aryl ring. It was clear that the pyrazole to isoxazole switch was very well tolerated in this series of compounds and that the preference for substitution at the para position of the 4-aryl ring compared to the meta position seen with analogous pyrazole series was maintained. All of the para-substituted examples had sub-70 nM IC<sub>50</sub> values in the binding assay and were at least equipotent with analogous pyrazoles (<b>30a</b> vs <b>19d</b>, <b>30b</b> vs <b>19c</b>, and <b>30f</b> vs <b>19a</b>). The meta-substituted compounds <b>31a</b>, <b>31b</b>, and <b>31c</b> were less potent, as was also observed in the pyrazole series, but when comparing analogous pyrazole analogues (<b>31a</b> vs <b>20a</b> and <b>31c</b> vs <b>20f</b>), the isoxazoles were more potent. Most importantly, the significant improved inhibition of cell proliferation seen with isoxazole <b>33</b> compared to that of pyrazole <b>6</b> was retained in this subseries (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Thus <b>30d</b>, <b>30f</b>, <b>30g</b>, and <b>30k</b> have sub-100 nM GI<sub>50</sub> values against HCT116 cells.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Binding (FP Assay) and Cell Growth Inhibition (SRB Assay) Data for Aminomethyl-Functionalized Diarylisoxazoles<a class="ref internalNav" href="#tbl4-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table single-image frame_topbot"><colgroup><col /></col></colgroup><tbody><tr valign="top"><td><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/medium/jm-2007-01018h_0016.gif" alt="" id="gr17" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl4-fn1"><div class="footnote" id="tbl4-fn1"><sup>a</sup><p class="last">Values are reported as the mean of at least two independent determinations.</p></div></div></div><div class="NLM_p">We next turned our attention to the 5′ position of the resorcinol. We had previously shown<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> that the removal of ethyl or chloro from this position resulted in a 20-fold decrease in binding affinity for ligands closely related to <b>6</b>. This loss in potency is rationalized by structural information showing that the ethyl and chloro groups are interacting at the edge of a lipophilic pocket created by Phe138, Met98, Val150, Leu103, Leu107, Trp162, and Tyr139. This region of the protein is also flexible and able to accommodate larger groups by a conformational movement of the loop defined by Ile104 to Ala111.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> The data presented in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>. clearly demonstrate that a large steric variance is tolerated at the 5′ position. Groups such as phenethyl (<b>40i</b>, <b>40j</b>, and <b>41i</b>) and phenyl (<b>40c</b>, <b>41c</b>, and <b>41m)</b> retain binding affinity similar to those of the chloro analogues, such as <b>30d</b>, or small alkyl-substituted analogues, such as <b>42d</b> and <b>42f</b>. Additionally, these analogues demonstrated excellent potency in cell growth inhibition assays, as demonstrated by a number of the compounds in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>, in particular, the 5′-isopropyl analogues <b>40f</b> and <b>42f</b>.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Effects of Modifications to the 5′ Position of the Resorcinol on Binding (FP Assay) and Cell Growth Inhibition (SRB Assay)<a class="ref internalNav" href="#tbl5-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/medium/jm-2007-01018h_0017.gif" alt="" id="gr19" /></img><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead valign="bottom"><tr valign="bottom"><th align="center" valign="bottom">compound number</th><th align="center" valign="bottom">X</th><th align="center" valign="bottom">amine moiety</th><th align="center" valign="bottom" char=".">FP IC50<a class="ref internalNav" href="#tbl5-fn1" aria-label="a">a</a> (µM)</th><th align="center" valign="bottom" char=".">GI<sub>50</sub><a class="ref internalNav" href="#tbl5-fn1" aria-label="a">a</a> (HCT116) (µM)</th></tr></thead><tbody><tr valign="top"><td align="left" valign="top"><b>40b</b></td><td align="left" valign="top">−CH<sub>2</sub>CH<sub>2</sub>Ph</td><td align="left" valign="top">morpholino</td><td align="char" valign="top" char=".">0.032</td><td align="char" valign="top" char=".">0.029</td></tr><tr valign="top"><td align="left" valign="top"><b>40d</b></td><td align="left" valign="top">Et</td><td align="left" valign="top">morpholino</td><td align="char" valign="top" char=".">0.029</td><td align="char" valign="top" char=".">0.025</td></tr><tr valign="top"><td align="left" valign="top"><b>42d</b></td><td align="left" valign="top">Et</td><td align="left" valign="top">NEt<sub>2</sub></td><td align="char" valign="top" char=".">0.013</td><td align="char" valign="top" char=".">0.041</td></tr><tr valign="top"><td align="left" valign="top"><b>40i</b></td><td align="left" valign="top">−CH<sub>2</sub>CH<sub>2</sub>(4-FPh)</td><td align="left" valign="top">morpholino</td><td align="char" valign="top" char=".">0.020</td><td align="char" valign="top" char=".">0.039</td></tr><tr valign="top"><td align="left" valign="top"><b>41i</b></td><td align="left" valign="top">−CH<sub>2</sub>CH<sub>2</sub>(4-FPh)</td><td align="left" valign="top">piperidinyl</td><td align="char" valign="top" char=".">0.026</td><td align="char" valign="top" char=".">0.029</td></tr><tr valign="top"><td align="left" valign="top"><b>40j</b></td><td align="left" valign="top">−CH<sub>2</sub>CH<sub>2</sub>(3-FPh)</td><td align="left" valign="top">morpholino</td><td align="char" valign="top" char=".">0.026</td><td align="char" valign="top" char=".">0.058</td></tr><tr valign="top"><td align="left" valign="top"><b>40c</b></td><td align="left" valign="top">Ph</td><td align="left" valign="top">morpholino</td><td align="char" valign="top" char=".">0.022</td><td align="char" valign="top" char=".">0.152</td></tr><tr valign="top"><td align="left" valign="top"><b>41c</b></td><td align="left" valign="top">Ph</td><td align="left" valign="top">piperidinyl</td><td align="char" valign="top" char=".">0.014</td><td align="char" valign="top" char=".">0.086</td></tr><tr valign="top"><td align="left" valign="top"><b>40l</b></td><td align="left" valign="top">2-FPh</td><td align="left" valign="top">morpholino</td><td align="char" valign="top" char=".">0.039</td><td align="char" valign="top" char=".">0.087</td></tr><tr valign="top"><td align="left" valign="top"><b>41m</b></td><td align="left" valign="top">2-MePh</td><td align="left" valign="top">piperidinyl</td><td align="char" valign="top" char=".">0.014</td><td align="char" valign="top" char=".">0.114</td></tr><tr valign="top"><td align="left" valign="top"><b>41k</b></td><td align="left" valign="top">4-FPh</td><td align="left" valign="top">piperidinyl</td><td align="char" valign="top" char=".">0.036</td><td align="char" valign="top" char=".">0.035</td></tr><tr valign="top"><td align="left" valign="top"><b>40e</b></td><td align="left" valign="top">isobutyl</td><td align="left" valign="top">morpholino</td><td align="char" valign="top" char=".">0.035</td><td align="char" valign="top" char=".">0.133</td></tr><tr valign="top"><td align="left" valign="top"><b>40g</b></td><td align="left" valign="top"><i>tert</i>-butyl</td><td align="left" valign="top">morpholino</td><td align="char" valign="top" char=".">0.008</td><td align="char" valign="top" char=".">0.070</td></tr><tr valign="top"><td align="left" valign="top"><b>41g</b></td><td align="left" valign="top"><i>tert-</i>butyl</td><td align="left" valign="top">piperidinyl</td><td align="char" valign="top" char=".">0.011</td><td align="char" valign="top" char=".">0.065</td></tr><tr valign="top"><td align="left" valign="top"><b>40f</b></td><td align="left" valign="top">isopropyl</td><td align="left" valign="top">morpholino</td><td align="char" valign="top" char=".">0.021</td><td align="char" valign="top" char=".">0.016</td></tr><tr valign="top"><td align="left" valign="top"><b>42f</b></td><td align="left" valign="top">isopropyl</td><td align="left" valign="top">NEt<sub>2</sub></td><td align="char" valign="top" char=".">0.006</td><td align="char" valign="top" char=".">0.006</td></tr><tr valign="top"><td align="left" valign="top"><b>41f</b></td><td align="left" valign="top">isopropyl</td><td align="left" valign="top">piperidinyl</td><td align="char" valign="top" char=".">0.006</td><td align="char" valign="top" char=".">0.040</td></tr><tr valign="top"><td align="left" valign="top"><b>43c</b></td><td align="left" valign="top">Ph</td><td align="left" valign="top">ethyl</td><td align="char" valign="top" char=".">0.074</td><td align="char" valign="top" char=".">0.091</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl5-fn1"><div class="footnote" id="tbl5-fn1"><sup>a</sup><p class="last">Values are reported as the mean of at least two independent determinations.</p></div></div></div><div class="NLM_p">To evaluate the importance of the resorcinol OH moieties in the binding of this class of inhibitor, several O-methylated analogues of the 5′-ethyl compound <b>40d</b> were synthesized. As demonstrated in Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>, O-methylation at C-2′ caused a large drop in binding affinity. O-Methylation at C-4′ was tolerated, but compound <b>70</b> had reduced potency and cellular activity and thus demonstrated no advantage over the free resorcinol.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Effect of Oxygen-methylation on Binding (FP Assay) and Cell Growth Inhibition (SRB Assay)<a class="ref internalNav" href="#tbl6-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/medium/jm-2007-01018h_0018.gif" alt="" id="gr20" /></img><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead valign="bottom"><tr valign="top"><th align="center" valign="bottom">compoundnumber</th><th align="center" valign="bottom">R1</th><th align="center" valign="bottom">R2</th><th align="center" valign="bottom" char=".">FPIC<sub>50</sub> (µM)</th><th align="center" valign="bottom" char=".">GI<sub>50</sub>(HCT116) (µM)</th></tr></thead><tbody><tr valign="top"><td align="left" valign="top"><b>40d</b></td><td align="left" valign="top">H</td><td align="left" valign="top">H</td><td align="char" valign="top" char=".">0.029</td><td align="char" valign="top" char=".">0.025</td></tr><tr valign="top"><td align="left" valign="top"><b>70</b></td><td align="left" valign="top">Me</td><td align="left" valign="top">H</td><td align="char" valign="top" char=".">0.015</td><td align="char" valign="top" char=".">0.080</td></tr><tr valign="top"><td align="left" valign="top"><b>71</b></td><td align="left" valign="top">H</td><td align="left" valign="top">Me</td><td align="char" valign="top" char=".">0.540</td><td align="char" valign="top" char=".">2.15</td></tr><tr valign="top"><td align="left" valign="top"><b>72</b></td><td align="left" valign="top">Me</td><td align="left" valign="top">Me</td><td align="char" valign="top" char=".">1.56</td><td align="char" valign="top" char=".">32.0</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl6-fn1"><div class="footnote" id="tbl6-fn1"><sup>a</sup><p class="last">Values are reported as the mean of at least two independent determinations.</p></div></div></div><div class="NLM_p">At all stages in the optimization process, X-ray crystal structures were obtained with ligands bound to the N-terminal domain of Hsp90α to confirm that the changes made in the elaboration of <b>6</b> had not altered the binding mode of the ligands. Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>shows an overlay of the X-ray structures of <b>6</b> and the isoxazole <b>40f</b>.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> The structural data for <b>40f</b> demonstrate an equivalent binding mode as we previously reported<a onclick="showRef(event, 'ref41 ref43 ref47'); return false;" href="javascript:void(0);" class="ref ref41 ref43 ref47">(41, 43, 47)</a> for <b>5</b>, <b>6</b>, and <b>33</b>, with the same network of hydrogen-bonding interactions involving the resorcinol moiety and the heterocyclic ring with Asp93, Thr184, and a cluster of structurally conserved and highly ordered water molecules. The isoxazole 3-amide group in compound <b>40f</b> makes the same hydrogen-bond interactions with the protein backbone via Gly97 as that seen with <b>6</b> and <b>33</b>, as well as a further interaction with Lys58, but as previously reported, the latter reaction does not significantly contribute to the binding free energy.<a onclick="showRef(event, 'ref43 ref48'); return false;" href="javascript:void(0);" class="ref ref43 ref48">(43, 48)</a> Replacement of the chlorine of the resorcinol ring in <b>6</b> or <b>30d</b><a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> by an isopropyl group in <b>40f</b> results in an additional hydrophobic interaction with Leu107 in the flexible lipophilic pocket, and additional hydrophobic interactions are also seen with Thr109 and Gly135 from the morpholine moiety present in <b>40f</b>.</div><figure id="fig5" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/medium/jm-2007-01018h_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0019.jpeg" id="gr21" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Overlay of X-ray structure of <b>6</b> and <b>40f</b> bound to the ATP binding site of human Hsp90α. Red spheres represent structurally conserved water molecules.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701018h&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">It was important to establish that the new ligands retained the well-established molecular signature of known Hsp90 inhibitors with respect to the effect of the ligands on cellular markers. Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>shows that the pyrazoles <b>6</b> and <b>19e</b> and the isoxazoles <b>33</b>, <b>30d</b>, and <b>40f</b> gave the expected depletion of the client proteins Raf-1 and Her2 and induction of Hsp72 in HCT116 cells in vitro, as determined by western blots at 1 and 2 × GI<sub>50</sub> concentrations. These results support the premise that the effects on cell growth were a consequence of Hsp90 chaperone inhibition.</div><figure id="fig6" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/medium/jm-2007-01018h_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0020.jpeg" id="gr22" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effects of 17-AAG, pyrazoles <b>6</b> and <b>19e</b>, and isoxazoles <b>30d</b>, <b>33</b>, and <b>40f</b> on expression of Raf-1, Hsp72, and Her2 in HCT116 cells as determined by western blot. Compounds were dosed for 24 h at concentrations of 1 and 2 times the GI<sub>50</sub> value. GAPDH was used as a loading control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701018h&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We had previously shown<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> that the resorcinol moiety was glucuronidated but that in vitro microsomal metabolism rates were not predictive of the plasma clearance of this chemical series. Preferred compounds from the foregoing research were therefore further characterized in vivo using cassette dosing to mice bearing subcutaneous HCT116 human colon cancer xenografts, followed by quantitative LC/MS/MS analysis in various tissues.<a onclick="showRef(event, 'ref54 ref55'); return false;" href="javascript:void(0);" class="ref ref54 ref55">(54, 55)</a> The method was first validated by comparing results for a set of five compounds dosed singly and in mixture by measuring tumor concentrations 6 h post administration. Concentrations in tumors were similar in both experiments (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>), with the same rank order, suggesting that compound−compound interactions were not significant. In subsequent studies, selected compounds were administered i.p. in cassettes of five compounds to tumor-bearing mice at a dose of 4 mg/kg each. Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>. shows a summary of three cassettes dosed with some of the most potent diarylisoxazole amides. Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a> shows some additional pharmacodynamic (PK) parameters for cassette dosing experiment 3. The pharmacokinetic standard used, <b>33</b>, gave consistent results for tumor levels but exhibited variable plasma concentrations (up to 60% between cassettes 1 and 3). Overall, tumor-to-plasma ratios were found to vary from 0.3 to 20. Compounds with aliphatic substituents such as ethyl (<b>40d</b>) and isopropyl (<b>40f</b>) in the 5′ position of the resorcinol had higher tumor exposure than compounds with aromatic substituents (such as <b>40b</b>, <b>41i</b>, and <b>41m)</b>. The 5′-phenyl derivative <b>43c</b> had a comparatively high tumor concentration but still higher plasma levels. The 5′-chloro compounds also achieved high tumor concentrations (<b>30f</b>, <b>30g</b> and <b>30c</b>). The isopropyl analogue <b>40f</b> clearly showed the highest ratio of tumor concentration to cellular GI<sub>50</sub> (up to 35-fold), with a half-life of 9.5 h in the tumor, and this compound was therefore taken forward for further study.</div><figure id="fig7" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/medium/jm-2007-01018h_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0021.jpeg" id="gr23" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Cassette dosing method validation, showing the compound tumor concentration 6 h post administration in mice bearing HCT116 subcutaneous human colon tumor xenografts dosed at 4 mg per kg i.p. Compounds were dosed as single agents or were cassette dosed with mixtures of five compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701018h&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Pharmacokinetic Data Obtained by Cassette Dosing with Isoxazole Compounds<a class="ref internalNav" href="#tbl7-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead valign="bottom"><tr valign="bottom"><th align="center" valign="bottom">cassette</th><th align="center" valign="bottom">compound</th><th align="center" valign="bottom" char=".">AUClast tumor (hr*nmol/L)</th><th align="center" valign="bottom" char=".">AUClast plasma (hr*nmol/L)</th><th align="center" valign="bottom" char=".">tumor/plasma ratio</th><th align="center" valign="bottom" char=".">max fold above GI<sub>50</sub></th></tr></thead><tbody><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top"><b>33</b></td><td align="char" valign="top" char=".">1332.8</td><td align="char" valign="top" char=".">1222.8</td><td align="char" valign="top" char=".">1.1</td><td align="char" valign="top" char=".">6.5</td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top"><b>30c</b></td><td align="char" valign="top" char=".">2522.9</td><td align="char" valign="top" char=".">1542.3</td><td align="char" valign="top" char=".">1.6</td><td align="char" valign="top" char=".">4.7</td></tr><tr valign="top"><td align="left" valign="top">cassette 1</td><td align="left" valign="top"><b>45</b></td><td align="char" valign="top" char=".">597.5</td><td align="char" valign="top" char=".">1191.8</td><td align="char" valign="top" char=".">0.5</td><td align="char" valign="top" char=".">1.5</td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top"><b>30f</b></td><td align="char" valign="top" char=".">2930.4</td><td align="char" valign="top" char=".">925.8</td><td align="char" valign="top" char=".">3.2</td><td align="char" valign="top" char=".">12.0</td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top"><b>30g</b></td><td align="char" valign="top" char=".">2403.5</td><td align="char" valign="top" char=".">989.0</td><td align="char" valign="top" char=".">2.4</td><td align="char" valign="top" char=".">20.0</td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top"><b>33</b></td><td align="char" valign="top" char=".">1437.6</td><td align="char" valign="top" char=".">814.9</td><td align="char" valign="top" char=".">1.8</td><td align="char" valign="top" char=".">6.0</td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top"><b>40b</b></td><td align="char" valign="top" char=".">655.9</td><td align="char" valign="top" char=".">2547.2</td><td align="char" valign="top" char=".">0.3</td><td align="char" valign="top" char=".">4.2</td></tr><tr valign="top"><td align="left" valign="top">cassette 2</td><td align="left" valign="top"><b>40d</b></td><td align="char" valign="top" char=".">1750.9</td><td align="char" valign="top" char=".">618.8</td><td align="char" valign="top" char=".">2.8</td><td align="char" valign="top" char=".">24.0</td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top"><b>41i</b></td><td align="char" valign="top" char=".">668.2</td><td align="char" valign="top" char=".">1327.4</td><td align="char" valign="top" char=".">0.5</td><td align="char" valign="top" char=".">5.6</td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top"><b>41m</b></td><td align="char" valign="top" char=".">685.5</td><td align="char" valign="top" char=".">1630.4</td><td align="char" valign="top" char=".">0.4</td><td align="char" valign="top" char=".">1.9</td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top"><b>33</b></td><td align="char" valign="top" char=".">1733.0</td><td align="char" valign="top" char=".">659.5</td><td align="char" valign="top" char=".">2.6</td><td align="char" valign="top" char=".">7.0</td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top"><b>43c</b></td><td align="char" valign="top" char=".">1248.0</td><td align="char" valign="top" char=".">3708.1</td><td align="char" valign="top" char=".">0.3</td><td align="char" valign="top" char=".">2.8</td></tr><tr valign="top"><td align="left" valign="top">cassette 3</td><td align="left" valign="top"><b>40f</b></td><td align="char" valign="top" char=".">1720.0</td><td align="char" valign="top" char=".">754.2</td><td align="char" valign="top" char=".">2.3</td><td align="char" valign="top" char=".">35.0</td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top"><b>40g</b></td><td align="char" valign="top" char=".">751.1</td><td align="char" valign="top" char=".">792.2</td><td align="char" valign="top" char=".">0.9</td><td align="char" valign="top" char=".">2.9</td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top"><b>41c</b></td><td align="char" valign="top" char=".">994.8</td><td align="char" valign="top" char=".">966.7</td><td align="char" valign="top" char=".">1.0</td><td align="char" valign="top" char=".">2.8</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl7-fn1"><div class="footnote" id="tbl7-fn1"><sup>a</sup><p class="last">A graphical representation of cassette dosing PK results for cassette 3 is provided in the <a class="ref internalNav" href="#si1" aria-label="Supporting Information">Supporting Information</a> section.</p></div></div></div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Details of Pharmacokinetic Parameters for Cassette Dosing Experiment 3</div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead valign="bottom"><tr valign="bottom"><th align="center" valign="bottom">compound</th><th align="center" valign="bottom" char="."><i>T</i><sub>max</sub> (hr)</th><th align="center" valign="bottom" char="."><i>C</i><sub>max</sub> (nmol/L)</th><th align="center" valign="bottom" char=".">AUClast (hr*nmol/L)</th><th align="center" valign="bottom" char=".">HL_Lambda_z (hr)</th><th align="center" valign="bottom" char=".">Vz_F_obs (L)</th><th align="center" valign="bottom" char=".">CL_F_obs (L/hr)</th></tr></thead><tbody><tr valign="top"><td align="left" valign="top"><b>33</b></td><td align="char" valign="top" char=".">1</td><td align="char" valign="top" char=".">482.1</td><td align="char" valign="top" char=".">1733.0</td><td align="char" valign="top" char=".">3.9</td><td align="char" valign="top" char=".">0.432</td><td align="char" valign="top" char=".">0.076</td></tr><tr valign="top"><td align="left" valign="top"><b>43c</b></td><td align="char" valign="top" char=".">4</td><td align="char" valign="top" char=".">252.5</td><td align="char" valign="top" char=".">1248.0</td><td align="char" valign="top" char=".">14.6</td><td align="char" valign="top" char=".">0.736</td><td align="char" valign="top" char=".">0.035</td></tr><tr valign="top"><td align="left" valign="top"><b>40f</b></td><td align="char" valign="top" char=".">1</td><td align="char" valign="top" char=".">385.4</td><td align="char" valign="top" char=".">1720.0</td><td align="char" valign="top" char=".">9.5</td><td align="char" valign="top" char=".">0.478</td><td align="char" valign="top" char=".">0.035</td></tr><tr valign="top"><td align="left" valign="top"><b>40g</b></td><td align="char" valign="top" char=".">1</td><td align="char" valign="top" char=".">202.9</td><td align="char" valign="top" char=".">751.1</td><td align="char" valign="top" char=".">5.0</td><td align="char" valign="top" char=".">0.809</td><td align="char" valign="top" char=".">0.111</td></tr><tr valign="top"><td align="left" valign="top"><b>41c</b></td><td align="char" valign="top" char=".">1</td><td align="char" valign="top" char=".">237.4</td><td align="char" valign="top" char=".">994.8</td><td align="char" valign="top" char=".">7.3</td><td align="char" valign="top" char=".">0.652</td><td align="char" valign="top" char=".">0.062</td></tr></tbody></table></div></div><div class="NLM_p">Isoxazole <b>40f</b> showed potent antiproliferative effects in a range of human cancer cell lines (Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a>), and the expected depletion of client proteins and induction of Hsp72 were observed in all of the cell lines examined (data not shown). Compound <b>40f</b> was administered at 50 mg/kg daily i.p. to athymic mice bearing HCT116 human colon carcinoma xenografts. The rate of tumor growth was significantly inhibited by <b>40f</b> administration (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>A), and treated tumor weights measured at day 12 were 49.8% of the control values (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>B). This dose schedule was well-tolerated, with no body weight losses (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>C), and the pharmacodynamic (PD) marker changes at the end of the study were consistent with Hsp90 inhibition (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>D).</div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. Binding (FP Assay) and Cell Growth Inhibition (SRB Assay) in Various Human Cancer Cell Lines for Compound <b>40f</b><a class="ref internalNav" href="#tbl9-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead valign="bottom"><tr valign="bottom"><th align="center" valign="bottom">compound number</th><th align="center" valign="bottom" char=".">human Hsp90β FP IC<sub>50</sub> (µM)</th><th align="center" valign="bottom" char=".">HCT116 (colon GI<sub>50</sub> (µM)</th><th align="center" valign="bottom" char=".">DU145 (prostate) GI<sub>50</sub> (µM)</th><th align="center" valign="bottom" char=".">PC3M (prostate) GI<sub>50</sub> (µM)</th><th align="center" valign="bottom" char=".">SKMel28 (melanoma) GI50 (µM)</th><th align="center" valign="bottom" char=".">SF268 (glioma) GI<sub>50</sub> (µM)</th><th align="center" valign="bottom" char=".">U87MG (glioma)GI<sub>50</sub> (µM)</th></tr></thead><tbody><tr valign="top"><td align="left" valign="top"><b>40f</b></td><td align="char" valign="top" char=".">0.021</td><td align="char" valign="top" char=".">0.016</td><td align="char" valign="top" char=".">0.005</td><td align="char" valign="top" char=".">0.006</td><td align="char" valign="top" char=".">0.005</td><td align="char" valign="top" char=".">0.006</td><td align="char" valign="top" char=".">0.008</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl9-fn1"><div class="footnote" id="tbl9-fn1"><sup>a</sup><p class="last">Values are reported as the mean of at least two independent determinations.</p></div></div></div><figure id="fig8" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/medium/jm-2007-01018h_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0022.jpeg" id="_i25" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Response of HCT116 human colon carcinoma xenografts to <b>40f</b> therapy (50 mg/kg i.p. q.d). (A) Mean tumor volumes (therapy vs vehicle controls). (B) Mean weights of excised tumors after 12 days of therapy. Therapy/control ratio (T/C) = 49.9. (C) Mouse body weights during therapy. (D) Changes in PD markers as measured at 6, 16, and 24 h after the final dose. GAPDH was used as a loading control for the western blots.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701018h&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53262" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53262" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">A significant reduction of tumor growth in HCT116 colon cancer xenografts was observed with the potent Hsp90 inhibitor VER-52296/NVP-AUY922<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> (<b>40f</b>). This compound has excellent potency against Hsp90 in a FP binding assay (IC<sub>50</sub> = 21 nM) and inhibits proliferation in a wide range of human cancer cell lines with an average GI<sub>50</sub> of 9 nM. Treated cells show the characteristic molecular signature of Hsp90 inhibition, namely, elevation of Hsp72 and degradation of oncogenic client proteins. The compound is retained in HCT116 xenograft tumors at concentrations well above the GI<sub>50</sub>, with a half-life of 9.5 h following i.p. administration at 50 mg/kg qd. The identification of <b>40f</b> as a potential therapeutic agent for treatment of cancer was strongly influenced by X-ray structures of protein−inhibitor complexes and was the culmination of studies that optimized the physical and biological properties of lead compounds, including, in particular, tumor drug levels. In addition, <b>40f</b> showed excellent efficacy in a range of subcutaneous and orthotopic human tumor xenograft models covering major cancer types and diverse oncogenic profiles, and these data will be published elsewhere.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> The overall properties warrant further studies of this compound, and an i.v. formulation of NVP-AUY922 (<b>40f</b>) is currently in a Phase-I study in patients with a range of cancer indications.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77377" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77377" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Fluorescence Polarization Assay</h3><div class="NLM_p last">The ability of compounds to compete with a fluorescently labeled probe for binding to full-length human Hsp90β was determined, as described previously,<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> with a modified probe (VER-00051001). This probe binds with greater affinity to Hsp90 than that described previously, allowing the accurate determination of IC<sub>50</sub> for higher-affinity compounds. Synthetic procedures for VER-00051001 and details relating to the FP assay can be found in the Supporting Information section.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Cell Growth and Client Protein Degradation</h3><div class="NLM_p last">Growth inhibition assays using the SRB method were undertaken as previously described.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Client protein degradation was determined by western blotting. In brief, HCT116 cells were exposed to compounds <b>6</b>, <b>19e</b>, <b>30d</b>, <b>33</b>, <b>40f</b>, or 17-AAG at either 1× or 2× their cellular GI<sub>50</sub> for 24 h. Cell lysates were prepared in 50 mM tris-HCl and 2% SDS (pH 6.8), and protein levels were determined by the BCA method (Pierce, Rockford, IL). Equal amounts of lysate were separated by SDS-PAGE and proteins transferred to PVDF membrane. Her2 (ab8054, Abcam), Raf-1 (sc-133, Santa Cruz Biotechnology), and Hsp72 (SPA-810, StressGen) were determined using ECL (GE Bioscience). GAPDH (MAB374, Chemicon International) levels were determined to show equal protein loading.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Pharmacokinetics and Metabolism. Cassette Dosing in Tumor-Bearing Mice</h3><div class="NLM_p">All work was performed in accordance with the Home Office regulations under the Animals (Scientific Procedures) Act 1986 and according to the UKCCCR guidelines for animal experimentation.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> HCT116 human colon cancer cells were cultured in DMEM plus 5% fetal calf serum. When ∼80% confluent, they were released from plastic flasks by a short exposure to trypsin, washed, and re-suspended in PBS. Two million cells were injected s.c. bilaterally in the flanks of female NCr athymic mice. Dosing commenced when tumors were well established, 4–5 mm mean diameter for therapy and 8–9 mm for cassette dosing pharmacokinetic studies.</div><div class="NLM_p">Compounds were dissolved in DMSO and diluted in sterile saline/Tween 20 such that animals received the dose required in 0.1 mL of final solution per 10 g of body weight. Final concentrations were 10% DMSO, 5% Tween 20, and 85% saline. The compound was stable in this vehicle and, for repeat dosing in the therapy study, was stored for 3–4 days at 4 °C between doses. Controls received an equal volume of vehicle. For cassette dosing, animals received 4 mg/kg of each compound. The approach used was consistent with the guidelines for cassette dosing that we have published previously<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> and our prior experience with early pyrazole−resorcinol Hsp90 inhibitors.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a></div><div class="NLM_p last">The plasma and tumors were taken as previously described<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> at 0, 0.25, 0.5, 1, 2, 4, and 6 h post administration (<i>N</i> = 3 animals per time point) and snap frozen. Quantitative analysis of the plasma and tumors was performed by LC/MS/MS. The LC system comprised a Waters Alliance 2795 separations module (Hertford, U.K.). Chromatography was achieved on a Synergi Polar-RP 4µ 50 × 2.1 mm column (Phenomenex, Macclesfield, U.K.) with an A100-X precolumn filter (Anachem, Luton, Bedfordshire, UK). The mobile phase, initially containing 0.1% formic acid and methanol, 80/20 v/v, was increased linearly to 90% methanol from 0 to 6 min, kept isocratic for 5 min, and then washed with 100% methanol for 1 min before returning to the initial conditions. The flow rate was 0.2 mL/min. Detection was achieved on a Micromass Quattro Ultima triple-quadrupole mass spectrometer (Manchester, U.K.). The electrospray interface was used in negative-ionization mode (ES-) with a capillary voltage of 4 kV and a source temperature of 200 °C. Detection was accomplished by multiple reaction monitoring of the optimized transitions and collision energy for each of the six compounds (five compounds and an analytical internal standard). The program WinNonlin was used to evaluate the half life of test compounds.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Therapeutic Activity in Human Tumor Xenografts</h3><div class="NLM_p last">The compound <b>40f</b> was prepared as described below. Therapy was initiated when tumors were established with a mean diameter of 4–5 mm and continued for 12 days. The dose selected (50 mg/kg) had been shown in pilot studies to be well-tolerated and to give plasma levels within the therapeutic range. Tumors were measured three times weekly and weighed when excised at the end of the experiment. Animals were weighed daily as an indication of general health. Tumor samples were also collected for analysis of pharmacodynamic biomarkers, as described earlier.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Chemistry. 1-(5-Chloro-2,4-dihydroxyphenyl)ethanone (10)</h3><div class="NLM_p last">Acetic acid (17.5 mL) was added dropwise to a suspension of 4-chlorobenzene-1,3-diol (42.5 g, 0.294 mol) in BF<sub>3</sub>·OEt<sub>2</sub> (200 mL, 1.62 mol) under a nitrogen atmosphere. The reaction mixture was heated at 90 °C for 3.5 h and then allowed to cool to room temperature, causing a solid to precipitate. The mixture was poured into a 10% w/v aqueous sodium acetate solution (700 mL). This mixture was then stirred vigorously for 2.5 h to afford a light-brown solid, which was filtered, washed with water, and air-dried overnight to afford the title compound <b>10</b> (31.6 g, 58%): TLC <i>R</i><sub>f</sub> = 0.40 (1:3 EtOAc/hexane); LCMS <i>t</i><sub>R</sub> = 1.75 min; <i>m</i>/<i>z</i> = 185[M − H]<sup>−</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 2.70 (s, 3H), 6.62 (s, 1H), 8.03 (s, 1H), 11.45 (s, 1H), 12.35 (s, 1H); <sup>13</sup>C ΝΜR (100.6 MHz, DMSO-<i>d</i><sub>6</sub>) δ 27.0 (CH<sub>3</sub>), 103.5 (CH), 111.4 (C), 113.6 (C), 132.6 (CH), 159.9 (CH), 162.1 (C), 202.1 (C); ν = 3257, 1608 cm<sup>−1</sup>.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 1-(2,4-Bis(benzyloxy)-5-chlorophenyl)ethanone (11)</h3><div class="NLM_p last">Benzyl bromide (30 mL, 0.252 mol) was added to a mixture of 1-(5-chloro-2,4-dihydroxyphenyl)ethanone (<b>10</b>) (20 g, 0.107 mol) and potassium carbonate (37 g, 0.27 mol) in acetonitrile (350 mL). The mixture was heated at reflux for 6 h and then allowed to cool to ambient temperature and stirred overnight. The mixture was filtered, and the solids were washed with dichloromethane (3 × 100 mL). The combined organic filtrates were evaporated in vacuo to leave a pale-yellow solid, which was triturated with a mixture of hexane (350 mL)/EtOAc (15 mL) and filtered to give the title compound <b>11</b> (35.4 g, 90% yield) as an off-white solid: TLC <i>R</i><sub>f</sub> = 0.33 (1:4 EtOAc/hexane); LCMS <i>t</i><sub>R</sub> = 2.66 min; <i>m</i>/<i>z</i> = 389[M + Na]<sup>+</sup>, 367[M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 2.55 (s, 3H), 5.06 (s, 2H), 5.13 (s, 2H), 6.55 (s, 1H), 7.3–7.4 (m, 10H), 7.90 (s, 1H); ν = 3035, 1660 cm<sup>−1</sup>.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 4-(2,4-Bis(benzyloxy)-5-chlorophenyl)-2-hydroxy-4-oxobut-2-enoic Acid Ethyl Ester (12)</h3><div class="NLM_p last">Sodium metal (1.35 g, 58 mmol) was cut into small pieces, washed with hexane to remove mineral oil, and added to anhydrous EtOH (35 mL) under a nitrogen atmosphere over a period of 20 min. The reaction mixture was stirred for a further 10 min until all sodium had reacted. Compound <b>11</b> (10 g, 27.26 mmol) was added in portions over 5 min, and the resulting suspension was then stirred for a further 5 min. Diethyl oxalate (6 mL, 43 mmol) was added, resulting in a thicker yellow-colored precipitate. The reaction mixture was heated to reflux for 4 h, affording a dark-colored homogeneous solution, which, upon cooling, produced a solid mass to which acetic acid (6 mL) was added. The mixture was triturated to afford a yellow solid, which was filtered, washed sequentially with water, EtOH, and diethyl ether, and then dried in vacuo to afford the title compound <b>12</b> (12 g, 94%) as a yellow solid. LCMS <i>t</i><sub>R</sub> = 2.93 min; <i>m</i>/<i>z</i> = 489[M + Na]<sup>+</sup>, 467[M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ, 1.29 (t, 3H, <i>J</i> = 7.0 Hz), 4.28 (q, 2H, <i>J</i> = 7.0 Hz), 5.11 (s, 2H), 5.17 (s, 2H), 6.58 (s, 1H), 7.33–7.42 (m, 10H), 8.01 (s, 1H), 15.34 (brs, 1H); <sup>13</sup>C ΝΜR (100.6 MHz, CDCl<sub>3</sub>) δ 14.0 (CH<sub>3</sub>), 62.2 (CH<sub>2</sub>), 99.5 (CH), 103.0 (CH), 116.1 (C), 118.4 (C), 127.0 (CH), 127.4 (CH), 128.4 (CH), 128.5 (CH), 128.8 (CH), 128.8 (CH), 132.1 (CH), 135.2 (CH), 135.4 (CH), 158.6 (C), 158.7 (C), 162.4 (C), 168.6 (C).</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 5-(2,4-(Bis)benzyloxy-5-chlorophenyl)-2H-pyrazole-3-carboxylic Acid Ethyl Ester (13)</h3><div class="NLM_p last">Method a: Compound <b>12</b> (20 g, 42.8 mmol) was added portionwise to cooled glacial acetic acid (100 mL) with mechanical stirring under nitrogen, with the temperature maintained at ∼14 °C with an ice bath. The suspension was treated dropwise with hydrazine hydrate (2.4 mL, 47.2 mmol). The cooling was removed at the initiation of freezing in order to maintain stirring, and the reaction was allowed to warm to room temperature over 3 h during continued stirring. The resultant suspension was poured into ice/water (500 mL), and the pale-yellow precipitate was filtered and washed with water. The solid was recrystallized from hot EtOH to furnish the title compound <b>13</b> (17 g, 86%). Method b: Compound <b>12</b> (18.34 g, 39.3 mmol) was added to EtOH (350 mL) and mechanically stirred. Hydrazine hydrochloride (3.41 g, 49.1 mmol) was added, and the mixture was then heated at reflux for 3.75 h and then allowed to cool. The resulting solid was filtered, and the filtered solids were washed with EtOH and then diethyl ether and dried in vacuo to afford the title compound <b>13</b> (14.78 g, 87% yield) as a yellow solid: LCMS <i>t</i><sub>R</sub> = 2.82 min; <i>m</i>/<i>z</i> = 463[M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.27 (t, 3H, <i>J</i> = 7.1 Hz), 4.24 (q, 2H, <i>J</i> = 7.1 Hz), 5.29 (s, 2H), 5.30 (s, 2H), 7.10 (s, 1H), 7.16 (s, 1H), 7.35–7.44 (m, 6H), 7.45–7.49 (m, 4H), 7.96 (s, 1H); <sup>13</sup>C ΝΜR (100.6 MHz, DMSO-<i>d</i><sub>6</sub>) δ 14.3 (CH<sub>3</sub>), 61.0 (CH<sub>2</sub>), 71.2 (CH<sub>2</sub>), 71.6 (CH<sub>2</sub>), 100.1 (C), 104.9 (CH), 111.1 (C), 116.2 (C), 127.0 (CH), 128.0 (CH), 128.3 (CH), 128.8 (CH), 128.9 (CH), 129.1 (CH), 129.2 (CH), 134.9 (C), 135.8 (C), 141.4 (C), 143.3 (C), 154.5 (C), 154.8 (C), 162.2 (C).</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 5-(2,4-Bis(benzyloxy)-5-chlorophenyl)-4-iodo-2<i>H</i>-pyrazole-3-carboxylic Acid Ethyl Ester (14)</h3><div class="NLM_p last">Compound <b>13</b> (30 g, 64.8 mmol) was suspended in acetonitrile (1000 mL) and treated with <i>N</i>-iodosuccinimide (16 g, 71 mmol) followed by ceric ammonium nitrate (350 mg, 0.64 mmol), and the mixture was heated to reflux overnight. The reaction mixture was cooled to ambient temperature, and solvents were removed in vacuo to leave a foam-like solid. The residual solid was triturated with water and then filtered and washed with 1% sodium thiosulfate solution and then further water. The solid product was dried, then stirred in EtOH, and filtered, and the filtered solids were stirred with diethyl ether and filtered. The resultant solid was dried in vacuo to afford title the compound <b>14</b> (37.5 g, 98%) as a colorless solid: TLC <i>R</i><sub>f</sub> = 0.56 (1:1 EtOAc/hexane); LCMS <i>t</i><sub>R</sub> = 2.66 min; <i>m</i>/<i>z</i> = 589[M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.42 (t, 3H, <i>J</i> = 7.1 Hz), 4.43 (q, 2H, <i>J</i> = 7.1 Hz), 4.99 (s, 2H), 5.16 (s, 2H), 6.66 (s, 1H), 7.22–7.26 (m, 2H), 7.30–7.45 (m, 8H), 7.84 (s, 1H), NH not observed.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 5-(2,4-Bis(benzyloxy)-5-chlorophenyl)-4-iodo-2<i>H</i>-pyrazole-3-carboxylic Acid (15)</h3><div class="NLM_p last">Compound <b>14</b> (37.5 g, 63.8 mmol) was dissolved in a mixture of 1,4-dioxane (300 mL) and aqueous sodium hydroxide solution (2.0 M, 50 mL, 100 mmol), and the mixture was heated to reflux for 5 h. The reaction mixture was cooled to ambient temperature and then acidified with aqueous HCl (2.0 M). The majority of the 1,4-dioxane was removed in vacuo and the residual mixture diluted with more water. The resulting precipitate was filtered and dried in vacuo, and the solid was stirred with EtOH, filtered, and then stirred with diethyl ether and filtered again. Drying in vacuo afforded the title compound <b>15</b> (32.7 g, 92%) as a colorless solid: LCMS <i>t</i><sub>R</sub> = 2.60 min; <i>m</i>/<i>z</i> = 561[M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 5.17 (s, 2H), 5.30 (s, 2H), 7.16 (brs, 1H), 7.29–7.40 (m, 7H), 7.41–7.47 (m, 2H), 7.48–7.51 (m, 2H), 13.8 (brs, 1H).</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 5-(2,4-Bis(benzyloxy)-5-chlorophenyl)-4-iodo-2<i>H</i>-pyrazole-3-carboxylic Acid Ethylamide (16)</h3><div class="NLM_p last">Oxalyl chloride (42 µL, 0.50 mmol) was added to a suspension of compound <b>13</b> (242 mg, 0.43 mmol) in dichloromethane (10 mL). One drop of DMF was added, and the reaction mixture was stirred at ambient temperature for 1 h; then, the solvents were removed in vacuo to afford a yellow residue, which was suspended in dichloromethane (5 mL) and added dropwise to a stirred solution of ethylamine hydrochloride (350 mg, 4.3 mmol) and triethylamine (600 µL, 4.3 mmol) in dichloromethane (15 mL). After 1 h, the solvents were evaporated in vacuo and the residue dissolved in EtOAc and washed sequentially with aqueous HCl (2N), a 5% w/v Na<sub>2</sub>CO<sub>3</sub> solution, and a saturated aqueous NaCl solution. The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub> and filtered; the filtrate solvents were removed in vacuo to afford title compound <b>16</b> (250 mg, 99% yield) as an off-white solid: TLC <i>R</i><sub>f</sub> = 0.35 (1:1 EtOAc/hexane); LCMS <i>t</i><sub>R</sub> = 2.80 min; <i>m</i>/<i>z</i> = 588[M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.23 (t, 3H, <i>J</i> = 7.4 Hz), 3.47 (dt, 2H, <i>J</i> = 7.4, 5.5 Hz), 5.01 (s, 2H), 5.17 (s, 2H), 6.66 (s, 1H), 6.91 (t, 1H, <i>J</i> = 5.5 Hz), 7.25 (m, 2H), 7.31–7.45 (m, 8H), 7.88 (s, 1H), NH not observed.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 5-(2,4-Bis(benzyloxy)-5-chlorophenyl)-4-(4-formylphenyl)-2<i>H</i>-pyrazole-3-carboxylic Acid Ethylamide (17)</h3><div class="NLM_p last">Compound <b>16</b> (235 mg, 0.4 mmol) was dissolved in THF (4 mL) and water (0.4 mL). 4-Formylphenylboronic acid (120 mg, 0.8 mmol) was added, followed by potassium carbonate (110 mg, 0.8 mmol). The mixture was degassed,[1,1′-bis(diphenylphosphino)ferrocene]dichloropalladium(II) (5 mol%) was added, and the reaction mixture was heated in a microwave synthesizer at 160 °C for 10 min. The solvents were removed in vacuo to afford a solid residue, which was adsorbed onto silica gel and then purified by flash chromatography on silica gel, eluting with a gradient of 1:2 to 1:1 EtOAc/hexane. This afforded the title compound <b>17</b> (153 mg, 68%) as a colorless solid: LCMS <i>t</i><sub>R</sub> = 2.76 min; <i>m</i>/<i>z</i> = 566[M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.06 (t, 3H, <i>J</i> = 7.0 Hz), 3.20 (dt, 2H, <i>J</i> = 7.0, 6.0 Hz), 4.92 (s, 2H), 5.23 (s, 2H), 7.02 (s, 1H), 7.04–7.08 (m, 2H), 7.25 (s, 1H), 7.26–7.46 (m, 11H), 7.70 (d, 2H, <i>J</i> = 8 Hz), 8.24 (brt, 1H, <i>J</i> = 6 Hz), 9.95 (s, 1H), 13.45 (s, 1H).</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 5-(2,4-Bis(benzyloxy)-5-chlorophenyl)-4-(3-formylphenyl)-2H-pyrazole-3-carboxylic Acid Ethylamide (18)</h3><div class="NLM_p last">The title compound was made by same synthetic method as that used for compound <b>17</b>. Thus, <b>16</b> was reacted with 3-formylphenylboronic acid to afford the title compound as a colorless solid: LCMS <i>t</i><sub>R</sub> = 2.78 min; <i>m</i>/<i>z</i> = 566[M + H]<sup>+</sup>.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> General Procedure A: Preparation of Amines 19e and 20a−i from 17 and 18 by Reductive Amination</h3><div class="NLM_p last">The appropriate amine (0.265 mmol, 2 equiv) was added to a solution of <b>17</b> or <b>18</b> (75 mg, 0.133 mmol, 1 equiv) in MeOH (5 mL). Molecular sieves (Aldrich, 3 Å) were added, followed by acetic acid (12 µL, 0.2 mmol) and sodium cyanoborohydride (13 mg, 0.2 mmol, 1.5 equiv). The reaction mixture was stirred for 2–4 h (analyzed by LCMS), and when judged complete, the solvents were removed in vacuo, and the residue was purified by flash chromatography on silica gel (eluting with a gradient of dichloromethane to DMAW 120). Alternatively, the reactions underwent an aqueous workup. The reaction mixture was quenched with MeOH or saturated NaHCO<sub>3</sub> solution, solvents were removed in vacuo, and the residue was partitioned between water and EtOAc. The organic phase was washed with saturated aqueous NaCl solution, dried with sodium sulfate, and evaporated in vacuo. The resulting amine products were purified as above or used directly in the debenzylation step. The amine product of reductive amination (0.122 mmol) was dissolved in acetic acid (5 mL), and the solution was degassed by evacuation−nitrogen purge (two cycles). Palladium on carbon catalyst (10%) was added, and the reaction mixture was hydrogenated with shaking for 16 h. The reaction mixture was filtered through a pad of Celite 521 and the filtrate concentrated in vacuo. Final product purification was by preparative HPLC unless otherwise stated.</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 5-(5-Chloro-2,4-dihydroxyphenyl)-4-(4-morpholin-4-ylmethylphenyl)-2<i>H</i>-pyrazole-3-carboxylic Acid Ethylamide (19e)</h3><div class="NLM_p last">By general procedure A, morpholine was reacted with <b>17</b>, and benzyl groups were removed by catalytic hydrogenation to afford the title compound <b>19e</b> (11%) as a colorless solid: LCMS <i>t</i><sub>R</sub> = 1.69 min; <i>m</i>/<i>z</i> = 457[M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.05 (t, 3H, <i>J</i> = 7.4 Hz), 2.34 (brm, 4H), 3.18 (m, 2H), 3.41 (brs, 2H), 3.56 (brm, 4H), 6.56 (s, 1H), 6.71 (s, 1H), 7.13 (d, 2H, <i>J</i> = 8.4 Hz), 7.16 (d, 2H, <i>J</i> = 8.4 Hz), 8.00 (brs, 1H); <sup>13</sup>C NMR (100.6 MHz, DMSO-<i>d</i><sub>6</sub>) δ 14.9 (CH<sub>3</sub>), 33.2 (CH<sub>2</sub>), 53.2 (CH<sub>2</sub>), 62.3 (CH<sub>2</sub>), 66.2 (CH<sub>2</sub>), 103.7 (CH), 108.7 (C), 109.5 (C), 119.2 (C), 128.2 (CH), 129.8 (CH), 131.2 (CH), 131.8 (C), 135.4 (C), 137.5 (C), 143.4 (C), 153.9 (C), 155.3 (C), 162.4 (C); HRMS calcd for C<sub>23</sub>H<sub>25</sub>ClN<sub>4</sub>O<sub>4</sub>[M + H]<sup>+</sup> 457.1642, found 457.1626; HPLC 98.7% (<i>t</i><sub>R</sub> = 2.87 min).</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> {4-[3-(2,4-Bis(benzyloxy)-5-chlorophenyl)-5-ethylcarbamoyl-1H-pyrazol-4-yl]benzyl}carbamic Acid <i>tert</i>-Butyl Ester (21)</h3><div class="NLM_p last">4-Aminomethylphenylboronic acid hydrochloride (80 mg, 0.43 mmol) was added to 5-(2,4-bis(benzyloxy)-5-chlorophenyl)-4-iodo-2<i>H</i>-pyrazole-3-carboxylic acid ethylamide (<b>16</b>) (200 mg, 0.34 mmol) and potassium carbonate (140 mg, 1.01 mmol) in a microwave vial. THF (3 mL) and water (0.3 mL) were added, and the mixture was degassed by bubbling nitrogen through the reaction mixture. 1,1-Bis(diphenylphosphino)ferrocenedichloropalladium was added (10 mol%), and the reaction mixture was heated in a microwave synthesizer at 150 °C for 10 min. The reaction mixture after cooling was filtered through a pad of Celite 521, and the solvents were removed in vacuo. The residue was dissolved in THF (5 mL), and triethylamine (142 µL) was added followed by di-<i>tert</i>-butyldicarbonate (222 mg, 1.02 mmol). The reaction mixture was heated for 10 min at 100 °C and then allowed to cool and was partitioned between EtOAc and water. The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub>, evaporated in vacuo, and purified by flash chromatography on silica gel, eluting 15–75% gradient of EtOAc in hexane, to afford title compound <b>21</b> (60 mg, 26%) as a glass-like solid: LCMS <i>t</i><sub>R</sub> = 2.8 min; <i>m</i>/<i>z</i> = 667[M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.23 (t, 3H, <i>J</i> = 7.2 Hz), 1.47 (s, 9H), 3.36 (m, 2H), 4.34 (brd, 2H, <i>J</i> = 5.8 Hz), 4.85 (brs, 1H), 4.94 (s, 2H), 5.07 (s, 2H), 6.56 (s, 1H), 6.6 (brs, 1H), 7.06 (s, 1H), 7.15–7.30 (m, 8H), 7.31–7.43 (m, 6H), pyrazole NH not observed.</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 4-(4-Aminomethylphenyl)-5-(2,4-bis-benzyloxy-5-chlorophenyl)-2<i>H</i>-pyrazole-3-carboxylic Acid Ethylamide (22)</h3><div class="NLM_p last">Compound <b>21</b> (0.191 g, 0.0286 mmol) was dissolved in dichoromethane (5 mL), trifluoroacetic acid (5 mL) was added, and the mixture was stirred at room temperature for 1 h. The mixture was then concentrated to give a yellow oil, which was partitioned between EtOAc and saturated aqueous NaHCO<sub>3</sub> solution. The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated to give a yellow oil, which was triturated with hexane/EtOAc mixture to afford the title compound <b>22</b> (0.154 g, 95%) as a cream-colored powder: LCMS <i>t</i><sub>R</sub> = 2.11 min; <i>m</i>/<i>z</i> = 568[M + H]<sup>+</sup>.</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 5-(5-Chloro-2,4-dihydroxyphenyl)-4-(4-diethylaminomethylphenyl)-2<i>H</i>-pyrazole-3-carboxylic Acid Ethylamide (19a)</h3><div class="NLM_p last">Compound <b>22</b> (0.03 g, 0.056mMol) was dissolved in dichloroethane (10 mL). To this mixture were added sodium triacetoxyborohydride (0.034 mg, 0.16 mmol) and acetaldehyde (0.07 mL, 0.16 mmol). The mixture was stirred at room temperature for 1 h, and then, sodium borohydride (0.01 g, 0.26 mmol) in EtOH (1 mL) was added, and the mixture was stirred at room temperature for 1 h. The mixture was filtered, and filtrate solvents were removed in vacuo to give a white solid. The solid was suspended in MeOH (10 mL), and cyclohexadiene (1 mL) was added. The mixture was then heated to reflux for 1 h in the presence of a catalytic amount of palladium on carbon. The reaction mixture was filtered, and the filtrate was concentrated to give a brown solid, which was purified by preparative HPLC to give the title compound <b>19a</b> (4 mg, 16%) as a colorless solid: LCMS <i>t</i><sub>R</sub> = 1.63 min; <i>m</i>/<i>z</i> = 443[M + H]<sup>+</sup>; purity > 95%;<sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 1.16 (t, 6H, <i>J</i> = 7.0 Hz), 1.18 (t, 3H, <i>J</i> = 7.0 Hz), 2.73 (q, 4H, <i>J</i> = 7.0 Hz), 3.34 (m, 2 H), 3.87 (s, 2 H), 6.51 (s, 1 H), 6.80 (s, 1 H), 7.16 (d, 2H, <i>J</i> = 7.8 Hz), 7.3 (d, 2H, <i>J</i> = 7.1 Hz).</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 5-(2,4-Bis(benzyloxy)-5-chlorophenyl)isoxazole-3-carboxylic Acid Ethyl Ester (23)</h3><div class="NLM_p last">4-(2,4-Bis(benzyloxy)-5-chlorophenyl)-2-hydroxy-4-oxobut-2-enoic acid ethyl ester (<b>12</b>) (12.0 g, 25.7 mmol) was suspended in EtOH (230 mL), and hydroxylamine hydrochloride (2.23 g, 1.25 equiv) was added. The reaction mixture was heated to reflux for 3.5 h and then allowed to cool to ambient temperature. The resulting suspension was filtered, washed sequentially with EtOH (2 × 20 mL), water (2 × 20 mL), and EtOH (2 × 20 mL), and dried in vacuo to afford the title compound <b>23</b> (10.23 g, 86%) as a flocculent light-yellow solid: TLC <i>R</i><sub>f</sub> = 0.41 (20:80 EtOAc/hexane); LCMS <i>t</i><sub>R</sub> = 2.94 min; <i>m</i>/<i>z</i> = 466, 464[M + H]<sup>+</sup>, chlorine isotope pattern observed; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.40 (s, 3H, <i>J</i> = 7.1 Hz), 4.42 (q, 2H, <i>J</i> = 7.1 Hz), 5.13 (s, 2H), 5.15 (s, 2H), 6.62 (s, 1H), 7.01 (s, 1H), 7.30–7.43 (m, 10H), 8.80 (s, 1H); <sup>13</sup>C ΝΜR (100.6 MHz, CDCl<sub>3</sub>) δ 14.1, 62.0, 71.0, 71.1, 99.8, 103.0, 109.8, 115.7, 127.0, 127.3, 128.3, 128.6, 128.6, 128.8, 128.9, 135.5, 135.7, 155.0, 156.3, 157.0, 160.2, 166.6.</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 5-(2,4-Bis(benzyloxy)-5-chlorophenyl)isoxazole-3-carboxylic Acid Ethylamide (24)</h3><div class="NLM_p last">Compound <b>23</b> (10.0 g, 21.5 mmol) was suspended in EtOH (120 mL), and ethylamine in MeOH solution (2.0 M, 70 mL, 140 mmol) was added. The reaction mixture was heated to 80 °C with stirring for 18 h, affording a yellow homogeneous solution, which was allowed to cool to ambient temperature. A flocculent colorless solid formed upon cooling, and the reaction mixture was cooled further to 4 °C and then filtered. The filtered product was washed with cold EtOH and dried in vacuo to afford the title compound <b>24</b> (8.86 g, 89%) as a colorless solid: TLC <i>R</i><sub>f</sub> = 0.22 (20:80 EtOAc/hexane); LCMS <i>t</i><sub>R</sub> = 2.86 min; <i>m</i>/<i>z</i> = 465, 463[M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.25 (s, 3H, <i>J</i> = 7.4 Hz), 3.47 (dq, 2H, <i>J</i> = 7.3, 5.2 Hz), 5.10 (s, 2H), 5.16 (s, 2H), 6.59 (s, 1H), 6.82 (brt, 1H, <i>J</i> = 5.2 Hz) 7.08 (s, 1H), 7.30–7.43 (m, 10H), 7.96 (s, 1H).</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 5-(2,4-Bis(benzyloxy)-5-chlorophenyl)-4-bromoisoxazole-3-carboxylic Acid Ethylamide (25)</h3><div class="NLM_p last"><i>N</i>-bromosuccinimide (1.90 g, 10.7 mmol) was added to a suspension of <b>24</b> (4.50 g, 9.73 mmol) in acetonitrile (120 mL). Ceric ammonium nitrate (2.66 g, 4.86 mmol) was added, and the resulting orange suspension was heated to reflux for 4.5 h. The mixture was allowed to cool to room temperature, and the acetonitrile was removed in vacuo. The residue was partitioned between EtOAc (120 mL) and water (100 mL), the phases were then separated, and the organic phase was washed with water (50 mL) and saturated aqueous NaCl solution (100 mL) and dried over MgSO<sub>4</sub>. The mixture was filtered, and the filtrate solvents were removed in vacuo to afford an orange solid, which was triturated with diethyl ether, filtered, and dried in vacuo to give the title compound <b>25</b> (3.90 g, 74%) as a cream-colored solid: <i>R</i><sub>f</sub> = 0.22 (30:70 EtOAc/hexane); LCMS <i>t</i><sub>R</sub> = 2.93 min; <i>m</i>/<i>z</i> = 543, 541[M + H]<sup>+</sup>, chlorine isotope pattern observed; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.26 (t, 3H); 3.50 (m, 2H); 5.07 (s, 2H); 5.12 (s, 2H); 6.62 (s, 1H); 6.74 (t, 1H), 7.28–7.43 (m, 10H); 7.52 (s, 1H).</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 5-(2,4-Bis(benzyloxy)-5-chlorophenyl)-4-(4-formylphenyl)isoxazole-3-carboxylic Acid Ethylamide (26)</h3><div class="NLM_p last">4-Formylphenylboronic acid (1.52 g, 10.2 mmol) was added to a mixture of <b>25</b> (4.60 g, 8.5 mmol) and NaHCO<sub>3</sub> (2.14 g, 25.5 mmol). DMF (105 mL) was added followed by water (21 mL), and the resulting suspension was degassed by evacuation−nitrogen purge (three cycles) and then bubbling nitrogen gas through the reaction mix for 10 min. Dichlorobis(triphenylphosphine)palladium(II) (5 mol%) was added, and the reaction mixture was heated under nitrogen atmosphere at 80 °C for 3 h. The mixture was allowed to cool, and the majority of the solvents was removed in vacuo. The residual mixture was partitioned between EtOAc (200 mL) and water (200 mL), and this mixture was then filtered through a pad of Celite 521. The filtrate phases were separated, and the organic phase was washed with water (2 × 200 mL) and saturated aqueous sodium chloride solution (250 mL) and then dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and filtered. The filtrate solvents were evaporated in vacuo, and the crude was product purified by trituration with diethyl ether to afford the title compound <b>26</b> (3.51 g, 73%) as a yellow solid: LCMS <i>t</i><sub>R</sub> = 2.91 min; <i>m</i>/<i>z</i> = 567[M + H]<sup>+</sup>, chlorine isotope pattern observed; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.23 (t, 3H, <i>J</i> = 7.3 Hz), 3.44 (m, 2H), 4.59 (s, 2H), 5.05 (s, 2H), 6.44 (s, 1H), 6.81 (brt, 1H, <i>J</i> = 5.3 Hz), 6.88 (m, 2H), 7.21–7.30 (m, 3H), 7.31–7.41 (7H), 7.48 (s, 1H), 7.69 (d, 2H, <i>J</i> = 8.4 Hz), 9.96 (s, 1H).</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 5-(5-Chloro-2,4-dihydroxyphenyl)-4-[4-(1,1-dioxo-1-thiomorpholin-4-ylmethyl)phenyl]isoxazole-3-carboxylic Acid Ethylamide (30a)</h3><div class="NLM_p last">Triethylamine (800 µL, 76 mmol) was added to a solution of 4-aminomethyl phenylboronic acid (710 mg, 3.8 mmol) in EtOH (3 mL). Divinylsulfone (380 µL, 3.8 mmol) was added, and the mixture was then heated at 100 °C for 3 h. The EtOH was removed in vacuo and the residue triturated with a small quantity of water, filtered, and dried in vacuo to afford the crude boronic acid as a solid. To the boronic acid (60 mg, 0.19 mmol) was added <b>25</b> (110 mg, 0.19 mmol), followed by DME (3 mL) and saturated NaHCO<sub>3</sub>(aq) solution (1 mL). The mixture was degassed and tetrakis(triphenylphosphine)palladium(0) (5 mol%) was added, and the mixture was heated in a microwave synthesizer at 130 °C for 10 min. The reaction mixture was partitioned between dichloromethane and water, and the phases were separated. The organic phase was dried over sodium sulfate and filtered, and the filtrate solvents were removed in vacuo to afford the crude dibenzylated product, which was then dissolved in dichloromethane (5 mL), and boron trichloride in dichloromethane solution (2.0 M, 5 mL, 10 mmol) was added and the mixture stirred at room temperature for 10 min. After this time, water (10 mL) was added, the mixture was concentrated, and the residue was purified by preparative HPLC to afford the title compound <b>30a</b> (0.016 g, 17%) as a colorless solid: LCMS <i>t</i><sub>R</sub> = 2.09 min; <i>m</i>/<i>z</i> = 528[M + Na]<sup>+</sup>, 506[M + H]<sup>+</sup>, chlorine isotope pattern observed; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 1.23 (t, 3H, <i>J</i> = 7.3 Hz), 3.01 (m, 4H), 3.13 (m, 4H), 3.39 (q, 2H, <i>J</i> = 7.3 Hz), 3.71 (s, 2H), 6.51 (s, 1H), 7.07 (s, 1H), 7.30 (d, 2H, <i>J</i> = 8.6 Hz), 7.35 (d, 2H, <i>J</i> = 8.6 Hz); <sup>13</sup>C ΝΜR (100.6 MHz, DMSO-<i>d</i><sub>6</sub>) δ 14.3 (CH<sub>3</sub>), 33.7 (CH<sub>2</sub>), 50.2 (CH<sub>2</sub>), 50.2 (CH<sub>2</sub>), 59.1 (CH<sub>2</sub>), 103.8 (CH), 106.2 (C), 110.2 (C), 115.8 (C), 128.1 (C), 128.4 (CH), 128.6 (CH), 130.8 (CH), 137.1 (C), 155.8 (C), 155.8 (C), 157.7 (C), 159.5 (C), 164.2 (C); HRMS calcd for C<sub>23</sub>H<sub>24</sub>ClN<sub>3</sub>O<sub>6</sub>S[M + H]<sup>+</sup> 506.1152, found 506.1162; HPLC 97.3% (<i>t</i><sub>R</sub> = 3.04 min).</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 5-(5-Chloro-2,4-dihydroxyphenyl)-4-[4-(4-methylpiperazin-1-ylmethyl)phenyl]isoxazole-3-carboxylic Acid Ethylamide (30c)</h3><div class="NLM_p last">Methyl iodide (250 µL, 4.6 mmol) was added to a mixture of 1-(4-bromobenzyl)piperazine (1.0 g, 4.15 mmol) and potassium carbonate (1.8 g, 12.45 mmol) in DMF (15 mL) and stirred overnight. The reaction mixture was partitioned between EtOAc and water, the phases were separated, the organic phase was dried over MgSO<sub>4</sub>, and the filtrate solvents were evaporated in vacuo. The resulting product (750 mg, 6.5 mmol) was dissolved in DMSO (15 mL), and potassium carbonate (900 mg, 3.0 equiv) was added followed by bis(pinnacolato)diboron (1.1 g, 4.5 mmol). The mixture was degassed, 1,1′-bis(diphenylphosphinoferrocene)dichloropalladium(II) (5 mol%) was added, and the reaction mixture was heated at 85 °C for 3 h under a nitrogen atmosphere; another 1.0 equiv of bis(pinnacolato)diboron was added, and heating continued for 3 h. The reaction mixture was allowed to cool and was worked up as above. The crude product was purified by flash chromatography on silica gel (eluting with 0–8% gradient of MeOH in DCM) to afford the product as a colorless solid. To the boronate ester (82.5 mg (0.26 mmol) were added <b>27</b> (106 mg, 0.18 mmol) followed by DME (3 mL) and saturated NaHCO<sub>3</sub>(aq) solution (1 mL). The mixture was degassed, tetrakis(triphenylphosphine)palladium(0) (5 mol%) was added, and the mixture was heated in a microwave synthesizer at 130 °C for 10 min. The reaction mixture was partitioned between DCM and water, and the phases were separated. The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub> and filtered, and the filtrate solvents were removed in vacuo to afford the crude dibenzylated product, which was then dissolved in DCM (5 mL); boron trichloride in DCM solution (1.0 M, 2 mL) was added, and the mixture was stirred at room temperature for 10 min. Water (10 mL) was added, the mixture was concentrated, and the residue was purified by preparative HPLC to give the title compound <b>30c</b> (0.5 formate salt) as a colorless solid: LCMS <i>t</i><sub>R</sub> = 1.75 min; <i>m</i>/<i>z</i> = 473, 471[M + H]<sup>+</sup>, chlorine isotope pattern observed; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 1.23 (t, 3H, <i>J</i> = 7.4 Hz), 2.67 (s, 3H), 2.69 (brs, 4H), 3.00 (brs, 4H), 3.40 (q, 2H, <i>J</i> = 7.4 Hz), 6.51 (s, 1H), 7.06 (s, 1H), 7.30 (d, 2H, <i>J</i> = 8.6 Hz), 7.34 (d, 2H, <i>J</i> = 8.6 Hz), 8.54 (s, 0.5H, formate); HRMS calcd for C<sub>24</sub>H<sub>27</sub>ClN<sub>4</sub>O<sub>4</sub>[M + H]<sup>+</sup> 471.1799, found 471.1792; HPLC 98.3% (<i>t</i><sub>R</sub> = 1.46 min).</div></div><div id="sec5_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 5-(5-Chloro-2,4-dihydroxyphenyl)-4-(4-diethylaminomethylphenyl)isoxazole-3-carboxylic Acid Ethylamide (30f)</h3><div class="NLM_p last">AcOH (0.51 mL, 8.85 mmol) was added dropwise to a mixture of <b>26</b> (1.0 g, 1.77 mmol), diethylamine (0.55 mL, 5.3 mmol), NaCNBH<sub>3</sub> (222 mg, 3.5 mmol), CH<sub>2</sub>Cl<sub>2</sub> (30 mL), and 3 Å molecular sieves (1 g). The reaction mixture was left to stir at RT under a nitrogen atmosphere for 16 h. The mixture was then filtered through a sintered funnel, and the filtrate was washed with saturated NaHCO<sub>3</sub> solution (40 mL). The aqueous phase was extracted further with CH<sub>2</sub>Cl<sub>2</sub> (2 × 40 mL). The combined organics were dried over Na<sub>2</sub>SO<sub>4</sub> and evaporated in vacuo to give a crude product, which was purified by flash chromatography on silica gel, eluting with a gradient of 50% EtOAc/hexane − 100% EtOAc, to afford 5-(2,4-bis(benzyloxy)-5-chlorophenyl)-4-(4-diethylaminomethylphenyl)isoxazole-3-carboxylic acid ethylamide (0.65 g, 59%) as a colorless oil: LCMS <i>t</i><sub>R</sub> = 2.43 min; <i>m</i>/<i>z</i> = 624, 626. To this product (55 mg, 0.09 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (1 mL) cooled to 0 °C under N<sub>2</sub> was added BCl<sub>3</sub> (1.0 M in CH<sub>2</sub>Cl<sub>2</sub>, 0.27 mL, 0.26 mmol). The reaction was allowed to warm to RT and was stirred for 1.5 h. Saturated NaHCO<sub>3</sub> solution (5 mL) was added and the CH<sub>2</sub>Cl<sub>2</sub> removed in vacuo. The aqueous residue was extracted with EtOAc (4 × 10 mL), passed through a hydrophobic frit, and evaporated in vacuo. Flash chromatography on silica gel, eluting with 10% MeOH/CH<sub>2</sub>Cl<sub>2</sub> then 20% MeOH/CH<sub>2</sub>Cl<sub>2</sub>, afforded the title compound <b>30f</b> (0.018 g, 45%) as a yellow solid: LCMS <i>t</i><sub>R</sub> = 1.78 min; <i>m</i>/<i>z</i> = 444, 446[M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.97 (t, 6H, <i>J</i> = 7.0 Hz), 1.07 (t, 3H, <i>J</i> = 7.0 Hz), 2.41–2.54 (m, 4H), 3.19–3.28 (m, 2H), 3.52 (brs, 2H), 6.61 (s, 1H), 7.07 (s, 1H), 7.18 (d, 2H, <i>J</i> = 8.0 Hz), 7.25 (d, 2H, <i>J</i> = 8.0 Hz), 8.89 (t, 1H, <i>J</i> = 8.0 Hz), 10.15 (s, 1H), 10.67 (brs, 1H); <sup>13</sup>C ΝΜR (100.6 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.4 (CH<sub>3</sub>), 14.3 (CH<sub>3</sub>), 33.8 (CH<sub>2</sub>), 46.12 (CH<sub>2</sub>), 56.4, 104.0 (C<sub>H</sub>), 106.2 (C), 110.2 (C), 115.8 (C), 127.7 (C), 128.4 (CH), 128.5 (CH), 130.8 (CH), 138.6 (C), 155.9 (C), 156.0 (C), 157.8 (C), 159.6 (C), 164.3 (C); HRMS calcd for C<sub>23</sub>H<sub>26</sub>ClN<sub>3</sub>O<sub>4</sub>[M + H]<sup>+</sup> 444.1690, found 444.1693; HPLC 96.4% (<i>t</i><sub>R</sub> = 2.31 min).</div></div><div id="sec5_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 1-(2,4-Bis(benzyloxyphenyl)ethanone (47)</h3><div class="NLM_p last">Potassium carbonate (90.80 g, 0.657 mol) was added to a solution of 2,4-dihydroxyacetophenone <b>46</b> (40.00 g, 0.263 mol) in acetonitrile (400 mL), and the suspension was stirred at room temperature. Benzyl bromide (78 mL, 112.00 g, 0.657 mol) was added dropwise over 10 min and the mixture heated at reflux for 18 h. The mixture was cooled, the solvents were evaporated in vacuo to afford a slurry, which was partitioned between water (1 L) and EtOAc (1 L), and the phases were separated. The aqueous layer was further extracted with dichloromethane (250 mL), and the organic extracts were combined, dried over MgSO<sub>4</sub>, and evaporated in vacuo. The product was triturated with hexane, filtered, washed with cold hexane, and dried in vacuo at 45 °C to give the title compound <b>47</b> (84.69 g, 97%) as a white powder: LCMS <i>t</i><sub>R</sub> = 2.87 min; <i>m</i>/<i>z</i> = 333[M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.55 (s 3H), 5.08 (s, 2H), 5.11 (s, 2H), 6.63–6.60 (m, 2H), 7.44–7.35 (m, 10H), 7.85 (d, 1H, <i>J</i> = 9.3 Hz).</div></div><div id="sec5_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 1-(2,4-Bis(benzyloxy)-5-bromophenyl)ethanone (48)</h3><div class="NLM_p last">1-(2,4-Bis(benzyloxyphenyl)ethanone (<b>47</b>) (84.60 g, 0.255 mol) was dissolved in DMF (250 mL) and stirred at room temperature. <i>N</i>-Bromosuccinimide (45.30 g, 0.255 mol) was added portionwise over 10 min and stirred for 3 h, over which time a white precipitate formed. The suspension was poured into water (1 L), and the product was removed by filtration and dried in vacuo at 45 °C to give the title compound <b>48</b> (101.37 g, 97%) as a white powder: LCMS <i>t</i><sub>R</sub> = 2.97 min; <i>m</i>/<i>z</i> = 411.2, 413.2[M + H]<sup>+</sup>, bromine isotope pattern observed; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.52 (s, 3H), 5.07 (s, 2H), 5.14 (s, 2H), 6.52 (s, 1H), 7.42–7.33 (m, 10H), 8.06 (s, 1H).</div></div><div id="sec5_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 4-(5-Bromo-2,4-diphenoxyphenyl)-2-hydroxy-4-oxobut-2-enoic Acid Ethyl Ester (49)</h3><div class="NLM_p last">Sodium (8.38 g, 364.71 mmol) was added portionwise to EtOH (350 mL) over 1 h with mechanical stirring under nitrogen, and the resulting solution was stirred at room temperature for 18 h. 1-(2,4-Bis(benzyloxy)-5-bromophenyl)ethanone (<b>48</b>) (49.31 g, 119.9 mmol) was added over 5 min followed by diethyl oxalate (24.77 mL, 26.65 g, 182.4 mmol). The suspension became pale-yellow in color. The mixture was warmed to reflux, whereupon the solids dissolved and a dark orange solution formed. The mixture was heated under reflux for 2 h and then cooled to 65 °C. Glacial acetic acid (30 mL) was added, and the hot solution was poured into 800 mL of cold water. The suspension was stirred while cooling, and the cooled suspension was filtered, washed with water (500 mL), and dried in vacuo at 45 °C to give the title compound <b>49</b> (59.59 g, 96%) as a golden-yellow powder: LCMS <i>t</i><sub>R</sub> = 3.12 min; <i>m</i>/<i>z</i> = 511.2, 513.2[M + H]<sup>+</sup>, bromine isotope pattern observed; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.27 (t, 3H, <i>J</i> = 7.1 Hz), 4.27 (q, 2H, <i>J</i> = 7.1 Hz), 5.11 (s, 2H), 5.16 (s, 2H), 6.54 (s, 1H), 7.42–7.34 (m, 11H), 8.17 (s, 1H), 13.5–13.0 (brs, 1H).</div></div><div id="sec5_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> 5-(2,4-Bis(benzyloxy)-5-bromophenyl)isoxazole-3-carboxylic Acid Ethyl Ester (50)</h3><div class="NLM_p last">Hydroxylamine hydrochloride (1.41 g, 20.4 mmol) was added to a solution of <b>49</b> (8.69 g, 17 mmol) in EtOH (170 mL), and the mixture was heated at reflux for 1 h and 10 min. The reaction mixture was allowed to cool to room temperature and was then filtered; the filtered solids were washed with water (2 × 30 mL) and EtOH (2 × 15 mL) and dried in vacuo to afford the title compound <b>50</b> (7.98 g, 92%) as a flocculent yellow solid: TLC <i>R</i><sub>f</sub> = 0.63 (30:70 EtOAc/hexane); LCMS <i>t</i><sub>R</sub> = 3.11 min; <i>m</i>/<i>z</i> = 508, 510[M + H]<sup>+</sup>, bromine isotope pattern observed; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.40 (t, 3H, <i>J</i> = 7.2 Hz), 4.42 (q, 2H, <i>J</i> = 7.2 Hz), 5.13 (s, 2H), 5.15 (s, 2H), 6.58 (s, 1H), 7.00 (s, 1H), 7.32–7.44 (m, 10H), 8.15 (s, 1H); <sup>13</sup>C ΝΜR (100.62 MHz, CDCl<sub>3</sub>) δ 14.1, 62.0, 71.0, 71.0, 99.5, 102.9, 103.8, 110.4, 126.9, 127.3, 128.3, 128.6, 128.7, 128.9, 131.5, 135.4, 135.6, 155.7, 156.9, 157.3, 160.2.</div></div><div id="sec5_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 5-(2,4-Bis(benzyloxy)-5-bromophenyl)isoxazole-3-carboxylic Acid Ethylamide (51)</h3><div class="NLM_p last">Ethylamine in MeOH solution (2.0M, 65 mL, 130 mmol) was added to a suspension of <b>50</b> (7.89 g, 15.5 mmol) in EtOH (80 mL), and the mixture was heated to reflux for 18 h, affording a homogeneous solution which was allowed to cool to ambient temperature. A colorless precipitate formed, which was filtered, washed with EtOH, and dried in vacuo to afford the title compound <b>51</b> (6.31 g, 80%) as a colorless solid: TLC <i>R</i><sub>f</sub> = 0.39 (30:70 EtOAc/hexane); LCMS <i>t</i><sub>R</sub> = 2.98 min; <i>m</i>/<i>z</i> = 509, 507[M + H]<sup>+</sup>, bromine isotope pattern observed; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.25 (t, 3H, <i>J</i> = 7.3 Hz), 3.48 (dt, 2H, <i>J</i> = 7.3, 5.3 Hz), 5.10 (s, 2H), 5.16 (s, 2H), 6.56 (s, 1H), 6.82 (brt, 1H, <i>J</i> = 5.4 Hz), 7.08 (s, 1H) 7.30–7.42 (m, 10H), 8.12 (s, 1H).</div></div><div id="sec5_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 5-(2,4-Bis(benzyloxy)-5-styrylphenyl)isoxazole-3-carboxylic Acid Ethylamide (34a)</h3><div class="NLM_p last"><i>trans</i>-2-Phenylvinylboronic acid (472 mg, 3.2 mmol) was added to <b>51</b> (1.079 g, 2.13 mmol) and NaHCO<sub>3</sub> (536 mg, 6.39 mmol). Water (5 mL) and DMF (25 mL) were added, and the mixture was degassed by evacuation−nitrogen purge followed by bubbling nitrogen gas through the reaction mixture for 5 min. Dichlorobis(triphenylphosphine)palladium(II) chloride (149 mg, 5 mol%) was added, and the reaction mixture was heated at 80 °C for 7 h. The mixture was allowed to cool, and the majority of solvents was removed in vacuo. The residual mixture was partitioned between dichloromethane (200 mL) and water (200 mL), and this mixture was then filtered through a pad of Celite 521. The filtrate phases were separated, and the organic phase was washed with water (2 × 50 mL) and saturated aqueous NaCl solution (100 mL) and then dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and filtered. The filtrate solvents were evaporated in vacuo, and the crude product was purified by trituration with a hexane/EtOAc mixture (9:1) to afford the title compound <b>34a</b> (808 mg, 71%) as a light-brown solid: TLC <i>R</i><sub>f</sub> = 0.40 (30:70 EtOAc/hexane); LCMS <i>t</i><sub>R</sub> = 3.13 min; <i>m</i>/<i>z</i> = 531[M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.27 (t, 3H, <i>J</i> = 7.3 Hz), 3.50 (dq, 2H, <i>J</i> = 7.3, 5.4 Hz), 5.11 (s, 2H), 5.19 (s, 2H), 6.57 (s, 1H), 6.83 (brt, 1H, <i>J</i> = 5.5 Hz), 7.10 (s, 1H), 7.17 (d, 1H, <i>J</i> = 16.5 Hz), 7.23 (m, 1H), 7.31–7.45 (m, 13H), 7.48–7.52 (m, 2H), 8.21 (s, 1H).</div></div><div id="sec5_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> 5-(2,4-Bis(benzyloxy)-5-phenethylphenyl)isoxazole-3-carboxylic Acid Ethylamide (34b)</h3><div class="NLM_p last">Compound <b>34a</b> (690 mg, 1.30 mmol) was dissolved in 1,4-dioxane, and 10% palladium on carbon catalyst (50 mg) was added. The reaction mixture was hydrogenated at atmospheric pressure for a total of 4 h and 45 min, with further catalyst (50 mg) added at 1.5 and 4.0 h. The reaction mixture was filtered through a pad of Celite 521, and the filter cake was washed with 1,4 dioxane and dichloromethane. The combined filtrate solvents were removed in vacuo to leave a cream-colored solid, which was adsorbed onto silica gel and purified by flash chromatography on silica gel (20 g), eluting with a gradient of 10–50% EtOAc in hexane. This afforded the title compound <b>34a</b> (609 mg, 88%) as a pale-yellow solid: TLC <i>R</i><sub>f</sub> = 0.43 (30:70 EtOAc/hexane); LCMS <i>t</i><sub>R</sub> = 3.12 min; <i>m</i>/<i>z</i> = 533[M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.09 (t, 3H, <i>J</i> = 7.1 Hz), 2.79–2.89 (m, 4H), 3.25 (dq, 2H, <i>J</i> = 7.1, 5.8 Hz), 5.23 (s, 2H), 5.35 (s, 2H), 6.85 (s, 1H), 7.08 (s, 1H), 7.13–7.19 (m, 2H), 7.21–7.27 (m, 2H), 7.34–7.46 (m, 6H), 7.47–7.53 (m, 4H), 7.66 (s, 1H), 8.75 (brt, 1H, <i>J</i> = 5.8 Hz).</div></div><div id="sec5_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> 5-(2,4-Bis(benzyloxy)-5-phenethylphenyl)-4-bromoisoxazole-3-carboxylic Acid Ethylamide (35b)</h3><div class="NLM_p last"><i>N</i>-bromosuccinimide (207 mg, 1.16 mmol) was added to a stirred suspension of <b>34b</b> (564 mg, 1.06 mmol) in acetonitrile (230 mL). Ceric ammonium nitrate (290 mg, 0.53 mmol) was added, and the mixture was heated to reflux for 30 min. Acetonitrile was removed in vacuo, and the residue was partitioned between EtOAc (50 mL) and water (50 mL). The organic phase was washed with saturated aqueous NaCl solution and dried over Na<sub>2</sub>SO<sub>4</sub> and filtered. The filtrate solvents were removed in vacuo to afford a yellow oil, which was purified by flash chromatography on silica gel (20 g), eluting with a gradient of 10–30% EtOAc in hexane. This afforded the title compound <b>35b</b> (326 mg, 53%) as a colorless solid: LCMS <i>t</i><sub>R</sub> = 3.09 min; <i>m</i>/<i>z</i> = 613, 611[M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.11 (t, 3H, <i>J</i> = 7.3 Hz), 2.82 (m, 4H), 3.27 (q, 2H, <i>J</i> = 7.3 Hz), 5.24 (s, 2H), 5.25 (s, 1H), 7.09 (s, 1H), 7.12–7.10 (m, 3H), 7.22–7.27 (m, 2H), 7.29 (s, 1H), 7.30–7.50 (m, 10H), 8.93 (t, 1H, <i>J</i> = 5.8 Hz); <sup>13</sup>C ΝΜR (100.62 MHz, CDCl<sub>3</sub>) δ 14.4, 31.2, 33.7, 35.5, 69.8, 70.1, 90.9, 99.0, 99.9, 106.0, 122.3, 127.9, 128.1, 128.3, 128.3, 128.5, 128.6, 131.3, 136.5, 136.7, 141.6, 156.1, 158.0, 157.6, 159.6, 166.8.</div></div><div id="sec5_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> 5-(2,4-Dihydroxy-5-phenethylphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic Acid Ethylamide (40b)</h3><div class="NLM_p last">This compound was made using the procedure described for <b>30c</b>, utilizing 5-(2,4-bis(benzyloxy)-5-phenethylphenyl)-4-bromoisoxazole-3-carboxylic acid ethylamide (<b>35b</b>) and 4-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)benzyl]morpholine. Thus, <b>35b</b> (374 mg, 0.576 mmol) was reacted with boronate ester (215 mg, 0.72 mmol), and the resulting crude product after workup was purified by flash chromatography on silica gel, eluting with a gradient of 50–100% EtOAc in hexane. Deprotection with BCl<sub>3</sub>, as described previously, gave a crude product, which was purified by flash chromatography on silica gel, eluting with 10% MeOH in EtOAc, to afford title compound <b>40b</b> as a light-brown oil. The HCl salt was made by trituration with 1.0 M HCl in ether solution, affording the title compound <b>40b</b>·HCl (19 mg, 6%) as a light-brown solid: LCMS <i>t</i><sub>R</sub> = 2.02 min; <i>m</i>/<i>z</i> = 528[M + H]<sup>+</sup>; purity 90–95%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.11 (t, 3H, <i>J</i> = 6.9 Hz), 2.60–2.70 (m, 4H), 3.00–3.30 (m, 4H), 3.69 (m, 2H), 3.87 (m, 2H), 4.3 (m, 2H), 6.45 (s, 1H), 6.84 (s, 1H), 7.11–7.32 (m, 6H), 7.46–7.65 (m, 3H), 8.93 (brt, 1H), 9.67 (s, 1H), 9.90 (s, 1H), 10.73 (brs, 1H); HRMS calcd for C<sub>31</sub>H<sub>33</sub>N<sub>3</sub>O<sub>5</sub>[M + H]<sup>+</sup> 528.2498, found 528.2486.</div></div><div id="sec5_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> 1-(2,4-Dihydroxyphenyl)-2-methylpropane-1-one (53)</h3><div class="NLM_p last">Resorcinol (2.42 g, 22 mmol) was taken up in BF<sub>3</sub>·OEt<sub>2</sub> (15 mL), and isobutyric acid (2.04 mL, 22 mmol) was added. The solution was heated for 1.5 h at 90 °C and then allowed to cool to room temperature. The solution was added dropwise to 10% NaOAc(aq) (100 mL) and allowed to stand for 4 h before being extracted in EtOAc. The organic phases were combined and washed with saturated NaHCO<sub>3</sub>(aq), dried over anhydrous MgSO<sub>4</sub>, filtered, and concentrated in vacuo to give the title compound <b>53</b> (3.96 g, 100%) as a red oil, which was used without additional purification: LCMS <i>t</i><sub>R</sub> = 2.28 min; <i>m</i>/<i>z</i> = 181[M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.18 (d, 6H, <i>J</i> = 6.8 Hz), 3.49 (m, 1H), 6.38 (m, 1H), 7.24 (s, 1H), 7.64 (d, 1H, <i>J</i> = 9.6 Hz), 13.06 (s, 1H).</div></div><div id="sec5_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> 4-Isobutylbenzene-1,3-diol (54)</h3><div class="NLM_p last">Ethyl chloroformate (6.3 mL, 66 mmol) was added slowly to a cooled (0 °C) solution of compound <b>53</b> (3.96 g, 22 mmol) and triethylamine (9.2 mL, 66 mmol) in THF (50 mL). The mixture was warmed to ambient temperature and stirred for 3 h before being filtered, and the solids were washed with cold THF (10 mL). The combined filtrates were cooled to 0 °C, and sodium borohydride (3.35 g, 88 mmol) in water (60 mL) was added slowly. The mixture was warmed to ambient temperature, stirred for 3 h, and diluted with water. The mixture was twice extracted with diethyl ether, and the combined extracts were concentrated to dryness and resuspended in 10% aqueous sodium hydroxide solution (40 mL). After refluxing for 90 min, the mixture was cooled, acidified with 5.0 M aqueous HCl, and twice extracted with diethyl ether. The organic extracts were dried over anhydrous MgSO<sub>4</sub> and filtered, and the solvents were removed in vacuo to give 4-isobutylbenzene-1,3-diol <b>54</b> (3.61 g, 98%) as a cloudy oil, which was used without further purification: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 0.89 (d, 6H, <i>J</i> = 6.8 Hz), 1.85 (m, 1H), 2.37 (d, 2H, <i>J</i> = 7.2 Hz), 6.31 (m, 2H), 7.24 (s, 1H), 6.87 (d, 1H, <i>J</i> = 8.1 Hz).</div></div><div id="sec5_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> 1-(2,4-Bis(benzyloxy)-5-isobutylphenyl)ethanone (55)</h3><div class="NLM_p last">4-Isobutylbenzene-1,3-diol (<b>54</b>) (3.61 g, 21.7 mmol) was dissolved in BF<sub>3</sub>·OEt<sub>2</sub> (16 mL), and acetic acid (2.48 mL, 43.4 mmol) was added. The solution was heated for 16 h at 90 °C and then allowed to cool to room temperature. The solution was added dropwise to 10% NaOAc(aq) and allowed to stand for 4 h before being extracted twice with diethyl ether. The organic phases were combined and washed with saturated NaHCO<sub>3</sub>(aq), dried over anhydrous MgSO<sub>4</sub>, filtered, and concentrated in vacuo to give 6-acetyl-4-isobutylresorcinol, which was dissolved in DMF (50 mL). Potassium carbonate (12.7 g, 92 mmol) and then benzyl bromide (11 mL, 92 mmol) were added. The suspension was heated, with stirring to 150 °C, under nitrogen for 16 h. The solution was cooled to room temperature, filtered, and concentrated in vacuo. The resulting solid was purified by flash column chromatography on silica gel, eluting with hexane/EtOAc (4:1), and then recrystallized from the EtOAc/hexane mixture to give the title compound <b>55</b> (2.14 g, 25%) as colorless crystals: LCMS <i>t</i><sub>R</sub> = 3.03 min; <i>m</i>/<i>z</i> = 389.3[M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 0.91 (d, 6H, <i>J</i> = 8.8 Hz), 1.85 (m, 1H), 2.41 (d, 2H, <i>J</i> = 6.8 Hz), 2.54 (s, 3H), 6.36 (s, 1H), 7.39 (s, 1H).</div></div><div id="sec5_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> 4-(2,4-Bis(benzyloxy)-5-isobutylphenyl)-2-hydroxy-4-oxobut-2-enoic Acid Ethyl Ester (56)</h3><div class="NLM_p last">This compound was made using the procedure described for compound <b>12</b>. Thus, <b>55</b> (2.14 g, 5.51 mmol) was reacted with sodium ethoxide and diethyl oxalate to afford title compound <b>56</b> (1.55 g, 58%) as a yellow solid, used without further purification: LCMS <i>t</i><sub>R</sub> = 3.25 min; <i>m</i>/<i>z</i> = 489.3[M + H]<sup>+</sup>.</div></div><div id="sec5_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> 5-(2,4-Bis(benzyloxy)-5-isobutylphenyl)isoxazole-3-carboxylic Acid Ethyl Ester (57)</h3><div class="NLM_p last">This compound was made using the procedure described for <b>23</b>. Thus, compound <b>56</b> (0.73 g, 1.52 mmol) was reacted with hydroxylamine hydrochloride to afford title compound <b>57</b> (0.73 g, 74%) as a colorless solid: LCMS <i>t</i><sub>R</sub> = 3.26 min; <i>m</i>/<i>z</i> = 486.3[M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 0.90 (d, 6H, <i>J</i> = 6.6 Hz), 1.38 (t, 3H, <i>J</i> = 7.1 Hz), 1.91 (m, 1H), 2.51 (d, 2H, <i>J</i> = 7.1 Hz), 4.40 (q, 2H, <i>J</i> = 7.1 Hz), 5.03 (s, 2H), 5.13 (s, 2H), 6.54 (s, 1H), 6.97 (s, 1H), 7.37 (m, 10 H), 7.71 (s, 1H).</div></div><div id="sec5_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> 5-(2,4-Bis(benzyloxy)-5-isobutylphenyl)isoxazole-3-carboxylic Acid Ethyl Amide (34e)</h3><div class="NLM_p last">Compound <b>57</b> (0.73 g, 1.52 mmol) was dissolved in ethylamine in MeOH solution (2.0 M, 7.6 mL, 15.2 mmol) and heated in a Smith microwave synthesizer at 120 °C for 10 min. The solution was concentrated in vacuo to give the title compound <b>34e</b> (0.73 g, 100%) as a colorless solid, which was used without additional purification: LCMS <i>t</i><sub>R</sub> = 3.11 min; <i>m</i>/<i>z</i> = 485.3[M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 0.89 (d, 6H, <i>J</i> = 6.6 Hz), 1.23 (t, 3H, <i>J</i> = 7.1 Hz), 1.92 (m, 1H), 2.49 (d, 2H, <i>J</i> = 7.3 Hz), 3.46 (dt, 2H, <i>J</i> = 5.7 Hz, 7.1 Hz), 5.00 (s, 2H), 5.14 (s, 2H), 6.52 (s, 1H), 6.79 (1H, bt, <i>J</i> = 5.7 Hz), 7.04 (s, 1H), 7.35 (m, 10 H), 7.67 (s, 1H).</div></div><div id="sec5_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> 5-(2,4-Bis(benzyloxy)-5-isobutylphenyl)-4-iodoisoxazole-3-carboxylic Acid Ethyl Amide (35e)</h3><div class="NLM_p last">Compound <b>34e</b> (0.63 g, 1.30 mmol) and <i>N</i>-iodosuccinimide (0.58 g, 2.6 mmol) were dissolved in acetonitrile (50 mL), ceric ammonium nitrate (0.07 g, 0.13 mmol) was added, and the solution was stirred at room temperature overnight. The reaction mixture was concentrated in vacuo, and the resulting gum was partitioned between EtOAc and saturated aqueous NaCl solution. The organic phase was dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was purified by column chromatography on silica gel, eluting with 4:1 hexane/EtOAc, to give the title compound <b>35e</b> (0.43 g, 54%) as an oil: LCMS <i>t</i><sub>R</sub> = 3.09 min; <i>m</i>/<i>z</i> = 611.2[M + H]<sup>+</sup>.</div></div><div id="sec5_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> 5-(2,4-Bis(benzyloxy-5-isobutylphenyl)-4-(4-formylphenyl)isoxazole-3-carboxylic Acid Ethyl Amide (36e)</h3><div class="NLM_p last">This compound was made using the procedure described for compound <b>32</b>. Thus, compound <b>35e</b> (0.42 g, 0.69 mmol) was reacted with 4-formylphenylboronic acid (0.21 g, 1.38 mmol) to afford a crude product after workup, which was purified by flash chromatography on silica gel, eluting with 10% EtOAc in hexane, to afford the title compound <b>36e</b> (4.85 g, 58%) as a yellow solid: LCMS <i>t</i><sub>R</sub> = 5.57 min (7.5 min run time); <i>m</i>/<i>z</i> = 589.1[M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 0.79 (d, 6H, <i>J</i> = 6.8 Hz), 1.21 (t, 3H, <i>J</i> = 7.2 Hz), 1.81 (m, 1H), 2.39 (d, 2H, <i>J</i> = 7.0 Hz), 3.43 (dt, 2H, <i>J</i> = 3.7 Hz, 7.2 Hz), 4.67 (s, 2H), 4.96 (s, 2H), 6.41 (s, 1H), 6.87 (brt, 1H, <i>J</i> = 3.7 Hz), 6.98 (m, 2H), 7.06 (s, 1H), 7.25 (m, 2 H), 7.33 (m, 6H), 7.38 (d, 2H, <i>J</i> = 8.2 Hz), 7.67 (d, 2H, <i>J</i> = 8.2 Hz), 9.92 (s, 1H).</div></div><div id="sec5_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> 5-(2,4-Dihydroxy-5-isobutylphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic Acid Ethylamide (40e)</h3><div class="NLM_p last">This compound was made using the procedure described for compound <b>30f</b>, using morpholine in reaction with compound <b>36e</b> (0.13 g, 0.22 mmol). The crude product after debenzylation was purified by preparative HPLC to afford the title compound <b>40e</b> as a colorless solid: LCMS <i>t</i><sub>R</sub> = 2.17 min; <i>m</i>/<i>z</i> = 480[M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 0.72 (d, 6H, <i>J</i> = 6.6 Hz), 1.17 (t, 3H, <i>J</i> = 7.3 Hz), 1.68 (m, 1H), 2.20 (d, 2H, <i>J</i> = 7.1 Hz), 2.60 (m, 4H), 3.38 (m, 2H), 3.57 (s, 2H), 3.68 (m, 4H), 6.11 (s, 1H), 6.81 (s, 1H), 6.85 (t, 1H, <i>J</i> = 5.8 Hz), 7.20 (d, 2H, <i>J</i> = 8.1 Hz), 7.25 (d, 2H, <i>J</i> = 8.1 Hz); <sup>13</sup>C ΝΜR (100.6 MHz, CDCl<sub>3</sub>) 14.5 (CH<sub>3</sub>), 22.4 (CH<sub>3</sub>), 28.4 (CH), 34.5 (CH<sub>2</sub>), 38.4 (CH<sub>2</sub>), 52.9 (CH<sub>2</sub>), 62.6 (CH<sub>2</sub>), 65.7 (CH<sub>2</sub>), 104.0 (CH), 105.6 (C), 115.8 (C), 120.7 (C), 129.7 (C), 129.9 (CH), 130.2 (CH), 132.1 (CH), 133.5 (C), 153.8 (C), 156.1 (C), 157.8 (C), 159.7 (C), 167.6 (C); HRMS calcd for C<sub>27</sub>H<sub>33</sub>N<sub>3</sub>O<sub>5</sub>[M + H]<sup>+</sup> 480.2498, found 480.2485; HPLC 93% (<i>t</i><sub>R</sub> = 4.61 min).</div></div><div id="sec5_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> 2,4-Bis(benzyloxy)-1-isopropenylbenzene (58)</h3><div class="NLM_p last">Methyltriphenylphosphonium bromide (64.99 g, 0.182 mol) was suspended in anhydrous THF (300 mL), and the mixture was cooled to 0 °C under a nitrogen atmosphere. <i>n</i>-Butyllithium (1.6 M solution in hexanes, 114 mL, 0.182 mol) was added dropwise, and the resulting mixture was stirred at 0 °C for 30 min. A solution of 1-(2,4-bis(benzyloxy)phenyl)ethanone (<b>47</b>) (46.78 g, 0.14 mol) in anhydrous THF (150 mL) was then added dropwise to the reaction mixture. When the addition was complete, the ice bath was removed, and the reaction mixture was stirred at room temperature under nitrogen for 18 h. MeOH (100 mL) was added to the reaction mixture, and the resulting solution was evaporated in vacuo. Hexane was added to the resulting oil, and the mixture was heated to reflux for 30 min and then filtered through a pad of Celite 521. The liquors were combined and were evaporated in vacuo to give an oil, which was purified by flash column chromatography on silica gel, eluting with 5% EtOAc in hexane, to give the title compound <b>58</b> (37.15 g, 80%) as a colorless oil: TLC <i>R</i><sub>f</sub> = 0.73 (25:75 EtOAc/hexane); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.12 (s, 3H), 5.03 (s, 2H), 5.05 (s, 2H), 5.07 (brs, 2H), 6.54 (dd, 1H, <i>J</i> = 8.3 Hz, 2.5 Hz), 6.59 (d, 1H, <i>J</i> = 2.5 Hz), 7.14 (d, 1H, <i>J</i> = 8.3 Hz). 7.29–7.44 (m, 10H).</div></div><div id="sec5_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> 4-Isopropylbenzene-1,3-diol (59)</h3><div class="NLM_p last">Compound <b>58</b> (37.15 g, 0.113 mol) was dissolved in EtOH (300 mL) and carefully added to 10% palladium on carbon, which had been prewetted with water under a nitrogen atmosphere. Hydrogen was introduced to the flask, and the mixture was allowed to shake under a positive hydrogen atmosphere for 16 h. The catalyst was filtered from the reaction mixture, and the filtrate solvents were removed in vacuo to give the title compound <b>59</b> (12.05 g, 70%) as a white crystalline solid: LCMS <i>t</i><sub>R</sub> = 2.08 min; <i>m</i>/<i>z</i> = 153.1[M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.22 (d, 6H, <i>J</i> = 7.1 Hz), 3.09 (sept, 1H, <i>J</i> = 7.1 Hz), 4.63 (brs, 1H), 4.74 (brs, 1H), 6.29 (d, 1H, <i>J</i> = 2.5 Hz), 6.38 (dd, 1H, <i>J</i> = 8.3, 2.5 Hz), 7.03 (d, 1H, <i>J</i> = 8.3 Hz).</div></div><div id="sec5_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> 1-(2,4-Dihydroxy-5-isopropylphenyl)ethanone (60)</h3><div class="NLM_p last">4-Isopropylbenzene-1,3-diol (<b>59</b>) (12.05 g, 0.079 mol) was dissolved in BF<sub>3</sub>·OEt<sub>2</sub> (60 mL, 0.486 mol) and acetic acid (9 mL, 0.157 mol) was added. The solution was heated for 16 h at 90 °C, allowed to cool to room temperature, added dropwise to 10% NaOAc(aq) solution (1000 mL), and allowed to stand for 4 h before being extracted with EtOAc (2 × 200 mL). The organic phases were combined and washed with saturated NaHCO<sub>3</sub>(aq), dried over MgSO<sub>4</sub> and filtered, and the filtrate solvents were removed in vacuo. The residual oil was triturated with cold hexane to afford the title compound <b>60</b> (13.57 g, 88%) as an off-white solid: LCMS <i>t</i><sub>R</sub> = 2.63 min; <i>m</i>/<i>z</i> = 195.1[M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.25 (d, 6H, <i>J</i> = 6.8 Hz), 2.57 (s, 3H), 3.13 (sept, 1H, <i>J</i> = 6.8 Hz), 5.64 (s, 1H), 6.30 (s, 1H), 7.50 (s, 1H), 12.56 (s, 1H).</div></div><div id="sec5_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> 1-(2,4-Bis(benzyloxy)-5-isopropylphenyl)ethanone (61)</h3><div class="NLM_p last">1-(2,4-Dihydroxy-5-isopropylphenyl)ethanone (<b>60</b>) (13.57 g, 0.070 mol) was dissolved in DMF (120 mL), and potassium carbonate (21.27 g, 0.154 mol) and benzyl bromide (18.3 mL, 0.154 mol) were added. The resulting suspension was heated, with stirring, to 150 °C under a nitrogen atmosphere for 16 h. The solution was cooled to room temperature, and the mixture was poured into 1.0 M HCl(aq) (1000 mL) and then extracted with EtOAc (2 × 300 mL). The organic phases were combined and washed with 1.0 M HCl(aq) and saturated NaCl(aq) solution (3 × 300 mL). The organic phase was dried over MgSO<sub>4</sub> and filtered, and the filtrate solvents were removed in vacuo to give a solid, which was purified by trituration with diethyl ether/hexane (1:1) to give the title compound <b>61</b> (23.10 g, 88%) as a colorless solid: LCMS <i>t</i><sub>R</sub> = 3.03 min; <i>m</i>/<i>z</i> = 375.2[M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.22 (d, 6H, <i>J</i> = 6.9 Hz), 2.56 (s, 3H), 3.28 (sept, 1H, <i>J</i> = 6.9 Hz), 5.08 (s, 2H), 5.10 (s, 2H), 6.51 (s, 1H), 7.31–7.44 (m, 10H), 7.76 (s, 1H).</div></div><div id="sec5_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> 4-(2,4-Bis(benzyloxy)-5-isopropylphenyl)-2-hydroxy-4-oxobut-2-enoic Acid Ethyl Ester (62)</h3><div class="NLM_p last">Sodium hydride (60% in mineral oil) (2.19 g, 54.9 mmol) was added to an ice-cold homogeneous solution of 1-(2,4-bis(benzyloxy)-5-isopropylphenyl)ethanone (<b>61</b>) (13.65 g, 36.5 mmol) in toluene (200 mL). Diethyl oxalate (5.0 mL, 36.8 mmol) was added, and the reaction mixture was heated to reflux for 4 h. The mixture was allowed to cool to room temperature, and 1.0 M HCl(aq) (600 mL) was added to acidify the reaction mixture. Solvents were removed in vacuo, and the resulting gum was partitioned between dichloromethane and saturated NaCl(aq) solution. The phases were separated, and the organic phase was dried over MgSO<sub>4</sub> and filtered, and the filtrate solvents were removed in vacuo to afford an orange gum, which slowly crystallized. Trituration with hexane and filtration afforded the title compound <b>62</b> (14.94 g, 86%) as a yellow−orange crystalline solid: LCMS <i>t</i><sub>R</sub> = 3.06 min; <i>m</i>/<i>z</i> = 475[M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.23 (d, 6H, <i>J</i> = 6.8 Hz), 1.28 (t, 3H, <i>J</i> = 7.1 Hz), 3.29 (sept, 1H, <i>J</i> = 6.8 Hz), 4.28 (q, 2H, <i>J</i> = 7.1 Hz), 5.11 (s, 2H), 5.14 (s, 2H), 6.53 (s, 1H), 7.32–7.46 (m, 11H), 7.87 (s, 1H).</div></div><div id="sec5_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> 5-(2,4-Bis(benzyloxy)-5-isopropylphenyl)isoxazole-3-carboxylic Acid Ethyl Ester (63)</h3><div class="NLM_p last">Compound <b>62</b> (14.94 g, 31.5 mmol) was dissolved in EtOH (150 mL), hydroxylamine hydrochloride (2.63 g, 37.8 mmol) was added, and the solution was heated to reflux for 4 h under a nitrogen atmosphere. The reaction mixture was cooled to room temperature and concentrated in vacuo. The residue was partitioned between dichloromethane and saturated NaCl(aq) solution. The organic phase was dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo to give a yellow solid, which was triturated with an EtOH/water mix, filtered, and dried to afford the title compound <b>62</b> (13.5 g, 91%) as a yellow solid: LCMS <i>t</i><sub>R</sub> = 3.20 min; <i>m</i>/<i>z</i> = 472[M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.26 (d, 6H, <i>J</i> = 6.8 Hz), 1.41 (t, 3H, <i>J</i> = 7.1 Hz), 3.34 (sept, 1H, <i>J</i> = 6.8 Hz), 4.42 (q, 2H, <i>J</i> = 7.1 Hz), 5.07 (s, 2H), 5.16 (s, 2H), 6.57 (s, 1H), 7.00 (s, 1H), 7.32–7.43 (m, 10H), 7.83 (s, 1H); <sup>13</sup>C NMR (100.6 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.9 (CH<sub>3</sub>), 22.4 (CH<sub>3</sub>), 26.2 (CH), 61.7 (CH<sub>2</sub>), 69.8 (CH<sub>2</sub>), 70.4 (CH<sub>2</sub>), 98.8 (CH), 101.5 (CH), 107.2 (C), 124.0 (CH), 127.5 (CH), 128.0 (CH), 128.0 (CH), 128.2 (CH), 128.6 (CH), 128.6 (CH), 129.3 (C), 136.3 (C), 136.7 (C), 154.9 (C), 156.5 (C), 158.6 (C), 159.4 (C), 167.8 (C).</div></div><div id="sec5_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> 5-(2,4-Bis(benzyloxy)-5-isopropylphenyl)isoxazole-3-carboxylic Acid Ethylamide (34f)</h3><div class="NLM_p last">Compound <b>63</b> (13.57 g, 28.8 mmol) was suspended in ethylamine in MeOH solution (2.0M, 140 mL, 280 mmol) and heated to 90 °C for 1 h to afford a homogeneous solution. The solution was allowed to cool to room temperature, and a colorless solid precipitated. The solid was collected by filtration, washed with cold MeOH, and dried in vacuo to afford title compound <b>63</b> (11.5 g, 85%) as a colorless solid: LCMS <i>t</i><sub>R</sub> = 3.06 min; <i>m</i>/<i>z</i> = 471[M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ.1.25 (d, 6H, <i>J</i> = 6.8 Hz), 1.26 (t, 3H, <i>J</i> = 7.0 Hz), 3.33 (sept, 1H, <i>J</i> = 6.9 Hz), 3.49 (m, 2H), 5.03 (s, 2H), 5.17 (s, 2H), 6.55 (s, 1H), 6.81 (brt, 1H, <i>J</i> = 5.7 Hz), 7.07 (s, 1H), 7.30–7.42 (m, 10H), 7.78 (s, 1H).</div></div><div id="sec5_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> 5-(2,4-Bis(benzyloxy)-5-isopropylphenyl)-4-iodoisoxazole-3-carboxylic Acid Ethylamide (35f)</h3><div class="NLM_p last">Compound <b>34f</b> (11.94 g, 25.4 mmol) was dissolved in a mixture of anhydrous acetonitrile (150 mL) and dichloromethane (60 mL), <i>N</i>-iodosuccinimide (11.44 g, 50.8 mmol) was added followed by ceric ammonium nitrate (0.697 g, 1.27 mmol), and the solution was stirred at room temperature overnight. The reaction mixture was concentrated in vacuo, and the resulting gum was partitioned between EtOAc and saturated NaCl(aq) solution. The organic phase was dried over MgSO<sub>4</sub> and filtered, and the filtrate solvents were removed in vacuo. The residue was purified by column chromatography, eluting with 9:1 hexane/EtOAc, to give the title compound <b>35f</b> (9.1 g, 60%) as a pale-yellow solid: LCMS <i>t</i><sub>R</sub> = 2.97 min; <i>m</i>/<i>z</i> = 597.2[M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ.1.23 (d, 6H, <i>J</i> = 6.8 Hz), 1.26 (t, 3H, <i>J</i> = 7.3 Hz), 3.35 (sept, 1H, <i>J</i> = 6.8 Hz), 3.50 (m, 2H), 5.05 (s, 2H), 5.09 (s, 2H), 6.58 (s, 1H), 6.80 (brt, 1H, <i>J</i> = 5.7 Hz), (s, 1H), 7.28–7.41 (m, 11H).</div></div><div id="sec5_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> 5-(2,4-Bis(benzyloxy)-5-isopropylphenyl)-4-(4-formylphenyl)isoxazole-3-carboxylic Acid Ethylamide (36f)</h3><div class="NLM_p last">This compound was made using the procedure described for compound <b>32</b>. Thus, compound <b>35f</b> (9.0 g, 15.1 mmol) was reacted with 4-formylphenyl boronic acid (4.53 g, 30.2 mmol) to afford a crude product after workup, which was purified by flash chromatography on silica gel, eluting with dichloromethane, to afford the title compound <b>36f</b> (6.0 g, 69% yield) as a yellow solid: LCMS <i>t</i><sub>R</sub> = 2.98 min; <i>m</i>/<i>z</i> = 575.3[M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.04 (d, 6H, <i>J</i> = 6.8 Hz), 1.08 (t, 3H, <i>J</i> = 7.1 Hz), 3.16 (sept, 1H, <i>J</i> = 6.8 Hz), 3.23 (m, 2H), 4.95 (s, 2H), 5.18 (s, 2H), 6.93 (s, 1H), 7.05 (m, 2H), 7.12 (s, 1H), 7.25–7.29 (m, 3H), 7.32–7.37 (m, 3H), 7.39–7.47 (m, 4H), 7.78 (d, 2H, <i>J</i> = 8.3 Hz), 8.95 (brt, 1H, <i>J</i> = 5.6 Hz), 9.98 (s, 1H); <sup>13</sup>C NMR (100.6 MHz, DMSO-<i>d</i><sub>6</sub>) δ 14.3 (CH<sub>3</sub>), 22.3 (CH<sub>3</sub>), 25.8 (CH), 33.8 (CH<sub>2</sub>), 69.7 (CH<sub>2</sub>), 69.9 (CH<sub>2</sub>), 98.9 (CH), 107.2 (C), 115.0 (C), 127.3 (CH), 127.5 (CH), 127.8 (CH), 127.9 (CH), 127.9 (CH), 128.2 (CH), 128.5 (CH), 128.9 (C), 129.2 (CH), 129.3 (CH), 135.0 (C), 135.8 (C), 136.3 (C), 136.7 (C), 155.2 (C), 157.6 (C), 158.5 (C), 159.2 (C), 165.7 (C), 192.6 (CH).</div></div><div id="sec5_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> 5-(2,4-Dihydroxy-5-isopropylphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic Acid Ethylamide (40f)</h3><div class="NLM_p last">This compound was made using the procedure described for compound <b>30f</b>, using morpholine in reaction with compound <b>36f</b>. The crude product after debenzylation was purified by flash chromatography (eluting with a gradient of 2–4% MeOH in dichloromethane) to afford the title compound as a colorless solid: LCMS <i>t</i><sub>R</sub> = 1.99 min; <i>m</i>/<i>z</i> = 466.3[M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.90 (d, 6H, <i>J</i> = 7.1 Hz), 1.07 (t, 3H, <i>J</i> = 7.4 Hz), 2.33 (brm, 4H), 2.97 (sept, 1H, <i>J</i> = 7.1 Hz), 3.22 (m, 2H), 3.42 (s, 2H), 3.55 (brm, 4H), 6.43 (s, 1H), 6.72 (s,1H), 7.18 (d, 2H, <i>J</i> = 8.4 Hz), 7.23 (d, 2H, <i>J</i> = 8.4 Hz), 8.83 (brt, 1H, <i>J</i> = 5.9 Hz), 9.65 (s, 1H), 9.76 (s, 1H); <sup>13</sup>C NMR (100.6 MHz, DMSO-<i>d</i><sub>6</sub>) δ 14.4 (CH<sub>3</sub>), 22.4 (CH<sub>3</sub>), 25.4 (CH), 33.7 (CH<sub>2</sub>), 53.1 (CH<sub>2</sub>), 62.1 (CH<sub>2</sub>), 66.2 (CH<sub>2</sub>), 102.7 (CH), 104.5 (C), 114.7 (C), 125.6 (C), 127.7 (CH), 128.5 (C), 128.7 (CH), 128.8 (CH), 136.9 (C), 154.7 (C), 157.4 (C), 157.8 (C), 159.8 (C), 166.3 (C); HRMS calcd for C<sub>26</sub>H<sub>31</sub>N<sub>3</sub>O<sub>5</sub>[M + Na]<sup>+</sup> 488.2161, found 488.2162; HPLC 96% (<i>t</i><sub>R</sub> = 4.90 min).</div></div><div id="sec5_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> 1-(5-Ethyl-2,4-dihydroxyphenyl)ethanone (65d)</h3><div class="NLM_p last">4-Ethylresorcinol (<b>64</b>) (6.23 g, 45.1 mmol) was dissolved in BF<sub>3</sub>·OEt<sub>2</sub> (50 mL) and acetic acid (5.42 g, 90.3 mmol) and stirred at 90 °C for 12 h. The reaction was cooled to room temperature and quenched with water (200 mL), and the reaction mixture pH was adjusted to pH = 3 with Na<sub>2</sub>CO<sub>3</sub>. The red precipitate was filtered and recrystallized from toluene (53 mL) to yield the title compound <b>65d</b> (5.63 g, 69%) as a light-pink crystalline solid: LCMS <i>t</i><sub>R</sub> = 2.26 min; <i>m</i>/<i>z</i> = 181.2[M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.12 (t, 3H, <i>J</i> = 7.5 Hz), 2.48 (q, 2H, <i>J</i> = 7.5 Hz), 2.52 (s, 3H), 6.29 (s, 1H), 7.58 (s, 1H), 10.61 (s, 1H), 12.49 (s, 1H).</div></div><div id="sec5_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> 1-(2,4-Bis(benzyloxy)-5-ethylphenyl)ethanone (66d)</h3><div class="NLM_p last">Compound <b>65d</b> (5.63 g, 31.24 mmol) was dissolved in DMF (100 mL). K<sub>2</sub>CO<sub>3</sub> (9.50 g, 68.7 mmol) and benzyl bromide (11.76 g, 68.7 mmol) were added, and the reaction mixture was stirred at room temperature for 3 h. The mixture was poured into water (300 mL), and the off-white precipitate was filtered off and recrystallized from acetonitrile (50 mL) to yield the title compound <b>66d</b> (7.85 g, 70%) as a colorless solid: LCMS <i>t</i><sub>R</sub> = 2.98 min; <i>m</i>/<i>z</i> = 361.2[M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.12 (t, 3H, <i>J</i> = 7.5 Hz), 2.49 (s, 3H), 2.56 (q, 2H, <i>J</i> = 7.5 Hz), 5.01 (s, 2H), 5.02 (s, 2H), 6.43 (s, 1H), 7.26–7.35 (m, 10H), 7.63 (s, 1H); <sup>13</sup>C NMR (100.6 MHz, CDCl<sub>3</sub>) δ 14.2 (CH<sub>3</sub>), 22.1 (CH<sub>2</sub>), 32.0 (CH<sub>3</sub>), 69.7 (CH<sub>2</sub>), 70.5 (CH<sub>2</sub>), 98.3 (CH), 119.7 (C), 124.22 (C), 127.5 (CH), 128.0 (CH), 128.0 (CH), 128.1 (CH), 128.6 (CH), 128.6 (CH), 130.2 (CH), 136.5 (C), 136.7 (C), 158.4 (C), 160.6 (C), 196.2 (C).</div></div><div id="sec5_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> 4-(2,4-Bis(benzyloxy)-5-ethylphenyl)-2-hydroxy-4-oxobut-2-enoic Acid Ethyl Ester (67d)</h3><div class="NLM_p last">Sodium (1.5 g, 65.2 mmol) was added in small pieces to absolute EtOH (200 mL) under nitrogen over a period of 20–30 min. When all of the sodium had reacted, compound <b>66d</b> (7.85 g, 21.8 mmol) and diethyl oxalate (4.77 g, 32.67 mmol) were added, and the mixture was heated at reflex for 3 h. The reaction was allowed to cool to room temperature and quenched with 2 N aqueous hydrochloric acid (33 mL). The yellow precipitate was filtered, washed with water, and dried in vacuo to afford the title compound <b>67d</b> (9.41 g, 94%) as a yellow solid: LCMS <i>t</i><sub>R</sub> = 3.14 min; <i>m</i>/<i>z</i> = 461.3[M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.46 (t, 3H, <i>J</i> = 7.5 Hz), 1.53 (t, 3H, <i>J</i> = 7.1 Hz), 2.90 (q, 2H, <i>J</i> = 7.5 Hz), 4.53 (q, 2H, <i>J</i> = 7.1 Hz), 5.36 (s, 2H), 5.38 (s, 2H), 6.77 (s, 1H), 7.59–7.70 (m, 11H), 8.06 (s, 1H), 15.62 (s, 1H); <sup>13</sup>C NMR (100.6 MHz, CDCl<sub>3</sub>) δ 13.8 (CH<sub>3</sub>), 14.0 (CH<sub>3</sub>), 22.1 (CH<sub>2</sub>), 61.8 (CH<sub>2</sub>), 69.9 (CH<sub>2</sub>), 70.8 (CH<sub>2</sub>), 98.5 (CH), 102.6 (CH), 115.7 (C), 125.1 (C), 127.6 (CH), 127.9 (CH), 128.1 (CH), 128.1 (CH), 128.6 (CH), 128.6 (CH), 130.2 (CH), 136.0 (C), 136.5 (C), 159.1 (C), 161.9 (C), 162.0 (C), 167.7 (C), 188.8 (C).</div></div><div id="sec5_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> 5-(2,4-Bis(benzyloxy)-5-ethylphenyl)isoxazole-3-carboxylic Acid Ethyl Ester (68d)</h3><div class="NLM_p last">Compound <b>67d</b> (4.0 g, 8.69 mmol) was suspended in EtOH (90 mL), and hydroxylamine hydrochloride (0.905 g, 13.0 mmol) was added. The reaction mixture was heated to reflux for 1.5 h, allowed to cool to room temperature, and poured into water (100 mL); the resulting off-white precipitate was filtered and recrystallized from EtOH (100 mL) to yield the title compound <b>68d</b> (3.51 g, 88%) as a white solid: LCMS <i>t</i><sub>R</sub> = 3.16 min; <i>m</i>/<i>z</i> = 458.3[M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.39 (t, 3H, <i>J</i> = 7.5), 1.56 (t, 3H, <i>J</i> = 7.1 Hz), 2.84 (q, 2H, <i>J</i> = 7.5 Hz), 4.58 (q, 2H, <i>J</i> = 7.1 Hz), 5.22 (s, 2H), 5.32 (s, 2H), 6.73 (s, 1H), 7.16 (s, 1H), 7.48–7.58 (m, 10H), 7.95 (s, 1H); <sup>13</sup>C NMR (100.6 MHz, CDCl<sub>3</sub>) δ 13.9 (CH<sub>3</sub>), 14.3 (CH<sub>3</sub>), 22.3 (CH<sub>2</sub>), 61.7 (CH<sub>2</sub>), 69.7 (CH<sub>2</sub>), 70.5 (CH<sub>2</sub>), 98.6 (CH), 101.5 (CH), 107.1 (C), 125.0 (C), 126.8 (CH), 127.5 (CH), 128.0 (CH), 128.0 (CH), 128.2 (CH), 128.6 (CH), 128.7 (CH), 136.3 (C), 136.7 (C), 155.1 (C), 156.5 (C), 159.1 (C), 159.5 (C), 167.8 (C).</div></div><div id="sec5_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> 5-(2,4-Bis(benzyloxy)-5-ethylphenyl)isoxazole-3-carboxylic Acid Ethylamide (34d)</h3><div class="NLM_p last">Compound <b>68d</b> (1.8 g, 3.93mmol) was suspended in EtOH (23 mL), ethylamine solution (2.0 M in MeOH, 15.7 mL, 31.4 mmol) was added, and the reaction mixture was heated to reflux for 3 h. The reaction was allowed to cool to room temperature and poured into water (50 mL), and the resulting white precipitate was filtered, washed with water, and recrystallized from EtOH (37 mL) to yield the title compound <b>34d</b> (1.53 g, 85%) as a colorless flaky solid: LCMS <i>t</i><sub>R</sub> = 3.01 min; <i>m</i>/<i>z</i> = 457.3[M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.10 (t, 3H, <i>J</i> = 7.2 Hz), 1.14 (t, 3H, <i>J</i> = 7.5 Hz), 2.60 (q, 2H, <i>J</i> = 7.5 Hz), 3.26 (m, 2H), 5.23 (s, 2H), 5.34 (s, 2H), 6.87 (s, 1H), 7.04 (s, 1H), 7.35–7.50 (m, 10H), 7.66 (s, 1H), 8.75 (t, 1H, <i>J</i> = 5.8 Hz); <sup>13</sup>C NMR (100.6 MHz, DMSO-<i>d</i><sub>6</sub>) δ 14.3 (CH<sub>3</sub>), 14.6 (CH<sub>3</sub>), 22.3 (CH<sub>2</sub>), 33.7 (CH<sub>2</sub>), 69.6 (CH<sub>2</sub>), 70.2 (CH<sub>2</sub>), 98.7 (CH), 100.7 (CH), 107.5 (C), 124.9 (C), 127.0 (CH), 127.5 (CH), 127.9 (CH), 128.0 (CH), 128.2 (CH), 128.6 (CH), 128.7 (CH), 136.4 (C), 136.7 (C), 154.9 (C), 158.4 (C), 158.95 (C), 159.4 (C), 167.0 (C).</div></div><div id="sec5_59" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> 5-(2,4-Bis(benzyloxy)-5-ethylphenyl)-4-iodoisoxazole-3-carboxylic Acid Ethylamide (35d)</h3><div class="NLM_p last">Compound <b>34d</b> (33.96 g, 74.38 mmol) was dissolved in acetonitrile (400 mL) and dichloromethane (250 mL). <i>N</i>-Iodosuccinimide (33.47 g, 148.77 mmol) and ceric ammonium nitrate (20.39 g, 37.19 mmol) were added, and the reaction was stirred at room temperature for 6 h. The solvent was removed under reduced pressure, and the residue was partitioned between dichloromethane and aqueous Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub> solution. The organic phase was washed with water and saturated NaCl(aq) and dried over Na<sub>2</sub>SO<sub>4</sub>. The solvents were removed in vacuo, and the residue was triturated with EtOH to afford title compound <b>35d</b> (16.43 g, 38%) as a yellow solid: LCMS <i>t</i><sub>R</sub> = 2.96 min; <i>m</i>/<i>z</i> = 583.2[M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.20 (t, 3H, <i>J</i> = 7.5 Hz), 1.25 (t, 3H, <i>J</i> = 7.3 Hz), 2.65 (q, 2H, <i>J</i> = 7.5 Hz), 3.46–3.53 (m, 2H), 5.01 (s, 2H), 5.04 (s, 2H), 6.58 (s, 1H), 6.80 (t, 1H, <i>J</i> = 5.2 Hz), 7.27 (s, 1H), 7.28–7.39 (m, 10H); <sup>13</sup>C NMR (100.6 MHz, CDCl<sub>3</sub>) δ 14.00 (CH<sub>3</sub>), 14.6 (CH<sub>3</sub>), 22.5 (CH<sub>2</sub>), 34.4 (CH<sub>2</sub>), 56.87 (C), 70.0 (CH<sub>2</sub>), 71.0 (CH<sub>2</sub>), 98.5 (CH), 107.8 (C), 125.6 (C), 127.0 (CH), 127.1 (CH), 127.9 (CH), 128.0 (CH), 128.6 (CH), 128.7 (CH), 131.3 (CH), 136.5 (C), 136.5 (C), 156.0 (C), 156.4 (C), 158.4 (C), 159.5 (C), 172.0 (C).</div></div><div id="sec5_60" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> 5-(2,4-Bis(benzyloxy)-5-ethylphenyl)-4-(4-formylphenyl)isoxazole-3-carboxylic Acid Ethylamide (36d)</h3><div class="NLM_p last">Compound <b>35d</b> (1.41 g, 2.42 mmol) was dissolved in THF (20 mL). 4-Formylphenylboronic acid (544 mg, 3.63 mmol),[1,1′-bis(diphenylphospino)ferrocene]dichloropalladium(II) (0.090 g, 0.12 mmol) and NaHCO<sub>3</sub> (1.0 M in water, 4.84 mL, 4.84 mmol) were added, and the mixture was degassed with nitrogen. The reaction was stirred at 80 °C for 8 h and then cooled to room temperature. Water and EtOAc were added, the phases were separated, and the organic phase was washed with water (2 ×) and then saturated NaCl(aq) solution. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and filtered through a silica plug. The solvent was removed in vacuo, and the residual solid was triturated with diethyl ether, filtered, and dried to afford the title compound <b>36d</b> (0.99 g, 74%) as a pink solid: LCMS <i>t</i><sub>R</sub> = 2.90 min; <i>m</i>/<i>z</i> = 561.2[M + H]<sup>+</sup>; <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.04 (t, 3H, <i>J</i> = 7.5 Hz), 1.11 (t, 3H, <i>J</i> = 7.0 Hz), 2.50 (q, 2H, <i>J</i> = 7.5 Hz), 3.32–3.41 (m, 2H), 4.55 (s, 2H), 4.89 (s, 2H), 6.31 (s, 1H), 6.72 (s, 1H), 6.85–6.87 (m, 2H), 7.12 (s, 1H), 7.15–7.17 (m, 2H), 7.23–7.32 (m, 8H), 7.59 (d, 2H, <i>J</i> = 8.4 Hz), 9.86 (s, 1H); <sup>13</sup>C NMR (100.6 MHz, CDCl<sub>3</sub>) δ 13.9 (CH<sub>3</sub>), 14.3 (CH<sub>3</sub>), 21.9 (CH<sub>2</sub>), 33.8 (CH<sub>2</sub>), 69.5 (CH<sub>2</sub>), 69.8 (CH<sub>2</sub>), 98.7 (CH), 107.1 (C), 115.0 (C), 124.5 (C), 127.2 (CH), 127.5 (CH), 127.7 (CH), 127.9 (CH), 128.2 (CH), 128.5 (CH), 129.1 (CH), 129.1 (CH), 130.3 (CH), 134.9 (C), 135.7 (C), 136.1 (C), 136.6 (C), 155.2 (C), 157.6 (C), 159.0 (C), 159.1 (C), 165.4 (C), 192.5 (CH).</div></div><div id="sec5_61" class="NLM_sec NLM_sec_level_2"><div id="ac_i88" class="anchor-spacer"></div><h3 class="article-section__title" id="_i88"> 5-(2,4-Dihydroxy-5-ethylphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic Acid Ethylamide (40d)</h3><div class="NLM_p last">This compound was made using the procedure described for compound <b>30f</b>, using morpholine in reaction with compound <b>36d</b>. The crude product after debenzylation was purified by preparative HPLC to afford the title compound <b>40d</b> (15.3 mg, 69%) as an off-white solid: LCMS <i>t</i><sub>R</sub> = 1.78 min; <i>m</i>/<i>z</i> = 452.2[M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.93 (t, 3H, <i>J</i> = 7.5 Hz), 1.07 (t, 3H, <i>J</i> = 7.2 Hz), 2.30–2.35 (m, 6H), 3.23 (m, 2H), 3.42 (s, 2H), 3.55 (m, 4H), 6.42 (d, 1H, <i>J</i> = 2.4 Hz), 6.77 (s, 1H), 7.17–7.23 (m, 4H), 8.86 (t, 1H, <i>J</i> = 5.7 Hz), 9.61 (bs, 1H), 9.74 (bs, 1H); <sup>13</sup>C NMR (100.6 MHz, DMSO-<i>d</i><sub>6</sub>) δ 14.0 (CH<sub>3</sub>), 14.4 (CH<sub>3</sub>), 21.6 (CH<sub>2</sub>), 33.8 (CH<sub>2</sub>), 53.2 (CH<sub>2</sub>), 62.1 (CH<sub>2</sub>), 66.2 (CH<sub>2</sub>), 102.6 (CH), 104.6 (C), 114.9 (C), 121.2 (C), 128.4 (C), 128.6 (2 × CH), 130.3 (CH), 136.8 (C), 154.9 (C), 157.8 (C), 158.0 (C), 159.8 (C), 166.0 (C); HRMS calcd for C<sub>25</sub>H<sub>29</sub>N<sub>3</sub>O<sub>5</sub>[M + H]<sup>+</sup> 452.2185, found 452.2182; HPLC 97% (<i>t</i><sub>R</sub> = 3.97 min).</div></div><div id="sec5_62" class="NLM_sec NLM_sec_level_2"><div id="ac_i89" class="anchor-spacer"></div><h3 class="article-section__title" id="_i89"> 1-(5-<i>tert</i>-Butyl-2,4-dihydroxyphenyl)ethanone (65g)</h3><div class="NLM_p last">Sulfuric acid (4 mL, 75 mmol) was added to a suspension of 2,4-dihydroxyacetophenone (<b>46</b>) (22.8 g, 150 mmol) in a mixture of 2-methyl-2-propanol (35 g, 470 mmol) and trifluoroacetic acid (80 mL) under a nitrogen atmosphere. The resulting suspension was heated at 75 °C (oil bath temperature) for 3 h, generating a pale-red solution, which was allowed to cool to ambient temperature and then poured into an ice/water mixture (350 mL) to give a pale-pink precipitate. The solids were removed by filtration, washed with water (600 mL) and hexane (200 mL), and then dried in vacuo (at 40 °C) to give the title compound <b>65g</b> (28.8 g, 92%) as a pale-orange powder: LCMS <i>t</i><sub>R</sub> = 2.74 min; <i>m</i>/<i>z</i> = 209.1[M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.39 (s, 9H), 2.58 (s, 3H), 6.27 (s, 1H), 7.59 (s, 1H).</div></div><div id="sec5_63" class="NLM_sec NLM_sec_level_2"><div id="ac_i90" class="anchor-spacer"></div><h3 class="article-section__title" id="_i90"> 1-(2,4-Bis(benzyloxy)-5-<i>tert</i>-butylphenyl)ethanone (66g)</h3><div class="NLM_p last">Benzyl bromide (10 mL, 84 mmol) was added to a solution of <b>65g</b> (13.5 g, 65 mmol) in DMF (50 mL). Potassium carbonate (20 g, 145 mmol) was added, and the suspension was stirred at room temperature for 4 h. The resulting suspension was poured into water (200 mL) to give a pale-orange precipitate. The solids were removed by filtration, washed with water, and then dissolved in dichloromethane (150 mL), and the solution was washed with water (2 × 100 mL) and saturated NaCl(aq) solution (100 mL). The solution was dried over anhydrous, and the solvents were removed in vacuo to afford a pale-red oil. Benzylation was not complete at this stage, the crude product was dissolved in 2-methyl-2-propanol (100 mL), and potassium <i>tert</i>-butoxide (7.5 g, 67 mmol) was added to give a pale-yellow precipitate. Benzyl bromide (8 mL, 67 mmol) was added, and the mixture was heated at reflux for 1 h. The resulting suspension was allowed to cool and was poured into water (250 mL) to give a pale-orange precipitate. The solids were removed by filtration, washed with water, dissolved in EtOAc (150 mL), and washed sequentially with water (2 × 200 mL) and saturated NaCl(aq) solution (100 mL). The solution was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and filtered, and the filtrate solvents were removed in vacuo. Trituration with EtOH afforded a pale-pink solid, which was collected by filtration and dried in vacuo (at 40 °C) to give the title compound <b>66g</b> (9.1 g, 36%) as a pale-pink powder: LCMS <i>t</i><sub>R</sub> = 3.03 min; <i>m</i>/<i>z</i> = 389.3[M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.38 (s, 9H), 2.57 (s, 3H), 5.08 (s, 2H), 5.11 (s, 2H), 6.53 (s, 1H), 7.33–7.42 (m, 10 H), 7.85 (s, 1H).</div></div><div id="sec5_64" class="NLM_sec NLM_sec_level_2"><div id="ac_i91" class="anchor-spacer"></div><h3 class="article-section__title" id="_i91"> 4-(2,4-Bis(benzyloxy)-5-<i>tert</i>-butylphenyl)-2-hydroxy-4-oxobut-2-enoic Acid Ethyl Ester (67g)</h3><div class="NLM_p last">Sodium ethoxide (2.8 g, 41 mmol) was added to a suspension of <b>66g</b> (7.8 g, 20 mmol) in EtOH (40 mL). Diethyl oxalate (4 mL, 29.5 mmol) was added, and the resulting suspension was heated at reflux for 2 h to give a pale-red solution, which was allowed to cool and then poured into water (200 mL). The mixture was acidified with hydrochloric acid (50 mL, 1.0 M) and extracted with dichloromethane (150 mL). The organic extracts were washed with water (2 × 200 mL) and then saturated aqueous NaCl solution (100 mL). The organic solution was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and filtered, and the filtrate solvents were removed in vacuo to afford a yellow gum. Trituration with hexane gave a yellow solid, which was filtered, washed with hexane, and then dried in vacuo (at 40 °C) to afford the title compound <b>67g</b> (9.1 g, 93%) as a yellow powder: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.26 (t, 3H, <i>J</i> = 7.1 Hz), 1.39 (s, 9H), 4.28 (q, 2H, <i>J</i> = 7.1 Hz), 5.11 (s, 2H), 5.13 (s, 2H), 6.54 (s, 1H), 7.34–7.45 (m, 11H), 7.96 (s, 1H).</div></div><div id="sec5_65" class="NLM_sec NLM_sec_level_2"><div id="ac_i92" class="anchor-spacer"></div><h3 class="article-section__title" id="_i92"> 5-(2,4-Bis(benzyloxy)-5-<i>tert</i>-butylphenyl)isoxazole-3-carboxylic Acid Ethyl Ester (68g)</h3><div class="NLM_p last">Hydroxylamine hydrochloride (3.6 g, 52 mmol) was added to a solution of <b>67g</b> (9.0 g, 18.5 mmol) in EtOH (75 mL), and the suspension was heated at reflux for 4 h. The resulting solution was allowed to cool and poured into water (200 mL) to give an off-white precipitate. The solids were removed by filtration and then dissolved in dichloromethane (150 mL). The solution was washed with water (150 mL) and then saturated aqueous NaCl solution (50 mL). The organic phase was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and filtered, and the filtrate solvents were removed in vacuo to afford an off-white solid, which was washed with hexane and dried in vacuo (at 40 °C) to give the title compound <b>68g</b> (8.0 g, 89%) as a pale-brown powder: LCMS <i>t</i><sub>R</sub> = 3.13 min; <i>m</i>/<i>z</i> = 486.5[M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.41 (t, 3H, <i>J</i> = 7.1 Hz), 1.41 (s, 9H), 4.43 (q, 2H, <i>J</i> = 7.1 Hz), 5.09 (s, 2H), 5.15 (s, 2H), 6.59 (s, 1H), 7.00 (s, 1H), 7.33–7.43 (m, 10H), 7.93 (s, 1H).</div></div><div id="sec5_66" class="NLM_sec NLM_sec_level_2"><div id="ac_i93" class="anchor-spacer"></div><h3 class="article-section__title" id="_i93"> 5-(2,4-Bis(benzyloxy)-5-<i>tert</i>-butylphenyl)isoxazole-3-carboxylic Acid Ethylamide (34g)</h3><div class="NLM_p last">This compound was made using the procedure described for compound <b>34d</b>. Thus, <b>68g</b> (10.0 g, 20.6 mmol) was reacted with ethylamine in MeOH solution (2.0 M) to afford the title compound as a brown solid (9.9 g, 100%): LCMS <i>t</i><sub>R</sub> = 3.02 min; <i>m</i>/<i>z</i> = 485.3[M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.26 (t, 3H, <i>J</i> = 7.1 Hz), 1.41 (s, 9H), 3.49 (dq, 2H, <i>J</i> = 7.1, 5.4 Hz), 5.06 (s, 2H), 5.15 (s, 2H), 6.57 (s, 1H), 6.85 (brt, 1H, <i>J</i> = 5.4 Hz), 7.08 (s, 1H), 7.3–7.4 (m, 10H), 7.88 (s, 1H).</div></div><div id="sec5_67" class="NLM_sec NLM_sec_level_2"><div id="ac_i94" class="anchor-spacer"></div><h3 class="article-section__title" id="_i94"> 5-(2,4-Bis(benzyloxy)-5-<i>tert</i>-butylphenyl)-4-iodoisoxazole-3-carboxylic Acid Ethylamide (35g)</h3><div class="NLM_p last">This compound was made using the procedure described for compound <b>35d</b>. Thus, <b>34g</b> (9.9 g, 20.4 mmol) was reacted with NIS and CAN to afford the title compound <b>35g</b> (7.75, 62%) as an off-white powder: LCMS <i>t</i><sub>R</sub> = 3.07 min; <i>m</i>/<i>z</i> = 610[M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.26 (t, 3H, <i>J</i> = 7.1 Hz), 1.41 (s, 9H), 3.50 (dq, 2H, <i>J</i> = 7.1, 5.4 Hz), 5.07 (s, 4H), 6.60 (s, 1H), 6.80 (brt, 1H, <i>J</i> = 5.4 Hz), 7.28–7.44 (m, 11H).</div></div><div id="sec5_68" class="NLM_sec NLM_sec_level_2"><div id="ac_i95" class="anchor-spacer"></div><h3 class="article-section__title" id="_i95"> 5-(2,4-Bis(benzyloxy)-5-<i>tert</i>-butylyphenyl)-4-(4-formylphenyl)isoxazole-3-carboxylic Acid Ethylamide (36g)</h3><div class="NLM_p last">Aqueous potassium phosphate solution (25 mL, 1.2 M) was added to a solution of <b>35g</b> (6.1 g, 10 mmol) and 4-formylphenyl boronic acid (2.35 g, 15.7 mmol) in 1,4-dioxane (75 mL) under a nitrogen atmosphere. Dichlorobis(tri-<i>O</i>-tolylphosphine)palladium(II) (cat.) was added, and the mixture was heated at 100 °C (oil bath temperature) for 1 h. The mixture was allowed to cool, and the aqueous layer was separated and extracted with EtOAc (100 mL). The combined organic phases were concentrated in vacuo to give a pale-brown gum, which was purified by flash column chromatography on silica gel, eluting with EtOAc/hexane (1:3), to give the title compound <b>36g</b> (5.18 g, 88%) as a pale-yellow foam: LCMS <i>t</i><sub>R</sub> = 3.01 min; <i>m</i>/<i>z</i> = 589.4[M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.26 (t, 3H, <i>J</i> = 7.1 Hz), 1.27 (s, 9H), 3.44 (dq, 2H, <i>J</i> = 7.1, 5.4 Hz), 4.67 (s, 2H), 5.00 (s, 2H), 6.44 (s, 1H), 6.82 (brt, 1H, <i>J</i> = 5.4 Hz), 7.00 (m, 2H), 7.25–7.27 (m, 4H), 7.33–7.39 (m, 5H), 7.43 (d, 2H, <i>J</i> = 6.9 Hz), 7.72 (d, 2H, <i>J</i> = 6.9 Hz), 9.96 (s, 1H).</div></div><div id="sec5_69" class="NLM_sec NLM_sec_level_2"><div id="ac_i96" class="anchor-spacer"></div><h3 class="article-section__title" id="_i96"> 5-(2,4-Dihydroxy-5-ethylphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic Acid Ethylamide (40g)</h3><div class="NLM_p last">This compound was made using the procedure described for compound <b>30f</b>, using morpholine in reaction with compound <b>36g</b>. The crude product after debenzylation was purified by preparative HPLC to afford the title compound <b>40g</b> (21 mg, 75%) as an off-white solid (formate salt): LCMS <i>t</i><sub>R</sub> = 1.97 min; <i>m</i>/<i>z</i> = 480.5[M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.05 (t, 3H, <i>J</i> = 7.2 Hz), 1.1 (s, 9H), 2.3 (brs, 4H), 3.2 (dq, 2H, <i>J</i> = 7.2 Hz, 5.6 Hz), 3.45 (brs, 4H), 6.45 (s, 1H), 6.7 (s, 1H), 7.15 (d, 2H, <i>J</i> = 7.2 Hz), 7.25 (d, 2H, <i>J</i> = 7.2 Hz), 8.8 (t, 1H, <i>J</i> = 5.6 Hz); HRMS calcd for C<sub>27</sub>H<sub>33</sub>N<sub>3</sub>O<sub>5</sub>[M + H]<sup>+</sup> 480.2483, found 480.2500; HPLC 91% (<i>t</i><sub>R</sub> = 4.65 min).</div></div><div id="sec5_70" class="NLM_sec NLM_sec_level_2"><div id="ac_i97" class="anchor-spacer"></div><h3 class="article-section__title" id="_i97"> 5-(5-Ethyl-2-hydroxy-4-methoxyphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic Acid Ethylamide (70); 5-(5-Ethyl-4-hydroxy-2-methoxyphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic Acid Ethylamide (71); 5-(5-Ethyl-2,4-dimethoxyphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic Acid Ethylamide (72)</h3><div class="NLM_p last">To an argon-charged flask containing 5-(5-ethyl-2,4-dihydroxyphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic acid ethylamide (<b>42d</b>) (25 mg, 0.055 mmol) and <i>N</i>,<i>N</i>-(diisopropyl)aminomethylpolystyrene[PS-DIEA] (35 mg, 3.83 mmol/g, 2.4 equiv) were added anhydrous DCM (2.3 mL) and anhydrous MeOH (0.25 mL). During gentle stirring, 2 M (trimethylsilyl)diazomethane in hexanes (28 µL, 1.0 equiv) was added, and the solution was stirred overnight at room temperature. Argon was bubbled through the solution for 10 min, the resin was filtered off, and the volatiles were removed in vacuo. The crude residue was purified by semipreparative HPLC to isolate the three methylated products. <b>70</b> (1.14 mg, 4%): LCMS (method B) <i>t</i><sub>R</sub> = 5.13 min; <i>m</i>/<i>z</i> = 466.3[M + H]<sup>+</sup>; <sup>1</sup>H NMR (250 MHz, acetone-<i>d</i><sub>6</sub>) δ 1.10 (t, 3H, <i>J</i> = 7.5 Hz), 1.25 (t, 3H, <i>J</i> = 7.5 Hz), 2.42 (m, 4H), 2.50 (q, 2H, <i>J</i> = 7.5 Hz), 3.10–3.40 (m, 4H), 3.45 (q, 2H, <i>J</i> = 7.5 Hz), 3.82 (s, 2H), 3.95 (s, 2H), 4.10–4.40 (m, 4H), 6.65 (s, 1H), 7.05 (s, 1H), 7.40 (d, 2H, <i>J</i> = 8.2 Hz), 7.70 (d, 2H, <i>J</i> = 8.2 Hz), 7.90 (brs, 1H), 8.75 (s, 1H); HRMS calcd for C<sub>26</sub>H<sub>32</sub>N<sub>3</sub>O<sub>5</sub>[M + H]<sup>+</sup>, 466.2342, found 466.2342. <b>71</b> (5.5 mg, 21%): LCMS (method B) <i>t</i><sub>R</sub> = 4.88 min; <i>m</i>/<i>z</i> = 466.3[M + H]<sup>+</sup>; <sup>1</sup>H NMR (250 MHz, acetone-<i>d</i><sub>6</sub>) δ 0.95 (t, 3H, <i>J</i> = 8.4 Hz), 1.06 (t, 3H, <i>J</i> = 7.1 Hz), 2.25–2.29 (m, 4H), 2.40 (q, 2H <i>J</i> = 7.6 Hz), 3.26 (q, 2H, <i>J</i> = 7.2 Hz) 3.27 (s, 3H), 3.35 (s, 2H), 3.46–3.3.49 (m, 4H), 6.42 (s, 1H), 6.95 (s, 1H), 7.12 (s, 4H), 8.00 (brs, 1H). <b>72</b>: (1.46 mg, 5%): LCMS (method B) <i>t</i><sub>R</sub> = 5.44 min; <i>m</i>/<i>z</i> = 480.3; <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 1.08 (t, 3H, <i>J</i> = 7.4 Hz), 1.19 (t, 3H, <i>J</i> = 8.1 Hz), 2.48 (brs, 4H), 2.53 (q, 2H, <i>J</i> = 8.1 Hz), 3.37 (q, 2H, <i>J</i> = 7.4 Hz), 3.48 (s, 3H), 3.54 (s, 2H), 3.69 (t, 4H, <i>J</i> = 5.4 Hz), 3.89 (s, 3H), 6.58 (s, 1H), 7.09 (s, 1H), 7.21(d, 2H, <i>J</i> = 8.1 Hz), 7.29 (d, 2H, <i>J</i> = 8.1 Hz); HRMS calcd for C<sub>27</sub>H<sub>34</sub>N<sub>3</sub>O<sub>5</sub> 480.2498[M + H]<sup>+</sup>, found 480.2492.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i99"><a href="/doi/suppl/10.1021/jm701018h">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67364" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67364" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Experimental procedures for the FP assay and synthesis of the FP assay probe. Methods and parameters relating to X-ray crystallography and protein production are also provided as are graphical representations of PK cassette dosing results for cassette 3. Full chemistry experimental procedures and characterization data are presented in this section. This information is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm701018h/suppl_file/jm701018h-file001.pdf">jm701018h-file001.pdf (3.29 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm701018h" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51402" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51402" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul A. Brough</span> - <span class="hlFld-Affiliation affiliation">Vernalis Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K., and Cancer Research U.K. Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#47376925352832202f076731223529262b2e346924282a"><span class="__cf_email__" data-cfemail="2a5a044858455f4d426a">[email protected]</span> vernalis.com</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wynne Aherne</span> - <span class="hlFld-Affiliation affiliation">Vernalis Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K., and Cancer Research U.K. Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xavier Barril</span> - <span class="hlFld-Affiliation affiliation">Vernalis Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K., and Cancer Research U.K. Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jenifer Borgognoni</span> - <span class="hlFld-Affiliation affiliation">Vernalis Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K., and Cancer Research U.K. Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kathy Boxall</span> - <span class="hlFld-Affiliation affiliation">Vernalis Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K., and Cancer Research U.K. Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Julie E. Cansfield</span> - <span class="hlFld-Affiliation affiliation">Vernalis Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K., and Cancer Research U.K. Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kwai-Ming J. Cheung</span> - <span class="hlFld-Affiliation affiliation">Vernalis Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K., and Cancer Research U.K. Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ian Collins</span> - <span class="hlFld-Affiliation affiliation">Vernalis Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K., and Cancer Research U.K. Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nicholas G. M. Davies</span> - <span class="hlFld-Affiliation affiliation">Vernalis Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K., and Cancer Research U.K. Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martin J. Drysdale</span> - <span class="hlFld-Affiliation affiliation">Vernalis Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K., and Cancer Research U.K. Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brian Dymock</span> - <span class="hlFld-Affiliation affiliation">Vernalis Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K., and Cancer Research U.K. Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Suzanne A. Eccles</span> - <span class="hlFld-Affiliation affiliation">Vernalis Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K., and Cancer Research U.K. Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Harry Finch</span> - <span class="hlFld-Affiliation affiliation">Vernalis Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K., and Cancer Research U.K. Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alexandra Fink</span> - <span class="hlFld-Affiliation affiliation">Vernalis Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K., and Cancer Research U.K. Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Angela Hayes</span> - <span class="hlFld-Affiliation affiliation">Vernalis Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K., and Cancer Research U.K. Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert Howes</span> - <span class="hlFld-Affiliation affiliation">Vernalis Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K., and Cancer Research U.K. Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Roderick E. Hubbard</span> - <span class="hlFld-Affiliation affiliation">Vernalis Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K., and Cancer Research U.K. Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karen James</span> - <span class="hlFld-Affiliation affiliation">Vernalis Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K., and Cancer Research U.K. Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Allan M. Jordan</span> - <span class="hlFld-Affiliation affiliation">Vernalis Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K., and Cancer Research U.K. Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrea Lockie</span> - <span class="hlFld-Affiliation affiliation">Vernalis Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K., and Cancer Research U.K. Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vanessa Martins</span> - <span class="hlFld-Affiliation affiliation">Vernalis Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K., and Cancer Research U.K. Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew Massey</span> - <span class="hlFld-Affiliation affiliation">Vernalis Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K., and Cancer Research U.K. Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas P. Matthews</span> - <span class="hlFld-Affiliation affiliation">Vernalis Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K., and Cancer Research U.K. Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Edward McDonald</span> - <span class="hlFld-Affiliation affiliation">Vernalis Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K., and Cancer Research U.K. Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher J. Northfield</span> - <span class="hlFld-Affiliation affiliation">Vernalis Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K., and Cancer Research U.K. Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laurence H. Pearl</span> - <span class="hlFld-Affiliation affiliation">Vernalis Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K., and Cancer Research U.K. Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chrisostomos Prodromou</span> - <span class="hlFld-Affiliation affiliation">Vernalis Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K., and Cancer Research U.K. Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stuart Ray</span> - <span class="hlFld-Affiliation affiliation">Vernalis Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K., and Cancer Research U.K. Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Florence I. Raynaud</span> - <span class="hlFld-Affiliation affiliation">Vernalis Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K., and Cancer Research U.K. Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephen D. Roughley</span> - <span class="hlFld-Affiliation affiliation">Vernalis Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K., and Cancer Research U.K. Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Swee Y. Sharp</span> - <span class="hlFld-Affiliation affiliation">Vernalis Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K., and Cancer Research U.K. Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Allan Surgenor</span> - <span class="hlFld-Affiliation affiliation">Vernalis Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K., and Cancer Research U.K. Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">D. Lee Walmsley</span> - <span class="hlFld-Affiliation affiliation">Vernalis Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K., and Cancer Research U.K. Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Webb</span> - <span class="hlFld-Affiliation affiliation">Vernalis Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K., and Cancer Research U.K. Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mike Wood</span> - <span class="hlFld-Affiliation affiliation">Vernalis Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K., and Cancer Research U.K. Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Workman</span> - <span class="hlFld-Affiliation affiliation">Vernalis Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K., and Cancer Research U.K. Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lisa Wright</span> - <span class="hlFld-Affiliation affiliation">Vernalis Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K., and Cancer Research U.K. Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i98">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28402" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28402" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors are grateful to Heather Simmonite, Tim Haymes, and Amin Mirza for analytical support, to Adam Hold for compound purification, and to Kate Grant for assay determinations. This work was supported by Cancer Research UK[CUK] program, Grant Numbers CA309/A2187 and C309/A8274. We are also grateful to our colleagues for valuable discussions. Paul Workman is a Cancer UK Life Fellow.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i100">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67180" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67180" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 59 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Young, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agashe, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegers, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartl, F. U.</span><span> </span><span class="NLM_article-title">Pathways of chaperone-mediated protein folding in the cytosol</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">781</span><span class="NLM_x">–</span> <span class="NLM_lpage">789</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm701018h&amp;key=10.1038%2Fnrm1492" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm701018h&amp;key=15459659" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm701018h&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotVSlsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=781-789&author=J.+C.+Youngauthor=V.+R.+Agasheauthor=K.+Siegersauthor=F.+U.+Hartl&title=Pathways+of+chaperone-mediated+protein+folding+in+the+cytosol"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Pathways of chaperone-mediated protein folding in the cytosol</span></div><div class="casAuthors">Young, Jason C.; Agashe, Vishwas R.; Siegers, Katja; Hartl, F. Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">781-791</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Cells are faced with the task of folding thousands of different polypeptides into a wide range of conformations.  For many proteins, the folding process requires the action of mol. chaperones.  In the cytosol of prokaryotic and eukaryotic cells, mol. chaperones of different structural classes form a network of pathways that can handle substrate polypeptides from the point of initial synthesis on ribosomes to the final stages of folding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozOmZCjGhXsbVg90H21EOLACvtfcHk0lh-fFozQ-jKkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotVSlsrg%253D&md5=e5b25a79128866bd17f7915dd6f42c6d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrm1492&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm1492%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DJ.%2BC.%26aulast%3DAgashe%26aufirst%3DV.%2BR.%26aulast%3DSiegers%26aufirst%3DK.%26aulast%3DHartl%26aufirst%3DF.%2BU.%26atitle%3DPathways%2520of%2520chaperone-mediated%2520protein%2520folding%2520in%2520the%2520cytosol%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2004%26volume%3D5%26spage%3D781%26epage%3D789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Mosser, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morimoto, R. I.</span><span> </span><span class="NLM_article-title">Molecular chaperones and the stress of oncogenesis</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">2907</span><span class="NLM_x">–</span> <span class="NLM_lpage">2918</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm701018h&amp;key=10.1038%2Fsj.onc.1207529" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm701018h&amp;key=15077153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm701018h&amp;key=1%3ACAS%3A528%3ADC%252BD2cXivFKmsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2004&pages=2907-2918&author=D.+D.+Mosserauthor=R.+I.+Morimoto&title=Molecular+chaperones+and+the+stress+of+oncogenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular chaperones and the stress of oncogenesis</span></div><div class="casAuthors">Mosser, Dick D.; Morimoto, Richard I.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2907-2918</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Protein-damaging stresses induce the expression of heat-shock proteins', which have essential roles in protecting cells from the potentially lethal effects of stress and proteotoxicity.  These stress-protective heat-shock proteins are often overexpressed in cells of various cancers and have been suggested to be contributing factors in tumorigenesis.  An underlying basis of oncogenesis is the acquisition and accumulation of mutations that provide the transformed cell with the combined characteristics of deregulated cell proliferation and suppressed cell death.  Heat-shock proteins with dual roles as regulators of protein conformation and stress sensors may therefore have intriguing and central roles in both cell proliferation and apoptosis.  It has been established that heat-shock proteins exhibit specificity to particular classes of polypeptide substrates and client proteins in vivo, and that chaperones can stabilize mutations that affect the folded conformation.  Likewise, overexpression of chaperones has also been shown to protect cells against apoptotic cell death.  The involvement of chaperones, therefore, in such diverse roles might suggest novel anticancer therapeutic approaches targeting heat-shock protein function for a broad spectrum of tumor types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXglApcXUKQrVg90H21EOLACvtfcHk0liUQ1dYddI8eQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXivFKmsLs%253D&md5=535effb8bca3679c2e29bffcb0077cc3</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1207529&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1207529%26sid%3Dliteratum%253Aachs%26aulast%3DMosser%26aufirst%3DD.%2BD.%26aulast%3DMorimoto%26aufirst%3DR.%2BI.%26atitle%3DMolecular%2520chaperones%2520and%2520the%2520stress%2520of%2520oncogenesis%26jtitle%3DOncogene%26date%3D2004%26volume%3D23%26spage%3D2907%26epage%3D2918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Whitesell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindquist, S. L.</span><span> </span><span class="NLM_article-title">HSP90 and the chaperoning of cancer</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">761</span><span class="NLM_x">–</span> <span class="NLM_lpage">772</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm701018h&amp;key=10.1038%2Fnrc1716" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm701018h&amp;key=16175177" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm701018h&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVGjs7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=761-772&author=L.+Whitesellauthor=S.+L.+Lindquist&title=HSP90+and+the+chaperoning+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">HSP90 and the chaperoning of cancer</span></div><div class="casAuthors">Whitesell, Luke; Lindquist, Susan L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">761-772</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Standing watch over the proteome, mol. chaperones are an ancient and evolutionarily conserved class of proteins that guide the normal folding, intracellular disposition and proteolytic turnover of many of the key regulators of cell growth, differentiation and survival.  This essential guardian function is subverted during oncogenesis to allow malignant transformation and to facilitate rapid somatic evolution.  Pharmacol. 'bribing' the essential guard duty of the chaperone HSP90 (heat-shock protein of 90 kDa) seems to offer a unique anticancer strategy of considerable promise.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4Vmb5bGXgDLVg90H21EOLACvtfcHk0liUQ1dYddI8eQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVGjs7bF&md5=c418ec249a29c70047081cd241938931</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrc1716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1716%26sid%3Dliteratum%253Aachs%26aulast%3DWhitesell%26aufirst%3DL.%26aulast%3DLindquist%26aufirst%3DS.%2BL.%26atitle%3DHSP90%2520and%2520the%2520chaperoning%2520of%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2005%26volume%3D5%26spage%3D761%26epage%3D772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Maloney, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">HSP90 as a new therapeutic target for cancer therapy: the story unfolds</span> <span class="citation_source-journal">Expert Opin. Biol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm701018h&amp;key=10.1517%2F14712598.2.1.3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm701018h&amp;key=11772336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm701018h&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsVaksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=3-24&author=A.+Maloneyauthor=P.+Workman&title=HSP90+as+a+new+therapeutic+target+for+cancer+therapy%3A+the+story+unfolds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">HSP90 as a new therapeutic target for cancer therapy: the story unfolds</span></div><div class="casAuthors">Maloney, Alison; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Biological Therapy</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-24</span>CODEN:
                <span class="NLM_cas:coden">EOBTA2</span>;
        ISSN:<span class="NLM_cas:issn">1471-2598</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review. Current anticancer drug-development strategies involve identifying novel mol. targets which are crucial for tumorigenesis.  The mol. chaperone heat-shock protein (HSP) 90 is of interest as an anticancer drug target because of its importance in maintaining the conformation, stability and function of key oncogenic client proteins involved in signal transduction pathways leading to proliferation, cell cycle progression, and apoptosis, as well as other features of the malignant phenotype such as invasion, angiogenesis and metastasis.  The natural-product HSP90 inhibitors geldanamycin and radicicol exert their antitumor effect by inhibiting the intrinsic ATPase activity of HSP90, resulting in degrdn. of HSP90 client proteins via the ubiquitin proteosome pathway.  Anticancer selectivity may derive from the simultaneous combinatorial effects of HSP90 inhibitors on multiple cancer targets and pathways. 17-Allylamino-17-demethoxygeldanamycin (17AAG) showed good activity and cancer selectivity in preclin. models and has now progressed to Phase I clin. trials in cancer patients with encouraging initial results.  Phase II trials including combination studies with cytotoxic agents are now being planned and these should allow the therapeutic activity of 17AAG to be detd.  Second-generation HSP90 inhibitors may be designed to overcome some of the drawbacks of 17AAG, including limited oral bioavailability and soly.  They could also be engineered to target specific functions of HSP90, which may not only provide greater mol. selectivity and clin. benefit but may also increase understanding of the complex functions of this mol. chaperone.  HSP90 inhibitors provide proof of concept for drugs directed at HSP90 and protein folding and this principle may be applicable to other medical conditions involving protein aggregation and stability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxpya4HhGPu7Vg90H21EOLACvtfcHk0liUQ1dYddI8eQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsVaksw%253D%253D&md5=b0542acde22286a95578e3ef4dac0d8e</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1517%2F14712598.2.1.3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14712598.2.1.3%26sid%3Dliteratum%253Aachs%26aulast%3DMaloney%26aufirst%3DA.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DHSP90%2520as%2520a%2520new%2520therapeutic%2520target%2520for%2520cancer%2520therapy%253A%2520the%2520story%2520unfolds%26jtitle%3DExpert%2520Opin.%2520Biol.%2520Ther.%26date%3D2002%26volume%3D2%26spage%3D3%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Kamal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, F. J.</span><span> </span><span class="NLM_article-title">Therapeutic and diagnostic implications of Hsp90 activation</span> <span class="citation_source-journal">Trends Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">283</span><span class="NLM_x">–</span> <span class="NLM_lpage">290</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=283-290&author=A.+Kamalauthor=M.+F.+Boehmauthor=F.+J.+Burrows&title=Therapeutic+and+diagnostic+implications+of+Hsp90+activation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DBoehm%26aufirst%3DM.%2BF.%26aulast%3DBurrows%26aufirst%3DF.%2BJ.%26atitle%3DTherapeutic%2520and%2520diagnostic%2520implications%2520of%2520Hsp90%2520activation%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2004%26volume%3D10%26spage%3D283%26epage%3D290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Chiosis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilenchik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solit, D.</span><span> </span><span class="NLM_article-title">Hsp90: the vulnerable chaperone</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">888</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=881-888&author=G.+Chiosisauthor=M.+Vilenchikauthor=J.+Kimauthor=D.+Solit&title=Hsp90%3A+the+vulnerable+chaperone"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChiosis%26aufirst%3DG.%26aulast%3DVilenchik%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DSolit%26aufirst%3DD.%26atitle%3DHsp90%253A%2520the%2520vulnerable%2520chaperone%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D881%26epage%3D888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Hanahan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberg, R. A.</span><span> </span><span class="NLM_article-title">The hallmarks of cancer</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm701018h&amp;key=10.1016%2FS0092-8674%2800%2981683-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm701018h&amp;key=10647931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm701018h&amp;key=1%3ACAS%3A528%3ADC%252BD3cXks1CktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2000&pages=57-70&author=D.+Hanahanauthor=R.+A.+Weinberg&title=The+hallmarks+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The hallmarks of cancer</span></div><div class="casAuthors">Hanahan, Douglas; Weinberg, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-70</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review is given with many refs. on principles governing the transformation of normal human cells into malignant cancers.  The authors suggest that research over the past decades has revealed a small no. of mol., biochem., and cellular traits (acquired capabilities) shared by most and perhaps all types of cancer.  Topics included are the acquired capabilities self-sufficiency in growth signals, insensitivity to antigrowth signals, evading apoptosis, limitless replicative potential, sustained angiogenesis, and tissue invasion and metastasis followed by genome instability as an enabling characteristic and alternative pathways to cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooXmGqKjM1C7Vg90H21EOLACvtfcHk0lgTXRCUR9T0dQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXks1CktA%253D%253D&md5=1d23c4400dad34c7f32d4a0c41890349</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2981683-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252981683-9%26sid%3Dliteratum%253Aachs%26aulast%3DHanahan%26aufirst%3DD.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26atitle%3DThe%2520hallmarks%2520of%2520cancer%26jtitle%3DCell%26date%3D2000%26volume%3D100%26spage%3D57%26epage%3D70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">DeBoer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meulman, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wnuk, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, D. H.</span><span> </span><span class="NLM_article-title">Geldanamycin, a new antibiotic</span> <span class="citation_source-journal">J. Antibiot. (Tokyo)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1970</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">442</span><span class="NLM_x">–</span> <span class="NLM_lpage">447</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm701018h&amp;key=10.7164%2Fantibiotics.23.442" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm701018h&amp;key=5459626" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm701018h&amp;key=1%3ACAS%3A528%3ADyaE3MXhtFyltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1970&pages=442-447&author=C.+DeBoerauthor=P.+A.+Meulmanauthor=R.+J.+Wnukauthor=D.+H.+Peterson&title=Geldanamycin%2C+a+new+antibiotic"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Geldanamycin, a new antibiotic</span></div><div class="casAuthors">De Boer, Clarence; Meulman, P. A.; Wnuk, R. J.; Peterson, Durey Harold</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antibiotics</span>
        (<span class="NLM_cas:date">1970</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">442-7</span>CODEN:
                <span class="NLM_cas:coden">JANTAJ</span>;
        ISSN:<span class="NLM_cas:issn">0021-8820</span>.
    </div><div class="casAbstract">Geldanamycin, an antibiotic isolated in cryst. form from culture filtrates of Streptomyces hygroscopicus, was moderately active in vitro against protozoa, bacteria, and fungi.  Geldanamycin was also active against L-1210 and KB tumor cells growing in culture and against the parasite Syphacia obvelata in vivo.  Phys. and chem. properties indicated that geldanamycin is a complex mol. consisting of an unsatd. moiety attached to a quinone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpu-1yq8CsQ5bVg90H21EOLACvtfcHk0lgTXRCUR9T0dQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3MXhtFyltQ%253D%253D&md5=c3b43c17ee1cdafdf44ffbe0ae1348f7</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.7164%2Fantibiotics.23.442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7164%252Fantibiotics.23.442%26sid%3Dliteratum%253Aachs%26aulast%3DDeBoer%26aufirst%3DC.%26aulast%3DMeulman%26aufirst%3DP.%2BA.%26aulast%3DWnuk%26aufirst%3DR.%2BJ.%26aulast%3DPeterson%26aufirst%3DD.%2BH.%26atitle%3DGeldanamycin%252C%2520a%2520new%2520antibiotic%26jtitle%3DJ.%2520Antibiot.%2520%2528Tokyo%2529%26date%3D1970%26volume%3D23%26spage%3D442%26epage%3D447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Supko, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grever, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malspeis, L.</span><span> </span><span class="NLM_article-title">Preclinical pharmacologic evaluation of geldanamycin as an antitumor agent</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">305</span><span class="NLM_x">–</span> <span class="NLM_lpage">315</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm701018h&amp;key=10.1007%2FBF00689048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm701018h&amp;key=7628050" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm701018h&amp;key=1%3ACAS%3A528%3ADyaK2MXnsFShtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1995&pages=305-315&author=J.+G.+Supkoauthor=R.+L.+Hickmanauthor=M.+R.+Greverauthor=L.+Malspeis&title=Preclinical+pharmacologic+evaluation+of+geldanamycin+as+an+antitumor+agent"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical pharmacologic evaluation of geldanamycin as an antitumor agent</span></div><div class="casAuthors">Supko, Jeffrey G.; Hickman, Robert L.; Grever, Michael R.; Malspeis, Louis</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">305-15</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The plasma pharmacokinetics of the antitumor antibiotic geldanamycin (GM; NSC 122750), a naturally occurring benzoquinoid ansamycin, were characterized in mice and a beagle dog.  Concns. of GM well above 0.1 μg/mL, which were typically effective against neoplastic cell lines responsive to the drug in vitro, were achieved in the plasma of the mice and the dog treated by i.v. injection.  However, the systemic duration of the drug was relatively short.  Plasma levels decayed to <0.1 μg/mL within 3-4 h after administration of the apparent max. tolerated doses, which were approx. 20 mg/kg for the mice and 4 mg/kg for the dog.  The drug exhibited linear pharmacokinetic behavior within the dose ranges studied.  However, there were significant interspecies differences in its disposition.  Whereas the mean biol. half-life of GM was slightly longer in the mice (77.7 min) than in the dog (57.9 min), its mean residence time in the dog (46.6 min) was >2-fold greater than that in the mice (20.7 min).  Nevertheless, the drug was cleared from plasma much faster by the dog (49.4 mL/min/kg) than by the mice (30.5 mL/min/kg).  These apparent anomalies were principally assocd. with differences in the relative significance of the terminal phase upon overall drug disposition.  The liver appeared to be the principal target organ of acute drug toxicity in the dog.  Doses of 2.0 and 4.2 mg/kg both produced elevations in serum levels of the transaminases and other indicators of liver function characteristic of acute hepatic necrosis.  Addnl. effects included symptoms of minor gastrointestinal toxicity and alterations in serum chem. parameters consistent with less severe nephrotoxicity.  The drug-related toxicity appeared to be reversible.  In consideration of the potential for acute hepatotoxic reactions to GM, as well as to the other benzoquinoid ansamycins based upon structural analogy, addnl. pharmacol. and therapeutic information is required to ascertain whether these compds. are viable candidates for clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9-P4wBmA1f7Vg90H21EOLACvtfcHk0lgTXRCUR9T0dQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXnsFShtLs%253D&md5=cde4aa9e616ff38b67dafed67b05d174</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1007%2FBF00689048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00689048%26sid%3Dliteratum%253Aachs%26aulast%3DSupko%26aufirst%3DJ.%2BG.%26aulast%3DHickman%26aufirst%3DR.%2BL.%26aulast%3DGrever%26aufirst%3DM.%2BR.%26aulast%3DMalspeis%26aufirst%3DL.%26atitle%3DPreclinical%2520pharmacologic%2520evaluation%2520of%2520geldanamycin%2520as%2520an%2520antitumor%2520agent%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D1995%26volume%3D36%26spage%3D305%26epage%3D315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Neckers, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulte, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mimnaugh, E.</span><span> </span><span class="NLM_article-title">Geldanamycin as a potential anti-cancer agent: its molecular target and biochemical activity</span> <span class="citation_source-journal">Invest. New Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">361</span><span class="NLM_x">–</span> <span class="NLM_lpage">373</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm701018h&amp;key=10.1023%2FA%3A1006382320697" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm701018h&amp;key=10759403" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm701018h&amp;key=1%3ACAS%3A528%3ADC%252BD3cXisFShtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1999&pages=361-373&author=L.+Neckersauthor=T.+W.+Schulteauthor=E.+Mimnaugh&title=Geldanamycin+as+a+potential+anti-cancer+agent%3A+its+molecular+target+and+biochemical+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Geldanamycin as a potential anticancer agent: Its molecular target and biochemical activity</span></div><div class="casAuthors">Neckers, Len; Schulte, Theodor W.; Mimnaugh, Edward</div><div class="citationInfo"><span class="NLM_cas:title">Investigational New Drugs</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">361-373</span>CODEN:
                <span class="NLM_cas:coden">INNDDK</span>;
        ISSN:<span class="NLM_cas:issn">0167-6997</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">A review with 116 refs. Heat shock protein 90 (Hsp90) is one of the most abundant cellular proteins.  Although its functions are still being characterized, it appears to serve as a chaperone for a growing list of cell signaling proteins, including many tyrosine and serine/threonine kinases, involved in proliferation and/or survival.  The benzoquinone ansamycin geldanamycin has been shown to bind to Hsp90 and to specifically inhibit this chaperone's function, resulting in client protein destabilization.  Its ability to simultaneously stimulate depletion of multiple oncogenic proteins suggests that geldanamycin, or other mols. capable of targeting Hsp90 in cancer cells, may be of clin. benefit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruKnQUuvE6HLVg90H21EOLACvtfcHk0lgTXRCUR9T0dQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXisFShtb0%253D&md5=bb021e72d31a0f93d17aefc88c8da725</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1023%2FA%3A1006382320697&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1006382320697%26sid%3Dliteratum%253Aachs%26aulast%3DNeckers%26aufirst%3DL.%26aulast%3DSchulte%26aufirst%3DT.%2BW.%26aulast%3DMimnaugh%26aufirst%3DE.%26atitle%3DGeldanamycin%2520as%2520a%2520potential%2520anti-cancer%2520agent%253A%2520its%2520molecular%2520target%2520and%2520biochemical%2520activity%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D1999%26volume%3D17%26spage%3D361%26epage%3D373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Delmotte, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delmotte-Plaque, J.</span><span> </span><span class="NLM_article-title">A new antifungal substance of fungal origin</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1953</span><span class="NLM_x">, </span> <span class="NLM_volume">171</span><span class="NLM_x">, </span> <span class="NLM_fpage">344</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=1953&pages=344&author=P.+Delmotteauthor=J.+Delmotte-Plaque&title=A+new+antifungal+substance+of+fungal+origin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDelmotte%26aufirst%3DP.%26aulast%3DDelmotte-Plaque%26aufirst%3DJ.%26atitle%3DA%2520new%2520antifungal%2520substance%2520of%2520fungal%2520origin%26jtitle%3DNature%26date%3D1953%26volume%3D171%26spage%3D344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Soga, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiotsu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akinaga, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S. V.</span><span> </span><span class="NLM_article-title">Development of radicicol analogues</span> <span class="citation_source-journal">Curr. Cancer Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">369</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm701018h&amp;key=10.2174%2F1568009033481859" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm701018h&amp;key=14529387" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm701018h&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnsV2is74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=359-369&author=S.+Sogaauthor=Y.+Shiotsuauthor=S.+Akinagaauthor=S.+V.+Sharma&title=Development+of+radicicol+analogues"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Development of radicicol analogues</span></div><div class="casAuthors">Soga, Shiro; Shiotsu, Yukimasa; Akinaga, Shiro; Sharma, Sreenath V.</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">359-369</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Radicicol, a macrocyclic antibiotic produced by fungi, was originally isolated many years ago, and was described as tyrosine kinase inhibitor.  We also rediscovered radicicol as an inhibitor of signal transduction of oncogene products, such as K-ras and v-Src, using yeast and mammalian cell-based assays.  In a study of mechanisms of action, it was revealed that radicicol depletes the Hsp90 client signaling mols. in cells, and thus inhibit the signal transduction pathway.  In addn., direct binding of radicicol to the N-terminal ATP/ADP binding site of Hsp90 was shown, and thus radicicol has been recognized as a structurally unique antibiotic that binds and inhibits the mol. chaperone Hsp90.  Although radicicol itself has little or no activity in animals because of instability in animals, its oxime derivs. showed potent antitumor activities against human tumor xenograft models.  Hsp90 client proteins were depleted and apoptosis was induced in the tumor specimen treated with radicicol oxime derivs.  Taken together, these results suggest that the antitumor activity of radicicol oxime derivs. is mediated by binding to Hsp90 and destabilization of Hsp90 client proteins in the tumor.  Among Hsp90 clients, we focused on ErbB2 and Bcr-Abl as examples of important targets of Hsp90 inhibitors.  Radicicol oxime showed potent antitumor activity against ER neg./ErbB2 overexpressing breast cancer and Bcr-Abl expressing CML.  Putative mechanisms of action and future directions of radicicol oxime against these kinds of tumor are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-uapkd0TYQrVg90H21EOLACvtfcHk0lgFdRF4adD2ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnsV2is74%253D&md5=59ef4ec5535cec06665a164be0b12305</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2174%2F1568009033481859&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568009033481859%26sid%3Dliteratum%253Aachs%26aulast%3DSoga%26aufirst%3DS.%26aulast%3DShiotsu%26aufirst%3DY.%26aulast%3DAkinaga%26aufirst%3DS.%26aulast%3DSharma%26aufirst%3DS.%2BV.%26atitle%3DDevelopment%2520of%2520radicicol%2520analogues%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2003%26volume%3D3%26spage%3D359%26epage%3D369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Pearl, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodromou, C.</span><span> </span><span class="NLM_article-title">Structure and mechanism of the Hsp90 molecular chaperone machinery</span> <span class="citation_source-journal">Annu. Rev. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">271</span><span class="NLM_x">–</span> <span class="NLM_lpage">294</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm701018h&amp;key=10.1146%2Fannurev.biochem.75.103004.142738" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm701018h&amp;key=16756493" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm701018h&amp;key=1%3ACAS%3A528%3ADC%252BD28XosVKhs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2006&pages=271-294&author=L.+H.+Pearlauthor=C.+Prodromou&title=Structure+and+mechanism+of+the+Hsp90+molecular+chaperone+machinery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and mechanism of the Hsp90 molecular chaperone machinery</span></div><div class="casAuthors">Pearl, Laurence H.; Prodromou, Chrisostomos</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">271-294</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Heat-shock protein 90 (Hsp90) is a mol. chaperone essential for activating many signaling proteins in the eukaryotic cell.  Biochem. and structural anal. of Hsp90 has revealed a complex mechanism of ATPase-coupled conformational changes and interactions with cochaperone proteins, which facilitate activation of Hsp90's diverse "clientele.".  Despite recent progress, key aspects of the ATPase-coupled mechanism of Hsp90 remain controversial, and the nature of the changes, engendered by Hsp90 in client proteins, is largely unknown.  Here, the authors discuss present knowledge of Hsp90 structure and function gleaned from crystallog. studies of individual domains and recent progress in obtaining a structure for the ATP-bound conformation of the intact dimeric chaperone.  Addnl., the authors describe the roles of the plethora of cochaperones with which Hsp90 cooperates and growing insights into their biochem. mechanisms, which come from crystal structures of Hsp90-cochaperone complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1Aa7D8Mk_qbVg90H21EOLACvtfcHk0lgFdRF4adD2ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XosVKhs78%253D&md5=a954553202a2a81fce297ac6a8378c67</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.75.103004.142738&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.75.103004.142738%26sid%3Dliteratum%253Aachs%26aulast%3DPearl%26aufirst%3DL.%2BH.%26aulast%3DProdromou%26aufirst%3DC.%26atitle%3DStructure%2520and%2520mechanism%2520of%2520the%2520Hsp90%2520molecular%2520chaperone%2520machinery%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2006%26volume%3D75%26spage%3D271%26epage%3D294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Obermann, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sondermann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russo, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavletich, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartl, F. U.</span><span> </span><span class="NLM_article-title">In vivo function of Hsp90 is dependent on ATP binding and ATP hydrolysis</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">901</span><span class="NLM_x">–</span> <span class="NLM_lpage">910</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=1998&pages=901-910&author=W.+M.+Obermannauthor=H.+Sondermannauthor=A.+A.+Russoauthor=N.+P.+Pavletichauthor=F.+U.+Hartl&title=In+vivo+function+of+Hsp90+is+dependent+on+ATP+binding+and+ATP+hydrolysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DObermann%26aufirst%3DW.%2BM.%26aulast%3DSondermann%26aufirst%3DH.%26aulast%3DRusso%26aufirst%3DA.%2BA.%26aulast%3DPavletich%26aufirst%3DN.%2BP.%26aulast%3DHartl%26aufirst%3DF.%2BU.%26atitle%3DIn%2520vivo%2520function%2520of%2520Hsp90%2520is%2520dependent%2520on%2520ATP%2520binding%2520and%2520ATP%2520hydrolysis%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D1998%26volume%3D143%26spage%3D901%26epage%3D910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Panaretou, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodromou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roe, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladbury, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piper, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearl, L. H.</span><span> </span><span class="NLM_article-title">ATP binding and hydrolysis are essential to the function of the Hsp90 molecular chaperone in vivo</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">4829</span><span class="NLM_x">–</span> <span class="NLM_lpage">4836</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1998&pages=4829-4836&author=B.+Panaretouauthor=C.+Prodromouauthor=S.+M.+Roeauthor=R.+O%E2%80%99Brienauthor=J.+E.+Ladburyauthor=P.+W.+Piperauthor=L.+H.+Pearl&title=ATP+binding+and+hydrolysis+are+essential+to+the+function+of+the+Hsp90+molecular+chaperone+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPanaretou%26aufirst%3DB.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DRoe%26aufirst%3DS.%2BM.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DR.%26aulast%3DLadbury%26aufirst%3DJ.%2BE.%26aulast%3DPiper%26aufirst%3DP.%2BW.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26atitle%3DATP%2520binding%2520and%2520hydrolysis%2520are%2520essential%2520to%2520the%2520function%2520of%2520the%2520Hsp90%2520molecular%2520chaperone%2520in%2520vivo%26jtitle%3DEMBO%2520J.%26date%3D1998%26volume%3D17%26spage%3D4829%26epage%3D4836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Roe, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodromou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladbury, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piper, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearl, L. H.</span><span> </span><span class="NLM_article-title">Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">260</span><span class="NLM_x">–</span> <span class="NLM_lpage">266</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm980403y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=260-266&author=S.+M.+Roeauthor=C.+Prodromouauthor=R.+O%E2%80%99Brienauthor=J.+E.+Ladburyauthor=P.+W.+Piperauthor=L.+H.+Pearl&title=Structural+basis+for+inhibition+of+the+Hsp90+molecular+chaperone+by+the+antitumor+antibiotics+radicicol+and+geldanamycin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm980403y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980403y%26sid%3Dliteratum%253Aachs%26aulast%3DRoe%26aufirst%3DS.%2BM.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DR.%26aulast%3DLadbury%26aufirst%3DJ.%2BE.%26aulast%3DPiper%26aufirst%3DP.%2BW.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26atitle%3DStructural%2520basis%2520for%2520inhibition%2520of%2520the%2520Hsp90%2520molecular%2520chaperone%2520by%2520the%2520antitumor%2520antibiotics%2520radicicol%2520and%2520geldanamycin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D260%26epage%3D266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neckers, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, N.</span><span> </span><span class="NLM_article-title">Drugging the cancer chaperone HSP90: combinatorial therapeutic exploitation of oncogene addiction and tumor stress</span> <span class="citation_source-journal">Ann. N. Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">1113</span><span class="NLM_x">, </span> <span class="NLM_fpage">202</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm701018h&amp;key=10.1196%2Fannals.1391.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm701018h&amp;key=17513464" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm701018h&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVanurfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1113&publication_year=2007&pages=202-216&author=P.+Workmanauthor=F.+Burrowsauthor=L.+Neckersauthor=N.+Rosen&title=Drugging+the+cancer+chaperone+HSP90%3A+combinatorial+therapeutic+exploitation+of+oncogene+addiction+and+tumor+stress"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Drugging the cancer chaperone HSP90: combinatorial therapeutic expolitation on oncogene addiction and tumor stress</span></div><div class="casAuthors">Workman, Paul; Burrows, Francis; Neckers, Len; Rosen, Neal</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">1113</span>
        (<span class="NLM_cas:issue">Stress Responses in Biology and Medicine</span>),
    <span class="NLM_cas:pages">202-216</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing, Inc.</span>)
        </div><div class="casAbstract">A review.  The mol. chaperone HSP90 has emerged as an exciting target for cancer treatment.  We review the potential advantages of HSP90 inhibitors, particularly the simultaneous combinatorial depletion of multiple oncogenic "client" proteins, leading to blockade of many cancer-causing pathways and the antagonism of all of the hallmark pathol. traits of malignancy.  Cancer selectivity is achieved by exploiting cancer "dependencies," including oncogene addiction and the stressed state of malignant cells.  The multiple downstream effects of HSP90 inhibitors should make the development of resistance more difficult than with agents having more restricted effects.  We review the various classes of HSP90 inhibitor that have been developed, including the natural products geldanamycin and radicicol and also the purine scaffold and pyrazole/isoxazole class of synthetic small mol. inhibitors.  A first-in-class HSP90 drug, the geldanamycin analog 17-AAG, has provided proof of concept for HSP90 inhibition in patients at well tolerated doses and therapeutic activity has been seen.  Other inhibitors show promise in preclin. and clin. development.  Opportunities and challenges for HSP90 inhibitors are discussed, including use in combination with other agents.  Most of the current HSP90 inhibitors act by blocking the essential nucleotide binding and ATPase activity required for chaperone function.  Potential new approaches are discussed, for example, interference with cochaperone binding and function in the superchaperone complex.  Biomarkers for use with HSP90 inhibitors are described.  We stress how basic and translational research has been mutually beneficial and indicate future directions to enhance our understanding of mol. chaperones and their exploitation in cancer and other diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoi_I-DGevqj7Vg90H21EOLACvtfcHk0lgkR0jokBZZdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVanurfF&md5=a537c5d947847c6b3cdf613968214623</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1196%2Fannals.1391.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1196%252Fannals.1391.012%26sid%3Dliteratum%253Aachs%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DBurrows%26aufirst%3DF.%26aulast%3DNeckers%26aufirst%3DL.%26aulast%3DRosen%26aufirst%3DN.%26atitle%3DDrugging%2520the%2520cancer%2520chaperone%2520HSP90%253A%2520combinatorial%2520therapeutic%2520exploitation%2520of%2520oncogene%2520addiction%2520and%2520tumor%2520stress%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2007%26volume%3D1113%26spage%3D202%26epage%3D216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Schulte, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neckers, L. M.</span><span> </span><span class="NLM_article-title">The benzoquinone ansamycin 17-allylamino17-demethoxygeldanamycin binds to HSP90 and shares important biologic activities with geldanamycin</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">273</span><span class="NLM_x">–</span> <span class="NLM_lpage">279</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm701018h&amp;key=10.1007%2Fs002800050817" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm701018h&amp;key=9744771" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm701018h&amp;key=1%3ACAS%3A528%3ADyaK1cXls1Wlt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1998&pages=273-279&author=T.+W.+Schulteauthor=L.+M.+Neckers&title=The+benzoquinone+ansamycin+17-allylamino17-demethoxygeldanamycin+binds+to+HSP90+and+shares+important+biologic+activities+with+geldanamycin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The benzoquinone ansamycin 17-allylamino-17-demethoxygeldanamycin binds to HSP90 and shares important biologic activities with geldanamycin</span></div><div class="casAuthors">Schulte, Theodor W.; Neckers, Leonard M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">273-279</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Binding of 17-allylamino-17-demethoxygeldanamycin (17-AG) to the heat-shock protein HSP90 was studied in vitro using a geldanamycin (GA)-affinity beads competition assay.  The drug-induced destabilization was studied of p185erbB2, Raf-1, and mutant p53 in SKBR3 breast cancer cells by Western blotting.  The antiproliferative activities of 17-AG and GA were compared using the MTT assay.  The 17-AG bound specifically to HSP90 in a similar manner as GA itself.  It also led to degrdn. of the receptor Tyr kinase p185erbB2, the Ser/Thr kinase Raf-1, and mutant p53.  GA and 17-AG displayed comparable antiproliferative effects in SKBR3 and MCF7 cells.  Even though HSP90 binding with 17-AG was weaker than by GA, 17-AG and GA caused biol. effects in tumor cells at similar doses.  Since 17-AG had a better toxicity profile than GA, it was suggested as benzoquinone ansamycin candidate for clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouj3pMDUB7kLVg90H21EOLACvtfcHk0lgkR0jokBZZdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXls1Wlt7Y%253D&md5=3d6ac0592b10d66b391f824272523de2</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1007%2Fs002800050817&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002800050817%26sid%3Dliteratum%253Aachs%26aulast%3DSchulte%26aufirst%3DT.%2BW.%26aulast%3DNeckers%26aufirst%3DL.%2BM.%26atitle%3DThe%2520benzoquinone%2520ansamycin%252017-allylamino17-demethoxygeldanamycin%2520binds%2520to%2520HSP90%2520and%2520shares%2520important%2520biologic%2520activities%2520with%2520geldanamycin%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D1998%26volume%3D42%26spage%3D273%26epage%3D279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Banerji, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scurr, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stapleton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asad, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmons, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloney, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lakhani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaye, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judson, I.</span><span> </span><span class="NLM_article-title">Phase I pharmacokinetic and pharmacodynamic study of 17-allylamino, 17-demethoxygeldanamycin in patients with advanced malignancies</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4152</span><span class="NLM_x">–</span> <span class="NLM_lpage">4161</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm701018h&amp;key=10.1200%2FJCO.2005.00.612" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm701018h&amp;key=15961763" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm701018h&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmt1elsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=4152-4161&author=U.+Banerjiauthor=A.+O%E2%80%99Donnellauthor=M.+Scurrauthor=S.+Paceyauthor=S.+Stapletonauthor=Y.+Asadauthor=L.+Simmonsauthor=A.+Maloneyauthor=F.+Raynaudauthor=M.+Campbellauthor=M.+Waltonauthor=S.+Lakhaniauthor=S.+Kayeauthor=P.+Workmanauthor=I.+Judson&title=Phase+I+pharmacokinetic+and+pharmacodynamic+study+of+17-allylamino%2C+17-demethoxygeldanamycin+in+patients+with+advanced+malignancies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I pharmacokinetic and pharmacodynamic study of 17-allylamino, 17-demethoxygeldanamycin in patients with advanced malignancies</span></div><div class="casAuthors">Banerji, Udai; O'Donnell, Anne; Scurr, Michelle; Pacey, Simon; Stapleton, Sarah; Asad, Yasmin; Simmons, Laura; Maloney, Alison; Raynaud, Florence; Campbell, Maeli; Walton, Michael; Lakhani, Sunil; Kaye, Stanley; Workman, Paul; Judson, Ian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4152-4161</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose: To study the toxicity and pharmacokinetic-pharmacodynamic profile of 17-allylamino, 17-demethoxygeldanamycin (17-AAG) and to recommend a dose for phase II trials.  Patients and Methods: This was a phase I study examg. a once-weekly dosing schedule of 17-AAG.  Thirty patients with advanced malignancies were treated.  Results: The highest dose level reached was 450 mg/m2/wk.  The dose-limiting toxicities (DLTs) encountered were grade 3 diarrhea in three patients (one at 320 mg/m2/wk and two at 450 mg/m2/wk) and grade 3 to 4 hepatotoxicity (AST/ALT) in one patient at 450 mg/m2/wk.  Two of nine DLTs were at the highest dose level.  Two patients with metastatic melanoma had stable disease and were treated for 15 and 41 mo, resp.  The dose vs. area under the curve-relationship for 17-AAG was linear (r2 = .71) over the dose range 10 to 450 mg/m2/wk, with peak plasma concns. of 8,998 μg/L (std. deviation, 2,881) at the highest dose level.  After the demonstration of pharmacodynamic changes in peripheral blood leukocytes, pre- and 24 h post-treatment, tumor biopsies were performed and demonstrated target inhibition (c-RAF-1 inhibition in four of six patients, CDK4 depletion in eight of nine patients and HSP70 induction in eight of nine patients) at the dose levels 320 and 450 mg/m2/wk.  It was not possible to reproducibly demonstrate these changes in biopsies taken 5 days after treatment.  Conclusion: It has been possible to demonstrate that 17-AAG exhibits a tolerable toxicity profile with therapeutic plasma concns. and target inhibition for 24 h after treatment and some indications of clin. activity at the dose level 450 mg/m2/wk.  We recommend this dose for phase II clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaKgFbodgT_bVg90H21EOLACvtfcHk0li-x7swuUNP7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmt1elsrY%253D&md5=6ba10e24a68a1d9bd09d87239eea1ca6</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1200%2FJCO.2005.00.612&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2005.00.612%26sid%3Dliteratum%253Aachs%26aulast%3DBanerji%26aufirst%3DU.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DA.%26aulast%3DScurr%26aufirst%3DM.%26aulast%3DPacey%26aufirst%3DS.%26aulast%3DStapleton%26aufirst%3DS.%26aulast%3DAsad%26aufirst%3DY.%26aulast%3DSimmons%26aufirst%3DL.%26aulast%3DMaloney%26aufirst%3DA.%26aulast%3DRaynaud%26aufirst%3DF.%26aulast%3DCampbell%26aufirst%3DM.%26aulast%3DWalton%26aufirst%3DM.%26aulast%3DLakhani%26aufirst%3DS.%26aulast%3DKaye%26aufirst%3DS.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DJudson%26aufirst%3DI.%26atitle%3DPhase%2520I%2520pharmacokinetic%2520and%2520pharmacodynamic%2520study%2520of%252017-allylamino%252C%252017-demethoxygeldanamycin%2520in%2520patients%2520with%2520advanced%2520malignancies%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2005%26volume%3D23%26spage%3D4152%26epage%3D4161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Goetz, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toft, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ames, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stensgard, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Safgren, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adjei, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sloan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atherton, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasile, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salazaar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adjei, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croghan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erlichman, C.</span><span> </span><span class="NLM_article-title">Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1078</span><span class="NLM_x">–</span> <span class="NLM_lpage">1087</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm701018h&amp;key=10.1200%2FJCO.2005.09.119" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm701018h&amp;key=15718306" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm701018h&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitl2gtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=1078-1087&author=M.+P.+Goetzauthor=D.+Toftauthor=J.+Reidauthor=M.+Amesauthor=B.+Stensgardauthor=S.+Safgrenauthor=A.+A.+Adjeiauthor=J.+Sloanauthor=P.+Athertonauthor=V.+Vasileauthor=S.+Salazaarauthor=A.+Adjeiauthor=G.+Croghanauthor=C.+Erlichman&title=Phase+I+trial+of+17-allylamino-17-demethoxygeldanamycin+in+patients+with+advanced+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer</span></div><div class="casAuthors">Goetz, Matthew P.; Toft, David; Reid, Joel; Ames, Matthew; Stensgard, Bridget; Safgren, Stephanie; Adjei, Araba A.; Sloan, Jeff; Atherton, Pamela; Vasile, Vlad; Salazaar, Sandra; Adjei, Alex; Croghan, Gary; Erlichman, Charles</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1078-1087</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose We detd. the max.-tolerated dose (MTD) and the dose-limiting toxicities (DLT) of 17-allylamino-17-demethoxygeldanamycin (17-AAG) when infused on days 1, 8, and 15 of a 28-day cycle in advanced solid tumor patients.  We also characterized the pharmacokinetics of 17-AAG, its effect on chaperone and client proteins, and whether cytochrome P 450 (CYP) 3A5 and NAD(P)H:quinone oxidoreductase 1 (NQO1) polymorphisms affected 17-AAG disposition or toxicity.  Patients and Methods An accelerated titrn. design was used.  Biomarkers were measured in peripheral-blood mononuclear cells (PBMCs) at baseline and on days 1 and 15, and pharmacokinetic anal. was performed on day 1 of cycle 1.  CYP3A5*3 and NQO1*2 genotypes were detd. and correlated with pharmacokinetics and toxicity.  Results Twenty-one patients received 52 courses at 11 dose levels.  DLTs at 431 mg/m2 were grade 3 bilirubin (n = 1), AST (n = 1), anemia (n = 1), nausea (n = 1), vomiting (n = 1), and myalgias (n = 1).  No tumor responses were seen.  17-AAG consistently increased heat shock protein (Hsp) 70 levels in PBMCs.  At the MTD, the clearance and half-life (t1/2) of 17-AAG were 11.6 L/h/m2 and 4.15 h, resp.; whereas the active metabolite 17-aminogeldanamycin had a t1/2 of 7.63 h.  The CYP3A5*3 and NQO1*2 polymorphisms were not assocd. with 17-AAG toxicity.  The CYP3A5*3 polymorphism was assocd. with higher 17-AAG clearance.  Conclusion The MTD of weekly 17-AAG is 308 mg/m2.  17-AAG induced Hsp70 in PBMCs, indicating that Hsp90 has been affected.  Further evaluation of 17-AAG is ongoing using a twice-weekly regimen, and this schedule of 17-AAG is being tested in combination with chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFPRrruDVbcLVg90H21EOLACvtfcHk0li-x7swuUNP7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitl2gtbw%253D&md5=b4ea280cb99c9977e6fa4bdb5f6efc06</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1200%2FJCO.2005.09.119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2005.09.119%26sid%3Dliteratum%253Aachs%26aulast%3DGoetz%26aufirst%3DM.%2BP.%26aulast%3DToft%26aufirst%3DD.%26aulast%3DReid%26aufirst%3DJ.%26aulast%3DAmes%26aufirst%3DM.%26aulast%3DStensgard%26aufirst%3DB.%26aulast%3DSafgren%26aufirst%3DS.%26aulast%3DAdjei%26aufirst%3DA.%2BA.%26aulast%3DSloan%26aufirst%3DJ.%26aulast%3DAtherton%26aufirst%3DP.%26aulast%3DVasile%26aufirst%3DV.%26aulast%3DSalazaar%26aufirst%3DS.%26aulast%3DAdjei%26aufirst%3DA.%26aulast%3DCroghan%26aufirst%3DG.%26aulast%3DErlichman%26aufirst%3DC.%26atitle%3DPhase%2520I%2520trial%2520of%252017-allylamino-17-demethoxygeldanamycin%2520in%2520patients%2520with%2520advanced%2520cancer%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2005%26volume%3D23%26spage%3D1078%26epage%3D1087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Weigel, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaney, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Safgren, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bagatell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kersey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neglia, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivy, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingle, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitesell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbertson, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krailo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ames, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adamson, P. C.</span><span> </span><span class="NLM_article-title">A phase I study of 17-allylaminogeldanamycin in relapsed/refractory pediatric patients with solid tumors: a children’s oncology group study</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1789</span><span class="NLM_x">–</span> <span class="NLM_lpage">1793</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm701018h&amp;key=10.1158%2F1078-0432.CCR-06-2270" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm701018h&amp;key=17363534" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm701018h&amp;key=1%3ACAS%3A528%3ADC%252BD2sXivV2gtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=1789-1793&author=B.+J.+Weigelauthor=S.+M.+Blaneyauthor=J.+M.+Reidauthor=S.+L.+Safgrenauthor=R.+Bagatellauthor=J.+Kerseyauthor=J.+P.+Negliaauthor=S.+P.+Ivyauthor=A.+M.+Ingleauthor=L.+Whitesellauthor=R.+J.+Gilbertsonauthor=M.+Krailoauthor=M.+Amesauthor=P.+C.+Adamson&title=A+phase+I+study+of+17-allylaminogeldanamycin+in+relapsed%2Frefractory+pediatric+patients+with+solid+tumors%3A+a+children%E2%80%99s+oncology+group+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">A phase I study of 17-allylaminogeldanamycin in relapsed/refractory pediatric patients with solid tumors: a children's oncology group Study</span></div><div class="casAuthors">Weigel, Brenda J.; Blaney, Susan M.; Reid, Joel M.; Safgren, Stephanie L.; Bagatell, Rochelle; Kersey, John; Neglia, Joseph P.; Ivy, S. Percy; Ingle, Ashish M.; Whitesell, Luke; Gilbertson, Richard J.; Krailo, Mark; Ames, Matthew; Adamson, Peter C.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1789-1793</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">To det. the recommended phase 2 dose, dose-limiting toxicities (DLT), pharmacokinetic profile, and pharmacodynamics of the heat shock protein (Hsp) 90 inhibitor, 17-allylaminogeldanamycin (17-AAG).  17-AAG was administered as a 60-min infusion, on days 1, 4, 8, and 11 of a 21-day cycle at dose levels of 150, 200, 270, and 360 mg/m2/dose.  Pharmacokinetic studies and evaluations for Hsp72 and Akt levels in peripheral blood mononuclear cells were done during the first course of therapy.  Seventeen patients (7 males), median 7 years of age (range, 1-19 years), were enrolled using a std. dose escalation scheme.  No DLTs were obsd.  Although there were no objective responses, three patients remain on therapy at 6+, 7+, and 9+ months with stable disease.  One patient with hepatoblastoma had a redn. in α-fetoprotein and stable disease over three cycles.  At 270 mg/m2/dose, the Cmax and areas under the plasma concn.-time curves of 17-AAG were 5,303 ± 1,591 ng/mL and 13,656 ± 4,757 ng/mL h, resp., similar to the exposure in adults.  The mean terminal half-life for 17-AAG was 3.24 ± 0.80 h.  Induction of Hsp72, a surrogate marker for inhibition of Hsp90, was detected at the 270 mg/m2 dose level.  Drug exposures consistent with those required for anticancer activity in preclin. models were achieved without DLT.  Evidence for drug-induced modulation of Hsp90 systemically was also detected.  The recommended phase II dose of 17-AAG is 360 mg/m2/d.  Non-DMSO-contg. formulations may improve acceptance of this drug by children and their families.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5bX_5e9xYaLVg90H21EOLACvtfcHk0li-x7swuUNP7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXivV2gtLw%253D&md5=993461ceb86c7e6fa3c759a482eea16e</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-2270&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-2270%26sid%3Dliteratum%253Aachs%26aulast%3DWeigel%26aufirst%3DB.%2BJ.%26aulast%3DBlaney%26aufirst%3DS.%2BM.%26aulast%3DReid%26aufirst%3DJ.%2BM.%26aulast%3DSafgren%26aufirst%3DS.%2BL.%26aulast%3DBagatell%26aufirst%3DR.%26aulast%3DKersey%26aufirst%3DJ.%26aulast%3DNeglia%26aufirst%3DJ.%2BP.%26aulast%3DIvy%26aufirst%3DS.%2BP.%26aulast%3DIngle%26aufirst%3DA.%2BM.%26aulast%3DWhitesell%26aufirst%3DL.%26aulast%3DGilbertson%26aufirst%3DR.%2BJ.%26aulast%3DKrailo%26aufirst%3DM.%26aulast%3DAmes%26aufirst%3DM.%26aulast%3DAdamson%26aufirst%3DP.%2BC.%26atitle%3DA%2520phase%2520I%2520study%2520of%252017-allylaminogeldanamycin%2520in%2520relapsed%252Frefractory%2520pediatric%2520patients%2520with%2520solid%2520tumors%253A%2520a%2520children%25E2%2580%2599s%2520oncology%2520group%2520study%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D1789%26epage%3D1793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">McDonald, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K.</span><span> </span><span class="NLM_article-title">Inhibitors of the HSP90 molecular chaperone: attacking the master regulator in cancer</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1091</span><span class="NLM_x">–</span> <span class="NLM_lpage">1107</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm701018h&amp;key=10.2174%2F156802606777812004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm701018h&amp;key=16842148" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm701018h&amp;key=1%3ACAS%3A528%3ADC%252BD28Xpt1ejt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=1091-1107&author=E.+McDonaldauthor=P.+Workmanauthor=K.+Jones&title=Inhibitors+of+the+HSP90+molecular+chaperone%3A+attacking+the+master+regulator+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of the HSP90 molecular chaperone: attacking the master regulator in cancer</span></div><div class="casAuthors">McDonald, Edward; Workman, Paul; Jones, Keith</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1091-1107</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The heat shock protein 90 (HSP90) chaperones represent some 1-2% of all cellular protein and are key players in protein quality control in cells.  They are over expressed in many human cancers and the fact that many oncogenic proteins are clients has prompted much recent research on HSP90 inhibitors as new cancer therapeutics.  A brief introduction is followed by a detailed review of the various classes of inhibitors, both natural product-based and synthetic, that have emerged over the last decade.  The natural products geldanamycin, radicicol and novobiocin have provided the start points for new drugs in this area and their medicinal chem. is reviewed, including the exciting recent results emerging from clin. trials using geldanamycin analogs.  The detailed understanding of the binding mode of these compds. to HSP90 has been significantly enhanced by x-ray crystallog. of HSP90 constructs co-crystd. with various ligands.  Efforts to replace the natural product inhibitors with more drug-like synthetic compds. have mushroomed over the last 4 years.  The purines and the 3,4-diarylpyrazoles have proven to be the most successful and their medicinal chem. is reviewed with particular emphasis on structure-based design.  Protein/ligand co-crystal structures have shown that conserved water mols. in the active site are a vital part of the hydrogen-bonding network established on binding both natural product and synthetic inhibitors.  Medicinal chemists have used this information to develop high affinity lead compds.  Recent research provides the platform for exciting developments in the area of HSP90 inhibition over the next few years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZvK2PleGilLVg90H21EOLACvtfcHk0lja0HJO-Tj_fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xpt1ejt7s%253D&md5=76ebc6e48e0b91a5a9dceba18f7c38f4</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.2174%2F156802606777812004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802606777812004%26sid%3Dliteratum%253Aachs%26aulast%3DMcDonald%26aufirst%3DE.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DJones%26aufirst%3DK.%26atitle%3DInhibitors%2520of%2520the%2520HSP90%2520molecular%2520chaperone%253A%2520attacking%2520the%2520master%2520regulator%2520in%2520cancer%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D1091%26epage%3D1107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Powers, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">Targeting of multiple signalling pathways by heat shock protein 90 molecular chaperone inhibitors</span> <span class="citation_source-journal">Endocr. Relat. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">S125</span><span class="NLM_x">–</span> <span class="NLM_lpage">S135</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=S125-S135&author=M.+V.+Powersauthor=P.+Workman&title=Targeting+of+multiple+signalling+pathways+by+heat+shock+protein+90+molecular+chaperone+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPowers%26aufirst%3DM.%2BV.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DTargeting%2520of%2520multiple%2520signalling%2520pathways%2520by%2520heat%2520shock%2520protein%252090%2520molecular%2520chaperone%2520inhibitors%26jtitle%3DEndocr.%2520Relat.%2520Cancer%26date%3D2006%26volume%3D13%26spage%3DS125%26epage%3DS135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Chiosis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldas, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solit, D.</span><span> </span><span class="NLM_article-title">Heat shock protein-90 inhibitors: a chronicle from geldanamycin to today’s agents</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">534</span><span class="NLM_x">–</span> <span class="NLM_lpage">541</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=534-541&author=G.+Chiosisauthor=L.+E.+Caldasauthor=D.+Solit&title=Heat+shock+protein-90+inhibitors%3A+a+chronicle+from+geldanamycin+to+today%E2%80%99s+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChiosis%26aufirst%3DG.%26aulast%3DCaldas%26aufirst%3DL.%2BE.%26aulast%3DSolit%26aufirst%3DD.%26atitle%3DHeat%2520shock%2520protein-90%2520inhibitors%253A%2520a%2520chronicle%2520from%2520geldanamycin%2520to%2520today%25E2%2580%2599s%2520agents%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2006%26volume%3D7%26spage%3D534%26epage%3D541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neckers, L.</span><span> </span><span class="NLM_article-title">Targeting the molecular chaperone heat shock protein 90 provides a multifaceted effect on diverse cell signaling Pathways of cancer cells</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1625</span><span class="NLM_x">–</span> <span class="NLM_lpage">1629</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm701018h&amp;key=10.1158%2F1078-0432.CCR-06-2966" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm701018h&amp;key=17363512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm701018h&amp;key=1%3ACAS%3A528%3ADC%252BD2sXivV2gsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=1625-1629&author=W.+Xuauthor=L.+Neckers&title=Targeting+the+molecular+chaperone+heat+shock+protein+90+provides+a+multifaceted+effect+on+diverse+cell+signaling+Pathways+of+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the Molecular Chaperone Heat Shock Protein 90 Provides a Multifaceted Effect on Diverse Cell Signaling Pathways of Cancer Cells</span></div><div class="casAuthors">Xu, Wanping; Neckers, Len</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1625-1629</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review with commentary on the title research of Bagatell et al., Ramanathan et al., Solit et al., and Weigel et al. (2007).  Heat shock protein 90 (Hsp90) is a mol. chaperone required for the stability and function of several conditionally activated and/or expressed signaling proteins as well as multiple mutated, chimeric, and/or overexpressed signaling proteins, which promote cancer cell growth and/or survival.  By interacting specifically with a single mol. target, Hsp90 inhibitors cause the eventual inactivation, destabilization, and degrdn. of numerous chaperone-dependent client proteins, and these drugs have shown promising antitumor activity in preclin. model systems.  Hsp90 inhibitors are unique in that, although they are directed toward a specific mol. target, they simultaneously inhibit multiple signaling pathways that frequently interact to promote cancer cell survival.  Several Hsp90 inhibitors, including the benzoquinone ansamycin 17-allylamino-17-demethoxygeldanamycin, are currently undergoing clin. evaluation.  Four phase 1 single-agent studies of 17-allylamino-17-demethoxygeldanamycin, two pediatric and two adult trials, are reviewed.  These studies highlight both the promise and the difficulty of successfully developing such molecularly targeted agents for the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouGXcBY2T52LVg90H21EOLACvtfcHk0lja0HJO-Tj_fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXivV2gsbc%253D&md5=b2adf96c4efbd13dab1056035fb704d4</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-2966&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-2966%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DW.%26aulast%3DNeckers%26aufirst%3DL.%26atitle%3DTargeting%2520the%2520molecular%2520chaperone%2520heat%2520shock%2520protein%252090%2520provides%2520a%2520multifaceted%2520effect%2520on%2520diverse%2520cell%2520signaling%2520Pathways%2520of%2520cancer%2520cells%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D1625%26epage%3D1629" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Egorin, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolff, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callery, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musser, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eiseman, J. L.</span><span> </span><span class="NLM_article-title">Metabolism of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) by murine and human hepatic preparations</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">2385</span><span class="NLM_x">–</span> <span class="NLM_lpage">2396</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1998&pages=2385-2396&author=M.+J.+Egorinauthor=D.+M.+Rosenauthor=J.+H.+Wolffauthor=P.+S.+Calleryauthor=S.+M.+Musserauthor=J.+L.+Eiseman&title=Metabolism+of+17-%28allylamino%29-17-demethoxygeldanamycin+%28NSC+330507%29+by+murine+and+human+hepatic+preparations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEgorin%26aufirst%3DM.%2BJ.%26aulast%3DRosen%26aufirst%3DD.%2BM.%26aulast%3DWolff%26aufirst%3DJ.%2BH.%26aulast%3DCallery%26aufirst%3DP.%2BS.%26aulast%3DMusser%26aufirst%3DS.%2BM.%26aulast%3DEiseman%26aufirst%3DJ.%2BL.%26atitle%3DMetabolism%2520of%252017-%2528allylamino%2529-17-demethoxygeldanamycin%2520%2528NSC%2520330507%2529%2520by%2520murine%2520and%2520human%2520hepatic%2520preparations%26jtitle%3DCancer%2520Res.%26date%3D1998%26volume%3D58%26spage%3D2385%26epage%3D2396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Kelland, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">DT-Diaphorase expression and tumor cell sensitivity to 17-allylamino, 17-demethoxygeldanamycin, an inhibitor of heat shock protein 90</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">1940</span><span class="NLM_x">–</span> <span class="NLM_lpage">1949</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm701018h&amp;key=10.1093%2Fjnci%2F91.22.1940" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm701018h&amp;key=10564678" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm701018h&amp;key=1%3ACAS%3A528%3ADyaK1MXotVaitr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1999&pages=1940-1949&author=L.+R.+Kellandauthor=S.+Y.+Sharpauthor=P.+M.+Rogersauthor=T.+G.+Myersauthor=P.+Workman&title=DT-Diaphorase+expression+and+tumor+cell+sensitivity+to+17-allylamino%2C+17-demethoxygeldanamycin%2C+an+inhibitor+of+heat+shock+protein+90"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">DT-diaphorase expression and tumor cell sensitivity to 17-allylamino-17-demethoxygeldanamycin, an inhibitor of heat shock protein 90</span></div><div class="casAuthors">Kelland, Lloyd R.; Sharp, Swee Y.; Rogers, Paul M.; Myers, Timothy G.; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">1940-1949</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background: To our knowledge, 17-allylamino-17-demethoxygeldanamycin (17AAG) is the first inhibitor of heat shock protein 90 (Hsp90) to enter a phase I clin. trial in cancer.  Inhibition of Hsp90, a chaperone protein (a protein that helps other proteins avoid misfolding pathways that produce inactive or aggregated states), leads to depletion of important oncogenic proteins, including Raf-1 and mutant p53 (also known as TP53).  Given its ansamycin benzoquinone structure, we questioned whether the antitumor activity of 17AAG was affected by expression of the NQO1 gene, which encodes the quinone-metabolizing enzyme DT-diaphorase.  Methods: The antitumor activity of 17AAG and other Hsp90 inhibitors was detd. by use of a sulforhodamine B-based cell growth inhibition assay in culture and by the arrest of xenograft tumor growth in nude mice.  DT-diaphorase activity was detd. by use of a spectrophotometric assay, and protein expression was detd. by western immunoblotting.  Results: In two independent in vitro human tumor cell panels, we obsd. a pos. relation between DT-diaphorase expression level and growth inhibition by 17AAG.  Stable, high-level expression of the active NQO1 gene transfected into the DT-diaphorase-deficient (by NQO1 mutation) BE human colon carcinoma cell line resulted in a 32-fold increase in 17AAG growth-inhibition activity.  Increased sensitivity to 17AAG in the transfected cell line was also confirmed in xenografts.  The extent of depletion of Raf-1 and mutant p53 protein confirmed that the Hsp90 inhibition mechanism was maintained in cells with high and low levels of DT-diaphorase.  17AAG was shown to be a substrate for purified human DT-diaphorase.  Conclusion: These results suggest that the antitumor activity and possibly the toxicol. properties of 17AAG in humans may be influenced by the expression of DT-diaphorase.  Careful monitoring for NQO1 polymorphism and the level of tumor DT-diaphorase activity is therefore recommended in clin. trials with 17AAG.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5zBsj7Xagm7Vg90H21EOLACvtfcHk0lgNlr08fG7EVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXotVaitr8%253D&md5=508d5f614ce715ae495263171b286bff</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F91.22.1940&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F91.22.1940%26sid%3Dliteratum%253Aachs%26aulast%3DKelland%26aufirst%3DL.%2BR.%26aulast%3DSharp%26aufirst%3DS.%2BY.%26aulast%3DRogers%26aufirst%3DP.%2BM.%26aulast%3DMyers%26aufirst%3DT.%2BG.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DDT-Diaphorase%2520expression%2520and%2520tumor%2520cell%2520sensitivity%2520to%252017-allylamino%252C%252017-demethoxygeldanamycin%252C%2520an%2520inhibitor%2520of%2520heat%2520shock%2520protein%252090%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D1999%26volume%3D91%26spage%3D1940%26epage%3D1949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Meli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennati, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daidone, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plescia, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toba, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altieri, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaffaroni, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colombo, G.</span><span> </span><span class="NLM_article-title">Small-molecule targeting of heat shock protein 90 chaperone function: rational identification of a new anticancer lead</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7721</span><span class="NLM_x">–</span> <span class="NLM_lpage">7730</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060836y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7721-7730&author=M.+Meliauthor=M.+Pennatiauthor=M.+Curtoauthor=M.+G.+Daidoneauthor=J.+Plesciaauthor=S.+Tobaauthor=D.+C.+Altieriauthor=N.+Zaffaroniauthor=G.+Colombo&title=Small-molecule+targeting+of+heat+shock+protein+90+chaperone+function%3A+rational+identification+of+a+new+anticancer+lead"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm060836y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060836y%26sid%3Dliteratum%253Aachs%26aulast%3DMeli%26aufirst%3DM.%26aulast%3DPennati%26aufirst%3DM.%26aulast%3DCurto%26aufirst%3DM.%26aulast%3DDaidone%26aufirst%3DM.%2BG.%26aulast%3DPlescia%26aufirst%3DJ.%26aulast%3DToba%26aufirst%3DS.%26aulast%3DAltieri%26aufirst%3DD.%2BC.%26aulast%3DZaffaroni%26aufirst%3DN.%26aulast%3DColombo%26aufirst%3DG.%26atitle%3DSmall-molecule%2520targeting%2520of%2520heat%2520shock%2520protein%252090%2520chaperone%2520function%253A%2520rational%2520identification%2520of%2520a%2520new%2520anticancer%2520lead%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7721%26epage%3D7730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Kaur, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belotti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burger, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher-Nielson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borsotti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riccardi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thillainathan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollingshead, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sausville, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giavazzi, R.</span><span> </span><span class="NLM_article-title">Antiangiogenic properties of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin: an orally bioavailable heat shock protein 90 modulator</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">4813</span><span class="NLM_x">–</span> <span class="NLM_lpage">4821</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm701018h&amp;key=10.1158%2F1078-0432.CCR-03-0795" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm701018h&amp;key=15269157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm701018h&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlvVegs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=4813-4821&author=G.+Kaurauthor=D.+Belottiauthor=A.+M.+Burgerauthor=K.+Fisher-Nielsonauthor=P.+Borsottiauthor=E.+Riccardiauthor=J.+Thillainathanauthor=M.+Hollingsheadauthor=E.+A.+Sausvilleauthor=R.+Giavazzi&title=Antiangiogenic+properties+of+17-%28dimethylaminoethylamino%29-17-demethoxygeldanamycin%3A+an+orally+bioavailable+heat+shock+protein+90+modulator"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Antiangiogenic properties of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin: an orally bioavailable heat shock protein 90 modulator</span></div><div class="casAuthors">Kaur, Gurmeet; Belotti, Dorina; Burger, Angelika M.; Fisher-Nielson, Kirsten; Borsotti, Patrizia; Riccardi, Elena; Thillainathan, Jagada; Hollingshead, Melinda; Sausville, Edward A.; Giavazzi, Raffaella</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4813-4821</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The purpose of this study was to investigate the antiangiogenic properties of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG; NSC707545), a water-sol. benzoquinone ansamycin.  The activity of 17-DMAG, in vivo, was evaluated for inhibition of fibroblast growth factor (FGF)-2-induced angiogenesis in s.c. implanted Matrigel in mice.  In vitro, the activity of 17-DMAG on endothelial cells (human umbilical vein endothelial cells; HUVEC) was tested in FGF-2; and vascular endothelial growth factor (VEGF)-induced proliferation and apoptosis, motility, and extracellular matrix invasion; and on the alignment of capillary like structures in Matrigel.  The protein level of heat shock protein (Hsp)90 and client proteins was examd. by Western blot in FGF-2 and VEGF-stimulated HUVEC.  Daily oral administration of 17-DMAG affected the angiogenic response in Matrigel in a dose-dependent manner.  The Hb content in the Matrigel implants was significantly inhibited, and the histol. anal. confirmed a decrease of CD31+ endothelial cells and of structures organized in cord and erythrocyte-contg. vessels.  In vitro, the compd. inhibited dose-dependently the migration and the extracellular matrix-invasiveness of HUVEC and their capacity to form capillary like structures in Matrigel. 17-DMAG treatment also inhibited FGF-2 and VEGF-induced HUVEC proliferation and resulted in apoptosis.  Accordingly, the expression of Hsp90 direct client proteins (pAkt and c-Raf-1) or their downstream substrates including pERK was also affected. 17-DMAG consistently increased the expression of Hsp70.  Throughout the study similar results were obtained with 17-allylamino-17-demethoxygeldanamycin (17-AAG; NSC330507), the analog compd. currently undergoing clin. trials.  We show that the Hsp90 targeting agents 17-DMAG and 17-AAG inhibit angiogenesis.  The strong effects on endothelial cell functions, in vitro, indicate that the antiangiogenic activity of 17-DMAG/17-AAG could also be due to a direct effect on endothelial cells.  The oral bioavailability of 17-DMAG might be of advantage in investigating the potential of this compd. in clin. trials with antiangiogenic as well as antiproliferative endpoints.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbGsLTxbCrQ7Vg90H21EOLACvtfcHk0lgNlr08fG7EVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlvVegs7s%253D&md5=e78331697485d2c1948adec2d4f124e6</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-03-0795&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-03-0795%26sid%3Dliteratum%253Aachs%26aulast%3DKaur%26aufirst%3DG.%26aulast%3DBelotti%26aufirst%3DD.%26aulast%3DBurger%26aufirst%3DA.%2BM.%26aulast%3DFisher-Nielson%26aufirst%3DK.%26aulast%3DBorsotti%26aufirst%3DP.%26aulast%3DRiccardi%26aufirst%3DE.%26aulast%3DThillainathan%26aufirst%3DJ.%26aulast%3DHollingshead%26aufirst%3DM.%26aulast%3DSausville%26aufirst%3DE.%2BA.%26aulast%3DGiavazzi%26aufirst%3DR.%26atitle%3DAntiangiogenic%2520properties%2520of%252017-%2528dimethylaminoethylamino%2529-17-demethoxygeldanamycin%253A%2520an%2520orally%2520bioavailable%2520heat%2520shock%2520protein%252090%2520modulator%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2004%26volume%3D10%26spage%3D4813%26epage%3D4821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Ge, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Normant, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dembski, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Georges, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grenier, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pak, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sydor, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tibbitts, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palombella, V. J.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of hydroquinone derivatives of 17-amino-17-demethoxygeldanamycin as potent, water-soluble inhibitors of Hsp90</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4606</span><span class="NLM_x">–</span> <span class="NLM_lpage">4615</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0603116" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4606-4615&author=J.+Geauthor=E.+Normantauthor=J.+R.+Porterauthor=J.+A.+Aliauthor=M.+S.+Dembskiauthor=Y.+Gaoauthor=A.+T.+Georgesauthor=L.+Grenierauthor=R.+H.+Pakauthor=J.+Pattersonauthor=J.+R.+Sydorauthor=T.+T.+Tibbittsauthor=J.+K.+Tongauthor=J.+Adamsauthor=V.+J.+Palombella&title=Design%2C+synthesis%2C+and+biological+evaluation+of+hydroquinone+derivatives+of+17-amino-17-demethoxygeldanamycin+as+potent%2C+water-soluble+inhibitors+of+Hsp90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm0603116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0603116%26sid%3Dliteratum%253Aachs%26aulast%3DGe%26aufirst%3DJ.%26aulast%3DNormant%26aufirst%3DE.%26aulast%3DPorter%26aufirst%3DJ.%2BR.%26aulast%3DAli%26aufirst%3DJ.%2BA.%26aulast%3DDembski%26aufirst%3DM.%2BS.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DGeorges%26aufirst%3DA.%2BT.%26aulast%3DGrenier%26aufirst%3DL.%26aulast%3DPak%26aufirst%3DR.%2BH.%26aulast%3DPatterson%26aufirst%3DJ.%26aulast%3DSydor%26aufirst%3DJ.%2BR.%26aulast%3DTibbitts%26aufirst%3DT.%2BT.%26aulast%3DTong%26aufirst%3DJ.%2BK.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DPalombella%26aufirst%3DV.%2BJ.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520hydroquinone%2520derivatives%2520of%252017-amino-17-demethoxygeldanamycin%2520as%2520potent%252C%2520water-soluble%2520inhibitors%2520of%2520Hsp90%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4606%26epage%3D4615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Sydor, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Normant, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pien, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ge, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grenier, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pak, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dembski, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penders, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pink, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodward, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grayzel, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palombella, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, J. K.</span><span> </span><span class="NLM_article-title">Development of 17-allylamino-17-demethoxygeldanamycin hydroquinone hydrochloride (IPI-504), an anti-cancer agent directed against Hsp90</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">17408</span><span class="NLM_x">–</span> <span class="NLM_lpage">17413</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=17408-17413&author=J.+R.+Sydorauthor=E.+Normantauthor=C.+S.+Pienauthor=J.+R.+Porterauthor=J.+Geauthor=L.+Grenierauthor=R.+H.+Pakauthor=J.+A.+Aliauthor=M.+S.+Dembskiauthor=J.+Hudakauthor=J.+Pattersonauthor=C.+Pendersauthor=M.+Pinkauthor=M.+A.+Readauthor=J.+Sangauthor=C.+Woodwardauthor=Y.+Zhangauthor=D.+S.+Grayzelauthor=J.+Wrightauthor=J.+A.+Barrettauthor=V.+J.+Palombellaauthor=J.+Adamsauthor=J.+K.+Tong&title=Development+of+17-allylamino-17-demethoxygeldanamycin+hydroquinone+hydrochloride+%28IPI-504%29%2C+an+anti-cancer+agent+directed+against+Hsp90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSydor%26aufirst%3DJ.%2BR.%26aulast%3DNormant%26aufirst%3DE.%26aulast%3DPien%26aufirst%3DC.%2BS.%26aulast%3DPorter%26aufirst%3DJ.%2BR.%26aulast%3DGe%26aufirst%3DJ.%26aulast%3DGrenier%26aufirst%3DL.%26aulast%3DPak%26aufirst%3DR.%2BH.%26aulast%3DAli%26aufirst%3DJ.%2BA.%26aulast%3DDembski%26aufirst%3DM.%2BS.%26aulast%3DHudak%26aufirst%3DJ.%26aulast%3DPatterson%26aufirst%3DJ.%26aulast%3DPenders%26aufirst%3DC.%26aulast%3DPink%26aufirst%3DM.%26aulast%3DRead%26aufirst%3DM.%2BA.%26aulast%3DSang%26aufirst%3DJ.%26aulast%3DWoodward%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DGrayzel%26aufirst%3DD.%2BS.%26aulast%3DWright%26aufirst%3DJ.%26aulast%3DBarrett%26aufirst%3DJ.%2BA.%26aulast%3DPalombella%26aufirst%3DV.%2BJ.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DTong%26aufirst%3DJ.%2BK.%26atitle%3DDevelopment%2520of%252017-allylamino-17-demethoxygeldanamycin%2520hydroquinone%2520hydrochloride%2520%2528IPI-504%2529%252C%2520an%2520anti-cancer%2520agent%2520directed%2520against%2520Hsp90%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2006%26volume%3D103%26spage%3D17408%26epage%3D17413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">McDonald, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brough, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">Discovery and development of pyrazole-scaffold Hsp90 inhibitors</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1193</span><span class="NLM_x">–</span> <span class="NLM_lpage">1203</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm701018h&amp;key=10.2174%2F156802606777812086" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm701018h&amp;key=16842156" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm701018h&amp;key=1%3ACAS%3A528%3ADC%252BD28Xpt1ejtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=1193-1203&author=E.+McDonaldauthor=K.+Jonesauthor=P.+A.+Broughauthor=M.+J.+Drysdaleauthor=P.+Workman&title=Discovery+and+development+of+pyrazole-scaffold+Hsp90+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and development of pyrazole-scaffold Hsp90 inhibitors</span></div><div class="casAuthors">McDonald, Edward; Jones, Keith; Brough, Paul A.; Drysdale, Martin J.; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1193-1203</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  This review explains why the chaperone Hsp90 is an exciting protein target for the discovery of new drugs to treat cancer in the clinic, and summarizes the properties of natural product derived inhibitors before relating the discovery and current state of development of synthetic pyrazole compds.  Blockade of Hsp90 results in reduced cellular levels of several proteins implicated in cancer including CDK4, ERBB2 and C-RAF, and causes simultaneous inhibition of cancer cell proliferation in culture and of tumor xenograft growth in vivo.  Hsp90 has an ATPase domain that is necessary for its Hsp chaperone function, and x-ray crystallog. has shown that natural product inhibitors (geldanamycin, radicicol) of Hsp90 function bind to this domain.  High throughput assays focusing on the ATPase activity of Hsp90 were developed and used to discover novel chem. starting points for cancer drug discovery.  The discovery, synthesis and SAR of 3,4-diaryl pyrazoles is described.  X-Ray crystallog. of protein-inhibitor complexes revealed important interactions involving the resorcinol substituent at C-3, and these x-ray structures strongly influenced subsequent medicinal chem. research that has resulted in highly potent inhibitors with sub-micromolar activity in cells.  SAR and x-ray data are summarized for analogs in which the 4-Ph substituent is replaced by amides or piperazine derivs.  Prospects for the pyrazoles as they progress towards clin. development are discussed in relation to current Phase I trials with derivs. of geldanamycin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSrzLa0m0ydrVg90H21EOLACvtfcHk0lgB9sV1EsHKEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xpt1ejtL0%253D&md5=0e97e917c8f045e2be444ab6fb78482d</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.2174%2F156802606777812086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802606777812086%26sid%3Dliteratum%253Aachs%26aulast%3DMcDonald%26aufirst%3DE.%26aulast%3DJones%26aufirst%3DK.%26aulast%3DBrough%26aufirst%3DP.%2BA.%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DDiscovery%2520and%2520development%2520of%2520pyrazole-scaffold%2520Hsp90%2520inhibitors%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D1193%26epage%3D1203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Discovery and development of purine-scaffold Hsp90 inhibitors</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1183</span><span class="NLM_x">–</span> <span class="NLM_lpage">1191</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm701018h&amp;key=10.2174%2F156802606777812013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm701018h&amp;key=16842155" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm701018h&amp;key=1%3ACAS%3A528%3ADC%252BD28Xpt1ejtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=1183-1191&author=G.+Chiosis&title=Discovery+and+development+of+purine-scaffold+Hsp90+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and development of purine-scaffold Hsp90 inhibitors</span></div><div class="casAuthors">Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1183-1191</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Hsp90 allows cancer cells to tolerate the many components of dysregulated pathways in a transformation-specific manner by interacting with several client substrates, such as kinases, hormone receptors and transcription factors that are directly involved in driving multistep malignancy, and also with mutated oncogenic proteins required for the transformed phenotype.  This distinctive broad involvement in maintaining the transformed phenotype has suggested Hsp90 as an important target in cancer therapy.  Discovery of pharmacol. agents that selectively inhibit its function have aided in probing the biol. functions of Hsp90 at the mol. level and in validating it as a novel target for anticancer drug action.  Two natural product derivs., 17-allylamino-17-desmethoxy-geldanamycin (17AAG) and 17-dimethylaminoethylamino-17-desmethoxy-geldanamycin (17DMAG) have further entered clin. trials, proving that Hsp90 may be modulated pharmacol. without causing target related toxicities in humans.  In spite of their usefulness as proof-of-principle compds., the clin. use of these two agents has been encumbered with some limitations due to their structural characteristics and also to less than optimal pharmacol. profiles.  Thus, the identification of Hsp90 inhibitors with improved structural characteristics and better pharmacol. profiles is a major focus of interest in the field.  One such emerging class is the purine-scaffold series.  This review intends to inform the reader on efforts ranging from the discovery to their clin. translation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtpMNMTF3zyLVg90H21EOLACvtfcHk0lgB9sV1EsHKEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xpt1ejtLw%253D&md5=f619bbb69cd7ac43a2112d56e5a904f2</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.2174%2F156802606777812013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802606777812013%26sid%3Dliteratum%253Aachs%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DDiscovery%2520and%2520development%2520of%2520purine-scaffold%2520Hsp90%2520inhibitors%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D1183%26epage%3D1191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Dymock, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">Inhibitors of HSP90 and other chaperones for the treatment of cancer</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">837</span><span class="NLM_x">–</span> <span class="NLM_lpage">847</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm701018h&amp;key=10.1517%2F13543776.14.6.837" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm701018h&amp;key=1%3ACAS%3A528%3ADC%252BD2cXktlyqsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=837-847&author=B.+W.+Dymockauthor=M.+J.+Drysdaleauthor=E.+McDonaldauthor=P.+Workman&title=Inhibitors+of+HSP90+and+other+chaperones+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of HSP90 and other chaperones for the treatment of cancer</span></div><div class="casAuthors">Dymock, Brian W.; Drysdale, Martin J.; McDonald, Edward; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">837-847</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review with refs.  Mol. chaperones are proteins that ensure the appropriate folding, stability and function of other proteins in the cell.  There is increasing evidence that mol. chaperones are not only important in normal cell homeostasis and response to stresses, such as heat shock, but can also be involved in disease pathol.  In particular, HSP90 has emerged as an important potential drug target in oncol.  This is because it is essential for the stability of a long list of client proteins', including ErbB2/human epithelial growth factor receptor (HER)2, Raf-1, Akt/protein kinase B (PKB), Polo-1, Met, mutant p53 and human telomerase reverse transcriptase (hTERT), as well as the estrogen and androgen receptor.  Inhibition of HSP90 leads to depletion of these oncogenic clients by the ubiquitin proteasome pathway, thereby providing a simultaneous combinatorial attack on all of the hallmark phenotypic traits of cancer cells.  Because of the rapid progress made, this review focuses on the patents dealing with the discovery and application of small mol. inhibitors of HSP90, although limited coverage of other applications in the area of HSP90 and addnl. chaperones is also included.  Pioneering work with natural products, namely geldanamycin and related ansamycin antibiotics together with radicicol macrocycle derivs., established the therapeutic potential of inhibiting the essential N-terminal ATPase of HSP90 by competing at the nucleotide binding site.  A geldanamycin analog, 17-(desmethoxy), 17-allylamino geldanamycin (17AAG), is completing Phase I clin. trials with promising initial results.  The use of high-throughput screening and rational design based on X-ray crystal structures of HSP90 has led to the discovery of small mol. HSP90 inhibitors based on purine and pyrazole scaffolds.  The continued progression of these various compd. classes into clin. trials should help to establish proof of concept for inhibition of HSP90 as a viable therapeutic approach for the treatment of cancer and potentially other diseases.  This would in turn validate protein folding as a strategy for drug development and encourage addnl. chaperones to be explored as mol. targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZ19fmQE-bzbVg90H21EOLACvtfcHk0lgB9sV1EsHKEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXktlyqsL8%253D&md5=68f468698084591e41c9c0a337542ca1</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1517%2F13543776.14.6.837&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.14.6.837%26sid%3Dliteratum%253Aachs%26aulast%3DDymock%26aufirst%3DB.%2BW.%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26aulast%3DMcDonald%26aufirst%3DE.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DInhibitors%2520of%2520HSP90%2520and%2520other%2520chaperones%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2004%26volume%3D14%26spage%3D837%26epage%3D847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Neckers, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neckers, K.</span><span> </span><span class="NLM_article-title">Heat-shock protein 90 inhibitors as novel cancer chemotherapeutics—an update</span> <span class="citation_source-journal">Expert. Opin. Emerging Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">137</span><span class="NLM_x">–</span> <span class="NLM_lpage">149</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm701018h&amp;key=10.1517%2F14728214.10.1.137" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm701018h&amp;key=15757409" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm701018h&amp;key=1%3ACAS%3A528%3ADC%252BD2MXislCrt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2005&pages=137-149&author=L.+Neckersauthor=K.+Neckers&title=Heat-shock+protein+90+inhibitors+as+novel+cancer+chemotherapeutics%E2%80%94an+update"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Heat-shock protein 90 inhibitors as novel cancer chemotherapeutics - an update</span></div><div class="casAuthors">Neckers, Len; Neckers, Katharine</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Emerging Drugs</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">137-149</span>CODEN:
                <span class="NLM_cas:coden">EOEDA3</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Heat-shock protein 90 (Hsp90) is a mol. chaperone whose assocn. is required for stability and function of a growing no. of signalling proteins that have been implicated in cancer cell survival, including several mutated proteins that are only found in specific cancers.  Furthermore, a growing body of evidence suggests that cancer cells are particularly dependent on Hsp90 for their growth and survival, and, therefore, are more sensitive to the effects of its inhibition than are non-transformed cells and tissues.  Several chem. distinct Hsp90 inhibitors have shown encouraging antitumor activity in multiple preclin. model systems, and one Hsp90 inhibitor, the benzoquinone ansamycin 17-allylamino, 17-demethoxygeldanamycin, has completed five Phase I clin. trials, with a no. of Phase II trials soon to be underway or in progress.  Other Hsp90 inhibitors are either in Phase I clin. trial or under development.  This update will focus on how the latest developments in Hsp90 biol. may better inform the clin. development of Hsp90 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozi0ii7Nj7IbVg90H21EOLACvtfcHk0liJlubwA-ARAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXislCrt7o%253D&md5=91e907d6208cb717cbc3648f3d025dd3</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1517%2F14728214.10.1.137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728214.10.1.137%26sid%3Dliteratum%253Aachs%26aulast%3DNeckers%26aufirst%3DL.%26aulast%3DNeckers%26aufirst%3DK.%26atitle%3DHeat-shock%2520protein%252090%2520inhibitors%2520as%2520novel%2520cancer%2520chemotherapeutics%25E2%2580%2594an%2520update%26jtitle%3DExpert.%2520Opin.%2520Emerging%2520Drugs%26date%3D2005%26volume%3D10%26spage%3D137%26epage%3D149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Janin, Y. L.</span><span> </span><span class="NLM_article-title">Heat shock protein 90 inhibitors. A text book example of medicinal chemistry</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7503</span><span class="NLM_x">–</span> <span class="NLM_lpage">7512</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050759r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7503-7512&author=Y.+L.+Janin&title=Heat+shock+protein+90+inhibitors.+A+text+book+example+of+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm050759r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050759r%26sid%3Dliteratum%253Aachs%26aulast%3DJanin%26aufirst%3DY.%2BL.%26atitle%3DHeat%2520shock%2520protein%252090%2520inhibitors.%2520A%2520text%2520book%2520example%2520of%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7503%26epage%3D7512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Drysdale, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brough, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepfer, J.</span><span> </span><span class="NLM_article-title">Targeting Hsp90 for the treatment of cancer</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">483</span><span class="NLM_x">–</span> <span class="NLM_lpage">495</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm701018h&amp;key=16889231" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm701018h&amp;key=1%3ACAS%3A528%3ADC%252BD28XntVChs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=483-495&author=M.+J.+Drysdaleauthor=P.+A.+Broughauthor=A.+Masseyauthor=M.+R.+Jensenauthor=J.+Schoepfer&title=Targeting+Hsp90+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Hsp90 for the treatment of cancer</span></div><div class="casAuthors">Drysdale, Martin J.; Brough, Paul A.; Massey, Andrew; Jensen, Michael Rugaard; Schoepfer, Joseph</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Drug Discovery & Development</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">483-495</span>CODEN:
                <span class="NLM_cas:coden">CODDFF</span>;
        ISSN:<span class="NLM_cas:issn">1367-6733</span>.
    
            (<span class="NLM_cas:orgname">Thomson Scientific</span>)
        </div><div class="casAbstract">A review.  Heat shock protein (Hsp)90 is a mol. chaperone that is responsible for the correct folding of a large no. of proteins, which allows these proteins to achieve their functional conformation.  Client proteins of Hsp90 include many overexpressed or mutated oncogenes that are known to be crit. for the transformed phenotype obsd. in tumors.  The compds. 17-AAG (Kosan Biosciences Inc/National Cancer Institute) and 17-DMAG (Kosan Biosciences Inc/National Cancer Institute) are Hsp90 inhibitors that are derived from the prototypical ansamycin natural product Hsp90 inhibitor geldanamycin.  These compds. have demonstrated preclin. efficacy in mouse xenograft models, and are now undergoing phase II and I clin. trials, resp.  Preclin. efficacy studies of these compds. are collated and discussed in this review.  More recent disclosures of small-mol. Hsp90 inhibitors include purine and resorcinol analogs, and the first small-mol. Hsp90 compds. showing oral efficacy have been described.  Inhibition of Hsp90 not only results in the degrdn. of client proteins, but also results in the induction of another chaperone, Hsp70.  Hsp70 is known to be anti-apoptotic, and therefore the induction of Hsp70 may ultimately limit the efficacy of Hsp90 inhibitors under certain circumstances.  Histone deacetylase inhibitors have recently been demonstrated to exert some of their effect through modulation of Hsp90 chaperoning activity, and some mechanistic aspects of this control are also discussed herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-VkK7aR3PuLVg90H21EOLACvtfcHk0liJlubwA-ARAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntVChs7k%253D&md5=117860d15c90611ea5da8fc356fe814f</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26aulast%3DBrough%26aufirst%3DP.%2BA.%26aulast%3DMassey%26aufirst%3DA.%26aulast%3DJensen%26aufirst%3DM.%2BR.%26aulast%3DSchoepfer%26aufirst%3DJ.%26atitle%3DTargeting%2520Hsp90%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2006%26volume%3D9%26spage%3D483%26epage%3D495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zatorska, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguirre, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llauger, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">She, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Immormino, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gewirth, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Identification of potent water soluble purine-scaffold inhibitors of the heat shock protein 90</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">381</span><span class="NLM_x">–</span> <span class="NLM_lpage">390</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0508078" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm701018h&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1ynsrrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=381-390&author=H.+Heauthor=D.+Zatorskaauthor=J.+Kimauthor=J.+Aguirreauthor=L.+Llaugerauthor=Y.+Sheauthor=N.+Wuauthor=R.+M.+Immorminoauthor=D.+T.+Gewirthauthor=G.+Chiosis&title=Identification+of+potent+water+soluble+purine-scaffold+inhibitors+of+the+heat+shock+protein+90"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Potent Water Soluble Purine-Scaffold Inhibitors of the Heat Shock Protein 90</span></div><div class="casAuthors">He, Huazhong; Zatorska, Danuta; Kim, Joungnam; Aguirre, Julia; Llauger, Laura; She, Yuhong; Wu, Nian; Immormino, Robert M.; Gewirth, Daniel T.; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">381-390</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hsp90 is a chaperone protein that allows cancer cells to tolerate the many components of dysregulated pathways.  Its inactivation may result in targeting multiple mol. alterations and, thus, in reverting the transformed phenotype.  The PU-class, a purine-scaffold Hsp90 inhibitor series, has been reported to be potent and selective against Hsp90 both in vitro and in vivo models of cancer.  Here, a series of this class was synthesized and evaluated as inhibitors of the chaperone.  The structure-activity relationship and selectivity for tumor Hsp90 of compds. within the series is presented.  The study identifies water sol. derivs. (>5 mM in PBS pH 7.4) of nanomolar potency (IC50 ∼ 50 nM) in cellular and animal models of cancer.  Binding affinities of these compds. for Hsp90 correlate well with their biol. activities.  When administered in vivo to mice bearing MDA-MB-468 human breast cancer xenografted tumors, these agents result in pharmacol. relevant concns. and, accordingly, in modulation of Hsp90-client proteins in tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRwHp1Wo_iW7Vg90H21EOLACvtfcHk0liJlubwA-ARAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1ynsrrF&md5=3bd02ca5bc0a147e9cffa58968433917</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm0508078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0508078%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DH.%26aulast%3DZatorska%26aufirst%3DD.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DAguirre%26aufirst%3DJ.%26aulast%3DLlauger%26aufirst%3DL.%26aulast%3DShe%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DN.%26aulast%3DImmormino%26aufirst%3DR.%2BM.%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DIdentification%2520of%2520potent%2520water%2520soluble%2520purine-scaffold%2520inhibitors%2520of%2520the%2520heat%2520shock%2520protein%252090%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D381%26epage%3D390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Biamonte, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busch, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karjian, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maldonado, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sensintaffar, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lough, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundgren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timony, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasibhatla, S. R.</span><span> </span><span class="NLM_article-title">Orally active purine-based inhibitors of the heat shock protein 90</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">817</span><span class="NLM_x">–</span> <span class="NLM_lpage">828</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0503087" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=817-828&author=M.+A.+Biamonteauthor=J.+Shiauthor=K.+Hongauthor=D.+C.+Hurstauthor=L.+Zhangauthor=J.+Fanauthor=D.+J.+Buschauthor=P.+L.+Karjianauthor=A.+A.+Maldonadoauthor=J.+L.+Sensintaffarauthor=Y.+C.+Yangauthor=A.+Kamalauthor=R.+E.+Loughauthor=K.+Lundgrenauthor=F.+J.+Burrowsauthor=G.+A.+Timonyauthor=M.+F.+Boehmauthor=S.+R.+Kasibhatla&title=Orally+active+purine-based+inhibitors+of+the+heat+shock+protein+90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm0503087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0503087%26sid%3Dliteratum%253Aachs%26aulast%3DBiamonte%26aufirst%3DM.%2BA.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DHong%26aufirst%3DK.%26aulast%3DHurst%26aufirst%3DD.%2BC.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DBusch%26aufirst%3DD.%2BJ.%26aulast%3DKarjian%26aufirst%3DP.%2BL.%26aulast%3DMaldonado%26aufirst%3DA.%2BA.%26aulast%3DSensintaffar%26aufirst%3DJ.%2BL.%26aulast%3DYang%26aufirst%3DY.%2BC.%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DLough%26aufirst%3DR.%2BE.%26aulast%3DLundgren%26aufirst%3DK.%26aulast%3DBurrows%26aufirst%3DF.%2BJ.%26aulast%3DTimony%26aufirst%3DG.%2BA.%26aulast%3DBoehm%26aufirst%3DM.%2BF.%26aulast%3DKasibhatla%26aufirst%3DS.%2BR.%26atitle%3DOrally%2520active%2520purine-based%2520inhibitors%2520of%2520the%2520heat%2520shock%2520protein%252090%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D817%26epage%3D828" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Kasibhatla, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biamonte, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busch, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karjian, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sensintaffar, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lough, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brekken, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundgren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grecko, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timony, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ran, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansfield, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fritz, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulm, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, M. F.</span><span> </span><span class="NLM_article-title">Rationally designed high-affinity 2-amino-6-halopurine heat shock protein 90 inhibitors that exhibit potent antitumor activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2767</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050752%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2767&author=S.+R.+Kasibhatlaauthor=K.+Hongauthor=M.+A.+Biamonteauthor=D.+J.+Buschauthor=P.+L.+Karjianauthor=J.+L.+Sensintaffarauthor=A.+Kamalauthor=R.+E.+Loughauthor=J.+Brekkenauthor=K.+Lundgrenauthor=R.+Greckoauthor=G.+A.+Timonyauthor=Y.+Ranauthor=R.+Mansfieldauthor=L.+C.+Fritzauthor=E.+Ulmauthor=F.+J.+Burrowsauthor=M.+F.+Boehm&title=Rationally+designed+high-affinity+2-amino-6-halopurine+heat+shock+protein+90+inhibitors+that+exhibit+potent+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm050752%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050752%252B%26sid%3Dliteratum%253Aachs%26aulast%3DKasibhatla%26aufirst%3DS.%2BR.%26aulast%3DHong%26aufirst%3DK.%26aulast%3DBiamonte%26aufirst%3DM.%2BA.%26aulast%3DBusch%26aufirst%3DD.%2BJ.%26aulast%3DKarjian%26aufirst%3DP.%2BL.%26aulast%3DSensintaffar%26aufirst%3DJ.%2BL.%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DLough%26aufirst%3DR.%2BE.%26aulast%3DBrekken%26aufirst%3DJ.%26aulast%3DLundgren%26aufirst%3DK.%26aulast%3DGrecko%26aufirst%3DR.%26aulast%3DTimony%26aufirst%3DG.%2BA.%26aulast%3DRan%26aufirst%3DY.%26aulast%3DMansfield%26aufirst%3DR.%26aulast%3DFritz%26aufirst%3DL.%2BC.%26aulast%3DUlm%26aufirst%3DE.%26aulast%3DBurrows%26aufirst%3DF.%2BJ.%26aulast%3DBoehm%26aufirst%3DM.%2BF.%26atitle%3DRationally%2520designed%2520high-affinity%25202-amino-6-halopurine%2520heat%2520shock%2520protein%252090%2520inhibitors%2520that%2520exhibit%2520potent%2520antitumor%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Cheung, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowlands, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boxall, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloney, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roe, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodromou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearl, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aherne, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">The identification, synthesis, protein crystal structure and in vitro biochemical evaluation of a new 3,4-diarylpyrazole class of Hsp90 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">3338</span><span class="NLM_x">–</span> <span class="NLM_lpage">3343</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=3338-3343&author=K.+M.+Cheungauthor=T.+P.+Matthewsauthor=K.+Jamesauthor=M.+G.+Rowlandsauthor=K.+J.+Boxallauthor=S.+Y.+Sharpauthor=A.+Maloneyauthor=S.+M.+Roeauthor=C.+Prodromouauthor=L.+H.+Pearlauthor=G.+W.+Aherneauthor=E.+McDonaldauthor=P.+Workman&title=The+identification%2C+synthesis%2C+protein+crystal+structure+and+in+vitro+biochemical+evaluation+of+a+new+3%2C4-diarylpyrazole+class+of+Hsp90+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCheung%26aufirst%3DK.%2BM.%26aulast%3DMatthews%26aufirst%3DT.%2BP.%26aulast%3DJames%26aufirst%3DK.%26aulast%3DRowlands%26aufirst%3DM.%2BG.%26aulast%3DBoxall%26aufirst%3DK.%2BJ.%26aulast%3DSharp%26aufirst%3DS.%2BY.%26aulast%3DMaloney%26aufirst%3DA.%26aulast%3DRoe%26aufirst%3DS.%2BM.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26aulast%3DAherne%26aufirst%3DG.%2BW.%26aulast%3DMcDonald%26aufirst%3DE.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DThe%2520identification%252C%2520synthesis%252C%2520protein%2520crystal%2520structure%2520and%2520in%2520vitro%2520biochemical%2520evaluation%2520of%2520a%2520new%25203%252C4-diarylpyrazole%2520class%2520of%2520Hsp90%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D3338%26epage%3D3343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Sharp, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boxall, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowlands, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodromou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roe, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloney, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Box, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanderson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ball, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marais, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearl, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aherne, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">In vitro biological characterization of a novel, synthetic diaryl pyrazole resorcinol class of heat shock protein 90 inhibitors</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">2206</span><span class="NLM_x">–</span> <span class="NLM_lpage">2216</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=2206-2216&author=S.+Y.+Sharpauthor=K.+Boxallauthor=M.+Rowlandsauthor=C.+Prodromouauthor=S.+M.+Roeauthor=A.+Maloneyauthor=M.+Powersauthor=P.+A.+Clarkeauthor=G.+Boxauthor=S.+Sandersonauthor=L.+Pattersonauthor=T.+P.+Matthewsauthor=K.+M.+Cheungauthor=K.+Ballauthor=A.+Hayesauthor=F.+Raynaudauthor=R.+Maraisauthor=L.+Pearlauthor=S.+Ecclesauthor=W.+Aherneauthor=E.+McDonaldauthor=P.+Workman&title=In+vitro+biological+characterization+of+a+novel%2C+synthetic+diaryl+pyrazole+resorcinol+class+of+heat+shock+protein+90+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSharp%26aufirst%3DS.%2BY.%26aulast%3DBoxall%26aufirst%3DK.%26aulast%3DRowlands%26aufirst%3DM.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DRoe%26aufirst%3DS.%2BM.%26aulast%3DMaloney%26aufirst%3DA.%26aulast%3DPowers%26aufirst%3DM.%26aulast%3DClarke%26aufirst%3DP.%2BA.%26aulast%3DBox%26aufirst%3DG.%26aulast%3DSanderson%26aufirst%3DS.%26aulast%3DPatterson%26aufirst%3DL.%26aulast%3DMatthews%26aufirst%3DT.%2BP.%26aulast%3DCheung%26aufirst%3DK.%2BM.%26aulast%3DBall%26aufirst%3DK.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DRaynaud%26aufirst%3DF.%26aulast%3DMarais%26aufirst%3DR.%26aulast%3DPearl%26aufirst%3DL.%26aulast%3DEccles%26aufirst%3DS.%26aulast%3DAherne%26aufirst%3DW.%26aulast%3DMcDonald%26aufirst%3DE.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DIn%2520vitro%2520biological%2520characterization%2520of%2520a%2520novel%252C%2520synthetic%2520diaryl%2520pyrazole%2520resorcinol%2520class%2520of%2520heat%2520shock%2520protein%252090%2520inhibitors%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D2206%26epage%3D2216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Dymock, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barril, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brough, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cansfield, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgenor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roughley, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M. J.</span><span> </span><span class="NLM_article-title">Novel, potent small-molecule inhibitors of the molecular chaperone Hsp90 discovered through structure-based design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">4212</span><span class="NLM_x">–</span> <span class="NLM_lpage">4215</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050355z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm701018h&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkslSnsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=4212-4215&author=B.+W.+Dymockauthor=X.+Barrilauthor=P.+A.+Broughauthor=J.+E.+Cansfieldauthor=A.+Masseyauthor=E.+McDonaldauthor=R.+E.+Hubbardauthor=A.+Surgenorauthor=S.+D.+Roughleyauthor=P.+Webbauthor=P.+Workmanauthor=L.+Wrightauthor=M.+J.+Drysdale&title=Novel%2C+potent+small-molecule+inhibitors+of+the+molecular+chaperone+Hsp90+discovered+through+structure-based+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Novel, Potent Small-Molecule Inhibitors of the Molecular Chaperone Hsp90 Discovered through Structure-Based Design</span></div><div class="casAuthors">Dymock, Brian W.; Barril, Xavier; Brough, Paul A.; Cansfield, Julie E.; Massey, Andrew; McDonald, Edward; Hubbard, Roderick E.; Surgenor, Allan; Roughley, Stephen D.; Webb, Paul; Workman, Paul; Wright, Lisa; Drysdale, Martin J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4212-4215</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The crystal structure of a previously reported screening hit 1 (CCT018159) bound to the N terminal domain of mol. chaperone Hsp90 has been used to design 5-amide analogs.  These exhibit enhanced potency against the target in binding and functional assays with accompanying appropriate cellular pharmacodynamic changes.  Compd. 11 (VER-49009) compares favorably with the clin. evaluated 17-AAG.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZR4ICeTnHxbVg90H21EOLACvtfcHk0lie4QHwjk6PQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkslSnsbg%253D&md5=3a854d5f6fd1eb0e292292b2a8d22401</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm050355z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050355z%26sid%3Dliteratum%253Aachs%26aulast%3DDymock%26aufirst%3DB.%2BW.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DBrough%26aufirst%3DP.%2BA.%26aulast%3DCansfield%26aufirst%3DJ.%2BE.%26aulast%3DMassey%26aufirst%3DA.%26aulast%3DMcDonald%26aufirst%3DE.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DRoughley%26aufirst%3DS.%2BD.%26aulast%3DWebb%26aufirst%3DP.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DWright%26aufirst%3DL.%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26atitle%3DNovel%252C%2520potent%2520small-molecule%2520inhibitors%2520of%2520the%2520molecular%2520chaperone%2520Hsp90%2520discovered%2520through%2520structure-based%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D4212%26epage%3D4215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Brough, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barril, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beswick, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dymock, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgenor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">3-(5-Chloro-2,4-dihydroxyphenyl)-pyrazole-4-carboxamides as inhibitors of the Hsp90 molecular chaperone</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">5197</span><span class="NLM_x">–</span> <span class="NLM_lpage">5201</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=5197-5201&author=P.+A.+Broughauthor=X.+Barrilauthor=M.+Beswickauthor=B.+W.+Dymockauthor=M.+J.+Drysdaleauthor=L.+Wrightauthor=K.+Grantauthor=A.+Masseyauthor=A.+Surgenorauthor=P.+Workman&title=3-%285-Chloro-2%2C4-dihydroxyphenyl%29-pyrazole-4-carboxamides+as+inhibitors+of+the+Hsp90+molecular+chaperone"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrough%26aufirst%3DP.%2BA.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DBeswick%26aufirst%3DM.%26aulast%3DDymock%26aufirst%3DB.%2BW.%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26aulast%3DWright%26aufirst%3DL.%26aulast%3DGrant%26aufirst%3DK.%26aulast%3DMassey%26aufirst%3DA.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3D3-%25285-Chloro-2%252C4-dihydroxyphenyl%2529-pyrazole-4-carboxamides%2520as%2520inhibitors%2520of%2520the%2520Hsp90%2520molecular%2520chaperone%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D5197%26epage%3D5201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Barril, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beswick, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collier, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dymock, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fink, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgenor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wayne, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L.</span><span> </span><span class="NLM_article-title">4-Amino derivatives of the Hsp90 inhibitor CCT018159</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2543</span><span class="NLM_x">–</span> <span class="NLM_lpage">2548</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=2543-2548&author=X.+Barrilauthor=M.+C.+Beswickauthor=A.+Collierauthor=M.+J.+Drysdaleauthor=B.+W.+Dymockauthor=A.+Finkauthor=K.+Grantauthor=R.+Howesauthor=A.+M.+Jordanauthor=A.+Masseyauthor=A.+Surgenorauthor=J.+Wayneauthor=P.+Workmanauthor=L.+Wright&title=4-Amino+derivatives+of+the+Hsp90+inhibitor+CCT018159"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DBeswick%26aufirst%3DM.%2BC.%26aulast%3DCollier%26aufirst%3DA.%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26aulast%3DDymock%26aufirst%3DB.%2BW.%26aulast%3DFink%26aufirst%3DA.%26aulast%3DGrant%26aufirst%3DK.%26aulast%3DHowes%26aufirst%3DR.%26aulast%3DJordan%26aufirst%3DA.%2BM.%26aulast%3DMassey%26aufirst%3DA.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DWayne%26aufirst%3DJ.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DWright%26aufirst%3DL.%26atitle%3D4-Amino%2520derivatives%2520of%2520the%2520Hsp90%2520inhibitor%2520CCT018159%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D2543%26epage%3D2548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><div class="note"><p class="first last">PDB id codes for <b>5</b><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2BTO">2BTO</a>; for <b>6</b><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2BSM">2BSM</a>; and for <b>7</b><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2BHY">2BHY</a></p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=PDB+id+codes+for+52BTO%3B+for+62BSM%3B+and+for+72BHY."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Sharp, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodromou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boxall, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Box, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalusa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardcastle, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dymock, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brough, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barril, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cansfield, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgenor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foloppe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aherne, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearl, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">Inhibition of the heat shock protein 90 molecular chaperone in vitro and in vivo by novel, synthetic, potent resorcinylic pyrazole/isoxazole amide analogues</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1198</span><span class="NLM_x">–</span> <span class="NLM_lpage">1211</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm701018h&amp;key=10.1158%2F1535-7163.MCT-07-0149" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm701018h&amp;key=17431102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm701018h&amp;key=1%3ACAS%3A528%3ADC%252BD2sXktFanu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=1198-1211&author=S.+Y.+Sharpauthor=C.+Prodromouauthor=K.+Boxallauthor=M.+V.+Powersauthor=J.+L.+Holmesauthor=G.+Boxauthor=T.+P.+Matthewsauthor=K.+M.+Cheungauthor=A.+Kalusaauthor=K.+Jamesauthor=A.+Hayesauthor=A.+Hardcastleauthor=B.+Dymockauthor=P.+A.+Broughauthor=X.+Barrilauthor=J.+E.+Cansfieldauthor=L.+Wrightauthor=A.+Surgenorauthor=N.+Foloppeauthor=R.+E.+Hubbardauthor=W.+Aherneauthor=L.+Pearlauthor=K.+Jonesauthor=E.+McDonaldauthor=F.+Raynaudauthor=S.+Ecclesauthor=M.+Drysdaleauthor=P.+Workman&title=Inhibition+of+the+heat+shock+protein+90+molecular+chaperone+in+vitro+and+in+vivo+by+novel%2C+synthetic%2C+potent+resorcinylic+pyrazole%2Fisoxazole+amide+analogues"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of the heat shock protein 90 molecular chaperone in vitro and in vivo by novel, synthetic, potent resorcinylic pyrazole/isoxazole amide analogues</span></div><div class="casAuthors">Sharp, Swee Y.; Prodromou, Chrisostomos; Boxall, Kathy; Powers, Marissa V.; Holmes, Joanna L.; Box, Gary; Matthews, Thomas P.; Cheung, Kwai-Ming J.; Kalusa, Andrew; James, Karen; Hayes, Angela; Hardcastle, Anthea; Dymock, Brian; Brough, Paul A.; Barril, Xavier; Cansfield, Julie E.; Wright, Lisa; Surgenor, Allan; Foloppe, Nicolas; Hubbard, Roderick E.; Aherne, Wynne; Pearl, Laurence; Jones, Keith; McDonald, Edward; Raynaud, Florence; Eccles, Sue; Drysdale, Martin; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1198-1211</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Although the heat shock protein 90 (HSP90) inhibitor 17-allylamino-17-demethoxygeldanamycin (17-AAG) shows clin. promise, potential limitations encourage development of alternative chemotypes.  We discovered the 3,4-diarylpyrazole resorcinol CCT018159 by high-throughput screening and used structure-based design to generate more potent pyrazole amide analogs, exemplified by VER-49009.  Here, we describe the detailed biol. properties of VER-49009 and the corresponding isoxazole VER-50589.  X-ray crystallog. showed a virtually identical HSP90 binding mode.  However, the dissocn. const. (Kd) of VER-50589 was 4.5±2.2 nmol/L compared with 78.0±10.4 nmol/L for VER-49009, attributable to higher enthalpy for VER-50589 binding.  A competitive binding assay gave a lower IC50 of 21±4 nmol/L for VER-50589 compared with 47±9 nmol/L for VER-49009.  Cellular uptake of VER-50589 was 4-fold greater than for VER-49009.  Mean cellular antiproliferative GI50 values for VER-50589 and VER-49009 for a human cancer cell line panel were 78±15 and 685±119 nmol/L, resp., showing a 9-fold potency gain for the isoxazole.  Unlike 17-AAG, but as with CCT018159, cellular potency of these analogs was independent of NAD(P)H:quinone oxidoreductase 1/DT-diaphorase and P-glycoprotein expression.  Consistent with HSP90 inhibition, VER-50589 and VER-49009 caused induction of HSP72 and HSP27 alongside depletion of client proteins, including C-RAF, B-RAF, and survivin, and the protein arginine methyltransferase PRMT5.  Both caused cell cycle arrest and apoptosis.  Extent and duration of pharmacodynamic changes in an orthotopic human ovarian carcinoma model confirmed the superiority of VER-50589 over VER-49009.  VER-50589 accumulated in HCT116 human colon cancer xenografts at levels above the cellular GI50 for 24 h, resulting in 30% growth inhibition.  The results indicate the therapeutic potential of the resorcinylic pyrazole/isoxazole amide analogs as HSP90 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdCmDXnfwFjrVg90H21EOLACvtfcHk0liuT7X4iLCmTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXktFanu7Y%253D&md5=58678b76ed7fbda4d21942c69346946c</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-07-0149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-07-0149%26sid%3Dliteratum%253Aachs%26aulast%3DSharp%26aufirst%3DS.%2BY.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DBoxall%26aufirst%3DK.%26aulast%3DPowers%26aufirst%3DM.%2BV.%26aulast%3DHolmes%26aufirst%3DJ.%2BL.%26aulast%3DBox%26aufirst%3DG.%26aulast%3DMatthews%26aufirst%3DT.%2BP.%26aulast%3DCheung%26aufirst%3DK.%2BM.%26aulast%3DKalusa%26aufirst%3DA.%26aulast%3DJames%26aufirst%3DK.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DHardcastle%26aufirst%3DA.%26aulast%3DDymock%26aufirst%3DB.%26aulast%3DBrough%26aufirst%3DP.%2BA.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DCansfield%26aufirst%3DJ.%2BE.%26aulast%3DWright%26aufirst%3DL.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DFoloppe%26aufirst%3DN.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26aulast%3DAherne%26aufirst%3DW.%26aulast%3DPearl%26aufirst%3DL.%26aulast%3DJones%26aufirst%3DK.%26aulast%3DMcDonald%26aufirst%3DE.%26aulast%3DRaynaud%26aufirst%3DF.%26aulast%3DEccles%26aufirst%3DS.%26aulast%3DDrysdale%26aufirst%3DM.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DInhibition%2520of%2520the%2520heat%2520shock%2520protein%252090%2520molecular%2520chaperone%2520in%2520vitro%2520and%2520in%2520vivo%2520by%2520novel%252C%2520synthetic%252C%2520potent%2520resorcinylic%2520pyrazole%252Fisoxazole%2520amide%2520analogues%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2007%26volume%3D6%26spage%3D1198%26epage%3D1211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Kreusch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesley, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, X. J.</span><span> </span><span class="NLM_article-title">Crystal structures of human HSP90alpha-complexed with dihydroxyphenylpyrazoles</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1475</span><span class="NLM_x">–</span> <span class="NLM_lpage">1478</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1475-1478&author=A.+Kreuschauthor=S.+Hanauthor=A.+Brinkerauthor=V.+Zhouauthor=H.+S.+Choiauthor=Y.+Heauthor=S.+A.+Lesleyauthor=J.+Caldwellauthor=X.+J.+Gu&title=Crystal+structures+of+human+HSP90alpha-complexed+with+dihydroxyphenylpyrazoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKreusch%26aufirst%3DA.%26aulast%3DHan%26aufirst%3DS.%26aulast%3DBrinker%26aufirst%3DA.%26aulast%3DZhou%26aufirst%3DV.%26aulast%3DChoi%26aufirst%3DH.%2BS.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DLesley%26aufirst%3DS.%2BA.%26aulast%3DCaldwell%26aufirst%3DJ.%26aulast%3DGu%26aufirst%3DX.%2BJ.%26atitle%3DCrystal%2520structures%2520of%2520human%2520HSP90alpha-complexed%2520with%2520dihydroxyphenylpyrazoles%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D1475%26epage%3D1478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Carpino, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imazumi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Faham, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrer, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foxman, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henklein, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanay, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mugge, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wenschuh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klose, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beyermann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bienert, M.</span><span> </span><span class="NLM_article-title">The uronium/guanidinium peptide coupling reagents: finally the true uronium salts</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">442</span><span class="NLM_x">–</span> <span class="NLM_lpage">445</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2002&pages=442-445&author=L.+A.+Carpinoauthor=H.+Imazumiauthor=A.+El-Fahamauthor=F.+J.+Ferrerauthor=C.+Zhangauthor=Y.+Leeauthor=B.+M.+Foxmanauthor=P.+Henkleinauthor=C.+Hanayauthor=C.+Muggeauthor=H.+Wenschuhauthor=K.+Kloseauthor=M.+Beyermannauthor=M.+Bienert&title=The+uronium%2Fguanidinium+peptide+coupling+reagents%3A+finally+the+true+uronium+salts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarpino%26aufirst%3DL.%2BA.%26aulast%3DImazumi%26aufirst%3DH.%26aulast%3DEl-Faham%26aufirst%3DA.%26aulast%3DFerrer%26aufirst%3DF.%2BJ.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DY.%26aulast%3DFoxman%26aufirst%3DB.%2BM.%26aulast%3DHenklein%26aufirst%3DP.%26aulast%3DHanay%26aufirst%3DC.%26aulast%3DMugge%26aufirst%3DC.%26aulast%3DWenschuh%26aufirst%3DH.%26aulast%3DKlose%26aufirst%3DK.%26aulast%3DBeyermann%26aufirst%3DM.%26aulast%3DBienert%26aufirst%3DM.%26atitle%3DThe%2520uronium%252Fguanidinium%2520peptide%2520coupling%2520reagents%253A%2520finally%2520the%2520true%2520uronium%2520salts%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2002%26volume%3D41%26spage%3D442%26epage%3D445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Wright, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barril, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dymock, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheridan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgenor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beswick, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collier, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fink, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fromont, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aherne, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boxall, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, R. E.</span><span> </span><span class="NLM_article-title">Structure−activity relationships in purine-based inhibitor binding to HSP90 isoforms</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">775</span><span class="NLM_x">–</span> <span class="NLM_lpage">785</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm701018h&amp;key=10.1016%2Fj.chembiol.2004.03.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm701018h&amp;key=15217611" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm701018h&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlt1Sjsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=775-785&author=L.+Wrightauthor=X.+Barrilauthor=B.+Dymockauthor=L.+Sheridanauthor=A.+Surgenorauthor=M.+Beswickauthor=M.+Drysdaleauthor=A.+Collierauthor=A.+Masseyauthor=N.+Daviesauthor=A.+Finkauthor=C.+Fromontauthor=W.+Aherneauthor=K.+Boxallauthor=S.+Sharpauthor=P.+Workmanauthor=R.+E.+Hubbard&title=Structure%E2%88%92activity+relationships+in+purine-based+inhibitor+binding+to+HSP90+isoforms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationships in Purine-Based Inhibitor Binding to HSP90 Isoforms</span></div><div class="casAuthors">Wright, Lisa; Barril, Xavier; Dymock, Brian; Sheridan, Louisa; Surgenor, Allan; Beswick, Mandy; Drysdale, Martin; Collier, Adam; Massey, Andy; Davies, Nick; Fink, Alex; Fromont, Christophe; Aherne, Wynne; Boxall, Kathy; Sharp, Swee; Workman, Paul; Hubbard, Roderick E.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">775-785</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Inhibition of the ATPase activity of the chaperone protein HSP90 is a potential strategy for treatment of cancers.  We have detd. structures of the HSP90α N-terminal domain complexed with the purine-based inhibitor, PU3, and analogs with enhanced potency both in enzyme and cell-based assays.  The compds. induce upregulation of HSP70 and downregulation of the known HSP90 client proteins Raf-1, CDK4, and ErbB2, confirming that the mols. inhibit cell growth by a mechanism dependent on HSP90 inhibition.  We have also detd. the first structure of the N-terminal domain of HSP90β, complexed with PU3.  The structures allow a detailed rationale to be developed for the obsd. affinity of the PU3 class of compds. for HSP90 and also provide a structural framework for design of compds. with improved binding affinity and drug-like properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2Z11Wd4hiXrVg90H21EOLACvtfcHk0ljR4Br6CG--Iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlt1Sjsrs%253D&md5=dd2146dba0f4b3198d5bc7023e645812</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2004.03.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2004.03.033%26sid%3Dliteratum%253Aachs%26aulast%3DWright%26aufirst%3DL.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DDymock%26aufirst%3DB.%26aulast%3DSheridan%26aufirst%3DL.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DBeswick%26aufirst%3DM.%26aulast%3DDrysdale%26aufirst%3DM.%26aulast%3DCollier%26aufirst%3DA.%26aulast%3DMassey%26aufirst%3DA.%26aulast%3DDavies%26aufirst%3DN.%26aulast%3DFink%26aufirst%3DA.%26aulast%3DFromont%26aufirst%3DC.%26aulast%3DAherne%26aufirst%3DW.%26aulast%3DBoxall%26aufirst%3DK.%26aulast%3DSharp%26aufirst%3DS.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26atitle%3DStructure%25E2%2588%2592activity%2520relationships%2520in%2520purine-based%2520inhibitor%2520binding%2520to%2520HSP90%2520isoforms%26jtitle%3DChem.%2520Biol.%26date%3D2004%26volume%3D11%26spage%3D775%26epage%3D785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Mitchell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doecke, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hay, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koenig, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wirth, D. D.</span><span> </span><span class="NLM_article-title"><i>ortho</i>-Hydroxy assisted deoxygenation of phenones. Regiochemical control in the synthesis of monoprotected resorcinols and related polyphenolic hydroxyl systems</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">5335</span><span class="NLM_x">–</span> <span class="NLM_lpage">5338</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1995&pages=5335-5338&author=D.+Mitchellauthor=C.+W.+Doeckeauthor=L.+A.+Hayauthor=T.+M.+Koenigauthor=D.+D.+Wirth&title=ortho-Hydroxy+assisted+deoxygenation+of+phenones.+Regiochemical+control+in+the+synthesis+of+monoprotected+resorcinols+and+related+polyphenolic+hydroxyl+systems"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMitchell%26aufirst%3DD.%26aulast%3DDoecke%26aufirst%3DC.%2BW.%26aulast%3DHay%26aufirst%3DL.%2BA.%26aulast%3DKoenig%26aufirst%3DT.%2BM.%26aulast%3DWirth%26aufirst%3DD.%2BD.%26atitle%3Dortho-Hydroxy%2520assisted%2520deoxygenation%2520of%2520phenones.%2520Regiochemical%2520control%2520in%2520the%2520synthesis%2520of%2520monoprotected%2520resorcinols%2520and%2520related%2520polyphenolic%2520hydroxyl%2520systems%26jtitle%3DTetrahedron%2520Lett.%26date%3D1995%26volume%3D36%26spage%3D5335%26epage%3D5338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><div class="note"><p class="first last">Atomic coordinates for <b>40f</b> have been deposited with the Protein Data Bank at Rutgers University;</p></div><a href="http://rcsb.rutgers.edu/pdb/index.html" class="extLink">http://rcsb.rutgers.edu/pdb/index.html</a>; PDB code <span class="NLM_ext-link">2VCI</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Atomic+coordinates+for+40f+have+been+deposited+with+the+Protein+Data+Bank+at+Rutgers+University%3Bhttp%3A%2F%2Frcsb.rutgers.edu%2Fpdb%2Findex.html%3B+PDB+code+2VCI."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><div class="note"><p class="first last">Compound <b>30d</b> binding mode was established also and shown to be similar to that of <b>6</b> and <b>40f</b>. Further details are in <a class="ref internalNav" href="#si1" aria-label="supporting information">supporting information</a>. PDB code for <b>30d</b><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2VCJ">2VCJ</a></p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Compound+30d+binding+mode+was+established+also+and+shown+to+be+similar+to+that+of+6+and+40f.+Further+details+are+in+supporting+information.+PDB+code+for+30d2VCJ."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Smith, N. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nutley, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henley, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dymock, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">Preclinical pharmacokinetics and metabolism of a novel diaryl pyrazole resorcinol series of heat shock protein 90 inhibitors</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1628</span><span class="NLM_x">–</span> <span class="NLM_lpage">1637</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm701018h&amp;key=10.1158%2F1535-7163.MCT-06-0041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm701018h&amp;key=16818523" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm701018h&amp;key=1%3ACAS%3A528%3ADC%252BD28XmsVamsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=1628-1637&author=N.+F.+Smithauthor=A.+Hayesauthor=K.+Jamesauthor=B.+P.+Nutleyauthor=E.+McDonaldauthor=A.+Henleyauthor=B.+Dymockauthor=M.+J.+Drysdaleauthor=F.+I.+Raynaudauthor=P.+Workman&title=Preclinical+pharmacokinetics+and+metabolism+of+a+novel+diaryl+pyrazole+resorcinol+series+of+heat+shock+protein+90+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical pharmacokinetics and metabolism of a novel diaryl pyrazole resorcinol series of heat shock protein 90 inhibitors</span></div><div class="casAuthors">Smith, Nicola F.; Hayes, Angela; James, Karen; Nutley, Bernard P.; McDonald, Edward; Henley, Alan; Dymock, Brian; Drysdale, Martin J.; Raynaud, Florence I.; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1628-1637</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">CCT018159 was recently identified as a novel inhibitor of heat shock protein (Hsp) 90, a promising target for cancer therapy.  Pharmacokinetic and metabolic properties are likely to be important for efficacy and need to be optimized during drug development.  Here, we define the preclin. metab. and pharmacokinetics of CCT018159 and some early derivs.  In addn., we assess in vitro metabolic stability screening and in vivo cassette dosing (simultaneous administration of several compds. to a single animal) as approaches to investigate these compds.  The plasma clearance following individual i.v. administration to mice was rapid (0.128-0.816 L/h), exceeding hepatic blood flow.  For CCT066950 and CCT066952, this could be attributed in part to extensive (>80%) blood cell binding.  Oral bioavailability ranged from 1.8% to 29.6%.  Tissue distribution of CCT066952 was rapid and moderate, and renal excretion of the compds. was minimal (<1% of dose excreted).  Compds. underwent rapid glucuronidation both in vivo and following incubation with mouse liver microsomes.  However, whereas CCT066965 was metabolized to the greatest extent in vitro, this compd. displayed the slowest plasma clearance.  The rank order of the compds. from the highest to lowest area under the curve was the same following discrete and cassette dosing.  Furthermore, pharmacokinetic variables were similar whether the compds. were dosed alone or in combination.  We conclude that the pharmacokinetics of CCT018159 are complex.  Cassette dosing is currently the best option available to assess the pharmacokinetics of this promising series of compds. in relatively high throughput and is now being applied to identify compds. with optimal pharmacokinetic properties during structural analog synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSePVxi9Nx6bVg90H21EOLACvtfcHk0ljR4Br6CG--Iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmsVamsLY%253D&md5=53529a34a7d7e9136a0bf191c0a55104</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-06-0041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-06-0041%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DN.%2BF.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DJames%26aufirst%3DK.%26aulast%3DNutley%26aufirst%3DB.%2BP.%26aulast%3DMcDonald%26aufirst%3DE.%26aulast%3DHenley%26aufirst%3DA.%26aulast%3DDymock%26aufirst%3DB.%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DPreclinical%2520pharmacokinetics%2520and%2520metabolism%2520of%2520a%2520novel%2520diaryl%2520pyrazole%2520resorcinol%2520series%2520of%2520heat%2520shock%2520protein%252090%2520inhibitors%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2006%26volume%3D5%26spage%3D1628%26epage%3D1637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Smith, N. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">The application of cassette dosing for pharmacokinetic screening in small-molecule cancer drug discovery</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">428</span><span class="NLM_x">–</span> <span class="NLM_lpage">440</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm701018h&amp;key=10.1158%2F1535-7163.MCT-06-0324" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Fjm701018h&amp;key=17308044" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm701018h&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvVWkurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=428-440&author=N.+F.+Smithauthor=F.+I.+Raynaudauthor=P.+Workman&title=The+application+of+cassette+dosing+for+pharmacokinetic+screening+in+small-molecule+cancer+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">The application of cassette dosing for pharmacokinetic screening in small-molecule cancer drug discovery</span></div><div class="casAuthors">Smith, Nicola F.; Raynaud, Florence I.; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">428-440</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Pharmacokinetic evaluation is an essential component of drug discovery and should be conducted early in the process so that those compds. with the best chance of success are prioritized and progressed.  However, pharmacokinetic anal. has become a serious bottleneck during the 'hit-to-lead' and lead optimization phases due to the availability of new targets and the large nos. of compds. resulting from advances in synthesis and screening technologies.  Cassette dosing, which involves the simultaneous administration of several compds. to a single animal followed by rapid sample anal. by liq. chromatog./tandem mass spectrometry, was developed to increase the throughput of in vivo pharmacokinetic screening.  Although cassette dosing is advantageous in terms of resources and throughput, there are possible complications assocd. with this approach, such as the potential for compd. interactions.  Following an overview of the cassette dosing literature, this article focuses on the application of the technique in anticancer drug discovery.  Specific examples are discussed, including the evaluation of cassette dosing to assess pharmacokinetic properties in the development of cyclin-dependent kinase and heat shock protein 90 inhibitors.  Subject to crit. anal. and validation in each case, the use of cassette dosing is recommended in appropriate chem. series to enhance the efficiency of drug discovery and reduce animal usage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOlFEDbCmwlbVg90H21EOLACvtfcHk0ljnptO2Ok5YjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvVWkurg%253D&md5=fd68aab19d8735a4ceccf27e4b9928ee</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-06-0324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-06-0324%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DN.%2BF.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DThe%2520application%2520of%2520cassette%2520dosing%2520for%2520pharmacokinetic%2520screening%2520in%2520small-molecule%2520cancer%2520drug%2520discovery%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2007%26volume%3D6%26spage%3D428%26epage%3D440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Eccles, S. A.; Massey, A.; Raynaud, F.; Sharp, S. Y.; Box, G.; Valenti, M.; Patterson, L.; Gowan, S.; Boxall, F.; Aherne, W.; Rowlands, M.; Hayes, A.; Martins, V.; Urban, F.; Boxall, K.; Prodromou, C.; Pearl, L.; James, K.; Matthews, T.; Cheung, K. M.; Kalusa, A.; Jones, K.; McDonald, E.; Barril, X.; Brough, P. A.; Cansfield, J. E.; Dymock, B.; Drysdale, M.; Finch, H.; Howes, R.; Hubbard, R. E.; Surgenor, A.; Webb, P.; Wood, L. M.; Wright, L.; Workman, P.</span><span> </span><span class="NLM_article-title">NVP-AUY922: a novel synthetic resorcinylic isoxazole amide HSP90 inhibitor with potent activity against xenograft tumor growth, angiogenesis and metastasis</span>.  <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span><div class="note"><p class="first last">submitted</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=S.+A.+Eccles&author=A.+Massey&author=F.+Raynaud&author=S.+Y.+Sharp&author=G.+Box&author=M.+Valenti&author=L.+Patterson&author=S.+Gowan&author=F.+Boxall&author=W.+Aherne&author=M.+Rowlands&author=A.+Hayes&author=V.+Martins&author=F.+Urban&author=K.+Boxall&author=C.+Prodromou&author=L.+Pearl&author=K.+James&author=T.+Matthews&author=K.+M.+Cheung&author=A.+Kalusa&author=K.+Jones&author=E.+McDonald&author=X.+Barril&author=P.+A.+Brough&author=J.+E.+Cansfield&author=B.+Dymock&author=M.+Drysdale&author=H.+Finch&author=R.+Howes&author=R.+E.+Hubbard&author=A.+Surgenor&author=P.+Webb&author=L.+M.+Wood&author=L.+Wright&author=P.+Workman&title=NVP-AUY922%3A+a+novel+synthetic+resorcinylic+isoxazole+amide+HSP90+inhibitor+with+potent+activity+against+xenograft+tumor+growth%2C+angiogenesis+and+metastasis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEccles%26aufirst%3DS.%2BA.%26atitle%3DNVP-AUY922%253A%2520a%2520novel%2520synthetic%2520resorcinylic%2520isoxazole%2520amide%2520HSP90%2520inhibitor%2520with%2520potent%2520activity%2520against%2520xenograft%2520tumor%2520growth%252C%2520angiogenesis%2520and%2520metastasis%26jtitle%3DCancer%2520Res.%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Howes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barril, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dymock, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Northfield, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgenor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wayne, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M. J.</span><span> </span><span class="NLM_article-title">A fluorescence polarization assay for inhibitors of Hsp90</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">350</span><span class="NLM_x">, </span> <span class="NLM_fpage">202</span><span class="NLM_x">–</span> <span class="NLM_lpage">213</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2006&pages=202-213&author=R.+Howesauthor=X.+Barrilauthor=B.+W.+Dymockauthor=K.+Grantauthor=C.+J.+Northfieldauthor=A.+G.+Robertsonauthor=A.+Surgenorauthor=J.+Wayneauthor=L.+Wrightauthor=K.+Jamesauthor=T.+Matthewsauthor=K.+M.+Cheungauthor=E.+McDonaldauthor=P.+Workmanauthor=M.+J.+Drysdale&title=A+fluorescence+polarization+assay+for+inhibitors+of+Hsp90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHowes%26aufirst%3DR.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DDymock%26aufirst%3DB.%2BW.%26aulast%3DGrant%26aufirst%3DK.%26aulast%3DNorthfield%26aufirst%3DC.%2BJ.%26aulast%3DRobertson%26aufirst%3DA.%2BG.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DWayne%26aufirst%3DJ.%26aulast%3DWright%26aufirst%3DL.%26aulast%3DJames%26aufirst%3DK.%26aulast%3DMatthews%26aufirst%3DT.%26aulast%3DCheung%26aufirst%3DK.%2BM.%26aulast%3DMcDonald%26aufirst%3DE.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26atitle%3DA%2520fluorescence%2520polarization%2520assay%2520for%2520inhibitors%2520of%2520Hsp90%26jtitle%3DAnal.%2520Biochem.%26date%3D2006%26volume%3D350%26spage%3D202%26epage%3D213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Twentyman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balkwill, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balmain, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaplin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Double, J.</span><span> </span><span class="NLM_article-title">United Kingdom Co-ordinating Committee on Cancer research guidelines for the welfare of animals in experimental neoplasia, 2nd ed</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">10</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm701018h&amp;key=10.1038%2Fbjc.1998.1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=1998&pages=1-10&author=P.+Workmanauthor=P.+Twentymanauthor=F.+Balkwillauthor=A.+Balmainauthor=C.+Chaplinauthor=J.+Double&title=United+Kingdom+Co-ordinating+Committee+on+Cancer+research+guidelines+for+the+welfare+of+animals+in+experimental+neoplasia%2C+2nd+ed"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1038%2Fbjc.1998.1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.1998.1%26sid%3Dliteratum%253Aachs%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DTwentyman%26aufirst%3DP.%26aulast%3DBalkwill%26aufirst%3DF.%26aulast%3DBalmain%26aufirst%3DA.%26aulast%3DChaplin%26aufirst%3DC.%26aulast%3DDouble%26aufirst%3DJ.%26atitle%3DUnited%2520Kingdom%2520Co-ordinating%2520Committee%2520on%2520Cancer%2520research%2520guidelines%2520for%2520the%2520welfare%2520of%2520animals%2520in%2520experimental%2520neoplasia%252C%25202nd%2520ed%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D1998%26volume%3D77%26spage%3D1%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Drysdale, M. J.; Dymock, B. W.; Finch, H.; Webb, P.; McDonald, E.; James, K. E.; Cheung, K.-M.; Mathews, T. P.</span><span> </span><span class="NLM_article-title">Preparation of isoxazoles as inhibitors of heat shock proteins</span>. PCT International Application WO04072051,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=M.+J.+Drysdale&author=B.+W.+Dymock&author=H.+Finch&author=P.+Webb&author=E.+McDonald&author=K.+E.+James&author=K.-M.+Cheung&author=T.+P.+Mathews&title=Preparation+of+isoxazoles+as+inhibitors+of+heat+shock+proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26atitle%3DPreparation%2520of%2520isoxazoles%2520as%2520inhibitors%2520of%2520heat%2520shock%2520proteins%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 309 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Chihoko Yoshimura, Satoru Nagatoishi, Daisuke Kuroda, Yasuo Kodama, Takao Uno, Makoto Kitade, Khoontee Chong-Takata, Hiromi Oshiumi, Hiromi Muraoka, Satoshi Yamashita, Yuichi Kawai, Shuichi Ohkubo, <span class="NLM_string-name hlFld-ContribAuthor">Kouhei Tsumoto</span>. </span><span class="cited-content_cbyCitation_article-title">Thermodynamic Dissection of Potency and Selectivity of Cytosolic Hsp90 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (5)
                                     , 2669-2677. <a href="https://doi.org/10.1021/acs.jmedchem.0c01715" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01715</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01715&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01715%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThermodynamic%252BDissection%252Bof%252BPotency%252Band%252BSelectivity%252Bof%252BCytosolic%252BHsp90%252BInhibitors%26aulast%3DYoshimura%26aufirst%3DChihoko%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D29102020%26date%3D23022021%26volume%3D64%26issue%3D5%26spage%3D2669%26epage%3D2677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Mengyang Xu, Chao Zhao, Biying Zhu, Liangyue Wang, Huihao Zhou, Daoguang Yan, Qiong Gu, <span class="NLM_string-name hlFld-ContribAuthor">Jun Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovering High Potent Hsp90 Inhibitors as Antinasopharyngeal Carcinoma Agents through Fragment Assembling Approach. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (4)
                                     , 2010-2023. <a href="https://doi.org/10.1021/acs.jmedchem.0c01521" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01521</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01521&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01521%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovering%252BHigh%252BPotent%252BHsp90%252BInhibitors%252Bas%252BAntinasopharyngeal%252BCarcinoma%252BAgents%252Bthrough%252BFragment%252BAssembling%252BApproach%26aulast%3DXu%26aufirst%3DMengyang%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D03092020%26date%3D05022021%26volume%3D64%26issue%3D4%26spage%3D2010%26epage%3D2023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Paul T. Marcyk, Emmanuelle V. LeBlanc, Douglas A. Kuntz, Alice Xue, Francisco Ortiz, Richard Trilles, Stephen Bengtson, Tristan M. G. Kenney, David S. Huang, Nicole Robbins, Noelle S. Williams, Damian J. Krysan, Gilbert G. Privé, Luke Whitesell, Leah E. Cowen, <span class="NLM_string-name hlFld-ContribAuthor">Lauren E. Brown</span>. </span><span class="cited-content_cbyCitation_article-title">Fungal-Selective Resorcylate Aminopyrazole Hsp90 Inhibitors: Optimization of Whole-Cell Anticryptococcal Activity and Insights into the Structural Origins of Cryptococcal Selectivity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (2)
                                     , 1139-1169. <a href="https://doi.org/10.1021/acs.jmedchem.0c01777" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01777</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01777&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01777%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFungal-Selective%252BResorcylate%252BAminopyrazole%252BHsp90%252BInhibitors%25253A%252BOptimization%252Bof%252BWhole-Cell%252BAnticryptococcal%252BActivity%252Band%252BInsights%252Binto%252Bthe%252BStructural%252BOrigins%252Bof%252BCryptococcal%252BSelectivity%26aulast%3DMarcyk%26aufirst%3DPaul%2BT.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D20102020%26date%3D14012021%26volume%3D64%26issue%3D2%26spage%3D1139%26epage%3D1169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Shulei Zhu, Qianqian Shen, Yinglei Gao, Lei Wang, Yanfen Fang, Yi Chen, <span class="NLM_string-name hlFld-ContribAuthor">Wei Lu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Biological Evaluation of HSP90 Inhibitor–SN38 Conjugates for Targeted Drug Accumulation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (10)
                                     , 5421-5441. <a href="https://doi.org/10.1021/acs.jmedchem.0c00305" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00305</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00305%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252BHSP90%252BInhibitor%2525E2%252580%252593SN38%252BConjugates%252Bfor%252BTargeted%252BDrug%252BAccumulation%26aulast%3DZhu%26aufirst%3DShulei%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D20022020%26date%3D11052020%26date%3D30042020%26volume%3D63%26issue%3D10%26spage%3D5421%26epage%3D5441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Li Li, Lei Wang, Qi-Dong You, <span class="NLM_string-name hlFld-ContribAuthor">Xiao-Li Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Heat Shock Protein 90 Inhibitors: An Update on Achievements, Challenges, and Future Directions. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (5)
                                     , 1798-1822. <a href="https://doi.org/10.1021/acs.jmedchem.9b00940" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00940</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00940&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00940%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHeat%252BShock%252BProtein%252B90%252BInhibitors%25253A%252BAn%252BUpdate%252Bon%252BAchievements%25252C%252BChallenges%25252C%252Band%252BFuture%252BDirections%26aulast%3DLi%26aufirst%3DLi%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D13062019%26date%3D12112019%26date%3D30102019%26volume%3D63%26issue%3D5%26spage%3D1798%26epage%3D1822" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Takao Uno, Yuichi Kawai, Satoshi Yamashita, Hiromi Oshiumi, Chihoko Yoshimura, Takashi Mizutani, Tatsuya Suzuki, Khoon Tee Chong, Kazuhiko Shigeno, Mitsuru Ohkubo, Yasuo Kodama, Hiromi Muraoka, Kaoru Funabashi, Koichi Takahashi, Shuichi Ohkubo, <span class="NLM_string-name hlFld-ContribAuthor">Makoto Kitade</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 3-Ethyl-4-(3-isopropyl-4-(4-(1-methyl-1H-pyrazol-4-yl)-1H-imidazol-1-yl)-1H-pyrazolo[3,4-b]pyridin-1-yl)benzamide (TAS-116) as a Potent, Selective, and Orally Available HSP90 Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (2)
                                     , 531-551. <a href="https://doi.org/10.1021/acs.jmedchem.8b01085" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01085</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01085%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B3-Ethyl-4-%2525283-isopropyl-4-%2525284-%2525281-methyl-1H-pyrazol-4-yl%252529-1H-imidazol-1-yl%252529-1H-pyrazolo%25255B3%25252C4-b%25255Dpyridin-1-yl%252529benzamide%252B%252528TAS-116%252529%252Bas%252Ba%252BPotent%25252C%252BSelective%25252C%252Band%252BOrally%252BAvailable%252BHSP90%252BInhibitor%26aulast%3DUno%26aufirst%3DTakao%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D10072018%26date%3D21122018%26date%3D07122018%26volume%3D62%26issue%3D2%26spage%3D531%26epage%3D551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hye-Kyung  Park</span>, <span class="hlFld-ContribAuthor ">Hanbin  Jeong</span>, <span class="hlFld-ContribAuthor ">Eunhwa  Ko</span>, <span class="hlFld-ContribAuthor ">Geumwoo  Lee</span>, <span class="hlFld-ContribAuthor ">Ji-Eun  Lee</span>, <span class="hlFld-ContribAuthor ">Sang Kwang  Lee</span>, <span class="hlFld-ContribAuthor ">An-Jung  Lee</span>, <span class="hlFld-ContribAuthor ">Jin Young  Im</span>, <span class="hlFld-ContribAuthor ">Sung  Hu</span>, <span class="hlFld-ContribAuthor ">Seong Heon  Kim</span>, <span class="hlFld-ContribAuthor ">Ji Hoon  Lee</span>, <span class="hlFld-ContribAuthor ">Changwook  Lee</span>, <span class="hlFld-ContribAuthor ">Soosung  Kang</span>, and <span class="hlFld-ContribAuthor ">Byoung Heon  Kang</span>  . </span><span class="cited-content_cbyCitation_article-title">Paralog Specificity Determines Subcellular Distribution, Action Mechanism, and Anticancer Activity of TRAP1 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (17)
                                     , 7569-7578. <a href="https://doi.org/10.1021/acs.jmedchem.7b00978" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00978</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00978&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00978%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DParalog%252BSpecificity%252BDetermines%252BSubcellular%252BDistribution%25252C%252BAction%252BMechanism%25252C%252Band%252BAnticancer%252BActivity%252Bof%252BTRAP1%252BInhibitors%26aulast%3DPark%26aufirst%3DHye-Kyung%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D03072017%26date%3D30082017%26date%3D14092017%26date%3D17082017%26volume%3D60%26issue%3D17%26spage%3D7569%26epage%3D7578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeffrey R.  Wagner</span>, <span class="hlFld-ContribAuthor ">Jesper  Sørensen</span>, <span class="hlFld-ContribAuthor ">Nathan  Hensley</span>, <span class="hlFld-ContribAuthor ">Celia  Wong</span>, <span class="hlFld-ContribAuthor ">Clare  Zhu</span>, <span class="hlFld-ContribAuthor ">Taylor  Perison</span>, and <span class="hlFld-ContribAuthor ">Rommie E.  Amaro</span>  . </span><span class="cited-content_cbyCitation_article-title">POVME 3.0: Software for Mapping Binding Pocket Flexibility. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Theory and Computation</span><span> <strong>2017,</strong> <em>13 </em>
                                    (9)
                                     , 4584-4592. <a href="https://doi.org/10.1021/acs.jctc.7b00500" title="DOI URL">https://doi.org/10.1021/acs.jctc.7b00500</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jctc.7b00500&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jctc.7b00500%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Theory%2520and%2520Computation%26atitle%3DPOVME%252B3.0%25253A%252BSoftware%252Bfor%252BMapping%252BBinding%252BPocket%252BFlexibility%26aulast%3DWagner%26aufirst%3DJeffrey%2BR.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D14052017%26date%3D30082017%26date%3D12092017%26date%3D11082017%26volume%3D13%26issue%3D9%26spage%3D4584%26epage%3D4592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eric K.  Lei</span> and <span class="hlFld-ContribAuthor ">Shana O.  Kelley</span>  . </span><span class="cited-content_cbyCitation_article-title">Delivery and Release of Small-Molecule Probes in Mitochondria Using Traceless Linkers. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2017,</strong> <em>139 </em>
                                    (28)
                                     , 9455-9458. <a href="https://doi.org/10.1021/jacs.7b04415" title="DOI URL">https://doi.org/10.1021/jacs.7b04415</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.7b04415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.7b04415%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DDelivery%252Band%252BRelease%252Bof%252BSmall-Molecule%252BProbes%252Bin%252BMitochondria%252BUsing%252BTraceless%252BLinkers%26aulast%3DLei%26aufirst%3DEric%2BK.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D06052017%26date%3D05072017%26date%3D19072017%26date%3D30062017%26volume%3D139%26issue%3D28%26spage%3D9455%26epage%3D9458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthias  Bach</span>, <span class="hlFld-ContribAuthor ">Anna  Lehmann</span>, <span class="hlFld-ContribAuthor ">Daniela  Brünnert</span>, <span class="hlFld-ContribAuthor ">Jens T.  Vanselow</span>, <span class="hlFld-ContribAuthor ">Andreas  Hartung</span>, <span class="hlFld-ContribAuthor ">Ralf C.  Bargou</span>, <span class="hlFld-ContribAuthor ">Ulrike  Holzgrabe</span>, <span class="hlFld-ContribAuthor ">Andreas  Schlosser</span>, and <span class="hlFld-ContribAuthor ">Manik  Chatterjee</span>  . </span><span class="cited-content_cbyCitation_article-title">Ugi Reaction-Derived α-Acyl Aminocarboxamides Bind to Phosphatidylinositol 3-Kinase-Related Kinases, Inhibit HSF1-Dependent Heat Shock Response, and Induce Apoptosis in Multiple Myeloma Cells. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (10)
                                     , 4147-4160. <a href="https://doi.org/10.1021/acs.jmedchem.6b01613" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01613</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01613%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DUgi%252BReaction-Derived%252B%2525CE%2525B1-Acyl%252BAminocarboxamides%252BBind%252Bto%252BPhosphatidylinositol%252B3-Kinase-Related%252BKinases%25252C%252BInhibit%252BHSF1-Dependent%252BHeat%252BShock%252BResponse%25252C%252Band%252BInduce%252BApoptosis%252Bin%252BMultiple%252BMyeloma%252BCells%26aulast%3DBach%26aufirst%3DMatthias%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D03112016%26date%3D08052017%26date%3D25052017%26date%3D28042017%26volume%3D60%26issue%3D10%26spage%3D4147%26epage%3D4160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul A.  Brough</span>, <span class="hlFld-ContribAuthor ">Lisa  Baker</span>, <span class="hlFld-ContribAuthor ">Simon  Bedford</span>, <span class="hlFld-ContribAuthor ">Kirsten  Brown</span>, <span class="hlFld-ContribAuthor ">Seema  Chavda</span>, <span class="hlFld-ContribAuthor ">Victoria  Chell</span>, <span class="hlFld-ContribAuthor ">Jalanie  D’Alessandro</span>, <span class="hlFld-ContribAuthor ">Nicholas G. M.  Davies</span>, <span class="hlFld-ContribAuthor ">Ben  Davis</span>, <span class="hlFld-ContribAuthor ">Loic  Le Strat</span>, <span class="hlFld-ContribAuthor ">Alba T.  Macias</span>, <span class="hlFld-ContribAuthor ">Daniel  Maddox</span>, <span class="hlFld-ContribAuthor ">Patrick C.  Mahon</span>, <span class="hlFld-ContribAuthor ">Andrew J.  Massey</span>, <span class="hlFld-ContribAuthor ">Natalia  Matassova</span>, <span class="hlFld-ContribAuthor ">Sean  McKenna</span>, <span class="hlFld-ContribAuthor ">Johannes W. G.  Meissner</span>, <span class="hlFld-ContribAuthor ">Jonathan D.  Moore</span>, <span class="hlFld-ContribAuthor ">James B.  Murray</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Northfield</span>, <span class="hlFld-ContribAuthor ">Charles  Parry</span>, <span class="hlFld-ContribAuthor ">Rachel  Parsons</span>, <span class="hlFld-ContribAuthor ">Stephen D.  Roughley</span>, <span class="hlFld-ContribAuthor ">Terry  Shaw</span>, <span class="hlFld-ContribAuthor ">Heather  Simmonite</span>, <span class="hlFld-ContribAuthor ">Stephen  Stokes</span>, <span class="hlFld-ContribAuthor ">Allan  Surgenor</span>, <span class="hlFld-ContribAuthor ">Emma  Stefaniak</span>, <span class="hlFld-ContribAuthor ">Alan  Robertson</span>, <span class="hlFld-ContribAuthor ">Yikang  Wang</span>, <span class="hlFld-ContribAuthor ">Paul  Webb</span>, <span class="hlFld-ContribAuthor ">Neil  Whitehead</span>, and <span class="hlFld-ContribAuthor ">Mike  Wood</span>  . </span><span class="cited-content_cbyCitation_article-title">Application of Off-Rate Screening in the Identification of Novel Pan-Isoform Inhibitors of Pyruvate Dehydrogenase Kinase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (6)
                                     , 2271-2286. <a href="https://doi.org/10.1021/acs.jmedchem.6b01478" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01478</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01478&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01478%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DApplication%252Bof%252BOff-Rate%252BScreening%252Bin%252Bthe%252BIdentification%252Bof%252BNovel%252BPan-Isoform%252BInhibitors%252Bof%252BPyruvate%252BDehydrogenase%252BKinase%26aulast%3DBrough%26aufirst%3DPaul%2BA.%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D21102016%26date%3D15022017%26date%3D23032017%26volume%3D60%26issue%3D6%26spage%3D2271%26epage%3D2286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ido Y.  Ben-Shalom</span>, <span class="hlFld-ContribAuthor ">Stefania  Pfeiffer-Marek</span>, <span class="hlFld-ContribAuthor ">Karl-Heinz  Baringhaus</span>, and <span class="hlFld-ContribAuthor ">Holger  Gohlke</span>  . </span><span class="cited-content_cbyCitation_article-title">Efficient Approximation of Ligand Rotational and Translational Entropy Changes upon Binding for Use in MM-PBSA Calculations. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2017,</strong> <em>57 </em>
                                    (2)
                                     , 170-189. <a href="https://doi.org/10.1021/acs.jcim.6b00373" title="DOI URL">https://doi.org/10.1021/acs.jcim.6b00373</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.6b00373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.6b00373%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DEfficient%252BApproximation%252Bof%252BLigand%252BRotational%252Band%252BTranslational%252BEntropy%252BChanges%252Bupon%252BBinding%252Bfor%252BUse%252Bin%252BMM-PBSA%252BCalculations%26aulast%3DBen-Shalom%26aufirst%3DIdo%2BY.%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D22062016%26date%3D20012017%26date%3D27022017%26date%3D20122016%26volume%3D57%26issue%3D2%26spage%3D170%26epage%3D189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fen  Jiang</span>, <span class="hlFld-ContribAuthor ">Hui-Jie  Wang</span>, <span class="hlFld-ContribAuthor ">Yu-Hui  Jin</span>, <span class="hlFld-ContribAuthor ">Qiong  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhi-Hui  Wang</span>, <span class="hlFld-ContribAuthor ">Jian-Min  Jia</span>, <span class="hlFld-ContribAuthor ">Fang  Liu</span>, <span class="hlFld-ContribAuthor ">Lei  Wang</span>, <span class="hlFld-ContribAuthor ">Qi-Chao  Bao</span>, <span class="hlFld-ContribAuthor ">Dong-Dong  Li</span>, <span class="hlFld-ContribAuthor ">Qi-Dong  You</span>, and <span class="hlFld-ContribAuthor ">Xiao-Li  Xu</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel Tetrahydropyrido[4,3-d]pyrimidines as Potent Inhibitors of Chaperone Heat Shock Protein 90. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (23)
                                     , 10498-10519. <a href="https://doi.org/10.1021/acs.jmedchem.6b00912" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00912</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00912&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00912%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BTetrahydropyrido%25255B4%25252C3-d%25255Dpyrimidines%252Bas%252BPotent%252BInhibitors%252Bof%252BChaperone%252BHeat%252BShock%252BProtein%252B90%26aulast%3DJiang%26aufirst%3DFen%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D17062016%26date%3D22112016%26date%3D08122016%26date%3D09112016%26volume%3D59%26issue%3D23%26spage%3D10498%26epage%3D10519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Virginia  Spanò</span>, <span class="hlFld-ContribAuthor ">Marzia  Pennati</span>, <span class="hlFld-ContribAuthor ">Barbara  Parrino</span>, <span class="hlFld-ContribAuthor ">Anna  Carbone</span>, <span class="hlFld-ContribAuthor ">Alessandra  Montalbano</span>, <span class="hlFld-ContribAuthor ">Vincenzo  Cilibrasi</span>, <span class="hlFld-ContribAuthor ">Valentina  Zuco</span>, <span class="hlFld-ContribAuthor ">Alessia  Lopergolo</span>, <span class="hlFld-ContribAuthor ">Denis  Cominetti</span>, <span class="hlFld-ContribAuthor ">Patrizia  Diana</span>, <span class="hlFld-ContribAuthor ">Girolamo  Cirrincione</span>, <span class="hlFld-ContribAuthor ">Paola  Barraja</span>, and <span class="hlFld-ContribAuthor ">Nadia  Zaffaroni</span>  . </span><span class="cited-content_cbyCitation_article-title">Preclinical Activity of New [1,2]Oxazolo[5,4-e]isoindole Derivatives in Diffuse Malignant Peritoneal Mesothelioma. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (15)
                                     , 7223-7238. <a href="https://doi.org/10.1021/acs.jmedchem.6b00777" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00777</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00777&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00777%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPreclinical%252BActivity%252Bof%252BNew%252B%25255B1%25252C2%25255DOxazolo%25255B5%25252C4-e%25255Disoindole%252BDerivatives%252Bin%252BDiffuse%252BMalignant%252BPeritoneal%252BMesothelioma%26aulast%3DSpan%25C3%25B2%26aufirst%3DVirginia%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D23052016%26date%3D26072016%26date%3D11082016%26date%3D18072016%26volume%3D59%26issue%3D15%26spage%3D7223%26epage%3D7238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Meining  Wang</span>, <span class="hlFld-ContribAuthor ">Aijun  Shen</span>, <span class="hlFld-ContribAuthor ">Chi  Zhang</span>, <span class="hlFld-ContribAuthor ">Zilan  Song</span>, <span class="hlFld-ContribAuthor ">Jing  Ai</span>, <span class="hlFld-ContribAuthor ">Hongchun  Liu</span>, <span class="hlFld-ContribAuthor ">Liping  Sun</span>, <span class="hlFld-ContribAuthor ">Jian  Ding</span>, <span class="hlFld-ContribAuthor ">Meiyu  Geng</span>, and <span class="hlFld-ContribAuthor ">Ao  Zhang</span>  . </span><span class="cited-content_cbyCitation_article-title">Development of Heat Shock Protein (Hsp90) Inhibitors To Combat Resistance to Tyrosine Kinase Inhibitors through Hsp90–Kinase Interactions. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (12)
                                     , 5563-5586. <a href="https://doi.org/10.1021/acs.jmedchem.5b01106" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01106</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01106%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252BHeat%252BShock%252BProtein%252B%252528Hsp90%252529%252BInhibitors%252BTo%252BCombat%252BResistance%252Bto%252BTyrosine%252BKinase%252BInhibitors%252Bthrough%252BHsp90%2525E2%252580%252593Kinase%252BInteractions%26aulast%3DWang%26aufirst%3DMeining%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D15072015%26date%3D16022016%26date%3D23062016%26date%3D04022016%26volume%3D59%26issue%3D12%26spage%3D5563%26epage%3D5586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julien  Malassis</span>, <span class="hlFld-ContribAuthor ">Nathan  Bartlett</span>, <span class="hlFld-ContribAuthor ">Kane  Hands</span>, <span class="hlFld-ContribAuthor ">Matthew D.  Selby</span>, and <span class="hlFld-ContribAuthor ">Bruno  Linclau</span>  . </span><span class="cited-content_cbyCitation_article-title">Total Synthesis of (−)-Luminacin D. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2016,</strong> <em>81 </em>
                                    (9)
                                     , 3818-3837. <a href="https://doi.org/10.1021/acs.joc.6b00489" title="DOI URL">https://doi.org/10.1021/acs.joc.6b00489</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.6b00489&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.6b00489%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DTotal%252BSynthesis%252Bof%252B%252528%2525E2%252588%252592%252529-Luminacin%252BD%26aulast%3DMalassis%26aufirst%3DJulien%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D07032016%26date%3D19042016%26date%3D06052016%26date%3D07042016%26volume%3D81%26issue%3D9%26spage%3D3818%26epage%3D3837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew  Anighoro</span>, <span class="hlFld-ContribAuthor ">Dagmar  Stumpfe</span>, <span class="hlFld-ContribAuthor ">Kathrin  Heikamp</span>, <span class="hlFld-ContribAuthor ">Kristin  Beebe</span>, <span class="hlFld-ContribAuthor ">Leonard M.  Neckers</span>, <span class="hlFld-ContribAuthor ">Jürgen  Bajorath</span>, and <span class="hlFld-ContribAuthor ">Giulio  Rastelli</span>  . </span><span class="cited-content_cbyCitation_article-title">Computational Polypharmacology Analysis of the Heat Shock Protein 90 Interactome. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2015,</strong> <em>55 </em>
                                    (3)
                                     , 676-686. <a href="https://doi.org/10.1021/ci5006959" title="DOI URL">https://doi.org/10.1021/ci5006959</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci5006959&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci5006959%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DComputational%252BPolypharmacology%252BAnalysis%252Bof%252Bthe%252BHeat%252BShock%252BProtein%252B90%252BInteractome%26aulast%3DAnighoro%26aufirst%3DAndrew%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D21112014%26date%3D23022015%26date%3D23032015%26date%3D16022015%26volume%3D55%26issue%3D3%26spage%3D676%26epage%3D686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Markus O.  Zimmermann</span>, <span class="hlFld-ContribAuthor ">Andreas  Lange</span>, and <span class="hlFld-ContribAuthor ">Frank M.  Boeckler</span>  . </span><span class="cited-content_cbyCitation_article-title">Evaluating the Potential of Halogen Bonding in Molecular Design: Automated Scaffold Decoration Using the New Scoring Function XBScore. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2015,</strong> <em>55 </em>
                                    (3)
                                     , 687-699. <a href="https://doi.org/10.1021/ci5007118" title="DOI URL">https://doi.org/10.1021/ci5007118</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci5007118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci5007118%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DEvaluating%252Bthe%252BPotential%252Bof%252BHalogen%252BBonding%252Bin%252BMolecular%252BDesign%25253A%252BAutomated%252BScaffold%252BDecoration%252BUsing%252Bthe%252BNew%252BScoring%252BFunction%252BXBScore%26aulast%3DZimmermann%26aufirst%3DMarkus%2BO.%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D01122014%26date%3D19022015%26date%3D23032015%26date%3D05022015%26volume%3D55%26issue%3D3%26spage%3D687%26epage%3D699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenwen  Chen</span>, <span class="hlFld-ContribAuthor ">Jianlan  Zhang</span>, <span class="hlFld-ContribAuthor ">Bo  Wang</span>, <span class="hlFld-ContribAuthor ">Zhouxing  Zhao</span>, <span class="hlFld-ContribAuthor ">Xinyan  Wang</span>, and <span class="hlFld-ContribAuthor ">Yuefei  Hu</span>  . </span><span class="cited-content_cbyCitation_article-title">Tandem Synthesis of 3-Chloro-4-iodoisoxazoles from 1-Copper(I) Alkynes, Dichloroformaldoxime, and Molecular Iodine. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2015,</strong> <em>80 </em>
                                    (4)
                                     , 2413-2417. <a href="https://doi.org/10.1021/jo502634h" title="DOI URL">https://doi.org/10.1021/jo502634h</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo502634h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo502634h%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DTandem%252BSynthesis%252Bof%252B3-Chloro-4-iodoisoxazoles%252Bfrom%252B1-Copper%252528I%252529%252BAlkynes%25252C%252BDichloroformaldoxime%25252C%252Band%252BMolecular%252BIodine%26aulast%3DChen%26aufirst%3DWenwen%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D18112014%26date%3D29012015%26date%3D20022015%26date%3D16012015%26volume%3D80%26issue%3D4%26spage%3D2413%26epage%3D2417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tao  Meng</span>, <span class="hlFld-ContribAuthor ">Dadong  Zhang</span>, <span class="hlFld-ContribAuthor ">Zuoquan  Xie</span>, <span class="hlFld-ContribAuthor ">Ting  Yu</span>, <span class="hlFld-ContribAuthor ">Shuchao  Wu</span>, <span class="hlFld-ContribAuthor ">Lorenza  Wyder</span>, <span class="hlFld-ContribAuthor ">Urs  Regenass</span>, <span class="hlFld-ContribAuthor ">Kurt  Hilpert</span>, <span class="hlFld-ContribAuthor ">Min  Huang</span>, <span class="hlFld-ContribAuthor ">Meiyu  Geng</span>, and <span class="hlFld-ContribAuthor ">Jingkang  Shen</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery and Optimization of 4,5-Diarylisoxazoles as Potent Dual Inhibitors of Pyruvate Dehydrogenase Kinase and Heat Shock Protein 90. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (23)
                                     , 9832-9843. <a href="https://doi.org/10.1021/jm5010144" title="DOI URL">https://doi.org/10.1021/jm5010144</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5010144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5010144%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BOptimization%252Bof%252B4%25252C5-Diarylisoxazoles%252Bas%252BPotent%252BDual%252BInhibitors%252Bof%252BPyruvate%252BDehydrogenase%252BKinase%252Band%252BHeat%252BShock%252BProtein%252B90%26aulast%3DMeng%26aufirst%3DTao%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D25042014%26date%3D26112014%26date%3D11122014%26date%3D10112014%26volume%3D57%26issue%3D23%26spage%3D9832%26epage%3D9843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Justin T.  Ernst</span>, <span class="hlFld-ContribAuthor ">Timothy  Neubert</span>, <span class="hlFld-ContribAuthor ">Michael  Liu</span>, <span class="hlFld-ContribAuthor ">Samuel  Sperry</span>, <span class="hlFld-ContribAuthor ">Harmon  Zuccola</span>, <span class="hlFld-ContribAuthor ">Amy  Turnbull</span>, <span class="hlFld-ContribAuthor ">Beth  Fleck</span>, <span class="hlFld-ContribAuthor ">William  Kargo</span>, <span class="hlFld-ContribAuthor ">Lisa  Woody</span>, <span class="hlFld-ContribAuthor ">Peggy  Chiang</span>, <span class="hlFld-ContribAuthor ">Dao  Tran</span>, <span class="hlFld-ContribAuthor ">Weichao  Chen</span>, <span class="hlFld-ContribAuthor ">Phillip  Snyder</span>, <span class="hlFld-ContribAuthor ">Timothy  Alcacio</span>, <span class="hlFld-ContribAuthor ">Azin  Nezami</span>, <span class="hlFld-ContribAuthor ">James  Reynolds</span>, <span class="hlFld-ContribAuthor ">Khisal  Alvi</span>, <span class="hlFld-ContribAuthor ">Lance  Goulet</span>, and <span class="hlFld-ContribAuthor ">Dean  Stamos</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification of Novel HSP90α/β Isoform Selective Inhibitors Using Structure-Based Drug Design. Demonstration of Potential Utility in Treating CNS Disorders such as Huntington’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (8)
                                     , 3382-3400. <a href="https://doi.org/10.1021/jm500042s" title="DOI URL">https://doi.org/10.1021/jm500042s</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm500042s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm500042s%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252BNovel%252BHSP90%2525CE%2525B1%25252F%2525CE%2525B2%252BIsoform%252BSelective%252BInhibitors%252BUsing%252BStructure-Based%252BDrug%252BDesign.%252BDemonstration%252Bof%252BPotential%252BUtility%252Bin%252BTreating%252BCNS%252BDisorders%252Bsuch%252Bas%252BHuntington%2525E2%252580%252599s%252BDisease%26aulast%3DErnst%26aufirst%3DJustin%2BT.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D08012014%26date%3D10042014%26date%3D24042014%26date%3D27032014%26volume%3D57%26issue%3D8%26spage%3D3382%26epage%3D3400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maurizio  Taddei</span>, <span class="hlFld-ContribAuthor ">Serena  Ferrini</span>, <span class="hlFld-ContribAuthor ">Luca  Giannotti</span>, <span class="hlFld-ContribAuthor ">Massimo  Corsi</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Manetti</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Giannini</span>, <span class="hlFld-ContribAuthor ">Loredana  Vesci</span>, <span class="hlFld-ContribAuthor ">Ferdinando M.  Milazzo</span>, <span class="hlFld-ContribAuthor ">Domenico  Alloatti</span>, <span class="hlFld-ContribAuthor ">Mario B.  Guglielmi</span>, <span class="hlFld-ContribAuthor ">Massimo  Castorina</span>, <span class="hlFld-ContribAuthor ">Maria L.  Cervoni</span>, <span class="hlFld-ContribAuthor ">Marcella  Barbarino</span>, <span class="hlFld-ContribAuthor ">Rosanna  Foderà</span>, <span class="hlFld-ContribAuthor ">Valeria  Carollo</span>, <span class="hlFld-ContribAuthor ">Claudio  Pisano</span>, <span class="hlFld-ContribAuthor ">Silvia  Armaroli</span>, and <span class="hlFld-ContribAuthor ">Walter  Cabri</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis and Evaluation of New Hsp90 Inhibitors Based on a 1,4,5-Trisubstituted 1,2,3-Triazole Scaffold. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (6)
                                     , 2258-2274. <a href="https://doi.org/10.1021/jm401536b" title="DOI URL">https://doi.org/10.1021/jm401536b</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401536b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401536b%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BEvaluation%252Bof%252BNew%252BHsp90%252BInhibitors%252BBased%252Bon%252Ba%252B1%25252C4%25252C5-Trisubstituted%252B1%25252C2%25252C3-Triazole%252BScaffold%26aulast%3DTaddei%26aufirst%3DMaurizio%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D02102013%26date%3D17032014%26date%3D27032014%26date%3D03032014%26volume%3D57%26issue%3D6%26spage%3D2258%26epage%3D2274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Diane  Joseph-McCarthy</span>, <span class="hlFld-ContribAuthor ">Arthur J.  Campbell</span>, <span class="hlFld-ContribAuthor ">Gunther  Kern</span>, and <span class="hlFld-ContribAuthor ">Demetri  Moustakas</span>  . </span><span class="cited-content_cbyCitation_article-title">Fragment-Based Lead Discovery and Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2014,</strong> <em>54 </em>
                                    (3)
                                     , 693-704. <a href="https://doi.org/10.1021/ci400731w" title="DOI URL">https://doi.org/10.1021/ci400731w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci400731w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci400731w%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DFragment-Based%252BLead%252BDiscovery%252Band%252BDesign%26aulast%3DJoseph-McCarthy%26aufirst%3DDiane%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D09122013%26date%3D19022014%26date%3D24032014%26date%3D03022014%26volume%3D54%26issue%3D3%26spage%3D693%26epage%3D704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Flavio  Ballante</span>, <span class="hlFld-ContribAuthor ">Antonia  Caroli</span>, <span class="hlFld-ContribAuthor ">Richard B.  Wickersham, III</span>, and <span class="hlFld-ContribAuthor ">Rino  Ragno</span>  . </span><span class="cited-content_cbyCitation_article-title">Hsp90 Inhibitors, Part 1: Definition of 3-D QSAutogrid/R Models as a Tool for Virtual Screening. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2014,</strong> <em>54 </em>
                                    (3)
                                     , 956-969. <a href="https://doi.org/10.1021/ci400759t" title="DOI URL">https://doi.org/10.1021/ci400759t</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci400759t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci400759t%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DHsp90%252BInhibitors%25252C%252BPart%252B1%25253A%252BDefinition%252Bof%252B3-D%252BQSAutogrid%25252FR%252BModels%252Bas%252Ba%252BTool%252Bfor%252BVirtual%252BScreening%26aulast%3DBallante%26aufirst%3DFlavio%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D22122013%26date%3D04032014%26date%3D24032014%26date%3D24022014%26volume%3D54%26issue%3D3%26spage%3D956%26epage%3D969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuling  An</span>, <span class="hlFld-ContribAuthor ">Woody  Sherman</span>, and <span class="hlFld-ContribAuthor ">Steven L.  Dixon</span>  . </span><span class="cited-content_cbyCitation_article-title">Kernel-Based Partial Least Squares: Application to Fingerprint-Based QSAR with Model Visualization. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2013,</strong> <em>53 </em>
                                    (9)
                                     , 2312-2321. <a href="https://doi.org/10.1021/ci400250c" title="DOI URL">https://doi.org/10.1021/ci400250c</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci400250c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci400250c%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DKernel-Based%252BPartial%252BLeast%252BSquares%25253A%252BApplication%252Bto%252BFingerprint-Based%252BQSAR%252Bwith%252BModel%252BVisualization%26aulast%3DAn%26aufirst%3DYuling%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D26042013%26date%3D19082013%26date%3D23092013%26date%3D31072013%26volume%3D53%26issue%3D9%26spage%3D2312%26epage%3D2321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tony  Taldone</span>, <span class="hlFld-ContribAuthor ">Pallav D.  Patel</span>, <span class="hlFld-ContribAuthor ">Maulik  Patel</span>, <span class="hlFld-ContribAuthor ">Hardik J.  Patel</span>, <span class="hlFld-ContribAuthor ">Christopher E.  Evans</span>, <span class="hlFld-ContribAuthor ">Anna  Rodina</span>, <span class="hlFld-ContribAuthor ">Stefan  Ochiana</span>, <span class="hlFld-ContribAuthor ">Smit K.  Shah</span>, <span class="hlFld-ContribAuthor ">Mohammad  Uddin</span>, <span class="hlFld-ContribAuthor ">Daniel  Gewirth</span>, and <span class="hlFld-ContribAuthor ">Gabriela  Chiosis</span>  . </span><span class="cited-content_cbyCitation_article-title">Experimental and Structural Testing Module to Analyze Paralogue-Specificity and Affinity in the Hsp90 Inhibitors Series. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (17)
                                     , 6803-6818. <a href="https://doi.org/10.1021/jm400619b" title="DOI URL">https://doi.org/10.1021/jm400619b</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm400619b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm400619b%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DExperimental%252Band%252BStructural%252BTesting%252BModule%252Bto%252BAnalyze%252BParalogue-Specificity%252Band%252BAffinity%252Bin%252Bthe%252BHsp90%252BInhibitors%252BSeries%26aulast%3DTaldone%26aufirst%3DTony%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D26042013%26date%3D21082013%26date%3D12092013%26volume%3D56%26issue%3D17%26spage%3D6803%26epage%3D6818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elinor  Meiby</span>, <span class="hlFld-ContribAuthor ">Heather  Simmonite</span>, <span class="hlFld-ContribAuthor ">Loic  le Strat</span>, <span class="hlFld-ContribAuthor ">Ben  Davis</span>, <span class="hlFld-ContribAuthor ">Natalia  Matassova</span>, <span class="hlFld-ContribAuthor ">Jonathan D.  Moore</span>, <span class="hlFld-ContribAuthor ">Michael  Mrosek</span>, <span class="hlFld-ContribAuthor ">James  Murray</span>, <span class="hlFld-ContribAuthor ">Roderick E.  Hubbard</span>, and <span class="hlFld-ContribAuthor ">Sten  Ohlson</span>  . </span><span class="cited-content_cbyCitation_article-title">Fragment Screening by Weak Affinity Chromatography: Comparison with Established Techniques for Screening against HSP90. </span><span class="cited-content_cbyCitation_journal-name">Analytical Chemistry</span><span> <strong>2013,</strong> <em>85 </em>
                                    (14)
                                     , 6756-6766. <a href="https://doi.org/10.1021/ac400715t" title="DOI URL">https://doi.org/10.1021/ac400715t</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ac400715t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fac400715t%26sid%3Dliteratum%253Aachs%26jtitle%3DAnalytical%2520Chemistry%26atitle%3DFragment%252BScreening%252Bby%252BWeak%252BAffinity%252BChromatography%25253A%252BComparison%252Bwith%252BEstablished%252BTechniques%252Bfor%252BScreening%252Bagainst%252BHSP90%26aulast%3DMeiby%26aufirst%3DElinor%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D08032013%26date%3D10062013%26date%3D27062013%26date%3D16072013%26date%3D10062013%26volume%3D85%26issue%3D14%26spage%3D6756%26epage%3D6766" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Russell R. A.  Kitson</span> and <span class="hlFld-ContribAuthor ">Christopher J.  Moody</span>  . </span><span class="cited-content_cbyCitation_article-title">Learning from Nature: Advances in Geldanamycin- and Radicicol-Based Inhibitors of Hsp90. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2013,</strong> <em>78 </em>
                                    (11)
                                     , 5117-5141. <a href="https://doi.org/10.1021/jo4002849" title="DOI URL">https://doi.org/10.1021/jo4002849</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo4002849&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo4002849%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DLearning%252Bfrom%252BNature%25253A%252BAdvances%252Bin%252BGeldanamycin-%252Band%252BRadicicol-Based%252BInhibitors%252Bof%252BHsp90%26aulast%3DKitson%26aufirst%3DRussell%2BR.%2BA.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D06022013%26date%3D26032013%26date%3D07062013%26date%3D15032013%26volume%3D78%26issue%3D11%26spage%3D5117%26epage%3D5141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Antonino  Lauria</span>, <span class="hlFld-ContribAuthor ">Ilenia  Abbate</span>, <span class="hlFld-ContribAuthor ">Carla  Gentile</span>, <span class="hlFld-ContribAuthor ">Francesca  Angileri</span>, <span class="hlFld-ContribAuthor ">Annamaria  Martorana</span>, and <span class="hlFld-ContribAuthor ">Anna Maria  Almerico</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Activities of a New Class of Heat Shock Protein 90 Inhibitors, Designed by Energy-Based Pharmacophore Virtual Screening. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (8)
                                     , 3424-3428. <a href="https://doi.org/10.1021/jm4002023" title="DOI URL">https://doi.org/10.1021/jm4002023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm4002023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm4002023%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BBiological%252BActivities%252Bof%252Ba%252BNew%252BClass%252Bof%252BHeat%252BShock%252BProtein%252B90%252BInhibitors%25252C%252BDesigned%252Bby%252BEnergy-Based%252BPharmacophore%252BVirtual%252BScreening%26aulast%3DLauria%26aufirst%3DAntonino%26date%3D2013%26date%3D2013%26date%3D2012%26date%3D19112012%26date%3D05042013%26date%3D25042013%26date%3D22032013%26volume%3D56%26issue%3D8%26spage%3D3424%26epage%3D3428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Angelo  Aguilar</span>, <span class="hlFld-ContribAuthor ">Haibin  Zhou</span>, <span class="hlFld-ContribAuthor ">Jianfang  Chen</span>, <span class="hlFld-ContribAuthor ">Liu  Liu</span>, <span class="hlFld-ContribAuthor ">Longchuan  Bai</span>, <span class="hlFld-ContribAuthor ">Donna  McEachern</span>, <span class="hlFld-ContribAuthor ">Chao-Yie  Yang</span>, <span class="hlFld-ContribAuthor ">Jennifer  Meagher</span>, <span class="hlFld-ContribAuthor ">Jeanne  Stuckey</span>, and <span class="hlFld-ContribAuthor ">Shaomeng  Wang</span>  . </span><span class="cited-content_cbyCitation_article-title">A Potent and Highly Efficacious Bcl-2/Bcl-xL Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (7)
                                     , 3048-3067. <a href="https://doi.org/10.1021/jm4001105" title="DOI URL">https://doi.org/10.1021/jm4001105</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm4001105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm4001105%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252BPotent%252Band%252BHighly%252BEfficacious%252BBcl-2%25252FBcl-xL%252BInhibitor%26aulast%3DAguilar%26aufirst%3DAngelo%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D23012013%26date%3D22032013%26date%3D11042013%26date%3D28022013%26volume%3D56%26issue%3D7%26spage%3D3048%26epage%3D3067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiandong  Shi</span>, <span class="hlFld-ContribAuthor ">Ryan  Van de Water</span>, <span class="hlFld-ContribAuthor ">Kevin  Hong</span>, <span class="hlFld-ContribAuthor ">Ryan B.  Lamer</span>, <span class="hlFld-ContribAuthor ">Kenneth W.  Weichert</span>, <span class="hlFld-ContribAuthor ">Cristina M.  Sandoval</span>, <span class="hlFld-ContribAuthor ">Srinivas R.  Kasibhatla</span>, <span class="hlFld-ContribAuthor ">Marcus F.  Boehm</span>, <span class="hlFld-ContribAuthor ">Jianhua  Chao</span>, <span class="hlFld-ContribAuthor ">Karen  Lundgren</span>, <span class="hlFld-ContribAuthor ">Noelito  Timple</span>, <span class="hlFld-ContribAuthor ">Rachel  Lough</span>, <span class="hlFld-ContribAuthor ">Gerardo  Ibanez</span>, <span class="hlFld-ContribAuthor ">Christina  Boykin</span>, <span class="hlFld-ContribAuthor ">Francis J.  Burrows</span>, <span class="hlFld-ContribAuthor ">Marilyn R.  Kehry</span>, <span class="hlFld-ContribAuthor ">Theodore J.  Yun</span>, <span class="hlFld-ContribAuthor ">Erin K.  Harning</span>, <span class="hlFld-ContribAuthor ">Christine  Ambrose</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Thompson</span>, <span class="hlFld-ContribAuthor ">Sarah A.  Bixler</span>, <span class="hlFld-ContribAuthor ">Anthone  Dunah</span>, <span class="hlFld-ContribAuthor ">Pamela  Snodgrass-Belt</span>, <span class="hlFld-ContribAuthor ">Joseph  Arndt</span>, <span class="hlFld-ContribAuthor ">Istvan J.  Enyedy</span>, <span class="hlFld-ContribAuthor ">Ping  Li</span>, <span class="hlFld-ContribAuthor ">Victor S.  Hong</span>, <span class="hlFld-ContribAuthor ">Andres  McKenzie</span>, and <span class="hlFld-ContribAuthor ">Marco A.  Biamonte</span>  . </span><span class="cited-content_cbyCitation_article-title">EC144 Is a Potent Inhibitor of the Heat Shock Protein 90. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (17)
                                     , 7786-7795. <a href="https://doi.org/10.1021/jm300810x" title="DOI URL">https://doi.org/10.1021/jm300810x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm300810x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm300810x%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DEC144%252BIs%252Ba%252BPotent%252BInhibitor%252Bof%252Bthe%252BHeat%252BShock%252BProtein%252B90%26aulast%3DShi%26aufirst%3DJiandong%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D08062012%26date%3D31082012%26date%3D13092012%26volume%3D55%26issue%3D17%26spage%3D7786%26epage%3D7795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David R.  Hall</span>, <span class="hlFld-ContribAuthor ">Chi Ho  Ngan</span>, <span class="hlFld-ContribAuthor ">Brandon S.  Zerbe</span>, <span class="hlFld-ContribAuthor ">Dima  Kozakov</span>, and <span class="hlFld-ContribAuthor ">Sandor  Vajda</span>  . </span><span class="cited-content_cbyCitation_article-title">Hot Spot Analysis for Driving the Development of Hits into Leads in Fragment-Based Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2012,</strong> <em>52 </em>
                                    (1)
                                     , 199-209. <a href="https://doi.org/10.1021/ci200468p" title="DOI URL">https://doi.org/10.1021/ci200468p</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci200468p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci200468p%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DHot%252BSpot%252BAnalysis%252Bfor%252BDriving%252Bthe%252BDevelopment%252Bof%252BHits%252Binto%252BLeads%252Bin%252BFragment-Based%252BDrug%252BDiscovery%26aulast%3DHall%26aufirst%3DDavid%2BR.%26date%3D2012%26date%3D2011%26date%3D2011%26date%3D03102011%26date%3D15122011%26date%3D23012012%26date%3D07122011%26volume%3D52%26issue%3D1%26spage%3D199%26epage%3D209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Riccardo  Baruchello</span>, <span class="hlFld-ContribAuthor ">Daniele  Simoni</span>, <span class="hlFld-ContribAuthor ">Giuseppina  Grisolia</span>, <span class="hlFld-ContribAuthor ">Giuseppina  Barbato</span>, <span class="hlFld-ContribAuthor ">Paolo  Marchetti</span>, <span class="hlFld-ContribAuthor ">Riccardo  Rondanin</span>, <span class="hlFld-ContribAuthor ">Stefania  Mangiola</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Giannini</span>, <span class="hlFld-ContribAuthor ">Tiziana  Brunetti</span>, <span class="hlFld-ContribAuthor ">Domenico  Alloatti</span>, <span class="hlFld-ContribAuthor ">Grazia  Gallo</span>, <span class="hlFld-ContribAuthor ">Andrea  Ciacci</span>, <span class="hlFld-ContribAuthor ">Loredana  Vesci</span>, <span class="hlFld-ContribAuthor ">Massimo  Castorina</span>, <span class="hlFld-ContribAuthor ">Ferdinando M.  Milazzo</span>, <span class="hlFld-ContribAuthor ">Maria L.  Cervoni</span>, <span class="hlFld-ContribAuthor ">Mario B.  Guglielmi</span>, <span class="hlFld-ContribAuthor ">Marcella  Barbarino</span>, <span class="hlFld-ContribAuthor ">Rosanna  Foderà</span>, <span class="hlFld-ContribAuthor ">Claudio  Pisano</span>, and <span class="hlFld-ContribAuthor ">Walter  Cabri</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel 3,4-Isoxazolediamides as Potent Inhibitors of Chaperone Heat Shock Protein 90. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (24)
                                     , 8592-8604. <a href="https://doi.org/10.1021/jm201155e" title="DOI URL">https://doi.org/10.1021/jm201155e</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm201155e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm201155e%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252B3%25252C4-Isoxazolediamides%252Bas%252BPotent%252BInhibitors%252Bof%252BChaperone%252BHeat%252BShock%252BProtein%252B90%26aulast%3DBaruchello%26aufirst%3DRiccardo%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D30082011%26date%3D23112011%26date%3D22122011%26date%3D09112011%26volume%3D54%26issue%3D24%26spage%3D8592%26epage%3D8604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James E. H.  Day</span>, <span class="hlFld-ContribAuthor ">Swee Y.  Sharp</span>, <span class="hlFld-ContribAuthor ">Martin G.  Rowlands</span>, <span class="hlFld-ContribAuthor ">Wynne  Aherne</span>, <span class="hlFld-ContribAuthor ">Angela  Hayes</span>, <span class="hlFld-ContribAuthor ">Florence I.  Raynaud</span>, <span class="hlFld-ContribAuthor ">William  Lewis</span>, <span class="hlFld-ContribAuthor ">S. Mark  Roe</span>, <span class="hlFld-ContribAuthor ">Chrisostomos  Prodromou</span>, <span class="hlFld-ContribAuthor ">Laurence H.  Pearl</span>, <span class="hlFld-ContribAuthor ">Paul  Workman</span>, and <span class="hlFld-ContribAuthor ">Christopher J.  Moody</span>  . </span><span class="cited-content_cbyCitation_article-title">Targeting the Hsp90 Molecular Chaperone with Novel Macrolactams. Synthesis, Structural, Binding, and Cellular Studies. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2011,</strong> <em>6 </em>
                                    (12)
                                     , 1339-1347. <a href="https://doi.org/10.1021/cb200196e" title="DOI URL">https://doi.org/10.1021/cb200196e</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cb200196e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcb200196e%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DTargeting%252Bthe%252BHsp90%252BMolecular%252BChaperone%252Bwith%252BNovel%252BMacrolactams.%252BSynthesis%25252C%252BStructural%25252C%252BBinding%25252C%252Band%252BCellular%252BStudies%26aulast%3DDay%26aufirst%3DJames%2BE.%2BH.%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D2010%26date%3D11112010%26date%3D20092011%26date%3D04102011%26date%3D16122011%26date%3D20092011%26volume%3D6%26issue%3D12%26spage%3D1339%26epage%3D1347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Helene  Köster</span>, <span class="hlFld-ContribAuthor ">Tobias  Craan</span>, <span class="hlFld-ContribAuthor ">Sascha  Brass</span>, <span class="hlFld-ContribAuthor ">Christian  Herhaus</span>, <span class="hlFld-ContribAuthor ">Matthias  Zentgraf</span>, <span class="hlFld-ContribAuthor ">Lars  Neumann</span>, <span class="hlFld-ContribAuthor ">Andreas  Heine</span>, and <span class="hlFld-ContribAuthor ">Gerhard  Klebe</span>  . </span><span class="cited-content_cbyCitation_article-title">A Small Nonrule of 3 Compatible Fragment Library Provides High Hit Rate of Endothiapepsin Crystal Structures with Various Fragment Chemotypes. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (22)
                                     , 7784-7796. <a href="https://doi.org/10.1021/jm200642w" title="DOI URL">https://doi.org/10.1021/jm200642w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm200642w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm200642w%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252BSmall%252BNonrule%252Bof%252B3%252BCompatible%252BFragment%252BLibrary%252BProvides%252BHigh%252BHit%252BRate%252Bof%252BEndothiapepsin%252BCrystal%252BStructures%252Bwith%252BVarious%252BFragment%252BChemotypes%26aulast%3DK%25C3%25B6ster%26aufirst%3DHelene%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D19052011%26date%3D25102011%26date%3D24112011%26date%3D06102011%26volume%3D54%26issue%3D22%26spage%3D7784%26epage%3D7796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter  Schmidtke</span>, <span class="hlFld-ContribAuthor ">F. Javier  Luque</span>, <span class="hlFld-ContribAuthor ">James B.  Murray</span>, and <span class="hlFld-ContribAuthor ">Xavier  Barril</span>  . </span><span class="cited-content_cbyCitation_article-title">Shielded Hydrogen Bonds as Structural Determinants of Binding Kinetics: Application in Drug Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2011,</strong> <em>133 </em>
                                    (46)
                                     , 18903-18910. <a href="https://doi.org/10.1021/ja207494u" title="DOI URL">https://doi.org/10.1021/ja207494u</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ja207494u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fja207494u%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DShielded%252BHydrogen%252BBonds%252Bas%252BStructural%252BDeterminants%252Bof%252BBinding%252BKinetics%25253A%252BApplication%252Bin%252BDrug%252BDesign%26aulast%3DSchmidtke%26aufirst%3DPeter%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D09082011%26date%3D28102011%26date%3D23112011%26date%3D07102011%26volume%3D133%26issue%3D46%26spage%3D18903%26epage%3D18910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sarah R.  Langdon</span>, <span class="hlFld-ContribAuthor ">Nathan  Brown</span>, and <span class="hlFld-ContribAuthor ">Julian  Blagg</span>  . </span><span class="cited-content_cbyCitation_article-title">Scaffold Diversity of Exemplified Medicinal Chemistry Space. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2011,</strong> <em>51 </em>
                                    (9)
                                     , 2174-2185. <a href="https://doi.org/10.1021/ci2001428" title="DOI URL">https://doi.org/10.1021/ci2001428</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci2001428&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci2001428%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DScaffold%252BDiversity%252Bof%252BExemplified%252BMedicinal%252BChemistry%252BSpace%26aulast%3DLangdon%26aufirst%3DSarah%2BR.%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D25032011%26date%3D31082011%26date%3D26092011%26volume%3D51%26issue%3D9%26spage%3D2174%26epage%3D2185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephen D.  Roughley</span> and <span class="hlFld-ContribAuthor ">Roderick E.  Hubbard</span>  . </span><span class="cited-content_cbyCitation_article-title">How Well Can Fragments Explore Accessed Chemical Space? A Case Study from Heat Shock Protein 90. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (12)
                                     , 3989-4005. <a href="https://doi.org/10.1021/jm200350g" title="DOI URL">https://doi.org/10.1021/jm200350g</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm200350g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm200350g%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHow%252BWell%252BCan%252BFragments%252BExplore%252BAccessed%252BChemical%252BSpace%25253F%252BA%252BCase%252BStudy%252Bfrom%252BHeat%252BShock%252BProtein%252B90%26aulast%3DRoughley%26aufirst%3DStephen%2BD.%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D25032011%26date%3D24052011%26date%3D23062011%26date%3D11052011%26volume%3D54%26issue%3D12%26spage%3D3989%26epage%3D4005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luke  Zehnder</span>, <span class="hlFld-ContribAuthor ">Michael  Bennett</span>, <span class="hlFld-ContribAuthor ">Jerry  Meng</span>, <span class="hlFld-ContribAuthor ">Buwen  Huang</span>, <span class="hlFld-ContribAuthor ">Sacha  Ninkovic</span>, <span class="hlFld-ContribAuthor ">Fen  Wang</span>, <span class="hlFld-ContribAuthor ">John  Braganza</span>, <span class="hlFld-ContribAuthor ">John  Tatlock</span>, <span class="hlFld-ContribAuthor ">Tanya  Jewell</span>, <span class="hlFld-ContribAuthor ">Joe Zhongxiang  Zhou</span>, <span class="hlFld-ContribAuthor ">Ben  Burke</span>, <span class="hlFld-ContribAuthor ">Jeff  Wang</span>, <span class="hlFld-ContribAuthor ">Karen  Maegley</span>, <span class="hlFld-ContribAuthor ">Pramod P.  Mehta</span>, <span class="hlFld-ContribAuthor ">Min-Jean  Yin</span>, <span class="hlFld-ContribAuthor ">Ketan S.  Gajiwala</span>, <span class="hlFld-ContribAuthor ">Michael J.  Hickey</span>, <span class="hlFld-ContribAuthor ">Shinji  Yamazaki</span>, <span class="hlFld-ContribAuthor ">Evan  Smith</span>, <span class="hlFld-ContribAuthor ">Ping  Kang</span>, <span class="hlFld-ContribAuthor ">Anand  Sistla</span>, <span class="hlFld-ContribAuthor ">Elena  Dovalsantos</span>, <span class="hlFld-ContribAuthor ">Michael R.  Gehring</span>, <span class="hlFld-ContribAuthor ">Robert  Kania</span>, <span class="hlFld-ContribAuthor ">Martin  Wythes</span>, and <span class="hlFld-ContribAuthor ">Pei-Pei  Kung</span>  . </span><span class="cited-content_cbyCitation_article-title">Optimization of Potent, Selective, and Orally Bioavailable Pyrrolodinopyrimidine-Containing Inhibitors of Heat Shock Protein 90. Identification of Development Candidate 2-Amino-4-{4-chloro-2-[2-(4-fluoro-1H-pyrazol-1-yl)ethoxy]-6-methylphenyl}-N-(2,2-difluoropropyl)-5,7-dihydro-6H-pyrrolo[3,4-d]pyrimidine-6-carboxamide. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (9)
                                     , 3368-3385. <a href="https://doi.org/10.1021/jm200128m" title="DOI URL">https://doi.org/10.1021/jm200128m</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm200128m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm200128m%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOptimization%252Bof%252BPotent%25252C%252BSelective%25252C%252Band%252BOrally%252BBioavailable%252BPyrrolodinopyrimidine-Containing%252BInhibitors%252Bof%252BHeat%252BShock%252BProtein%252B90.%252BIdentification%252Bof%252BDevelopment%252BCandidate%252B2-Amino-4-%25257B4-chloro-2-%25255B2-%2525284-fluoro-1H-pyrazol-1-yl%252529ethoxy%25255D-6-methylphenyl%25257D-N-%2525282%25252C2-difluoropropyl%252529-5%25252C7-dihydro-6H-pyrrolo%25255B3%25252C4-d%25255Dpyrimidine-6-carboxamide%26aulast%3DZehnder%26aufirst%3DLuke%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D05022011%26date%3D20042011%26date%3D12052011%26date%3D25032011%26volume%3D54%26issue%3D9%26spage%3D3368%26epage%3D3385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew J.  Massey</span>. </span><span class="cited-content_cbyCitation_article-title">ATPases as Drug Targets: Insights from Heat Shock Proteins 70 and 90. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (20)
                                     , 7280-7286. <a href="https://doi.org/10.1021/jm100342z" title="DOI URL">https://doi.org/10.1021/jm100342z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm100342z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm100342z%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DATPases%252Bas%252BDrug%252BTargets%25253A%252BInsights%252Bfrom%252BHeat%252BShock%252BProteins%252B70%252Band%252B90%26aulast%3DMassey%26aufirst%3DAndrew%2BJ.%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D16032010%26date%3D07072010%26date%3D28102010%26volume%3D53%26issue%3D20%26spage%3D7280%26epage%3D7286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mahmoud A.  Al-Sha’er</span> and <span class="hlFld-ContribAuthor ">Mutasem O.  Taha</span>  . </span><span class="cited-content_cbyCitation_article-title">Elaborate Ligand-Based Modeling Reveals New Nanomolar Heat Shock Protein 90α Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2010,</strong> <em>50 </em>
                                    (9)
                                     , 1706-1723. <a href="https://doi.org/10.1021/ci100222k" title="DOI URL">https://doi.org/10.1021/ci100222k</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci100222k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci100222k%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DElaborate%252BLigand-Based%252BModeling%252BReveals%252BNew%252BNanomolar%252BHeat%252BShock%252BProtein%252B90%2525CE%2525B1%252BInhibitors%26aulast%3DAl-Sha%25E2%2580%2599er%26aufirst%3DMahmoud%2BA.%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D8%252006%25202010%26date%3D10092010%26date%3D27092010%26volume%3D50%26issue%3D9%26spage%3D1706%26epage%3D1723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher W.  Murray</span>, <span class="hlFld-ContribAuthor ">Maria G.  Carr</span>, <span class="hlFld-ContribAuthor ">Owen  Callaghan</span>, <span class="hlFld-ContribAuthor ">Gianni  Chessari</span>, <span class="hlFld-ContribAuthor ">Miles  Congreve</span>, <span class="hlFld-ContribAuthor ">Suzanna  Cowan</span>, <span class="hlFld-ContribAuthor ">Joseph E.  Coyle</span>, <span class="hlFld-ContribAuthor ">Robert  Downham</span>, <span class="hlFld-ContribAuthor ">Eva  Figueroa</span>, <span class="hlFld-ContribAuthor ">Martyn  Frederickson</span>, <span class="hlFld-ContribAuthor ">Brent  Graham</span>, <span class="hlFld-ContribAuthor ">Rachel  McMenamin</span>, <span class="hlFld-ContribAuthor ">M. Alistair  O’Brien</span>, <span class="hlFld-ContribAuthor ">Sahil  Patel</span>, <span class="hlFld-ContribAuthor ">Theresa R.  Phillips</span>, <span class="hlFld-ContribAuthor ">Glyn  Williams</span>, <span class="hlFld-ContribAuthor ">Andrew J.  Woodhead</span> and <span class="hlFld-ContribAuthor ">Alison J.-A.  Woolford</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment-Based Drug Discovery Applied to Hsp90. Discovery of Two Lead Series with High Ligand Efficiency. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (16)
                                     , 5942-5955. <a href="https://doi.org/10.1021/jm100059d" title="DOI URL">https://doi.org/10.1021/jm100059d</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm100059d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm100059d%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFragment-Based%252BDrug%252BDiscovery%252BApplied%252Bto%252BHsp90.%252BDiscovery%252Bof%252BTwo%252BLead%252BSeries%252Bwith%252BHigh%252BLigand%252BEfficiency%26aulast%3DMurray%26aufirst%3DChristopher%2BW.%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D15012010%26date%3D27072010%26date%3D26082010%26volume%3D53%26issue%3D16%26spage%3D5942%26epage%3D5955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew J.  Woodhead</span>, <span class="hlFld-ContribAuthor ">Hayley  Angove</span>, <span class="hlFld-ContribAuthor ">Maria G.  Carr</span>, <span class="hlFld-ContribAuthor ">Gianni  Chessari</span>, <span class="hlFld-ContribAuthor ">Miles  Congreve</span>, <span class="hlFld-ContribAuthor ">Joseph E.  Coyle</span>, <span class="hlFld-ContribAuthor ">Jose  Cosme</span>, <span class="hlFld-ContribAuthor ">Brent  Graham</span>, <span class="hlFld-ContribAuthor ">Philip J.  Day</span>, <span class="hlFld-ContribAuthor ">Robert  Downham</span>, <span class="hlFld-ContribAuthor ">Lynsey  Fazal</span>, <span class="hlFld-ContribAuthor ">Ruth  Feltell</span>, <span class="hlFld-ContribAuthor ">Eva  Figueroa</span>, <span class="hlFld-ContribAuthor ">Martyn  Frederickson</span>, <span class="hlFld-ContribAuthor ">Jonathan  Lewis</span>, <span class="hlFld-ContribAuthor ">Rachel  McMenamin</span>, <span class="hlFld-ContribAuthor ">Christopher W.  Murray</span>, <span class="hlFld-ContribAuthor ">M. Alistair  O’Brien</span>, <span class="hlFld-ContribAuthor ">Lina  Parra</span>, <span class="hlFld-ContribAuthor ">Sahil  Patel</span>, <span class="hlFld-ContribAuthor ">Theresa  Phillips</span>, <span class="hlFld-ContribAuthor ">David C.  Rees</span>, <span class="hlFld-ContribAuthor ">Sharna  Rich</span>, <span class="hlFld-ContribAuthor ">Donna-Michelle  Smith</span>, <span class="hlFld-ContribAuthor ">Gary  Trewartha</span>, <span class="hlFld-ContribAuthor ">Mladen  Vinkovic</span>, <span class="hlFld-ContribAuthor ">Brian  Williams</span> and <span class="hlFld-ContribAuthor ">Alison J.-A.  Woolford</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of (2,4-Dihydroxy-5-isopropylphenyl)-[5-(4-methylpiperazin-1-ylmethyl)-1,3-dihydroisoindol-2-yl]methanone (AT13387), a Novel Inhibitor of the Molecular Chaperone Hsp90 by Fragment Based Drug Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (16)
                                     , 5956-5969. <a href="https://doi.org/10.1021/jm100060b" title="DOI URL">https://doi.org/10.1021/jm100060b</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm100060b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm100060b%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B%2525282%25252C4-Dihydroxy-5-isopropylphenyl%252529-%25255B5-%2525284-methylpiperazin-1-ylmethyl%252529-1%25252C3-dihydroisoindol-2-yl%25255Dmethanone%252B%252528AT13387%252529%25252C%252Ba%252BNovel%252BInhibitor%252Bof%252Bthe%252BMolecular%252BChaperone%252BHsp90%252Bby%252BFragment%252BBased%252BDrug%252BDesign%26aulast%3DWoodhead%26aufirst%3DAndrew%2BJ.%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D15012010%26date%3D28072010%26date%3D26082010%26volume%3D53%26issue%3D16%26spage%3D5956%26epage%3D5969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marco A.  Biamonte</span>, <span class="hlFld-ContribAuthor ">Ryan  Van de Water</span>, <span class="hlFld-ContribAuthor ">Joseph W.  Arndt</span>, <span class="hlFld-ContribAuthor ">Robert H.  Scannevin</span>, <span class="hlFld-ContribAuthor ">Daniel  Perret</span> and <span class="hlFld-ContribAuthor ">Wen-Cherng  Lee</span>  . </span><span class="cited-content_cbyCitation_article-title">Heat Shock Protein 90: Inhibitors in Clinical Trials. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (1)
                                     , 3-17. <a href="https://doi.org/10.1021/jm9004708" title="DOI URL">https://doi.org/10.1021/jm9004708</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm9004708&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm9004708%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHeat%252BShock%252BProtein%252B90%25253A%252BInhibitors%252Bin%252BClinical%252BTrials%26aulast%3DBiamonte%26aufirst%3DMarco%2BA.%26date%3D2010%26date%3D2009%26date%3D2009%26date%3D12042009%26date%3D16092009%26date%3D14012010%26volume%3D53%26issue%3D1%26spage%3D3%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pei-Pei  Kung</span>, <span class="hlFld-ContribAuthor ">Buwen  Huang</span>, <span class="hlFld-ContribAuthor ">Gang  Zhang</span>, <span class="hlFld-ContribAuthor ">Joe Zhongxiang  Zhou</span>, <span class="hlFld-ContribAuthor ">Jeff  Wang</span>, <span class="hlFld-ContribAuthor ">Jennifer A.  Digits</span>, <span class="hlFld-ContribAuthor ">Judith  Skaptason</span>, <span class="hlFld-ContribAuthor ">Shinji  Yamazaki</span>, <span class="hlFld-ContribAuthor ">David  Neul</span>, <span class="hlFld-ContribAuthor ">Michael  Zientek</span>, <span class="hlFld-ContribAuthor ">Jeff  Elleraas</span>, <span class="hlFld-ContribAuthor ">Pramod  Mehta</span>, <span class="hlFld-ContribAuthor ">Min-Jean  Yin</span>, <span class="hlFld-ContribAuthor ">Michael J.  Hickey</span>, <span class="hlFld-ContribAuthor ">Ketan S.  Gajiwala</span>, <span class="hlFld-ContribAuthor ">Caroline  Rodgers</span>, <span class="hlFld-ContribAuthor ">Jay F.  Davies, II</span> and <span class="hlFld-ContribAuthor ">Michael R.  Gehring</span>. </span><span class="cited-content_cbyCitation_article-title">Dihydroxyphenylisoindoline Amides as Orally Bioavailable Inhibitors of the Heat Shock Protein 90 (Hsp90) Molecular Chaperone. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (1)
                                     , 499-503. <a href="https://doi.org/10.1021/jm901209q" title="DOI URL">https://doi.org/10.1021/jm901209q</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm901209q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm901209q%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDihydroxyphenylisoindoline%252BAmides%252Bas%252BOrally%252BBioavailable%252BInhibitors%252Bof%252Bthe%252BHeat%252BShock%252BProtein%252B90%252B%252528Hsp90%252529%252BMolecular%252BChaperone%26aulast%3DKung%26aufirst%3DPei-Pei%26date%3D2010%26date%3D2009%26date%3D2009%26date%3D16062009%26date%3D12112009%26date%3D14012010%26volume%3D53%26issue%3D1%26spage%3D499%26epage%3D503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sujin  Cho-Schultz</span>, <span class="hlFld-ContribAuthor ">Monica Jo  Patten</span>, <span class="hlFld-ContribAuthor ">Buwen  Huang</span>, <span class="hlFld-ContribAuthor ">Jeff  Elleraas</span>, <span class="hlFld-ContribAuthor ">Ketan S.  Gajiwala</span>, <span class="hlFld-ContribAuthor ">Michael J.  Hickey</span>, <span class="hlFld-ContribAuthor ">Jeff  Wang</span>, <span class="hlFld-ContribAuthor ">Pramod P.  Mehta</span>, <span class="hlFld-ContribAuthor ">Ping  Kang</span>, <span class="hlFld-ContribAuthor ">Michael R.  Gehring</span>, <span class="hlFld-ContribAuthor ">Pei-Pei  Kung</span> and <span class="hlFld-ContribAuthor ">Scott C.  Sutton</span>. </span><span class="cited-content_cbyCitation_article-title">Solution-Phase Parallel Synthesis of Hsp90 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Combinatorial Chemistry</span><span> <strong>2009,</strong> <em>11 </em>
                                    (5)
                                     , 860-874. <a href="https://doi.org/10.1021/cc900056d" title="DOI URL">https://doi.org/10.1021/cc900056d</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cc900056d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcc900056d%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Combinatorial%2520Chemistry%26atitle%3DSolution-Phase%252BParallel%252BSynthesis%252Bof%252BHsp90%252BInhibitors%26aulast%3DCho-Schultz%26aufirst%3DSujin%26date%3D2009%26date%3D2009%26date%3D2009%26date%3D6%252004%25202009%26date%3D07072009%26date%3D14092009%26volume%3D11%26issue%3D5%26spage%3D860%26epage%3D874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul A.  Brough</span>, <span class="hlFld-ContribAuthor ">Xavier  Barril</span>, <span class="hlFld-ContribAuthor ">Jenifer  Borgognoni</span>, <span class="hlFld-ContribAuthor ">Patrick  Chene</span>, <span class="hlFld-ContribAuthor ">Nicholas G. M.  Davies</span>, <span class="hlFld-ContribAuthor ">Ben  Davis</span>, <span class="hlFld-ContribAuthor ">Martin J.  Drysdale</span>, <span class="hlFld-ContribAuthor ">Brian  Dymock</span>, <span class="hlFld-ContribAuthor ">Suzanne A.  Eccles</span>, <span class="hlFld-ContribAuthor ">Carlos  Garcia-Echeverria</span>, <span class="hlFld-ContribAuthor ">Christophe  Fromont</span>, <span class="hlFld-ContribAuthor ">Angela  Hayes</span>, <span class="hlFld-ContribAuthor ">Roderick E.  Hubbard</span>, <span class="hlFld-ContribAuthor ">Allan M.  Jordan</span>, <span class="hlFld-ContribAuthor ">Michael Rugaard  Jensen</span>, <span class="hlFld-ContribAuthor ">Andrew  Massey</span>, <span class="hlFld-ContribAuthor ">Angela  Merrett</span>, <span class="hlFld-ContribAuthor ">Antony  Padfield</span>, <span class="hlFld-ContribAuthor ">Rachel  Parsons</span>, <span class="hlFld-ContribAuthor ">Thomas  Radimerski</span>, <span class="hlFld-ContribAuthor ">Florence I.  Raynaud</span>, <span class="hlFld-ContribAuthor ">Alan  Robertson</span>, <span class="hlFld-ContribAuthor ">Stephen D.  Roughley</span>, <span class="hlFld-ContribAuthor ">Joseph  Schoepfer</span>, <span class="hlFld-ContribAuthor ">Heather  Simmonite</span>, <span class="hlFld-ContribAuthor ">Swee Y.  Sharp</span>, <span class="hlFld-ContribAuthor ">Allan  Surgenor</span>, <span class="hlFld-ContribAuthor ">Melanie  Valenti</span>, <span class="hlFld-ContribAuthor ">Steven  Walls</span>, <span class="hlFld-ContribAuthor ">Paul  Webb</span>, <span class="hlFld-ContribAuthor ">Mike  Wood</span>, <span class="hlFld-ContribAuthor ">Paul  Workman</span> and <span class="hlFld-ContribAuthor ">Lisa  Wright</span>  . </span><span class="cited-content_cbyCitation_article-title">Combining Hit Identification Strategies: Fragment-Based and in Silico Approaches to Orally Active 2-Aminothieno[2,3-d]pyrimidine Inhibitors of the Hsp90 Molecular Chaperone. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2009,</strong> <em>52 </em>
                                    (15)
                                     , 4794-4809. <a href="https://doi.org/10.1021/jm900357y" title="DOI URL">https://doi.org/10.1021/jm900357y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm900357y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm900357y%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCombining%252BHit%252BIdentification%252BStrategies%25253A%252BFragment-Based%252Band%252Bin%252BSilico%252BApproaches%252Bto%252BOrally%252BActive%252B2-Aminothieno%25255B2%25252C3-d%25255Dpyrimidine%252BInhibitors%252Bof%252Bthe%252BHsp90%252BMolecular%252BChaperone%26aulast%3DBrough%26aufirst%3DPaul%2BA.%26date%3D2009%26date%3D2009%26date%3D2009%26date%3D21032009%26date%3D17072009%26date%3D13082009%26volume%3D52%26issue%3D15%26spage%3D4794%26epage%3D4809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kenneth H.  Huang</span>, <span class="hlFld-ContribAuthor ">James M.  Veal</span>, <span class="hlFld-ContribAuthor ">R. Patrick  Fadden</span>, <span class="hlFld-ContribAuthor ">John W.  Rice</span>, <span class="hlFld-ContribAuthor ">Jeron  Eaves</span>, <span class="hlFld-ContribAuthor ">Jon-Paul  Strachan</span>, <span class="hlFld-ContribAuthor ">Amy F.  Barabasz</span>, <span class="hlFld-ContribAuthor ">Briana E.  Foley</span>, <span class="hlFld-ContribAuthor ">Thomas E.  Barta</span>, <span class="hlFld-ContribAuthor ">Wei  Ma</span>, <span class="hlFld-ContribAuthor ">Melanie A.  Silinski</span>, <span class="hlFld-ContribAuthor ">Mei  Hu</span>, <span class="hlFld-ContribAuthor ">Jeffrey M.  Partridge</span>, <span class="hlFld-ContribAuthor ">Anisa  Scott</span>, <span class="hlFld-ContribAuthor ">Laura G.  DuBois</span>, <span class="hlFld-ContribAuthor ">Tiffany  Freed</span>, <span class="hlFld-ContribAuthor ">Paul M.  Steed</span>, <span class="hlFld-ContribAuthor ">Andy J.  Ommen</span>, <span class="hlFld-ContribAuthor ">Emilie D.  Smith</span>, <span class="hlFld-ContribAuthor ">Philip F.  Hughes</span>, <span class="hlFld-ContribAuthor ">Angela R.  Woodward</span>, <span class="hlFld-ContribAuthor ">Gunnar J.  Hanson</span>, <span class="hlFld-ContribAuthor ">W. Stephen  McCall</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Markworth</span>, <span class="hlFld-ContribAuthor ">Lindsay  Hinkley</span>, <span class="hlFld-ContribAuthor ">Matthew  Jenks</span>, <span class="hlFld-ContribAuthor ">Lifeng  Geng</span>, <span class="hlFld-ContribAuthor ">Meredith  Lewis</span>, <span class="hlFld-ContribAuthor ">James  Otto</span>, <span class="hlFld-ContribAuthor ">Bert  Pronk</span>, <span class="hlFld-ContribAuthor ">Katleen  Verleysen</span> and <span class="hlFld-ContribAuthor ">Steven E.  Hall</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel 2-Aminobenzamide Inhibitors of Heat Shock Protein 90 as Potent, Selective and Orally Active Antitumor Agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2009,</strong> <em>52 </em>
                                    (14)
                                     , 4288-4305. <a href="https://doi.org/10.1021/jm900230j" title="DOI URL">https://doi.org/10.1021/jm900230j</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm900230j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm900230j%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BNovel%252B2-Aminobenzamide%252BInhibitors%252Bof%252BHeat%252BShock%252BProtein%252B90%252Bas%252BPotent%25252C%252BSelective%252Band%252BOrally%252BActive%252BAntitumor%252BAgents%26aulast%3DHuang%26aufirst%3DKenneth%2BH.%26date%3D2009%26date%3D2009%26date%3D2009%26date%3D21022009%26date%3D24062009%26date%3D23072009%26volume%3D52%26issue%3D14%26spage%3D4288%26epage%3D4305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chrisostomos  Prodromou</span>, <span class="hlFld-ContribAuthor ">James M.  Nuttall</span>, <span class="hlFld-ContribAuthor ">Stefan H.  Millson</span>, <span class="hlFld-ContribAuthor ">S. Mark  Roe</span>, <span class="hlFld-ContribAuthor ">Tiow-Suan  Sim</span>, <span class="hlFld-ContribAuthor ">Doreen  Tan</span>, <span class="hlFld-ContribAuthor ">Paul  Workman</span>, <span class="hlFld-ContribAuthor ">Laurence H.  Pearl</span> and <span class="hlFld-ContribAuthor ">Peter W.  Piper</span>  . </span><span class="cited-content_cbyCitation_article-title">Structural Basis of the Radicicol Resistance Displayed by a Fungal Hsp90. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2009,</strong> <em>4 </em>
                                    (4)
                                     , 289-297. <a href="https://doi.org/10.1021/cb9000316" title="DOI URL">https://doi.org/10.1021/cb9000316</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cb9000316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcb9000316%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DStructural%252BBasis%252Bof%252Bthe%252BRadicicol%252BResistance%252BDisplayed%252Bby%252Ba%252BFungal%252BHsp90%26aulast%3DProdromou%26aufirst%3DChrisostomos%26date%3D2009%26date%3D2009%26date%3D2009%26date%3D2008%26date%3D8%252012%25202008%26date%3D23%25202%25202009%26date%3D18032009%26date%3D17042009%26date%3D23022009%26volume%3D4%26issue%3D4%26spage%3D289%26epage%3D297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Reyes  Aranda</span>, <span class="hlFld-ContribAuthor ">Karen  Villalba</span>, <span class="hlFld-ContribAuthor ">Enrique  Raviña</span>, <span class="hlFld-ContribAuthor ">Christian F.  Masaguer</span>, <span class="hlFld-ContribAuthor ">José  Brea</span>, <span class="hlFld-ContribAuthor ">Filipe  Areias</span>, <span class="hlFld-ContribAuthor ">Eduardo  Domínguez</span>, <span class="hlFld-ContribAuthor ">Jana  Selent</span>, <span class="hlFld-ContribAuthor ">Laura  López</span>, <span class="hlFld-ContribAuthor ">Ferran  Sanz</span>, <span class="hlFld-ContribAuthor ">Manuel  Pastor</span> and <span class="hlFld-ContribAuthor ">María I.  Loza</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, Binding Affinity, and Molecular Docking Analysis of New Benzofuranone Derivatives as Potential Antipsychotics. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2008,</strong> <em>51 </em>
                                    (19)
                                     , 6085-6094. <a href="https://doi.org/10.1021/jm800602w" title="DOI URL">https://doi.org/10.1021/jm800602w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm800602w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm800602w%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%25252C%252BBinding%252BAffinity%25252C%252Band%252BMolecular%252BDocking%252BAnalysis%252Bof%252BNew%252BBenzofuranone%252BDerivatives%252Bas%252BPotential%252BAntipsychotics%26aulast%3DAranda%26aufirst%3DReyes%26date%3D2008%26date%3D2008%26date%3D2008%26date%3D09%252010%25202008%26date%3D11%252009%25202008%26date%3D21%252005%25202008%26volume%3D51%26issue%3D19%26spage%3D6085%26epage%3D6094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dan  Song</span>, <span class="hlFld-ContribAuthor ">Ming  Guo</span>, <span class="hlFld-ContribAuthor ">Shuai  Xu</span>, <span class="hlFld-ContribAuthor ">Xiaotian  Song</span>, <span class="hlFld-ContribAuthor ">Bin  Bai</span>, <span class="hlFld-ContribAuthor ">Zhengyan  Li</span>, <span class="hlFld-ContribAuthor ">Jie  Chen</span>, <span class="hlFld-ContribAuthor ">Yanxin  An</span>, <span class="hlFld-ContribAuthor ">Yongzhan  Nie</span>, <span class="hlFld-ContribAuthor ">Kaichun  Wu</span>, <span class="hlFld-ContribAuthor ">Shiqi  Wang</span>, <span class="hlFld-ContribAuthor ">Qingchuan  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">HSP90-dependent PUS7 overexpression facilitates the metastasis of colorectal cancer cells by regulating LASP1 abundance. </span><span class="cited-content_cbyCitation_journal-name">Journal of Experimental & Clinical Cancer Research</span><span> <strong>2021,</strong> <em>40 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13046-021-01951-5" title="DOI URL">https://doi.org/10.1186/s13046-021-01951-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13046-021-01951-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13046-021-01951-5%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Experimental%2520%2526%2520Clinical%2520Cancer%2520Research%26atitle%3DHSP90-dependent%252BPUS7%252Boverexpression%252Bfacilitates%252Bthe%252Bmetastasis%252Bof%252Bcolorectal%252Bcancer%252Bcells%252Bby%252Bregulating%252BLASP1%252Babundance%26aulast%3DSong%26aufirst%3DDan%26date%3D2021%26date%3D2021%26volume%3D40%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brittany  Epp-Ducharme</span>, <span class="hlFld-ContribAuthor ">Michael  Dunne</span>, <span class="hlFld-ContribAuthor ">Linyu  Fan</span>, <span class="hlFld-ContribAuthor ">James C.  Evans</span>, <span class="hlFld-ContribAuthor ">Lubabah  Ahmed</span>, <span class="hlFld-ContribAuthor ">Pauric  Bannigan</span>, <span class="hlFld-ContribAuthor ">Christine  Allen</span>. </span><span class="cited-content_cbyCitation_article-title">Heat-activated nanomedicine formulation improves the anticancer potential of the HSP90 inhibitor luminespib in vitro. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2021,</strong> <em>11 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-021-90585-w" title="DOI URL">https://doi.org/10.1038/s41598-021-90585-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-021-90585-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-021-90585-w%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DHeat-activated%252Bnanomedicine%252Bformulation%252Bimproves%252Bthe%252Banticancer%252Bpotential%252Bof%252Bthe%252BHSP90%252Binhibitor%252Bluminespib%252Bin%252Bvitro%26aulast%3DEpp-Ducharme%26aufirst%3DBrittany%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tasqeeruddin  Syed</span>, <span class="hlFld-ContribAuthor ">Yahya I.  Asiri</span>, <span class="hlFld-ContribAuthor ">Shaheen  Shaheen</span>, <span class="hlFld-ContribAuthor ">Kiran  Gangarapu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and anticancer evaluation of structurally modified substituted aryl-quinazoline derivatives as anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Synthetic Communications</span><span> <strong>2021,</strong> <em>1 </em>, 1-14. <a href="https://doi.org/10.1080/00397911.2021.1941113" title="DOI URL">https://doi.org/10.1080/00397911.2021.1941113</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00397911.2021.1941113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00397911.2021.1941113%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthetic%2520Communications%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Banticancer%252Bevaluation%252Bof%252Bstructurally%252Bmodified%252Bsubstituted%252Baryl-quinazoline%252Bderivatives%252Bas%252Banticancer%252Bagents%26aulast%3DSyed%26aufirst%3DTasqeeruddin%26date%3D2021%26date%3D2021%26volume%3D1%26spage%3D1%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yi-Min  Liu</span>, <span class="hlFld-ContribAuthor ">Huang-Ju  Tu</span>, <span class="hlFld-ContribAuthor ">Chueh-Heng  Wu</span>, <span class="hlFld-ContribAuthor ">Mei-Jung  Lai</span>, <span class="hlFld-ContribAuthor ">Shu-Chieh  Yu</span>, <span class="hlFld-ContribAuthor ">Min-Wu  Chao</span>, <span class="hlFld-ContribAuthor ">Yi-Wen  Wu</span>, <span class="hlFld-ContribAuthor ">Che-Ming  Teng</span>, <span class="hlFld-ContribAuthor ">Shiow-Lin  Pan</span>, <span class="hlFld-ContribAuthor ">Jing-Ping  Liou</span>. </span><span class="cited-content_cbyCitation_article-title">Ring-opening of five-membered heterocycles conjugated 4-isopropylresorcinol scaffold-based benzamides as HSP90 inhibitors suppressing tumor growth in vitro and in vivo. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>219 </em>, 113428. <a href="https://doi.org/10.1016/j.ejmech.2021.113428" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113428</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113428&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113428%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRing-opening%252Bof%252Bfive-membered%252Bheterocycles%252Bconjugated%252B4-isopropylresorcinol%252Bscaffold-based%252Bbenzamides%252Bas%252BHSP90%252Binhibitors%252Bsuppressing%252Btumor%252Bgrowth%252Bin%2525C2%2525A0vitro%252Band%252Bin%2525C2%2525A0vivo%26aulast%3DLiu%26aufirst%3DYi-Min%26date%3D2021%26volume%3D219%26spage%3D113428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">V.  Shyni</span>, <span class="hlFld-ContribAuthor ">D. R.  Leenaraj</span>, <span class="hlFld-ContribAuthor ">Reena  Ittyachan</span>, <span class="hlFld-ContribAuthor ">Lynnette  Joseph</span>, <span class="hlFld-ContribAuthor ">D.  Sajan</span>. </span><span class="cited-content_cbyCitation_article-title">Spectroscopic, density functional theoretical study, molecular docking, and
              in vitro
              studies based on anticancer activity studies against
              
                A
                549
              
              lung cancer cell line of diphenylhydantoin adsorbed on
              AuNPs
              surface. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Recognition</span><span> <strong>2021,</strong> <em>5 </em><a href="https://doi.org/10.1002/jmr.2916" title="DOI URL">https://doi.org/10.1002/jmr.2916</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jmr.2916&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjmr.2916%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Recognition%26atitle%3DSpectroscopic%25252C%252Bdensity%252Bfunctional%252Btheoretical%252Bstudy%25252C%252Bmolecular%252Bdocking%25252C%252Band%252Bin%252Bvitro%252Bstudies%252Bbased%252Bon%252Banticancer%252Bactivity%252Bstudies%252Bagainst%252BA%252B549%252Blung%252Bcancer%252Bcell%252Bline%252Bof%252Bdiphenylhydantoin%252Badsorbed%252Bon%252BAuNPs%252Bsurface%26aulast%3DShyni%26aufirst%3DV.%26date%3D2021%26date%3D2021%26volume%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Benjamin L.  Woolbright</span>, <span class="hlFld-ContribAuthor ">Robert A.  Harris</span>. </span><span class="cited-content_cbyCitation_article-title">PDK2: An Underappreciated Regulator of Liver Metabolism. </span><span class="cited-content_cbyCitation_journal-name">Livers</span><span> <strong>2021,</strong> <em>1 </em>
                                    (2)
                                     , 82-97. <a href="https://doi.org/10.3390/livers1020008" title="DOI URL">https://doi.org/10.3390/livers1020008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/livers1020008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Flivers1020008%26sid%3Dliteratum%253Aachs%26jtitle%3DLivers%26atitle%3DPDK2%25253A%252BAn%252BUnderappreciated%252BRegulator%252Bof%252BLiver%252BMetabolism%26aulast%3DWoolbright%26aufirst%3DBenjamin%2BL.%26date%3D2021%26date%3D2021%26volume%3D1%26issue%3D2%26spage%3D82%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Albert A.  Antolin</span>, <span class="hlFld-ContribAuthor ">Paul A.  Clarke</span>, <span class="hlFld-ContribAuthor ">Ian  Collins</span>, <span class="hlFld-ContribAuthor ">Paul  Workman</span>, <span class="hlFld-ContribAuthor ">Bissan  Al-Lazikani</span>. </span><span class="cited-content_cbyCitation_article-title">Evolution of kinase polypharmacology across HSP90 drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Cell Chemical Biology</span><span> <strong>2021,</strong> <em>5 </em><a href="https://doi.org/10.1016/j.chembiol.2021.05.004" title="DOI URL">https://doi.org/10.1016/j.chembiol.2021.05.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chembiol.2021.05.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chembiol.2021.05.004%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Chemical%2520Biology%26atitle%3DEvolution%252Bof%252Bkinase%252Bpolypharmacology%252Bacross%252BHSP90%252Bdrug%252Bdiscovery%26aulast%3DAntolin%26aufirst%3DAlbert%2BA.%26date%3D2021%26volume%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roderick E.  Hubbard</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment‐Based Lead Discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-35. <a href="https://doi.org/10.1002/0471266949.bmc265" title="DOI URL">https://doi.org/10.1002/0471266949.bmc265</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc265%26sid%3Dliteratum%253Aachs%26atitle%3DFragment%2525E2%252580%252590Based%252BLead%252BDiscovery%26aulast%3DHubbard%26aufirst%3DRoderick%2BE.%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D35%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brian S.J.  Blagg</span>, <span class="hlFld-ContribAuthor ">Matthew Kyle  Hadden</span>, <span class="hlFld-ContribAuthor ">Reid S.  Tarpley</span>. </span><span class="cited-content_cbyCitation_article-title">Hsp90 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-88. <a href="https://doi.org/10.1002/0471266949.bmc212.pub2" title="DOI URL">https://doi.org/10.1002/0471266949.bmc212.pub2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc212.pub2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc212.pub2%26sid%3Dliteratum%253Aachs%26atitle%3DHsp90%252BInhibitors%26aulast%3DBlagg%26aufirst%3DBrian%2BS.J.%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D88%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shweta  Sharma</span>, <span class="hlFld-ContribAuthor ">Shubham  Srivastav</span>, <span class="hlFld-ContribAuthor ">Garima  Singh</span>, <span class="hlFld-ContribAuthor ">Smrita  Singh</span>, <span class="hlFld-ContribAuthor ">Ruchi  Malik</span>, <span class="hlFld-ContribAuthor ">Mohammad Mumtaz  Alam</span>, <span class="hlFld-ContribAuthor ">Mohammad  Shaqiquzamman</span>, <span class="hlFld-ContribAuthor ">Shakir  Ali</span>, <span class="hlFld-ContribAuthor ">Mymoona  Akhter</span>. </span><span class="cited-content_cbyCitation_article-title">In silico
              strategies for probing novel DPP-IV inhibitors as anti-diabetic agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2021,</strong> <em>39 </em>
                                    (6)
                                     , 2118-2132. <a href="https://doi.org/10.1080/07391102.2020.1751714" title="DOI URL">https://doi.org/10.1080/07391102.2020.1751714</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2020.1751714&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2020.1751714%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DIn%252Bsilico%252Bstrategies%252Bfor%252Bprobing%252Bnovel%252BDPP-IV%252Binhibitors%252Bas%252Banti-diabetic%252Bagents%26aulast%3DSharma%26aufirst%3DShweta%26date%3D2021%26date%3D2020%26volume%3D39%26issue%3D6%26spage%3D2118%26epage%3D2132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ahmad M.  Eid</span>, <span class="hlFld-ContribAuthor ">Mohammed  Hawash</span>, <span class="hlFld-ContribAuthor ">Johnny  Amer</span>, <span class="hlFld-ContribAuthor ">Abdullah  Jarrar</span>, <span class="hlFld-ContribAuthor ">Samira  Qadri</span>, <span class="hlFld-ContribAuthor ">Iman  Alnimer</span>, <span class="hlFld-ContribAuthor ">Aya  Sharaf</span>, <span class="hlFld-ContribAuthor ">Raya  Zalmoot</span>, <span class="hlFld-ContribAuthor ">Osama  Hammoudie</span>, <span class="hlFld-ContribAuthor ">Saba  Hameedi</span>, <span class="hlFld-ContribAuthor ">Ahmed  Mousa</span>, . </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Evaluation of Novel Isoxazole-Amide Analogues as Anticancer and Antioxidant Agents. </span><span class="cited-content_cbyCitation_journal-name">BioMed Research International</span><span> <strong>2021,</strong> <em>2021 </em>, 1-9. <a href="https://doi.org/10.1155/2021/6633297" title="DOI URL">https://doi.org/10.1155/2021/6633297</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2021/6633297&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2021%2F6633297%26sid%3Dliteratum%253Aachs%26jtitle%3DBioMed%2520Research%2520International%26atitle%3DSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BNovel%252BIsoxazole-Amide%252BAnalogues%252Bas%252BAnticancer%252Band%252BAntioxidant%252BAgents%26aulast%3DEid%26aufirst%3DAhmad%2BM.%26date%3D2021%26volume%3D2021%26spage%3D1%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rony  Mshaik</span>, <span class="hlFld-ContribAuthor ">John  Simonet</span>, <span class="hlFld-ContribAuthor ">Aleksandra  Georgievski</span>, <span class="hlFld-ContribAuthor ">Layla  Jamal</span>, <span class="hlFld-ContribAuthor ">Shaliha  Bechoua</span>, <span class="hlFld-ContribAuthor ">Paola  Ballerini</span>, <span class="hlFld-ContribAuthor ">Pierre-Simon  Bellaye</span>, <span class="hlFld-ContribAuthor ">Zandile  Mlamla</span>, <span class="hlFld-ContribAuthor ">Jean-Paul  Pais de Barros</span>, <span class="hlFld-ContribAuthor ">Audrey  Geissler</span>, <span class="hlFld-ContribAuthor ">Pierre-Jean  Francin</span>, <span class="hlFld-ContribAuthor ">François  Girodon</span>, <span class="hlFld-ContribAuthor ">Carmen  Garrido</span>, <span class="hlFld-ContribAuthor ">Ronan  Quéré</span>. </span><span class="cited-content_cbyCitation_article-title">HSP90 inhibitor NVP-BEP800 affects stability of SRC kinases and growth of T-cell and B-cell acute lymphoblastic leukemias. </span><span class="cited-content_cbyCitation_journal-name">Blood Cancer Journal</span><span> <strong>2021,</strong> <em>11 </em>
                                    (3)
                                     <a href="https://doi.org/10.1038/s41408-021-00450-2" title="DOI URL">https://doi.org/10.1038/s41408-021-00450-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41408-021-00450-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41408-021-00450-2%26sid%3Dliteratum%253Aachs%26jtitle%3DBlood%2520Cancer%2520Journal%26atitle%3DHSP90%252Binhibitor%252BNVP-BEP800%252Baffects%252Bstability%252Bof%252BSRC%252Bkinases%252Band%252Bgrowth%252Bof%252BT-cell%252Band%252BB-cell%252Bacute%252Blymphoblastic%252Bleukemias%26aulast%3DMshaik%26aufirst%3DRony%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">P.  Nordeman</span>, <span class="hlFld-ContribAuthor ">Z.P.  Jayendra</span>, <span class="hlFld-ContribAuthor ">E.  Briard</span>, <span class="hlFld-ContribAuthor ">S.C.  Li</span>, <span class="hlFld-ContribAuthor ">M.  Larhed</span>, <span class="hlFld-ContribAuthor ">G.  Antoni</span>, <span class="hlFld-ContribAuthor ">S.  Estrada</span>, <span class="hlFld-ContribAuthor ">R.K.  Selvaraju</span>, <span class="hlFld-ContribAuthor ">O.  Åberg</span>, <span class="hlFld-ContribAuthor ">M.R.  Jensen</span>, <span class="hlFld-ContribAuthor ">P.  Stålberg</span>, <span class="hlFld-ContribAuthor ">B.  Skogseid</span>, <span class="hlFld-ContribAuthor ">A.  Monazzam</span>. </span><span class="cited-content_cbyCitation_article-title">18F-Radiolabeling and Preliminary Evaluation of a HSP90 ligand. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmaceutical Sciences</span><span> <strong>2021,</strong> <em>157 </em>, 105647. <a href="https://doi.org/10.1016/j.ejps.2020.105647" title="DOI URL">https://doi.org/10.1016/j.ejps.2020.105647</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejps.2020.105647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejps.2020.105647%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3D18F-Radiolabeling%252Band%252BPreliminary%252BEvaluation%252Bof%252Ba%252BHSP90%252Bligand%26aulast%3DNordeman%26aufirst%3DP.%26date%3D2021%26volume%3D157%26spage%3D105647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Oliver  Binas</span>, <span class="hlFld-ContribAuthor ">Vanessa  Jesus</span>, <span class="hlFld-ContribAuthor ">Tom  Landgraf</span>, <span class="hlFld-ContribAuthor ">Albrecht Eduard  Völklein</span>, <span class="hlFld-ContribAuthor ">Jason  Martins</span>, <span class="hlFld-ContribAuthor ">Daniel  Hymon</span>, <span class="hlFld-ContribAuthor ">Jasleen  Kaur Bains</span>, <span class="hlFld-ContribAuthor ">Hannes  Berg</span>, <span class="hlFld-ContribAuthor ">Thomas  Biedenbänder</span>, <span class="hlFld-ContribAuthor ">Boris  Fürtig</span>, <span class="hlFld-ContribAuthor ">Santosh  Lakshmi Gande</span>, <span class="hlFld-ContribAuthor ">Anna  Niesteruk</span>, <span class="hlFld-ContribAuthor ">Andreas  Oxenfarth</span>, <span class="hlFld-ContribAuthor ">Nusrat  Shahin Qureshi</span>, <span class="hlFld-ContribAuthor ">Tatjana  Schamber</span>, <span class="hlFld-ContribAuthor ">Robbin  Schnieders</span>, <span class="hlFld-ContribAuthor ">Alix  Tröster</span>, <span class="hlFld-ContribAuthor ">Anna  Wacker</span>, <span class="hlFld-ContribAuthor ">Julia  Wirmer‐Bartoschek</span>, <span class="hlFld-ContribAuthor ">Maria Alexandra  Wirtz Martin</span>, <span class="hlFld-ContribAuthor ">Elke  Stirnal</span>, <span class="hlFld-ContribAuthor ">Kamal  Azzaoui</span>, <span class="hlFld-ContribAuthor ">Christian  Richter</span>, <span class="hlFld-ContribAuthor ">Sridhar  Sreeramulu</span>, <span class="hlFld-ContribAuthor ">Marcel Jules  José Blommers</span>, <span class="hlFld-ContribAuthor ">Harald  Schwalbe</span>. </span><span class="cited-content_cbyCitation_article-title">19
              F NMR‐Based Fragment Screening for 14 Different Biologically Active RNAs and 10 DNA and Protein Counter‐Screens. </span><span class="cited-content_cbyCitation_journal-name">ChemBioChem</span><span> <strong>2021,</strong> <em>22 </em>
                                    (2)
                                     , 423-433. <a href="https://doi.org/10.1002/cbic.202000476" title="DOI URL">https://doi.org/10.1002/cbic.202000476</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbic.202000476&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbic.202000476%26sid%3Dliteratum%253Aachs%26jtitle%3DChemBioChem%26atitle%3D19%252BF%252BNMR%2525E2%252580%252590Based%252BFragment%252BScreening%252Bfor%252B14%252BDifferent%252BBiologically%252BActive%252BRNAs%252Band%252B10%252BDNA%252Band%252BProtein%252BCounter%2525E2%252580%252590Screens%26aulast%3DBinas%26aufirst%3DOliver%26date%3D2021%26date%3D2020%26volume%3D22%26issue%3D2%26spage%3D423%26epage%3D433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shweta  Sharma</span>, <span class="hlFld-ContribAuthor ">Shubham  Srivastava</span>, <span class="hlFld-ContribAuthor ">Apeksha  Shrivastava</span>, <span class="hlFld-ContribAuthor ">Ruchi  Malik</span>, <span class="hlFld-ContribAuthor ">Faisal  Almalki</span>, <span class="hlFld-ContribAuthor ">Khalid  Saifullah</span>, <span class="hlFld-ContribAuthor ">Mohammad Mumtaz  Alam</span>, <span class="hlFld-ContribAuthor ">Mohammad  Shaqiquzzaman</span>, <span class="hlFld-ContribAuthor ">Shakir  Ali</span>, <span class="hlFld-ContribAuthor ">Mymoona  Akhter</span>. </span><span class="cited-content_cbyCitation_article-title">Mining of potential dipeptidyl peptidase-IV inhibitors as anti-diabetic agents using integrated
              in silico
              approaches. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2020,</strong> <em>38 </em>
                                    (18)
                                     , 5349-5361. <a href="https://doi.org/10.1080/07391102.2019.1701553" title="DOI URL">https://doi.org/10.1080/07391102.2019.1701553</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2019.1701553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2019.1701553%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DMining%252Bof%252Bpotential%252Bdipeptidyl%252Bpeptidase-IV%252Binhibitors%252Bas%252Banti-diabetic%252Bagents%252Busing%252Bintegrated%252Bin%252Bsilico%252Bapproaches%26aulast%3DSharma%26aufirst%3DShweta%26date%3D2020%26date%3D2019%26volume%3D38%26issue%3D18%26spage%3D5349%26epage%3D5361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nenad  Joksimović</span>, <span class="hlFld-ContribAuthor ">Nenad  Janković</span>, <span class="hlFld-ContribAuthor ">Goran  Davidović</span>, <span class="hlFld-ContribAuthor ">Zorica  Bugarčić</span>. </span><span class="cited-content_cbyCitation_article-title">2,4-Diketo esters: Crucial intermediates for drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>105 </em>, 104343. <a href="https://doi.org/10.1016/j.bioorg.2020.104343" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.104343</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.104343&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.104343%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3D2%25252C4-Diketo%252Besters%25253A%252BCrucial%252Bintermediates%252Bfor%252Bdrug%252Bdiscovery%26aulast%3DJoksimovi%25C4%2587%26aufirst%3DNenad%26date%3D2020%26volume%3D105%26spage%3D104343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Monika  Szeliga</span>, <span class="hlFld-ContribAuthor ">Monika  Karpińska</span>, <span class="hlFld-ContribAuthor ">Radosław  Rola</span>, <span class="hlFld-ContribAuthor ">Andrzej  Niewiadomy</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel 1,3,4-thiadiazole derivatives as anti-glioblastoma agents targeting the AKT pathway. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>105 </em>, 104362. <a href="https://doi.org/10.1016/j.bioorg.2020.104362" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.104362</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.104362&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.104362%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252B1%25252C3%25252C4-thiadiazole%252Bderivatives%252Bas%252Banti-glioblastoma%252Bagents%252Btargeting%252Bthe%252BAKT%252Bpathway%26aulast%3DSzeliga%26aufirst%3DMonika%26date%3D2020%26volume%3D105%26spage%3D104362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lisa M.  Baker</span>, <span class="hlFld-ContribAuthor ">Anthony  Aimon</span>, <span class="hlFld-ContribAuthor ">James B.  Murray</span>, <span class="hlFld-ContribAuthor ">Allan E.  Surgenor</span>, <span class="hlFld-ContribAuthor ">Natalia  Matassova</span>, <span class="hlFld-ContribAuthor ">Stephen D.  Roughley</span>, <span class="hlFld-ContribAuthor ">Patrick M.  Collins</span>, <span class="hlFld-ContribAuthor ">Tobias  Krojer</span>, <span class="hlFld-ContribAuthor ">Frank  von Delft</span>, <span class="hlFld-ContribAuthor ">Roderick E.  Hubbard</span>. </span><span class="cited-content_cbyCitation_article-title">Rapid optimisation of fragments and hits to lead compounds from screening of crude reaction mixtures. </span><span class="cited-content_cbyCitation_journal-name">Communications Chemistry</span><span> <strong>2020,</strong> <em>3 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s42004-020-00367-0" title="DOI URL">https://doi.org/10.1038/s42004-020-00367-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s42004-020-00367-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs42004-020-00367-0%26sid%3Dliteratum%253Aachs%26jtitle%3DCommunications%2520Chemistry%26atitle%3DRapid%252Boptimisation%252Bof%252Bfragments%252Band%252Bhits%252Bto%252Blead%252Bcompounds%252Bfrom%252Bscreening%252Bof%252Bcrude%252Breaction%252Bmixtures%26aulast%3DBaker%26aufirst%3DLisa%2BM.%26date%3D2020%26date%3D2020%26volume%3D3%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Niveshika</span>, <span class="hlFld-ContribAuthor ">Savita  Singh</span>, <span class="hlFld-ContribAuthor ">Ekta  Verma</span>, <span class="hlFld-ContribAuthor ">Arun Kumar  Mishra</span>. </span><span class="cited-content_cbyCitation_article-title">In silico molecular docking analysis of cancer biomarkers with GC/MS identified compounds of Scytonema sp.. </span><span class="cited-content_cbyCitation_journal-name">Network Modeling Analysis in Health Informatics and Bioinformatics</span><span> <strong>2020,</strong> <em>9 </em>
                                    (1)
                                     <a href="https://doi.org/10.1007/s13721-020-00235-w" title="DOI URL">https://doi.org/10.1007/s13721-020-00235-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s13721-020-00235-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs13721-020-00235-w%26sid%3Dliteratum%253Aachs%26jtitle%3DNetwork%2520Modeling%2520Analysis%2520in%2520Health%2520Informatics%2520and%2520Bioinformatics%26atitle%3DIn%252Bsilico%252Bmolecular%252Bdocking%252Banalysis%252Bof%252Bcancer%252Bbiomarkers%252Bwith%252BGC%25252FMS%252Bidentified%252Bcompounds%252Bof%252BScytonema%252Bsp.%26aulast%3DNiveshika%26date%3D2020%26date%3D2020%26volume%3D9%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sridhar  Sreeramulu</span>, <span class="hlFld-ContribAuthor ">Christian  Richter</span>, <span class="hlFld-ContribAuthor ">Till  Kuehn</span>, <span class="hlFld-ContribAuthor ">Kamal  Azzaoui</span>, <span class="hlFld-ContribAuthor ">Marcel Jules José  Blommers</span>, <span class="hlFld-ContribAuthor ">Rebecca  Del Conte</span>, <span class="hlFld-ContribAuthor ">Marco  Fragai</span>, <span class="hlFld-ContribAuthor ">Nils  Trieloff</span>, <span class="hlFld-ContribAuthor ">Peter  Schmieder</span>, <span class="hlFld-ContribAuthor ">Marc  Nazaré</span>, <span class="hlFld-ContribAuthor ">Edgar  Specker</span>, <span class="hlFld-ContribAuthor ">Vladimir  Ivanov</span>, <span class="hlFld-ContribAuthor ">Hartmut  Oschkinat</span>, <span class="hlFld-ContribAuthor ">Lucia  Banci</span>, <span class="hlFld-ContribAuthor ">Harald  Schwalbe</span>. </span><span class="cited-content_cbyCitation_article-title">NMR quality control of fragment libraries for screening. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular NMR</span><span> <strong>2020,</strong> <em>74 </em>
                                    (10-11)
                                     , 555-563. <a href="https://doi.org/10.1007/s10858-020-00327-9" title="DOI URL">https://doi.org/10.1007/s10858-020-00327-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10858-020-00327-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10858-020-00327-9%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520NMR%26atitle%3DNMR%252Bquality%252Bcontrol%252Bof%252Bfragment%252Blibraries%252Bfor%252Bscreening%26aulast%3DSreeramulu%26aufirst%3DSridhar%26date%3D2020%26date%3D2020%26volume%3D74%26issue%3D10-11%26spage%3D555%26epage%3D563" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei-Cheng  Wu</span>, <span class="hlFld-ContribAuthor ">Yi-Min  Liu</span>, <span class="hlFld-ContribAuthor ">Yu-Hsuan  Liao</span>, <span class="hlFld-ContribAuthor ">Kai-Cheng  Hsu</span>, <span class="hlFld-ContribAuthor ">Ssu-Ting  Lien</span>, <span class="hlFld-ContribAuthor ">I-Chung  Chen</span>, <span class="hlFld-ContribAuthor ">Mei-Jung  Lai</span>, <span class="hlFld-ContribAuthor ">Yu-Hsuan  Li</span>, <span class="hlFld-ContribAuthor ">Shiow-Lin  Pan</span>, <span class="hlFld-ContribAuthor ">Mei-Chuan  Chen</span>, <span class="hlFld-ContribAuthor ">Jing-Ping  Liou</span>. </span><span class="cited-content_cbyCitation_article-title">Fluoropyrimidin-2,4-dihydroxy-5-isopropylbenzamides as antitumor agents against CRC and NSCLC cancer cells. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>203 </em>, 112540. <a href="https://doi.org/10.1016/j.ejmech.2020.112540" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112540</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112540%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFluoropyrimidin-2%25252C4-dihydroxy-5-isopropylbenzamides%252Bas%252Bantitumor%252Bagents%252Bagainst%252BCRC%252Band%252BNSCLC%252Bcancer%252Bcells%26aulast%3DWu%26aufirst%3DWei-Cheng%26date%3D2020%26volume%3D203%26spage%3D112540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jong Youl  Kim</span>, <span class="hlFld-ContribAuthor ">Sumit  Barua</span>, <span class="hlFld-ContribAuthor ">Mei Ying  Huang</span>, <span class="hlFld-ContribAuthor ">Joohyun  Park</span>, <span class="hlFld-ContribAuthor ">Midori A.  Yenari</span>, <span class="hlFld-ContribAuthor ">Jong Eun  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Heat Shock Protein 70 (HSP70) Induction: Chaperonotherapy for Neuroprotection after Brain Injury. </span><span class="cited-content_cbyCitation_journal-name">Cells</span><span> <strong>2020,</strong> <em>9 </em>
                                    (9)
                                     , 2020. <a href="https://doi.org/10.3390/cells9092020" title="DOI URL">https://doi.org/10.3390/cells9092020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cells9092020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcells9092020%26sid%3Dliteratum%253Aachs%26jtitle%3DCells%26atitle%3DHeat%252BShock%252BProtein%252B70%252B%252528HSP70%252529%252BInduction%25253A%252BChaperonotherapy%252Bfor%252BNeuroprotection%252Bafter%252BBrain%252BInjury%26aulast%3DKim%26aufirst%3DJong%2BYoul%26date%3D2020%26date%3D2020%26volume%3D9%26issue%3D9%26spage%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ankit  K. Rochani</span>, <span class="hlFld-ContribAuthor ">Sivakumar  Balasubramanian</span>, <span class="hlFld-ContribAuthor ">Aswathy  Ravindran Girija</span>, <span class="hlFld-ContribAuthor ">Toru  Maekawa</span>, <span class="hlFld-ContribAuthor ">Gagan  Kaushal</span>, <span class="hlFld-ContribAuthor ">D. Sakthi  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Heat Shock Protein 90 (Hsp90)-Inhibitor-Luminespib-Loaded-Protein-Based Nanoformulation for Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name">Polymers</span><span> <strong>2020,</strong> <em>12 </em>
                                    (8)
                                     , 1798. <a href="https://doi.org/10.3390/polym12081798" title="DOI URL">https://doi.org/10.3390/polym12081798</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/polym12081798&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fpolym12081798%26sid%3Dliteratum%253Aachs%26jtitle%3DPolymers%26atitle%3DHeat%252BShock%252BProtein%252B90%252B%252528Hsp90%252529-Inhibitor-Luminespib-Loaded-Protein-Based%252BNanoformulation%252Bfor%252BCancer%252BTherapy%26aulast%3DK.%2BRochani%26aufirst%3DAnkit%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D8%26spage%3D1798" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jihoon  Kang</span>, <span class="hlFld-ContribAuthor ">Haushabhau S.  Pagire</span>, <span class="hlFld-ContribAuthor ">Donguk  Kang</span>, <span class="hlFld-ContribAuthor ">Yo Han  Song</span>, <span class="hlFld-ContribAuthor ">In Kyu  Lee</span>, <span class="hlFld-ContribAuthor ">Kang Taek  Lee</span>, <span class="hlFld-ContribAuthor ">Chin-Ju  Park</span>, <span class="hlFld-ContribAuthor ">Jin Hee  Ahn</span>, <span class="hlFld-ContribAuthor ">Jungwook  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Structural basis for the inhibition of PDK2 by novel ATP- and lipoyl-binding site targeting compounds. </span><span class="cited-content_cbyCitation_journal-name">Biochemical and Biophysical Research Communications</span><span> <strong>2020,</strong> <em>527 </em>
                                    (3)
                                     , 778-784. <a href="https://doi.org/10.1016/j.bbrc.2020.04.102" title="DOI URL">https://doi.org/10.1016/j.bbrc.2020.04.102</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbrc.2020.04.102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbrc.2020.04.102%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520and%2520Biophysical%2520Research%2520Communications%26atitle%3DStructural%252Bbasis%252Bfor%252Bthe%252Binhibition%252Bof%252BPDK2%252Bby%252Bnovel%252BATP-%252Band%252Blipoyl-binding%252Bsite%252Btargeting%252Bcompounds%26aulast%3DKang%26aufirst%3DJihoon%26date%3D2020%26volume%3D527%26issue%3D3%26spage%3D778%26epage%3D784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Juyoung  Jung</span>, <span class="hlFld-ContribAuthor ">Jinsun  Kwon</span>, <span class="hlFld-ContribAuthor ">Soojung  Hong</span>, <span class="hlFld-ContribAuthor ">An-Na  Moon</span>, <span class="hlFld-ContribAuthor ">Jinah  Jeong</span>, <span class="hlFld-ContribAuthor ">Sungwook  Kwon</span>, <span class="hlFld-ContribAuthor ">Jeong-ah  Kim</span>, <span class="hlFld-ContribAuthor ">Myoungjae  Lee</span>, <span class="hlFld-ContribAuthor ">Hongsub  Lee</span>, <span class="hlFld-ContribAuthor ">Jin Hee  Lee</span>, <span class="hlFld-ContribAuthor ">Jeewoo  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel heat shock protein (Hsp90) inhibitors based on luminespib with potent antitumor activity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (12)
                                     , 127165. <a href="https://doi.org/10.1016/j.bmcl.2020.127165" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127165</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127165%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bnovel%252Bheat%252Bshock%252Bprotein%252B%252528Hsp90%252529%252Binhibitors%252Bbased%252Bon%252Bluminespib%252Bwith%252Bpotent%252Bantitumor%252Bactivity%26aulast%3DJung%26aufirst%3DJuyoung%26date%3D2020%26volume%3D30%26issue%3D12%26spage%3D127165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jackee  Sanchez</span>, <span class="hlFld-ContribAuthor ">Trever R.  Carter</span>, <span class="hlFld-ContribAuthor ">Mark S.  Cohen</span>, <span class="hlFld-ContribAuthor ">Brian S.J.  Blagg</span>. </span><span class="cited-content_cbyCitation_article-title">Old and New Approaches to Target the Hsp90 Chaperone. </span><span class="cited-content_cbyCitation_journal-name">Current Cancer Drug Targets</span><span> <strong>2020,</strong> <em>20 </em>
                                    (4)
                                     , 253-270. <a href="https://doi.org/10.2174/1568009619666191202101330" title="DOI URL">https://doi.org/10.2174/1568009619666191202101330</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568009619666191202101330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568009619666191202101330%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Cancer%2520Drug%2520Targets%26atitle%3DOld%252Band%252BNew%252BApproaches%252Bto%252BTarget%252Bthe%252BHsp90%252BChaperone%26aulast%3DSanchez%26aufirst%3DJackee%26date%3D2020%26volume%3D20%26issue%3D4%26spage%3D253%26epage%3D270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tony  Taldone</span>, <span class="hlFld-ContribAuthor ">Tai  Wang</span>, <span class="hlFld-ContribAuthor ">Anna  Rodina</span>, <span class="hlFld-ContribAuthor ">Naga Vara Kishore  Pillarsetty</span>, <span class="hlFld-ContribAuthor ">Chander S.  Digwal</span>, <span class="hlFld-ContribAuthor ">Sahil  Sharma</span>, <span class="hlFld-ContribAuthor ">Pengrong  Yan</span>, <span class="hlFld-ContribAuthor ">Suhasini  Joshi</span>, <span class="hlFld-ContribAuthor ">Piyusha P.  Pagare</span>, <span class="hlFld-ContribAuthor ">Alexander  Bolaender</span>, <span class="hlFld-ContribAuthor ">Gail J.  Roboz</span>, <span class="hlFld-ContribAuthor ">Monica L.  Guzman</span>, <span class="hlFld-ContribAuthor ">Gabriela  Chiosis</span>. </span><span class="cited-content_cbyCitation_article-title">A Chemical Biology Approach to the Chaperome in Cancer—HSP90 and Beyond. </span><span class="cited-content_cbyCitation_journal-name">Cold Spring Harbor Perspectives in Biology</span><span> <strong>2020,</strong> <em>12 </em>
                                    (4)
                                     , a034116. <a href="https://doi.org/10.1101/cshperspect.a034116" title="DOI URL">https://doi.org/10.1101/cshperspect.a034116</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1101/cshperspect.a034116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1101%2Fcshperspect.a034116%26sid%3Dliteratum%253Aachs%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspectives%2520in%2520Biology%26atitle%3DA%252BChemical%252BBiology%252BApproach%252Bto%252Bthe%252BChaperome%252Bin%252BCancer%2525E2%252580%252594HSP90%252Band%252BBeyond%26aulast%3DTaldone%26aufirst%3DTony%26date%3D2020%26date%3D2019%26volume%3D12%26issue%3D4%26spage%3Da034116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ayanda M.  Magwenyane</span>, <span class="hlFld-ContribAuthor ">Ndumiso N.  Mhlongo</span>, <span class="hlFld-ContribAuthor ">Monsurat M.  Lawal</span>, <span class="hlFld-ContribAuthor ">Daniel G.  Amoako</span>, <span class="hlFld-ContribAuthor ">Anou M.  Somboro</span>, <span class="hlFld-ContribAuthor ">Sphelele C.  Sosibo</span>, <span class="hlFld-ContribAuthor ">Letitia  Shunmugam</span>, <span class="hlFld-ContribAuthor ">Rene B.  Khan</span>, <span class="hlFld-ContribAuthor ">Hezekiel M.  Kumalo</span>. </span><span class="cited-content_cbyCitation_article-title">Understanding the Hsp90 N-Terminal Dynamics: Structural and Molecular Insights into the Therapeutic Activities of Anticancer Inhibitors Radicicol (RD) and Radicicol Derivative (NVP-YUA922). </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (8)
                                     , 1785. <a href="https://doi.org/10.3390/molecules25081785" title="DOI URL">https://doi.org/10.3390/molecules25081785</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25081785&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25081785%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DUnderstanding%252Bthe%252BHsp90%252BN-Terminal%252BDynamics%25253A%252BStructural%252Band%252BMolecular%252BInsights%252Binto%252Bthe%252BTherapeutic%252BActivities%252Bof%252BAnticancer%252BInhibitors%252BRadicicol%252B%252528RD%252529%252Band%252BRadicicol%252BDerivative%252B%252528NVP-YUA922%252529%26aulast%3DMagwenyane%26aufirst%3DAyanda%2BM.%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D8%26spage%3D1785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Keyur M.  Pandya</span>, <span class="hlFld-ContribAuthor ">Arpan H.  Patel</span>, <span class="hlFld-ContribAuthor ">P. S.  Desai</span>. </span><span class="cited-content_cbyCitation_article-title">Development of Antimicrobial, Antimalarial and Antitubercular Compounds Based on a Quinoline-Pyrazole Clubbed Scaffold Derived via Doebner Reaction. </span><span class="cited-content_cbyCitation_journal-name">Chemistry Africa</span><span> <strong>2020,</strong> <em>3 </em>
                                    (1)
                                     , 89-98. <a href="https://doi.org/10.1007/s42250-019-00096-5" title="DOI URL">https://doi.org/10.1007/s42250-019-00096-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s42250-019-00096-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs42250-019-00096-5%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520Africa%26atitle%3DDevelopment%252Bof%252BAntimicrobial%25252C%252BAntimalarial%252Band%252BAntitubercular%252BCompounds%252BBased%252Bon%252Ba%252BQuinoline-Pyrazole%252BClubbed%252BScaffold%252BDerived%252Bvia%252BDoebner%252BReaction%26aulast%3DPandya%26aufirst%3DKeyur%2BM.%26date%3D2020%26date%3D2019%26volume%3D3%26issue%3D1%26spage%3D89%26epage%3D98" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sundeep  Kadasi</span>, <span class="hlFld-ContribAuthor ">Ravali  Yerroju</span>, <span class="hlFld-ContribAuthor ">Swetha  Gaddam</span>, <span class="hlFld-ContribAuthor ">Nikhila  Pullanagiri</span>, <span class="hlFld-ContribAuthor ">Meghana  Chary</span>, <span class="hlFld-ContribAuthor ">Divya  Pingili</span>, <span class="hlFld-ContribAuthor ">Shiva  Raj</span>, <span class="hlFld-ContribAuthor ">Nulgumnalli Manjunathaiah  Raghavendra</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of
              N
              ‐pyridoyl‐Δ
              2
              ‐pyrazolines as Hsp90 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2020,</strong> <em>353 </em>
                                    (2)
                                     , 1900192. <a href="https://doi.org/10.1002/ardp.201900192" title="DOI URL">https://doi.org/10.1002/ardp.201900192</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201900192&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201900192%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DDiscovery%252Bof%252BN%252B%2525E2%252580%252590pyridoyl%2525E2%252580%252590%2525CE%252594%252B2%252B%2525E2%252580%252590pyrazolines%252Bas%252BHsp90%252Binhibitors%26aulast%3DKadasi%26aufirst%3DSundeep%26date%3D2020%26date%3D2019%26volume%3D353%26issue%3D2%26spage%3D1900192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ben J.  Davis</span>, <span class="hlFld-ContribAuthor ">Roderick E.  Hubbard</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment‐Based Ligand Discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 79-98. <a href="https://doi.org/10.1002/9781118681121.ch4" title="DOI URL">https://doi.org/10.1002/9781118681121.ch4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118681121.ch4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118681121.ch4%26sid%3Dliteratum%253Aachs%26atitle%3DFragment%2525E2%252580%252590Based%252BLigand%252BDiscovery%26aulast%3DDavis%26aufirst%3DBen%2BJ.%26date%3D2020%26date%3D2020%26spage%3D79%26epage%3D98%26pub%3DWiley%26atitle%3DStructural%252BBiology%252Bin%252BDrug%252BDiscovery%26aulast%3DRenaud%26aufirst%3DJean%25E2%2580%2590Paul%26date%3D2020%26date%3D2020%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gaëtan  Jego</span>, <span class="hlFld-ContribAuthor ">François  Hermetet</span>, <span class="hlFld-ContribAuthor ">François  Girodon</span>, <span class="hlFld-ContribAuthor ">Carmen  Garrido</span>. </span><span class="cited-content_cbyCitation_article-title">Chaperoning STAT3/5 by Heat Shock Proteins: Interest of Their Targeting in Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2020,</strong> <em>12 </em>
                                    (1)
                                     , 21. <a href="https://doi.org/10.3390/cancers12010021" title="DOI URL">https://doi.org/10.3390/cancers12010021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers12010021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers12010021%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DChaperoning%252BSTAT3%25252F5%252Bby%252BHeat%252BShock%252BProteins%25253A%252BInterest%252Bof%252BTheir%252BTargeting%252Bin%252BCancer%252BTherapy%26aulast%3DJego%26aufirst%3DGa%25C3%25ABtan%26date%3D2020%26date%3D2019%26volume%3D12%26issue%3D1%26spage%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Samy  Mohamady</span>, <span class="hlFld-ContribAuthor ">Muhammad I.  Ismail</span>, <span class="hlFld-ContribAuthor ">Samar M.  Mogheith</span>, <span class="hlFld-ContribAuthor ">Yasmeen M.  Attia</span>, <span class="hlFld-ContribAuthor ">Scott D.  Taylor</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 5-aryl-3-thiophen-2-yl-1H-pyrazoles as a new class of Hsp90 inhibitors in hepatocellular carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>94 </em>, 103433. <a href="https://doi.org/10.1016/j.bioorg.2019.103433" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103433</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103433&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103433%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDiscovery%252Bof%252B5-aryl-3-thiophen-2-yl-1H-pyrazoles%252Bas%252Ba%252Bnew%252Bclass%252Bof%252BHsp90%252Binhibitors%252Bin%252Bhepatocellular%252Bcarcinoma%26aulast%3DMohamady%26aufirst%3DSamy%26date%3D2020%26volume%3D94%26spage%3D103433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luke  Whitesell</span>, <span class="hlFld-ContribAuthor ">Nicole  Robbins</span>, <span class="hlFld-ContribAuthor ">David S.  Huang</span>, <span class="hlFld-ContribAuthor ">Catherine A.  McLellan</span>, <span class="hlFld-ContribAuthor ">Tanvi  Shekhar-Guturja</span>, <span class="hlFld-ContribAuthor ">Emmanuelle V.  LeBlanc</span>, <span class="hlFld-ContribAuthor ">Catherine S.  Nation</span>, <span class="hlFld-ContribAuthor ">Raymond  Hui</span>, <span class="hlFld-ContribAuthor ">Ashley  Hutchinson</span>, <span class="hlFld-ContribAuthor ">Cathy  Collins</span>, <span class="hlFld-ContribAuthor ">Sharanya  Chatterjee</span>, <span class="hlFld-ContribAuthor ">Richard  Trilles</span>, <span class="hlFld-ContribAuthor ">Jinglin L.  Xie</span>, <span class="hlFld-ContribAuthor ">Damian J.  Krysan</span>, <span class="hlFld-ContribAuthor ">Susan  Lindquist</span>, <span class="hlFld-ContribAuthor ">John A.  Porco</span>, <span class="hlFld-ContribAuthor ">Utpal  Tatu</span>, <span class="hlFld-ContribAuthor ">Lauren E.  Brown</span>, <span class="hlFld-ContribAuthor ">Juan  Pizarro</span>, <span class="hlFld-ContribAuthor ">Leah E.  Cowen</span>. </span><span class="cited-content_cbyCitation_article-title">Structural basis for species-selective targeting of Hsp90 in a pathogenic fungus. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2019,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-018-08248-w" title="DOI URL">https://doi.org/10.1038/s41467-018-08248-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-018-08248-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-018-08248-w%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DStructural%252Bbasis%252Bfor%252Bspecies-selective%252Btargeting%252Bof%252BHsp90%252Bin%252Ba%252Bpathogenic%252Bfungus%26aulast%3DWhitesell%26aufirst%3DLuke%26date%3D2019%26date%3D2019%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dinesh S.  Barak</span>, <span class="hlFld-ContribAuthor ">Dipak J.  Dahatonde</span>, <span class="hlFld-ContribAuthor ">Sanjay  Batra</span>. </span><span class="cited-content_cbyCitation_article-title">Microwave‐Assisted Metal‐Free Decarboxylative Iodination/Bromination of Isoxazole‐4‐carboxylic Acids. </span><span class="cited-content_cbyCitation_journal-name">Asian Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>8 </em>
                                    (11)
                                     , 2149-2154. <a href="https://doi.org/10.1002/ajoc.201900572" title="DOI URL">https://doi.org/10.1002/ajoc.201900572</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ajoc.201900572&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fajoc.201900572%26sid%3Dliteratum%253Aachs%26jtitle%3DAsian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DMicrowave%2525E2%252580%252590Assisted%252BMetal%2525E2%252580%252590Free%252BDecarboxylative%252BIodination%25252FBromination%252Bof%252BIsoxazole%2525E2%252580%2525904%2525E2%252580%252590carboxylic%252BAcids%26aulast%3DBarak%26aufirst%3DDinesh%2BS.%26date%3D2019%26date%3D2019%26volume%3D8%26issue%3D11%26spage%3D2149%26epage%3D2154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aneliya  Antonova</span>, <span class="hlFld-ContribAuthor ">Barbara  Hummel</span>, <span class="hlFld-ContribAuthor ">Ashkan  Khavaran</span>, <span class="hlFld-ContribAuthor ">Desiree M.  Redhaber</span>, <span class="hlFld-ContribAuthor ">Fernando  Aprile-Garcia</span>, <span class="hlFld-ContribAuthor ">Prashant  Rawat</span>, <span class="hlFld-ContribAuthor ">Kathrin  Gundel</span>, <span class="hlFld-ContribAuthor ">Megan  Schneck</span>, <span class="hlFld-ContribAuthor ">Erik C.  Hansen</span>, <span class="hlFld-ContribAuthor ">Jan  Mitschke</span>, <span class="hlFld-ContribAuthor ">Gerhard  Mittler</span>, <span class="hlFld-ContribAuthor ">Cornelius  Miething</span>, <span class="hlFld-ContribAuthor ">Ritwick  Sawarkar</span>. </span><span class="cited-content_cbyCitation_article-title">Heat-Shock Protein 90 Controls the Expression of Cell-Cycle Genes by Stabilizing Metazoan-Specific Host-Cell Factor HCFC1. </span><span class="cited-content_cbyCitation_journal-name">Cell Reports</span><span> <strong>2019,</strong> <em>29 </em>
                                    (6)
                                     , 1645-1659.e9. <a href="https://doi.org/10.1016/j.celrep.2019.09.084" title="DOI URL">https://doi.org/10.1016/j.celrep.2019.09.084</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.celrep.2019.09.084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.celrep.2019.09.084%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Reports%26atitle%3DHeat-Shock%252BProtein%252B90%252BControls%252Bthe%252BExpression%252Bof%252BCell-Cycle%252BGenes%252Bby%252BStabilizing%252BMetazoan-Specific%252BHost-Cell%252BFactor%252BHCFC1%26aulast%3DAntonova%26aufirst%3DAneliya%26date%3D2019%26volume%3D29%26issue%3D6%26spage%3D1645%26epage%3D1659.e9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Annett  Kühnel</span>, <span class="hlFld-ContribAuthor ">Daniela  Schilling</span>, <span class="hlFld-ContribAuthor ">Stephanie E.  Combs</span>, <span class="hlFld-ContribAuthor ">Bernhard  Haller</span>, <span class="hlFld-ContribAuthor ">Melissa  Schwab</span>, <span class="hlFld-ContribAuthor ">Gabriele  Multhoff</span>. </span><span class="cited-content_cbyCitation_article-title">Radiosensitization of HSF-1 Knockdown Lung Cancer Cells by Low Concentrations of Hsp90 Inhibitor NVP-AUY922. </span><span class="cited-content_cbyCitation_journal-name">Cells</span><span> <strong>2019,</strong> <em>8 </em>
                                    (10)
                                     , 1166. <a href="https://doi.org/10.3390/cells8101166" title="DOI URL">https://doi.org/10.3390/cells8101166</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cells8101166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcells8101166%26sid%3Dliteratum%253Aachs%26jtitle%3DCells%26atitle%3DRadiosensitization%252Bof%252BHSF-1%252BKnockdown%252BLung%252BCancer%252BCells%252Bby%252BLow%252BConcentrations%252Bof%252BHsp90%252BInhibitor%252BNVP-AUY922%26aulast%3DK%25C3%25BChnel%26aufirst%3DAnnett%26date%3D2019%26date%3D2019%26volume%3D8%26issue%3D10%26spage%3D1166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jelena  Dinić</span>, <span class="hlFld-ContribAuthor ">Ana  Podolski-Renić</span>, <span class="hlFld-ContribAuthor ">Mirna  Jovanović</span>, <span class="hlFld-ContribAuthor ">Loana  Musso</span>, <span class="hlFld-ContribAuthor ">Ivanka  Tsakovska</span>, <span class="hlFld-ContribAuthor ">Ilza  Pajeva</span>, <span class="hlFld-ContribAuthor ">Sabrina  Dallavalle</span>, <span class="hlFld-ContribAuthor ">Milica  Pešić</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Heat Shock Protein 90 Inhibitors Suppress P-Glycoprotein Activity and Overcome Multidrug Resistance in Cancer Cells. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2019,</strong> <em>20 </em>
                                    (18)
                                     , 4575. <a href="https://doi.org/10.3390/ijms20184575" title="DOI URL">https://doi.org/10.3390/ijms20184575</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms20184575&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms20184575%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DNovel%252BHeat%252BShock%252BProtein%252B90%252BInhibitors%252BSuppress%252BP-Glycoprotein%252BActivity%252Band%252BOvercome%252BMultidrug%252BResistance%252Bin%252BCancer%252BCells%26aulast%3DDini%25C4%2587%26aufirst%3DJelena%26date%3D2019%26date%3D2019%26volume%3D20%26issue%3D18%26spage%3D4575" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna S.  Maksimenko</span>, <span class="hlFld-ContribAuthor ">Victor P.  Kislyi</span>, <span class="hlFld-ContribAuthor ">Natalia B.  Chernysheva</span>, <span class="hlFld-ContribAuthor ">Yuri A.  Strelenko</span>, <span class="hlFld-ContribAuthor ">Yan V.  Zubavichus</span>, <span class="hlFld-ContribAuthor ">Victor N.  Khrustalev</span>, <span class="hlFld-ContribAuthor ">Marina N.  Semenova</span>, <span class="hlFld-ContribAuthor ">Victor V.  Semenov</span>. </span><span class="cited-content_cbyCitation_article-title">Effective Synthesis of 3,4-Diaryl-isoxazole-5-carboxamides and their Antiproliferative Properties. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>2019 </em>
                                    (26)
                                     , 4260-4270. <a href="https://doi.org/10.1002/ejoc.201900643" title="DOI URL">https://doi.org/10.1002/ejoc.201900643</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201900643&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201900643%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DEffective%252BSynthesis%252Bof%252B3%25252C4-Diaryl-isoxazole-5-carboxamides%252Band%252Btheir%252BAntiproliferative%252BProperties%26aulast%3DMaksimenko%26aufirst%3DAnna%2BS.%26date%3D2019%26date%3D2019%26volume%3D2019%26issue%3D26%26spage%3D4260%26epage%3D4270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pragi</span>, <span class="hlFld-ContribAuthor ">Jagdeep Singh  Dua</span>, <span class="hlFld-ContribAuthor ">Jitender  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Chalcone Ditosylates as Potent Precursor for Synthesis of Some 4,5-Disubstituted Isoxazoles with Antioxidant and Anti-inflammatory Activities. </span><span class="cited-content_cbyCitation_journal-name">Asian Journal of Chemistry</span><span> <strong>2019,</strong> <em>31 </em>
                                    (8)
                                     , 1847-1850. <a href="https://doi.org/10.14233/ajchem.2019.22077" title="DOI URL">https://doi.org/10.14233/ajchem.2019.22077</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.14233/ajchem.2019.22077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.14233%2Fajchem.2019.22077%26sid%3Dliteratum%253Aachs%26jtitle%3DAsian%2520Journal%2520of%2520Chemistry%26atitle%3DChalcone%252BDitosylates%252Bas%252BPotent%252BPrecursor%252Bfor%252BSynthesis%252Bof%252BSome%252B4%25252C5-Disubstituted%252BIsoxazoles%252Bwith%252BAntioxidant%252Band%252BAnti-inflammatory%252BActivities%26aulast%3DPragi%26date%3D2019%26date%3D2019%26volume%3D31%26issue%3D8%26spage%3D1847%26epage%3D1850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mannem Rajeswara  Reddy</span>, <span class="hlFld-ContribAuthor ">Indrapal Singh  Aidhen</span>, <span class="hlFld-ContribAuthor ">Utkarsh A.  Reddy</span>, <span class="hlFld-ContribAuthor ">Geereddy Bhanuprakash  Reddy</span>, <span class="hlFld-ContribAuthor ">Kundane  Ingle</span>, <span class="hlFld-ContribAuthor ">Sami  Mukhopadhyay</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 4-
              C
              -β-D-Glucosylated Isoliquiritigenin and Analogues for Aldose Reductase Inhibition Studies. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>2019 </em>
                                    (24)
                                     , 3937-3948. <a href="https://doi.org/10.1002/ejoc.201900413" title="DOI URL">https://doi.org/10.1002/ejoc.201900413</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201900413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201900413%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252B4-%252BC%252B-%2525CE%2525B2-D-Glucosylated%252BIsoliquiritigenin%252Band%252BAnalogues%252Bfor%252BAldose%252BReductase%252BInhibition%252BStudies%26aulast%3DReddy%26aufirst%3DMannem%2BRajeswara%26date%3D2019%26date%3D2019%26volume%3D2019%26issue%3D24%26spage%3D3937%26epage%3D3948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hande  Gunduz</span>, <span class="hlFld-ContribAuthor ">Volkan  Kumbaraci</span>, <span class="hlFld-ContribAuthor ">Yılmaz  Özkılıç</span>, <span class="hlFld-ContribAuthor ">Nurcan Ş.  Tüzün</span>, <span class="hlFld-ContribAuthor ">Naciye  Talinli</span>. </span><span class="cited-content_cbyCitation_article-title">Amberlyst‐15‐catalyzed Procedure for the Synthesis of Novel 2,4‐Dihydroxybenzoyl‐1,2,3‐triazoles and Molecular Modelling Studies for Hsp‐90 Inhibition. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2019,</strong> <em>4 </em>
                                    (24)
                                     , 7278-7283. <a href="https://doi.org/10.1002/slct.201901403" title="DOI URL">https://doi.org/10.1002/slct.201901403</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201901403&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201901403%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DAmberlyst%2525E2%252580%25259015%2525E2%252580%252590catalyzed%252BProcedure%252Bfor%252Bthe%252BSynthesis%252Bof%252BNovel%252B2%25252C4%2525E2%252580%252590Dihydroxybenzoyl%2525E2%252580%2525901%25252C2%25252C3%2525E2%252580%252590triazoles%252Band%252BMolecular%252BModelling%252BStudies%252Bfor%252BHsp%2525E2%252580%25259090%252BInhibition%26aulast%3DGunduz%26aufirst%3DHande%26date%3D2019%26date%3D2019%26volume%3D4%26issue%3D24%26spage%3D7278%26epage%3D7283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chang  Gao</span>, <span class="hlFld-ContribAuthor ">Ya-Nan  Peng</span>, <span class="hlFld-ContribAuthor ">Hai-Zhou  Wang</span>, <span class="hlFld-ContribAuthor ">Shi-Lin  Fang</span>, <span class="hlFld-ContribAuthor ">Meng  Zhang</span>, <span class="hlFld-ContribAuthor ">Qiu  Zhao</span>, <span class="hlFld-ContribAuthor ">Jing  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of Heat Shock Protein 90 as a Novel Platform for the Treatment of Cancer. </span><span class="cited-content_cbyCitation_journal-name">Current Pharmaceutical Design</span><span> <strong>2019,</strong> <em>25 </em>
                                    (8)
                                     , 849-855. <a href="https://doi.org/10.2174/1381612825666190503145944" title="DOI URL">https://doi.org/10.2174/1381612825666190503145944</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1381612825666190503145944&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1381612825666190503145944%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Pharmaceutical%2520Design%26atitle%3DInhibition%252Bof%252BHeat%252BShock%252BProtein%252B90%252Bas%252Ba%252BNovel%252BPlatform%252Bfor%252Bthe%252BTreatment%252Bof%252BCancer%26aulast%3DGao%26aufirst%3DChang%26date%3D2019%26volume%3D25%26issue%3D8%26spage%3D849%26epage%3D855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dario  Valenti</span>, <span class="hlFld-ContribAuthor ">Stanimira  Hristeva</span>, <span class="hlFld-ContribAuthor ">Dimitrios  Tzalis</span>, <span class="hlFld-ContribAuthor ">Christian  Ottmann</span>. </span><span class="cited-content_cbyCitation_article-title">Clinical candidates modulating protein-protein interactions: The fragment-based experience. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>167 </em>, 76-95. <a href="https://doi.org/10.1016/j.ejmech.2019.01.084" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.01.084</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.01.084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.01.084%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DClinical%252Bcandidates%252Bmodulating%252Bprotein-protein%252Binteractions%25253A%252BThe%252Bfragment-based%252Bexperience%26aulast%3DValenti%26aufirst%3DDario%26date%3D2019%26volume%3D167%26spage%3D76%26epage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">N. A.  Pulina</span>, <span class="hlFld-ContribAuthor ">F. V.  Sobin</span>, <span class="hlFld-ContribAuthor ">T. A.  Yushkova</span>, <span class="hlFld-ContribAuthor ">V. V.  Novikova</span>. </span><span class="cited-content_cbyCitation_article-title">Reactions of 4-aryl-N-hetaryl-2-hydroxy-4-oxobut-2-enamides with hydroxylamine and biological activity of the products. </span><span class="cited-content_cbyCitation_journal-name">Russian Chemical Bulletin</span><span> <strong>2019,</strong> <em>68 </em>
                                    (3)
                                     , 628-633. <a href="https://doi.org/10.1007/s11172-019-2466-7" title="DOI URL">https://doi.org/10.1007/s11172-019-2466-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11172-019-2466-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11172-019-2466-7%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Chemical%2520Bulletin%26atitle%3DReactions%252Bof%252B4-aryl-N-hetaryl-2-hydroxy-4-oxobut-2-enamides%252Bwith%252Bhydroxylamine%252Band%252Bbiological%252Bactivity%252Bof%252Bthe%252Bproducts%26aulast%3DPulina%26aufirst%3DN.%2BA.%26date%3D2019%26date%3D2019%26volume%3D68%26issue%3D3%26spage%3D628%26epage%3D633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tai  Wang</span>, <span class="hlFld-ContribAuthor ">Anna  Rodina</span>, <span class="hlFld-ContribAuthor ">Mark P.  Dunphy</span>, <span class="hlFld-ContribAuthor ">Adriana  Corben</span>, <span class="hlFld-ContribAuthor ">Shanu  Modi</span>, <span class="hlFld-ContribAuthor ">Monica L.  Guzman</span>, <span class="hlFld-ContribAuthor ">Daniel T.  Gewirth</span>, <span class="hlFld-ContribAuthor ">Gabriela  Chiosis</span>. </span><span class="cited-content_cbyCitation_article-title">Chaperome heterogeneity and its implications for cancer study and treatment. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2019,</strong> <em>294 </em>
                                    (6)
                                     , 2162-2179. <a href="https://doi.org/10.1074/jbc.REV118.002811" title="DOI URL">https://doi.org/10.1074/jbc.REV118.002811</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/jbc.REV118.002811&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fjbc.REV118.002811%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DChaperome%252Bheterogeneity%252Band%252Bits%252Bimplications%252Bfor%252Bcancer%252Bstudy%252Band%252Btreatment%26aulast%3DWang%26aufirst%3DTai%26date%3D2019%26volume%3D294%26issue%3D6%26spage%3D2162%26epage%3D2179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maxim  Shevtsov</span>, <span class="hlFld-ContribAuthor ">Gabriele  Multhoff</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic Implications of Heat Shock Proteins in Cancer. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 211-243. <a href="https://doi.org/10.1007/978-3-030-02254-9_11" title="DOI URL">https://doi.org/10.1007/978-3-030-02254-9_11</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-02254-9_11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-02254-9_11%26sid%3Dliteratum%253Aachs%26atitle%3DTherapeutic%252BImplications%252Bof%252BHeat%252BShock%252BProteins%252Bin%252BCancer%26aulast%3DShevtsov%26aufirst%3DMaxim%26date%3D2019%26date%3D2019%26spage%3D211%26epage%3D243%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DChaperokine%252BActivity%252Bof%252BHeat%252BShock%252BProteins%26aulast%3DAsea%26aufirst%3DAlexzander%2BA.%2BA.%26date%3D2019%26volume%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Suman  Chatterjee</span>, <span class="hlFld-ContribAuthor ">Timothy F.  Burns</span>. </span><span class="cited-content_cbyCitation_article-title">Heat Shock Protein 90 Inhibitors in Lung Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 359-395. <a href="https://doi.org/10.1007/978-3-030-03952-3_19" title="DOI URL">https://doi.org/10.1007/978-3-030-03952-3_19</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-03952-3_19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-03952-3_19%26sid%3Dliteratum%253Aachs%26atitle%3DHeat%252BShock%252BProtein%252B90%252BInhibitors%252Bin%252BLung%252BCancer%252BTherapy%26aulast%3DChatterjee%26aufirst%3DSuman%26date%3D2019%26date%3D2019%26spage%3D359%26epage%3D395%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DHeat%252BShock%252BProteins%252Bin%252BSignaling%252BPathways%26aulast%3DAsea%26aufirst%3DAlexzander%2BA.%2BA.%26date%3D2019%26volume%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mario D.  Galigniana</span>. </span><span class="cited-content_cbyCitation_article-title">HSP90-Based Heterocomplex as Essential Regulator for Cancer Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 19-45. <a href="https://doi.org/10.1007/978-3-030-23158-3_2" title="DOI URL">https://doi.org/10.1007/978-3-030-23158-3_2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-23158-3_2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-23158-3_2%26sid%3Dliteratum%253Aachs%26atitle%3DHSP90-Based%252BHeterocomplex%252Bas%252BEssential%252BRegulator%252Bfor%252BCancer%252BDisease%26aulast%3DGaligniana%26aufirst%3DMario%2BD.%26date%3D2019%26date%3D2019%26spage%3D19%26epage%3D45%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DHeat%252BShock%252BProtein%252B90%252Bin%252BHuman%252BDiseases%252Band%252BDisorders%26aulast%3DAsea%26aufirst%3DAlexzander%2BA.%2BA.%26date%3D2019%26volume%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julie  Kang</span>, <span class="hlFld-ContribAuthor ">Jun  Young Lee</span>, <span class="hlFld-ContribAuthor ">İsa  Taş</span>, <span class="hlFld-ContribAuthor ">Kunal N.  More</span>, <span class="hlFld-ContribAuthor ">Hangun  Kim</span>, <span class="hlFld-ContribAuthor ">Jeong-Hoon  Park</span>, <span class="hlFld-ContribAuthor ">Dong-Jo  Chang</span>. </span><span class="cited-content_cbyCitation_article-title">Radiosynthesis, biological evaluation and preliminary microPET study of 18F-labeled 5-resorcinolic triazolone derivative based on ganetespib targeting HSP90. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (23-24)
                                     , 3658-3664. <a href="https://doi.org/10.1016/j.bmcl.2018.10.035" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.10.035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.10.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.10.035%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DRadiosynthesis%25252C%252Bbiological%252Bevaluation%252Band%252Bpreliminary%252BmicroPET%252Bstudy%252Bof%252B18F-labeled%252B5-resorcinolic%252Btriazolone%252Bderivative%252Bbased%252Bon%252Bganetespib%252Btargeting%252BHSP90%26aulast%3DKang%26aufirst%3DJulie%26date%3D2018%26volume%3D28%26issue%3D23-24%26spage%3D3658%26epage%3D3664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div><a href="#" data-source="/pb/widgets/cited-by?doi=10.1021%2Fjm701018h&amp;widgetId=9cf770f4-a9a2-46e0-bd29-3da15bcf4ae0&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2008.51.issue-2%3Barticle%3Aarticle%3A10.1021%2Fjm701018h%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text&amp;citedByCount=309&amp;pagesCount=4&amp;pageNumber=2" title="Load more citations" class="button_primary float-right cited-by__see-more mb-5"><i aria-hidden="”true”" class="icon-angle-double-down"></i><span>Load more citations</span></a></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_null" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/medium/jm-2007-01018h_0023.gif" alt="" id="_i2" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701018h&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/medium/jm-2007-01018h_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Natural product derived Hsp90 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701018h&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/medium/jm-2007-01018h_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Purine class Hsp90 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701018h&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/medium/jm-2007-01018h_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Pyrazole class Hsp90 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701018h&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/medium/jm-2007-01018h_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. X-ray structure of <b>6</b> bound to the ATP binding site of human Hsp90α. Red spheres represent structurally conserved water molecules.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701018h&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/medium/jm-2007-01018h_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0005.jpeg" id="rightTab-gs1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Pyrazole Hsp90 Inhibitors <b>19e</b> and <b>20a</b>−<b>i</b></div><p class="last"><sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701018h&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) AcOH, BF<sub>3</sub>·OEt<sub>2</sub>, 58%; (b) BnBr, MeCN, K<sub>2</sub>CO<sub>3</sub>, 90%; (c) (CO<sub>2</sub>Et)<sub>2</sub>, NaOEt, EtOH, 94%; (d) H<sub>2</sub>NNH<sub>2</sub>, AcOH, 87%, or H<sub>2</sub>NNH<sub>2</sub>·HCl, EtOH, Δ, 81%; (e) NIS, CAN (1 mol %), MeCN, Δ, 98%; (f) 2 M NaOH, dioxane; 92%; (g) (COCl)<sub>2</sub>, DMF, DCM; (h) EtNH<sub>2</sub>·HCl, NEt<sub>3</sub>, 99%; (i) 4-formylphenylboronic acid, Pd(dppf)Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, THF, H<sub>2</sub>O, microwave, 68%; (j) 3-formylphenylboronic acid, Pd(dppf)Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, THF, H<sub>2</sub>O, microwave, 71%; (k) R1R2NH, NaCNBH<sub>3</sub>, AcOH, MeOH; (l) H<sub>2</sub>, Pd/C, AcOH.</p></p></figure><figure data-id="sch2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/medium/jm-2007-01018h_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0006.jpeg" id="rightTab-gs2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Pyrazole Hsp90 Inhibitors <b>19a</b>−<b>d</b> and <b>19f</b>−<b>g</b></div><p class="last"><sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701018h&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 4-aminomethylphenyl boronic acid, H<sub>2</sub>O, THF, Pd(dppf)Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, Boc<sub>2</sub>O, Et<sub>3</sub>N, DMF, Δ, 26%; (b) (i) TFA; (ii) NaHCO<sub>3,</sub> 95%; (c) (i) vinylmethylsulfone or divinylsulfone; (ii) BCl<sub>3</sub>, DCM; (d) (i) acetaldehyde, NaBH(OAc)<sub>3</sub>, DCE then NaBH<sub>4</sub>, EtOH; (ii) cyclohexadiene, Pd/C, MeOH, 16%; (e) (i) HATU, DMF, DIPEA, 1-methylpiperidine-3-carboxylic acid or 2-carboxymethylpyrrolidine-1-carboxylic acid, rt; (ii) BCl<sub>3</sub>, DCM; (f) (i) 2-bromoethanol, EtOH, DIPEA; (ii) BCl<sub>3</sub>, DCM, 13%.</p></p></figure><figure data-id="sch3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/medium/jm-2007-01018h_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0007.jpeg" id="rightTab-gs3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Isoxazole Hsp90 Inhibitors</div><p class="last"><sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701018h&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) H<sub>2</sub>NOH·HCl, EtOH, 86%; (b) EtNH<sub>2</sub>, MeOH, Δ, 89%; (c) NBS, CAN, MeCN, Δ, 4.5 h, 74%; (d) 4-formylphenylboronic acid, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, NaHCO<sub>3</sub>, DMF, H<sub>2</sub>O, 73%; (e) 3-formylphenylboronic acid, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, NaHCO<sub>3</sub>, DMF, H<sub>2</sub>O; (f) R1R2NH, NaCNBH<sub>3</sub>, AcOH, MeOH; (g) boronate ester, DME, NaHCO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>; (h) BCl<sub>3</sub>, DCM, 0 °C.</p></p></figure><figure data-id="sch4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/medium/jm-2007-01018h_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0008.jpeg" id="rightTab-gs4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Preparation of <b>33</b> (the Isoxazole Analogue of Pyrazole <b>6</b>)</div><p class="last"><sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701018h&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 4-methoxyphenylboronic acid, NaHCO<sub>3</sub>, H<sub>2</sub>O, DMF, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, 63%; (b) BCl<sub>3</sub>, DCM, 0 °C, 65%.</p></p></figure><figure data-id="sch5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/medium/jm-2007-01018h_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0009.jpeg" id="rightTab-gs5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Conversion of Key Intermediate <b>34</b> to Isoxazole Hsp90 Inhibitors</div><p class="last"><sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701018h&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NBS or NIS, CAN, MeCN, Δ; (b) 4-formylphenylboronic acid, NaHCO<sub>3</sub>, H<sub>2</sub>O, DMF, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>; (c) R1R2NH, NaCNBH<sub>3</sub>, AcOH, MeOH; (d) BCl<sub>3</sub>, DCM, 0 °C.</p></p></figure><figure data-id="sch6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/medium/jm-2007-01018h_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0010.jpeg" id="rightTab-gs6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Key Isoxazole Intermediates <b>34a</b>−<b>c</b> and <b>34 h</b>−<b>j</b></div><p class="last"><sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701018h&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) BnBr, K<sub>2</sub>CO<sub>3</sub>, MeCN, 97%; (b) NBS, DMF, rt, 97%; (c) (CO<sub>2</sub>Et)<sub>2</sub>, NaOEt, EtOH, 96%; (d) hydroxylamine hydrochloride, EtOH, Δ, 92%; (e) EtNH<sub>2</sub>, MeOH, Δ, 80%; (f) <i>trans</i>-2-phenylvinylboronic acid, DMF, H<sub>2</sub>O, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, NaHCO<sub>3</sub>, Δ, 71%; (g) PhB(OH)<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, H<sub>2</sub>O, THF, Pd(dppf)Cl<sub>2</sub>, Δ, 68%; (h) <i>trans</i>-2-(4-fluorophenyl)vinylboronic acid, DMF, H<sub>2</sub>O, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, NaHCO<sub>3</sub>, 69%; (i) 1,4-dioxane, Pd(C), H<sub>2</sub>; (j) (i) 3-fluorostyrene, Pd(<i>o</i>-Tol<sub>3</sub>P)<sub>2</sub>Cl<sub>2</sub>, <i>n</i>-BuOH; <i>i</i>-Pr<sub>2</sub>NH, (ii) TsNH<sub>2</sub>NH<sub>2</sub>, NaOAc, 1,2-DME, Δ, 92%.</p></p></figure><figure data-id="sch7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/medium/jm-2007-01018h_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0011.jpeg" id="rightTab-gs7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of Isoxazole <b>45</b></div><p class="last"><sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701018h&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 4-fluorophenylboronic acid, NaHCO<sub>3</sub>, H<sub>2</sub>O, DMF, Pd(dppf)Cl<sub>2</sub>, 76%; (b) BCl<sub>3</sub>, DCM, 0 °C, 65%.</p></p></figure><figure data-id="sch8" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/medium/jm-2007-01018h_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0012.jpeg" id="rightTab-gs8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Synthesis of Isoxazole Intermediate <b>34e</b></div><p class="last"><sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701018h&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) isobutyric acid, BF<sub>3</sub>·OEt<sub>2</sub> quant; (b) (i) ethylchloroformate, NEt<sub>3</sub>, THF; (ii) NaBH<sub>4</sub>, THF/H<sub>2</sub>O; (iii) 10% aq NaOH, 98%; (c) (i) AcOH, BF<sub>3</sub>·OEt<sub>2</sub>; (ii) BnBr, K<sub>2</sub>CO<sub>3</sub>, MeCN, 25%; (d) (CO<sub>2</sub>Et)<sub>2</sub>, NaOEt, EtOH, Δ, 58%; (e) hydroxylamine hydrochloride, EtOH, Δ, 74%; (f) EtNH<sub>2</sub>, MeOH, Δ, quant.</p></p></figure><figure data-id="sch9" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/medium/jm-2007-01018h_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0013.jpeg" id="rightTab-gs9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. Synthesis of Isoxazole Intermediate <b>34f</b></div><p class="last"><sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701018h&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Ph<sub>3</sub>PMeBr, <i>n</i>-BuLi, THF, 80%; (b) H<sub>2</sub>, Pd/C, EtOH, 70%; (c) AcOH, BF<sub>3</sub>·OEt<sub>2</sub>, 88%; (d) BnBr, K<sub>2</sub>CO<sub>3</sub>, DMF, 88%; (e) (CO<sub>2</sub>Et)<sub>2</sub>, NaOEt, NaH, toluene, Δ, 86%; (f) hydroxylamine hydrochloride, EtOH, Δ, 91%; (g) EtNH<sub>2</sub>, MeOH, Δ, 85%.</p></p></figure><figure data-id="sch10" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/medium/jm-2007-01018h_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0014.jpeg" id="rightTab-gs10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 10. Synthesis of Key Isoxazole Intermediates <b>34d</b> and <b>34g</b></div><p class="last"><sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701018h&amp;id=sch10"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) H<sub>2</sub>SO<sub>4</sub>, 2-methylpropan-2-ol, TFA, 75 °C, 92%; (b) AcOH, BF<sub>3</sub>·OEt<sub>2</sub>, 90 °C; (c) BnBr, K<sub>2</sub>CO<sub>3</sub>; (d) (CO<sub>2</sub>Et)<sub>2</sub>; NaOEt, EtOH; (e) H<sub>2</sub>NOH·HCl, EtOH, Δ; (f) EtNH<sub>2</sub>, MeOH, Δ.</p></p></figure><figure data-id="fig5" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/medium/jm-2007-01018h_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0019.jpeg" id="rightTab-gr21" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Overlay of X-ray structure of <b>6</b> and <b>40f</b> bound to the ATP binding site of human Hsp90α. Red spheres represent structurally conserved water molecules.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701018h&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/medium/jm-2007-01018h_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0020.jpeg" id="rightTab-gr22" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effects of 17-AAG, pyrazoles <b>6</b> and <b>19e</b>, and isoxazoles <b>30d</b>, <b>33</b>, and <b>40f</b> on expression of Raf-1, Hsp72, and Her2 in HCT116 cells as determined by western blot. Compounds were dosed for 24 h at concentrations of 1 and 2 times the GI<sub>50</sub> value. GAPDH was used as a loading control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701018h&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/medium/jm-2007-01018h_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0021.jpeg" id="rightTab-gr23" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Cassette dosing method validation, showing the compound tumor concentration 6 h post administration in mice bearing HCT116 subcutaneous human colon tumor xenografts dosed at 4 mg per kg i.p. Compounds were dosed as single agents or were cassette dosed with mixtures of five compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701018h&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/medium/jm-2007-01018h_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0022.jpeg" id="rightTab-_i25" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Response of HCT116 human colon carcinoma xenografts to <b>40f</b> therapy (50 mg/kg i.p. q.d). (A) Mean tumor volumes (therapy vs vehicle controls). (B) Mean weights of excised tumors after 12 days of therapy. Therapy/control ratio (T/C) = 49.9. (C) Mouse body weights during therapy. (D) Changes in PD markers as measured at 6, 16, and 24 h after the final dose. GAPDH was used as a loading control for the western blots.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-2/jm701018h/production/images/large/jm-2007-01018h_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701018h&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i100">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16357" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16357" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 59 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Young, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agashe, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegers, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartl, F. U.</span><span> </span><span class="NLM_article-title">Pathways of chaperone-mediated protein folding in the cytosol</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">781</span><span class="NLM_x">–</span> <span class="NLM_lpage">789</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm701018h&amp;key=10.1038%2Fnrm1492" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm701018h&amp;key=15459659" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm701018h&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotVSlsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=781-789&author=J.+C.+Youngauthor=V.+R.+Agasheauthor=K.+Siegersauthor=F.+U.+Hartl&title=Pathways+of+chaperone-mediated+protein+folding+in+the+cytosol"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Pathways of chaperone-mediated protein folding in the cytosol</span></div><div class="casAuthors">Young, Jason C.; Agashe, Vishwas R.; Siegers, Katja; Hartl, F. Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">781-791</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Cells are faced with the task of folding thousands of different polypeptides into a wide range of conformations.  For many proteins, the folding process requires the action of mol. chaperones.  In the cytosol of prokaryotic and eukaryotic cells, mol. chaperones of different structural classes form a network of pathways that can handle substrate polypeptides from the point of initial synthesis on ribosomes to the final stages of folding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozOmZCjGhXsbVg90H21EOLACvtfcHk0ljjk1SU8tLFrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotVSlsrg%253D&md5=e5b25a79128866bd17f7915dd6f42c6d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrm1492&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm1492%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DJ.%2BC.%26aulast%3DAgashe%26aufirst%3DV.%2BR.%26aulast%3DSiegers%26aufirst%3DK.%26aulast%3DHartl%26aufirst%3DF.%2BU.%26atitle%3DPathways%2520of%2520chaperone-mediated%2520protein%2520folding%2520in%2520the%2520cytosol%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2004%26volume%3D5%26spage%3D781%26epage%3D789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Mosser, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morimoto, R. I.</span><span> </span><span class="NLM_article-title">Molecular chaperones and the stress of oncogenesis</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">2907</span><span class="NLM_x">–</span> <span class="NLM_lpage">2918</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm701018h&amp;key=10.1038%2Fsj.onc.1207529" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm701018h&amp;key=15077153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm701018h&amp;key=1%3ACAS%3A528%3ADC%252BD2cXivFKmsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2004&pages=2907-2918&author=D.+D.+Mosserauthor=R.+I.+Morimoto&title=Molecular+chaperones+and+the+stress+of+oncogenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular chaperones and the stress of oncogenesis</span></div><div class="casAuthors">Mosser, Dick D.; Morimoto, Richard I.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2907-2918</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Protein-damaging stresses induce the expression of heat-shock proteins', which have essential roles in protecting cells from the potentially lethal effects of stress and proteotoxicity.  These stress-protective heat-shock proteins are often overexpressed in cells of various cancers and have been suggested to be contributing factors in tumorigenesis.  An underlying basis of oncogenesis is the acquisition and accumulation of mutations that provide the transformed cell with the combined characteristics of deregulated cell proliferation and suppressed cell death.  Heat-shock proteins with dual roles as regulators of protein conformation and stress sensors may therefore have intriguing and central roles in both cell proliferation and apoptosis.  It has been established that heat-shock proteins exhibit specificity to particular classes of polypeptide substrates and client proteins in vivo, and that chaperones can stabilize mutations that affect the folded conformation.  Likewise, overexpression of chaperones has also been shown to protect cells against apoptotic cell death.  The involvement of chaperones, therefore, in such diverse roles might suggest novel anticancer therapeutic approaches targeting heat-shock protein function for a broad spectrum of tumor types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXglApcXUKQrVg90H21EOLACvtfcHk0liaPHagkAEqnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXivFKmsLs%253D&md5=535effb8bca3679c2e29bffcb0077cc3</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1207529&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1207529%26sid%3Dliteratum%253Aachs%26aulast%3DMosser%26aufirst%3DD.%2BD.%26aulast%3DMorimoto%26aufirst%3DR.%2BI.%26atitle%3DMolecular%2520chaperones%2520and%2520the%2520stress%2520of%2520oncogenesis%26jtitle%3DOncogene%26date%3D2004%26volume%3D23%26spage%3D2907%26epage%3D2918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Whitesell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindquist, S. L.</span><span> </span><span class="NLM_article-title">HSP90 and the chaperoning of cancer</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">761</span><span class="NLM_x">–</span> <span class="NLM_lpage">772</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm701018h&amp;key=10.1038%2Fnrc1716" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm701018h&amp;key=16175177" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm701018h&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVGjs7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=761-772&author=L.+Whitesellauthor=S.+L.+Lindquist&title=HSP90+and+the+chaperoning+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">HSP90 and the chaperoning of cancer</span></div><div class="casAuthors">Whitesell, Luke; Lindquist, Susan L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">761-772</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Standing watch over the proteome, mol. chaperones are an ancient and evolutionarily conserved class of proteins that guide the normal folding, intracellular disposition and proteolytic turnover of many of the key regulators of cell growth, differentiation and survival.  This essential guardian function is subverted during oncogenesis to allow malignant transformation and to facilitate rapid somatic evolution.  Pharmacol. 'bribing' the essential guard duty of the chaperone HSP90 (heat-shock protein of 90 kDa) seems to offer a unique anticancer strategy of considerable promise.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4Vmb5bGXgDLVg90H21EOLACvtfcHk0liaPHagkAEqnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVGjs7bF&md5=c418ec249a29c70047081cd241938931</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrc1716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1716%26sid%3Dliteratum%253Aachs%26aulast%3DWhitesell%26aufirst%3DL.%26aulast%3DLindquist%26aufirst%3DS.%2BL.%26atitle%3DHSP90%2520and%2520the%2520chaperoning%2520of%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2005%26volume%3D5%26spage%3D761%26epage%3D772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Maloney, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">HSP90 as a new therapeutic target for cancer therapy: the story unfolds</span> <span class="citation_source-journal">Expert Opin. Biol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm701018h&amp;key=10.1517%2F14712598.2.1.3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm701018h&amp;key=11772336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm701018h&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsVaksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=3-24&author=A.+Maloneyauthor=P.+Workman&title=HSP90+as+a+new+therapeutic+target+for+cancer+therapy%3A+the+story+unfolds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">HSP90 as a new therapeutic target for cancer therapy: the story unfolds</span></div><div class="casAuthors">Maloney, Alison; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Biological Therapy</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-24</span>CODEN:
                <span class="NLM_cas:coden">EOBTA2</span>;
        ISSN:<span class="NLM_cas:issn">1471-2598</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review. Current anticancer drug-development strategies involve identifying novel mol. targets which are crucial for tumorigenesis.  The mol. chaperone heat-shock protein (HSP) 90 is of interest as an anticancer drug target because of its importance in maintaining the conformation, stability and function of key oncogenic client proteins involved in signal transduction pathways leading to proliferation, cell cycle progression, and apoptosis, as well as other features of the malignant phenotype such as invasion, angiogenesis and metastasis.  The natural-product HSP90 inhibitors geldanamycin and radicicol exert their antitumor effect by inhibiting the intrinsic ATPase activity of HSP90, resulting in degrdn. of HSP90 client proteins via the ubiquitin proteosome pathway.  Anticancer selectivity may derive from the simultaneous combinatorial effects of HSP90 inhibitors on multiple cancer targets and pathways. 17-Allylamino-17-demethoxygeldanamycin (17AAG) showed good activity and cancer selectivity in preclin. models and has now progressed to Phase I clin. trials in cancer patients with encouraging initial results.  Phase II trials including combination studies with cytotoxic agents are now being planned and these should allow the therapeutic activity of 17AAG to be detd.  Second-generation HSP90 inhibitors may be designed to overcome some of the drawbacks of 17AAG, including limited oral bioavailability and soly.  They could also be engineered to target specific functions of HSP90, which may not only provide greater mol. selectivity and clin. benefit but may also increase understanding of the complex functions of this mol. chaperone.  HSP90 inhibitors provide proof of concept for drugs directed at HSP90 and protein folding and this principle may be applicable to other medical conditions involving protein aggregation and stability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxpya4HhGPu7Vg90H21EOLACvtfcHk0liaPHagkAEqnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsVaksw%253D%253D&md5=b0542acde22286a95578e3ef4dac0d8e</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1517%2F14712598.2.1.3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14712598.2.1.3%26sid%3Dliteratum%253Aachs%26aulast%3DMaloney%26aufirst%3DA.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DHSP90%2520as%2520a%2520new%2520therapeutic%2520target%2520for%2520cancer%2520therapy%253A%2520the%2520story%2520unfolds%26jtitle%3DExpert%2520Opin.%2520Biol.%2520Ther.%26date%3D2002%26volume%3D2%26spage%3D3%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Kamal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, F. J.</span><span> </span><span class="NLM_article-title">Therapeutic and diagnostic implications of Hsp90 activation</span> <span class="citation_source-journal">Trends Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">283</span><span class="NLM_x">–</span> <span class="NLM_lpage">290</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=283-290&author=A.+Kamalauthor=M.+F.+Boehmauthor=F.+J.+Burrows&title=Therapeutic+and+diagnostic+implications+of+Hsp90+activation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DBoehm%26aufirst%3DM.%2BF.%26aulast%3DBurrows%26aufirst%3DF.%2BJ.%26atitle%3DTherapeutic%2520and%2520diagnostic%2520implications%2520of%2520Hsp90%2520activation%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2004%26volume%3D10%26spage%3D283%26epage%3D290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Chiosis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilenchik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solit, D.</span><span> </span><span class="NLM_article-title">Hsp90: the vulnerable chaperone</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">888</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=881-888&author=G.+Chiosisauthor=M.+Vilenchikauthor=J.+Kimauthor=D.+Solit&title=Hsp90%3A+the+vulnerable+chaperone"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChiosis%26aufirst%3DG.%26aulast%3DVilenchik%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DSolit%26aufirst%3DD.%26atitle%3DHsp90%253A%2520the%2520vulnerable%2520chaperone%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D881%26epage%3D888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Hanahan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberg, R. A.</span><span> </span><span class="NLM_article-title">The hallmarks of cancer</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm701018h&amp;key=10.1016%2FS0092-8674%2800%2981683-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm701018h&amp;key=10647931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm701018h&amp;key=1%3ACAS%3A528%3ADC%252BD3cXks1CktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2000&pages=57-70&author=D.+Hanahanauthor=R.+A.+Weinberg&title=The+hallmarks+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The hallmarks of cancer</span></div><div class="casAuthors">Hanahan, Douglas; Weinberg, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-70</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review is given with many refs. on principles governing the transformation of normal human cells into malignant cancers.  The authors suggest that research over the past decades has revealed a small no. of mol., biochem., and cellular traits (acquired capabilities) shared by most and perhaps all types of cancer.  Topics included are the acquired capabilities self-sufficiency in growth signals, insensitivity to antigrowth signals, evading apoptosis, limitless replicative potential, sustained angiogenesis, and tissue invasion and metastasis followed by genome instability as an enabling characteristic and alternative pathways to cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooXmGqKjM1C7Vg90H21EOLACvtfcHk0liGTJO1EIHKMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXks1CktA%253D%253D&md5=1d23c4400dad34c7f32d4a0c41890349</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2981683-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252981683-9%26sid%3Dliteratum%253Aachs%26aulast%3DHanahan%26aufirst%3DD.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26atitle%3DThe%2520hallmarks%2520of%2520cancer%26jtitle%3DCell%26date%3D2000%26volume%3D100%26spage%3D57%26epage%3D70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">DeBoer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meulman, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wnuk, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, D. H.</span><span> </span><span class="NLM_article-title">Geldanamycin, a new antibiotic</span> <span class="citation_source-journal">J. Antibiot. (Tokyo)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1970</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">442</span><span class="NLM_x">–</span> <span class="NLM_lpage">447</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm701018h&amp;key=10.7164%2Fantibiotics.23.442" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm701018h&amp;key=5459626" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm701018h&amp;key=1%3ACAS%3A528%3ADyaE3MXhtFyltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1970&pages=442-447&author=C.+DeBoerauthor=P.+A.+Meulmanauthor=R.+J.+Wnukauthor=D.+H.+Peterson&title=Geldanamycin%2C+a+new+antibiotic"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Geldanamycin, a new antibiotic</span></div><div class="casAuthors">De Boer, Clarence; Meulman, P. A.; Wnuk, R. J.; Peterson, Durey Harold</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antibiotics</span>
        (<span class="NLM_cas:date">1970</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">442-7</span>CODEN:
                <span class="NLM_cas:coden">JANTAJ</span>;
        ISSN:<span class="NLM_cas:issn">0021-8820</span>.
    </div><div class="casAbstract">Geldanamycin, an antibiotic isolated in cryst. form from culture filtrates of Streptomyces hygroscopicus, was moderately active in vitro against protozoa, bacteria, and fungi.  Geldanamycin was also active against L-1210 and KB tumor cells growing in culture and against the parasite Syphacia obvelata in vivo.  Phys. and chem. properties indicated that geldanamycin is a complex mol. consisting of an unsatd. moiety attached to a quinone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpu-1yq8CsQ5bVg90H21EOLACvtfcHk0liGTJO1EIHKMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3MXhtFyltQ%253D%253D&md5=c3b43c17ee1cdafdf44ffbe0ae1348f7</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.7164%2Fantibiotics.23.442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7164%252Fantibiotics.23.442%26sid%3Dliteratum%253Aachs%26aulast%3DDeBoer%26aufirst%3DC.%26aulast%3DMeulman%26aufirst%3DP.%2BA.%26aulast%3DWnuk%26aufirst%3DR.%2BJ.%26aulast%3DPeterson%26aufirst%3DD.%2BH.%26atitle%3DGeldanamycin%252C%2520a%2520new%2520antibiotic%26jtitle%3DJ.%2520Antibiot.%2520%2528Tokyo%2529%26date%3D1970%26volume%3D23%26spage%3D442%26epage%3D447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Supko, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grever, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malspeis, L.</span><span> </span><span class="NLM_article-title">Preclinical pharmacologic evaluation of geldanamycin as an antitumor agent</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">305</span><span class="NLM_x">–</span> <span class="NLM_lpage">315</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm701018h&amp;key=10.1007%2FBF00689048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm701018h&amp;key=7628050" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm701018h&amp;key=1%3ACAS%3A528%3ADyaK2MXnsFShtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1995&pages=305-315&author=J.+G.+Supkoauthor=R.+L.+Hickmanauthor=M.+R.+Greverauthor=L.+Malspeis&title=Preclinical+pharmacologic+evaluation+of+geldanamycin+as+an+antitumor+agent"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical pharmacologic evaluation of geldanamycin as an antitumor agent</span></div><div class="casAuthors">Supko, Jeffrey G.; Hickman, Robert L.; Grever, Michael R.; Malspeis, Louis</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">305-15</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The plasma pharmacokinetics of the antitumor antibiotic geldanamycin (GM; NSC 122750), a naturally occurring benzoquinoid ansamycin, were characterized in mice and a beagle dog.  Concns. of GM well above 0.1 μg/mL, which were typically effective against neoplastic cell lines responsive to the drug in vitro, were achieved in the plasma of the mice and the dog treated by i.v. injection.  However, the systemic duration of the drug was relatively short.  Plasma levels decayed to <0.1 μg/mL within 3-4 h after administration of the apparent max. tolerated doses, which were approx. 20 mg/kg for the mice and 4 mg/kg for the dog.  The drug exhibited linear pharmacokinetic behavior within the dose ranges studied.  However, there were significant interspecies differences in its disposition.  Whereas the mean biol. half-life of GM was slightly longer in the mice (77.7 min) than in the dog (57.9 min), its mean residence time in the dog (46.6 min) was >2-fold greater than that in the mice (20.7 min).  Nevertheless, the drug was cleared from plasma much faster by the dog (49.4 mL/min/kg) than by the mice (30.5 mL/min/kg).  These apparent anomalies were principally assocd. with differences in the relative significance of the terminal phase upon overall drug disposition.  The liver appeared to be the principal target organ of acute drug toxicity in the dog.  Doses of 2.0 and 4.2 mg/kg both produced elevations in serum levels of the transaminases and other indicators of liver function characteristic of acute hepatic necrosis.  Addnl. effects included symptoms of minor gastrointestinal toxicity and alterations in serum chem. parameters consistent with less severe nephrotoxicity.  The drug-related toxicity appeared to be reversible.  In consideration of the potential for acute hepatotoxic reactions to GM, as well as to the other benzoquinoid ansamycins based upon structural analogy, addnl. pharmacol. and therapeutic information is required to ascertain whether these compds. are viable candidates for clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9-P4wBmA1f7Vg90H21EOLACvtfcHk0liGTJO1EIHKMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXnsFShtLs%253D&md5=cde4aa9e616ff38b67dafed67b05d174</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1007%2FBF00689048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00689048%26sid%3Dliteratum%253Aachs%26aulast%3DSupko%26aufirst%3DJ.%2BG.%26aulast%3DHickman%26aufirst%3DR.%2BL.%26aulast%3DGrever%26aufirst%3DM.%2BR.%26aulast%3DMalspeis%26aufirst%3DL.%26atitle%3DPreclinical%2520pharmacologic%2520evaluation%2520of%2520geldanamycin%2520as%2520an%2520antitumor%2520agent%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D1995%26volume%3D36%26spage%3D305%26epage%3D315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Neckers, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulte, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mimnaugh, E.</span><span> </span><span class="NLM_article-title">Geldanamycin as a potential anti-cancer agent: its molecular target and biochemical activity</span> <span class="citation_source-journal">Invest. New Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">361</span><span class="NLM_x">–</span> <span class="NLM_lpage">373</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm701018h&amp;key=10.1023%2FA%3A1006382320697" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm701018h&amp;key=10759403" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm701018h&amp;key=1%3ACAS%3A528%3ADC%252BD3cXisFShtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1999&pages=361-373&author=L.+Neckersauthor=T.+W.+Schulteauthor=E.+Mimnaugh&title=Geldanamycin+as+a+potential+anti-cancer+agent%3A+its+molecular+target+and+biochemical+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Geldanamycin as a potential anticancer agent: Its molecular target and biochemical activity</span></div><div class="casAuthors">Neckers, Len; Schulte, Theodor W.; Mimnaugh, Edward</div><div class="citationInfo"><span class="NLM_cas:title">Investigational New Drugs</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">361-373</span>CODEN:
                <span class="NLM_cas:coden">INNDDK</span>;
        ISSN:<span class="NLM_cas:issn">0167-6997</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">A review with 116 refs. Heat shock protein 90 (Hsp90) is one of the most abundant cellular proteins.  Although its functions are still being characterized, it appears to serve as a chaperone for a growing list of cell signaling proteins, including many tyrosine and serine/threonine kinases, involved in proliferation and/or survival.  The benzoquinone ansamycin geldanamycin has been shown to bind to Hsp90 and to specifically inhibit this chaperone's function, resulting in client protein destabilization.  Its ability to simultaneously stimulate depletion of multiple oncogenic proteins suggests that geldanamycin, or other mols. capable of targeting Hsp90 in cancer cells, may be of clin. benefit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruKnQUuvE6HLVg90H21EOLACvtfcHk0lgebrD1J7FlFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXisFShtb0%253D&md5=bb021e72d31a0f93d17aefc88c8da725</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1023%2FA%3A1006382320697&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1006382320697%26sid%3Dliteratum%253Aachs%26aulast%3DNeckers%26aufirst%3DL.%26aulast%3DSchulte%26aufirst%3DT.%2BW.%26aulast%3DMimnaugh%26aufirst%3DE.%26atitle%3DGeldanamycin%2520as%2520a%2520potential%2520anti-cancer%2520agent%253A%2520its%2520molecular%2520target%2520and%2520biochemical%2520activity%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D1999%26volume%3D17%26spage%3D361%26epage%3D373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Delmotte, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delmotte-Plaque, J.</span><span> </span><span class="NLM_article-title">A new antifungal substance of fungal origin</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1953</span><span class="NLM_x">, </span> <span class="NLM_volume">171</span><span class="NLM_x">, </span> <span class="NLM_fpage">344</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=1953&pages=344&author=P.+Delmotteauthor=J.+Delmotte-Plaque&title=A+new+antifungal+substance+of+fungal+origin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDelmotte%26aufirst%3DP.%26aulast%3DDelmotte-Plaque%26aufirst%3DJ.%26atitle%3DA%2520new%2520antifungal%2520substance%2520of%2520fungal%2520origin%26jtitle%3DNature%26date%3D1953%26volume%3D171%26spage%3D344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Soga, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiotsu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akinaga, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S. V.</span><span> </span><span class="NLM_article-title">Development of radicicol analogues</span> <span class="citation_source-journal">Curr. Cancer Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">369</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm701018h&amp;key=10.2174%2F1568009033481859" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm701018h&amp;key=14529387" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm701018h&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnsV2is74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=359-369&author=S.+Sogaauthor=Y.+Shiotsuauthor=S.+Akinagaauthor=S.+V.+Sharma&title=Development+of+radicicol+analogues"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Development of radicicol analogues</span></div><div class="casAuthors">Soga, Shiro; Shiotsu, Yukimasa; Akinaga, Shiro; Sharma, Sreenath V.</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">359-369</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Radicicol, a macrocyclic antibiotic produced by fungi, was originally isolated many years ago, and was described as tyrosine kinase inhibitor.  We also rediscovered radicicol as an inhibitor of signal transduction of oncogene products, such as K-ras and v-Src, using yeast and mammalian cell-based assays.  In a study of mechanisms of action, it was revealed that radicicol depletes the Hsp90 client signaling mols. in cells, and thus inhibit the signal transduction pathway.  In addn., direct binding of radicicol to the N-terminal ATP/ADP binding site of Hsp90 was shown, and thus radicicol has been recognized as a structurally unique antibiotic that binds and inhibits the mol. chaperone Hsp90.  Although radicicol itself has little or no activity in animals because of instability in animals, its oxime derivs. showed potent antitumor activities against human tumor xenograft models.  Hsp90 client proteins were depleted and apoptosis was induced in the tumor specimen treated with radicicol oxime derivs.  Taken together, these results suggest that the antitumor activity of radicicol oxime derivs. is mediated by binding to Hsp90 and destabilization of Hsp90 client proteins in the tumor.  Among Hsp90 clients, we focused on ErbB2 and Bcr-Abl as examples of important targets of Hsp90 inhibitors.  Radicicol oxime showed potent antitumor activity against ER neg./ErbB2 overexpressing breast cancer and Bcr-Abl expressing CML.  Putative mechanisms of action and future directions of radicicol oxime against these kinds of tumor are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-uapkd0TYQrVg90H21EOLACvtfcHk0lgebrD1J7FlFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnsV2is74%253D&md5=59ef4ec5535cec06665a164be0b12305</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2174%2F1568009033481859&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568009033481859%26sid%3Dliteratum%253Aachs%26aulast%3DSoga%26aufirst%3DS.%26aulast%3DShiotsu%26aufirst%3DY.%26aulast%3DAkinaga%26aufirst%3DS.%26aulast%3DSharma%26aufirst%3DS.%2BV.%26atitle%3DDevelopment%2520of%2520radicicol%2520analogues%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2003%26volume%3D3%26spage%3D359%26epage%3D369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Pearl, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodromou, C.</span><span> </span><span class="NLM_article-title">Structure and mechanism of the Hsp90 molecular chaperone machinery</span> <span class="citation_source-journal">Annu. Rev. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">271</span><span class="NLM_x">–</span> <span class="NLM_lpage">294</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm701018h&amp;key=10.1146%2Fannurev.biochem.75.103004.142738" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm701018h&amp;key=16756493" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm701018h&amp;key=1%3ACAS%3A528%3ADC%252BD28XosVKhs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2006&pages=271-294&author=L.+H.+Pearlauthor=C.+Prodromou&title=Structure+and+mechanism+of+the+Hsp90+molecular+chaperone+machinery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and mechanism of the Hsp90 molecular chaperone machinery</span></div><div class="casAuthors">Pearl, Laurence H.; Prodromou, Chrisostomos</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">271-294</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Heat-shock protein 90 (Hsp90) is a mol. chaperone essential for activating many signaling proteins in the eukaryotic cell.  Biochem. and structural anal. of Hsp90 has revealed a complex mechanism of ATPase-coupled conformational changes and interactions with cochaperone proteins, which facilitate activation of Hsp90's diverse "clientele.".  Despite recent progress, key aspects of the ATPase-coupled mechanism of Hsp90 remain controversial, and the nature of the changes, engendered by Hsp90 in client proteins, is largely unknown.  Here, the authors discuss present knowledge of Hsp90 structure and function gleaned from crystallog. studies of individual domains and recent progress in obtaining a structure for the ATP-bound conformation of the intact dimeric chaperone.  Addnl., the authors describe the roles of the plethora of cochaperones with which Hsp90 cooperates and growing insights into their biochem. mechanisms, which come from crystal structures of Hsp90-cochaperone complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1Aa7D8Mk_qbVg90H21EOLACvtfcHk0lgebrD1J7FlFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XosVKhs78%253D&md5=a954553202a2a81fce297ac6a8378c67</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.75.103004.142738&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.75.103004.142738%26sid%3Dliteratum%253Aachs%26aulast%3DPearl%26aufirst%3DL.%2BH.%26aulast%3DProdromou%26aufirst%3DC.%26atitle%3DStructure%2520and%2520mechanism%2520of%2520the%2520Hsp90%2520molecular%2520chaperone%2520machinery%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2006%26volume%3D75%26spage%3D271%26epage%3D294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Obermann, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sondermann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russo, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavletich, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartl, F. U.</span><span> </span><span class="NLM_article-title">In vivo function of Hsp90 is dependent on ATP binding and ATP hydrolysis</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">901</span><span class="NLM_x">–</span> <span class="NLM_lpage">910</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=1998&pages=901-910&author=W.+M.+Obermannauthor=H.+Sondermannauthor=A.+A.+Russoauthor=N.+P.+Pavletichauthor=F.+U.+Hartl&title=In+vivo+function+of+Hsp90+is+dependent+on+ATP+binding+and+ATP+hydrolysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DObermann%26aufirst%3DW.%2BM.%26aulast%3DSondermann%26aufirst%3DH.%26aulast%3DRusso%26aufirst%3DA.%2BA.%26aulast%3DPavletich%26aufirst%3DN.%2BP.%26aulast%3DHartl%26aufirst%3DF.%2BU.%26atitle%3DIn%2520vivo%2520function%2520of%2520Hsp90%2520is%2520dependent%2520on%2520ATP%2520binding%2520and%2520ATP%2520hydrolysis%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D1998%26volume%3D143%26spage%3D901%26epage%3D910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Panaretou, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodromou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roe, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladbury, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piper, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearl, L. H.</span><span> </span><span class="NLM_article-title">ATP binding and hydrolysis are essential to the function of the Hsp90 molecular chaperone in vivo</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">4829</span><span class="NLM_x">–</span> <span class="NLM_lpage">4836</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1998&pages=4829-4836&author=B.+Panaretouauthor=C.+Prodromouauthor=S.+M.+Roeauthor=R.+O%E2%80%99Brienauthor=J.+E.+Ladburyauthor=P.+W.+Piperauthor=L.+H.+Pearl&title=ATP+binding+and+hydrolysis+are+essential+to+the+function+of+the+Hsp90+molecular+chaperone+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPanaretou%26aufirst%3DB.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DRoe%26aufirst%3DS.%2BM.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DR.%26aulast%3DLadbury%26aufirst%3DJ.%2BE.%26aulast%3DPiper%26aufirst%3DP.%2BW.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26atitle%3DATP%2520binding%2520and%2520hydrolysis%2520are%2520essential%2520to%2520the%2520function%2520of%2520the%2520Hsp90%2520molecular%2520chaperone%2520in%2520vivo%26jtitle%3DEMBO%2520J.%26date%3D1998%26volume%3D17%26spage%3D4829%26epage%3D4836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Roe, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodromou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladbury, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piper, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearl, L. H.</span><span> </span><span class="NLM_article-title">Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">260</span><span class="NLM_x">–</span> <span class="NLM_lpage">266</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm980403y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=260-266&author=S.+M.+Roeauthor=C.+Prodromouauthor=R.+O%E2%80%99Brienauthor=J.+E.+Ladburyauthor=P.+W.+Piperauthor=L.+H.+Pearl&title=Structural+basis+for+inhibition+of+the+Hsp90+molecular+chaperone+by+the+antitumor+antibiotics+radicicol+and+geldanamycin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm980403y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980403y%26sid%3Dliteratum%253Aachs%26aulast%3DRoe%26aufirst%3DS.%2BM.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DR.%26aulast%3DLadbury%26aufirst%3DJ.%2BE.%26aulast%3DPiper%26aufirst%3DP.%2BW.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26atitle%3DStructural%2520basis%2520for%2520inhibition%2520of%2520the%2520Hsp90%2520molecular%2520chaperone%2520by%2520the%2520antitumor%2520antibiotics%2520radicicol%2520and%2520geldanamycin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D260%26epage%3D266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neckers, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, N.</span><span> </span><span class="NLM_article-title">Drugging the cancer chaperone HSP90: combinatorial therapeutic exploitation of oncogene addiction and tumor stress</span> <span class="citation_source-journal">Ann. N. Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">1113</span><span class="NLM_x">, </span> <span class="NLM_fpage">202</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm701018h&amp;key=10.1196%2Fannals.1391.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm701018h&amp;key=17513464" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm701018h&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVanurfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1113&publication_year=2007&pages=202-216&author=P.+Workmanauthor=F.+Burrowsauthor=L.+Neckersauthor=N.+Rosen&title=Drugging+the+cancer+chaperone+HSP90%3A+combinatorial+therapeutic+exploitation+of+oncogene+addiction+and+tumor+stress"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Drugging the cancer chaperone HSP90: combinatorial therapeutic expolitation on oncogene addiction and tumor stress</span></div><div class="casAuthors">Workman, Paul; Burrows, Francis; Neckers, Len; Rosen, Neal</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">1113</span>
        (<span class="NLM_cas:issue">Stress Responses in Biology and Medicine</span>),
    <span class="NLM_cas:pages">202-216</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing, Inc.</span>)
        </div><div class="casAbstract">A review.  The mol. chaperone HSP90 has emerged as an exciting target for cancer treatment.  We review the potential advantages of HSP90 inhibitors, particularly the simultaneous combinatorial depletion of multiple oncogenic "client" proteins, leading to blockade of many cancer-causing pathways and the antagonism of all of the hallmark pathol. traits of malignancy.  Cancer selectivity is achieved by exploiting cancer "dependencies," including oncogene addiction and the stressed state of malignant cells.  The multiple downstream effects of HSP90 inhibitors should make the development of resistance more difficult than with agents having more restricted effects.  We review the various classes of HSP90 inhibitor that have been developed, including the natural products geldanamycin and radicicol and also the purine scaffold and pyrazole/isoxazole class of synthetic small mol. inhibitors.  A first-in-class HSP90 drug, the geldanamycin analog 17-AAG, has provided proof of concept for HSP90 inhibition in patients at well tolerated doses and therapeutic activity has been seen.  Other inhibitors show promise in preclin. and clin. development.  Opportunities and challenges for HSP90 inhibitors are discussed, including use in combination with other agents.  Most of the current HSP90 inhibitors act by blocking the essential nucleotide binding and ATPase activity required for chaperone function.  Potential new approaches are discussed, for example, interference with cochaperone binding and function in the superchaperone complex.  Biomarkers for use with HSP90 inhibitors are described.  We stress how basic and translational research has been mutually beneficial and indicate future directions to enhance our understanding of mol. chaperones and their exploitation in cancer and other diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoi_I-DGevqj7Vg90H21EOLACvtfcHk0ljfqIJ-B0SL7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVanurfF&md5=a537c5d947847c6b3cdf613968214623</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1196%2Fannals.1391.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1196%252Fannals.1391.012%26sid%3Dliteratum%253Aachs%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DBurrows%26aufirst%3DF.%26aulast%3DNeckers%26aufirst%3DL.%26aulast%3DRosen%26aufirst%3DN.%26atitle%3DDrugging%2520the%2520cancer%2520chaperone%2520HSP90%253A%2520combinatorial%2520therapeutic%2520exploitation%2520of%2520oncogene%2520addiction%2520and%2520tumor%2520stress%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2007%26volume%3D1113%26spage%3D202%26epage%3D216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Schulte, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neckers, L. M.</span><span> </span><span class="NLM_article-title">The benzoquinone ansamycin 17-allylamino17-demethoxygeldanamycin binds to HSP90 and shares important biologic activities with geldanamycin</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">273</span><span class="NLM_x">–</span> <span class="NLM_lpage">279</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm701018h&amp;key=10.1007%2Fs002800050817" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm701018h&amp;key=9744771" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm701018h&amp;key=1%3ACAS%3A528%3ADyaK1cXls1Wlt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1998&pages=273-279&author=T.+W.+Schulteauthor=L.+M.+Neckers&title=The+benzoquinone+ansamycin+17-allylamino17-demethoxygeldanamycin+binds+to+HSP90+and+shares+important+biologic+activities+with+geldanamycin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The benzoquinone ansamycin 17-allylamino-17-demethoxygeldanamycin binds to HSP90 and shares important biologic activities with geldanamycin</span></div><div class="casAuthors">Schulte, Theodor W.; Neckers, Leonard M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">273-279</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Binding of 17-allylamino-17-demethoxygeldanamycin (17-AG) to the heat-shock protein HSP90 was studied in vitro using a geldanamycin (GA)-affinity beads competition assay.  The drug-induced destabilization was studied of p185erbB2, Raf-1, and mutant p53 in SKBR3 breast cancer cells by Western blotting.  The antiproliferative activities of 17-AG and GA were compared using the MTT assay.  The 17-AG bound specifically to HSP90 in a similar manner as GA itself.  It also led to degrdn. of the receptor Tyr kinase p185erbB2, the Ser/Thr kinase Raf-1, and mutant p53.  GA and 17-AG displayed comparable antiproliferative effects in SKBR3 and MCF7 cells.  Even though HSP90 binding with 17-AG was weaker than by GA, 17-AG and GA caused biol. effects in tumor cells at similar doses.  Since 17-AG had a better toxicity profile than GA, it was suggested as benzoquinone ansamycin candidate for clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouj3pMDUB7kLVg90H21EOLACvtfcHk0ljfqIJ-B0SL7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXls1Wlt7Y%253D&md5=3d6ac0592b10d66b391f824272523de2</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1007%2Fs002800050817&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002800050817%26sid%3Dliteratum%253Aachs%26aulast%3DSchulte%26aufirst%3DT.%2BW.%26aulast%3DNeckers%26aufirst%3DL.%2BM.%26atitle%3DThe%2520benzoquinone%2520ansamycin%252017-allylamino17-demethoxygeldanamycin%2520binds%2520to%2520HSP90%2520and%2520shares%2520important%2520biologic%2520activities%2520with%2520geldanamycin%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D1998%26volume%3D42%26spage%3D273%26epage%3D279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Banerji, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scurr, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stapleton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asad, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmons, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloney, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lakhani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaye, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judson, I.</span><span> </span><span class="NLM_article-title">Phase I pharmacokinetic and pharmacodynamic study of 17-allylamino, 17-demethoxygeldanamycin in patients with advanced malignancies</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4152</span><span class="NLM_x">–</span> <span class="NLM_lpage">4161</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm701018h&amp;key=10.1200%2FJCO.2005.00.612" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm701018h&amp;key=15961763" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm701018h&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmt1elsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=4152-4161&author=U.+Banerjiauthor=A.+O%E2%80%99Donnellauthor=M.+Scurrauthor=S.+Paceyauthor=S.+Stapletonauthor=Y.+Asadauthor=L.+Simmonsauthor=A.+Maloneyauthor=F.+Raynaudauthor=M.+Campbellauthor=M.+Waltonauthor=S.+Lakhaniauthor=S.+Kayeauthor=P.+Workmanauthor=I.+Judson&title=Phase+I+pharmacokinetic+and+pharmacodynamic+study+of+17-allylamino%2C+17-demethoxygeldanamycin+in+patients+with+advanced+malignancies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I pharmacokinetic and pharmacodynamic study of 17-allylamino, 17-demethoxygeldanamycin in patients with advanced malignancies</span></div><div class="casAuthors">Banerji, Udai; O'Donnell, Anne; Scurr, Michelle; Pacey, Simon; Stapleton, Sarah; Asad, Yasmin; Simmons, Laura; Maloney, Alison; Raynaud, Florence; Campbell, Maeli; Walton, Michael; Lakhani, Sunil; Kaye, Stanley; Workman, Paul; Judson, Ian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4152-4161</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose: To study the toxicity and pharmacokinetic-pharmacodynamic profile of 17-allylamino, 17-demethoxygeldanamycin (17-AAG) and to recommend a dose for phase II trials.  Patients and Methods: This was a phase I study examg. a once-weekly dosing schedule of 17-AAG.  Thirty patients with advanced malignancies were treated.  Results: The highest dose level reached was 450 mg/m2/wk.  The dose-limiting toxicities (DLTs) encountered were grade 3 diarrhea in three patients (one at 320 mg/m2/wk and two at 450 mg/m2/wk) and grade 3 to 4 hepatotoxicity (AST/ALT) in one patient at 450 mg/m2/wk.  Two of nine DLTs were at the highest dose level.  Two patients with metastatic melanoma had stable disease and were treated for 15 and 41 mo, resp.  The dose vs. area under the curve-relationship for 17-AAG was linear (r2 = .71) over the dose range 10 to 450 mg/m2/wk, with peak plasma concns. of 8,998 μg/L (std. deviation, 2,881) at the highest dose level.  After the demonstration of pharmacodynamic changes in peripheral blood leukocytes, pre- and 24 h post-treatment, tumor biopsies were performed and demonstrated target inhibition (c-RAF-1 inhibition in four of six patients, CDK4 depletion in eight of nine patients and HSP70 induction in eight of nine patients) at the dose levels 320 and 450 mg/m2/wk.  It was not possible to reproducibly demonstrate these changes in biopsies taken 5 days after treatment.  Conclusion: It has been possible to demonstrate that 17-AAG exhibits a tolerable toxicity profile with therapeutic plasma concns. and target inhibition for 24 h after treatment and some indications of clin. activity at the dose level 450 mg/m2/wk.  We recommend this dose for phase II clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaKgFbodgT_bVg90H21EOLACvtfcHk0liq9CEHCqk8Sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmt1elsrY%253D&md5=6ba10e24a68a1d9bd09d87239eea1ca6</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1200%2FJCO.2005.00.612&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2005.00.612%26sid%3Dliteratum%253Aachs%26aulast%3DBanerji%26aufirst%3DU.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DA.%26aulast%3DScurr%26aufirst%3DM.%26aulast%3DPacey%26aufirst%3DS.%26aulast%3DStapleton%26aufirst%3DS.%26aulast%3DAsad%26aufirst%3DY.%26aulast%3DSimmons%26aufirst%3DL.%26aulast%3DMaloney%26aufirst%3DA.%26aulast%3DRaynaud%26aufirst%3DF.%26aulast%3DCampbell%26aufirst%3DM.%26aulast%3DWalton%26aufirst%3DM.%26aulast%3DLakhani%26aufirst%3DS.%26aulast%3DKaye%26aufirst%3DS.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DJudson%26aufirst%3DI.%26atitle%3DPhase%2520I%2520pharmacokinetic%2520and%2520pharmacodynamic%2520study%2520of%252017-allylamino%252C%252017-demethoxygeldanamycin%2520in%2520patients%2520with%2520advanced%2520malignancies%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2005%26volume%3D23%26spage%3D4152%26epage%3D4161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Goetz, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toft, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ames, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stensgard, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Safgren, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adjei, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sloan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atherton, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasile, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salazaar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adjei, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croghan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erlichman, C.</span><span> </span><span class="NLM_article-title">Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1078</span><span class="NLM_x">–</span> <span class="NLM_lpage">1087</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm701018h&amp;key=10.1200%2FJCO.2005.09.119" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm701018h&amp;key=15718306" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm701018h&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitl2gtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=1078-1087&author=M.+P.+Goetzauthor=D.+Toftauthor=J.+Reidauthor=M.+Amesauthor=B.+Stensgardauthor=S.+Safgrenauthor=A.+A.+Adjeiauthor=J.+Sloanauthor=P.+Athertonauthor=V.+Vasileauthor=S.+Salazaarauthor=A.+Adjeiauthor=G.+Croghanauthor=C.+Erlichman&title=Phase+I+trial+of+17-allylamino-17-demethoxygeldanamycin+in+patients+with+advanced+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer</span></div><div class="casAuthors">Goetz, Matthew P.; Toft, David; Reid, Joel; Ames, Matthew; Stensgard, Bridget; Safgren, Stephanie; Adjei, Araba A.; Sloan, Jeff; Atherton, Pamela; Vasile, Vlad; Salazaar, Sandra; Adjei, Alex; Croghan, Gary; Erlichman, Charles</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1078-1087</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose We detd. the max.-tolerated dose (MTD) and the dose-limiting toxicities (DLT) of 17-allylamino-17-demethoxygeldanamycin (17-AAG) when infused on days 1, 8, and 15 of a 28-day cycle in advanced solid tumor patients.  We also characterized the pharmacokinetics of 17-AAG, its effect on chaperone and client proteins, and whether cytochrome P 450 (CYP) 3A5 and NAD(P)H:quinone oxidoreductase 1 (NQO1) polymorphisms affected 17-AAG disposition or toxicity.  Patients and Methods An accelerated titrn. design was used.  Biomarkers were measured in peripheral-blood mononuclear cells (PBMCs) at baseline and on days 1 and 15, and pharmacokinetic anal. was performed on day 1 of cycle 1.  CYP3A5*3 and NQO1*2 genotypes were detd. and correlated with pharmacokinetics and toxicity.  Results Twenty-one patients received 52 courses at 11 dose levels.  DLTs at 431 mg/m2 were grade 3 bilirubin (n = 1), AST (n = 1), anemia (n = 1), nausea (n = 1), vomiting (n = 1), and myalgias (n = 1).  No tumor responses were seen.  17-AAG consistently increased heat shock protein (Hsp) 70 levels in PBMCs.  At the MTD, the clearance and half-life (t1/2) of 17-AAG were 11.6 L/h/m2 and 4.15 h, resp.; whereas the active metabolite 17-aminogeldanamycin had a t1/2 of 7.63 h.  The CYP3A5*3 and NQO1*2 polymorphisms were not assocd. with 17-AAG toxicity.  The CYP3A5*3 polymorphism was assocd. with higher 17-AAG clearance.  Conclusion The MTD of weekly 17-AAG is 308 mg/m2.  17-AAG induced Hsp70 in PBMCs, indicating that Hsp90 has been affected.  Further evaluation of 17-AAG is ongoing using a twice-weekly regimen, and this schedule of 17-AAG is being tested in combination with chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFPRrruDVbcLVg90H21EOLACvtfcHk0liq9CEHCqk8Sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitl2gtbw%253D&md5=b4ea280cb99c9977e6fa4bdb5f6efc06</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1200%2FJCO.2005.09.119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2005.09.119%26sid%3Dliteratum%253Aachs%26aulast%3DGoetz%26aufirst%3DM.%2BP.%26aulast%3DToft%26aufirst%3DD.%26aulast%3DReid%26aufirst%3DJ.%26aulast%3DAmes%26aufirst%3DM.%26aulast%3DStensgard%26aufirst%3DB.%26aulast%3DSafgren%26aufirst%3DS.%26aulast%3DAdjei%26aufirst%3DA.%2BA.%26aulast%3DSloan%26aufirst%3DJ.%26aulast%3DAtherton%26aufirst%3DP.%26aulast%3DVasile%26aufirst%3DV.%26aulast%3DSalazaar%26aufirst%3DS.%26aulast%3DAdjei%26aufirst%3DA.%26aulast%3DCroghan%26aufirst%3DG.%26aulast%3DErlichman%26aufirst%3DC.%26atitle%3DPhase%2520I%2520trial%2520of%252017-allylamino-17-demethoxygeldanamycin%2520in%2520patients%2520with%2520advanced%2520cancer%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2005%26volume%3D23%26spage%3D1078%26epage%3D1087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Weigel, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaney, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Safgren, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bagatell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kersey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neglia, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivy, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingle, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitesell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbertson, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krailo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ames, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adamson, P. C.</span><span> </span><span class="NLM_article-title">A phase I study of 17-allylaminogeldanamycin in relapsed/refractory pediatric patients with solid tumors: a children’s oncology group study</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1789</span><span class="NLM_x">–</span> <span class="NLM_lpage">1793</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm701018h&amp;key=10.1158%2F1078-0432.CCR-06-2270" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm701018h&amp;key=17363534" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm701018h&amp;key=1%3ACAS%3A528%3ADC%252BD2sXivV2gtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=1789-1793&author=B.+J.+Weigelauthor=S.+M.+Blaneyauthor=J.+M.+Reidauthor=S.+L.+Safgrenauthor=R.+Bagatellauthor=J.+Kerseyauthor=J.+P.+Negliaauthor=S.+P.+Ivyauthor=A.+M.+Ingleauthor=L.+Whitesellauthor=R.+J.+Gilbertsonauthor=M.+Krailoauthor=M.+Amesauthor=P.+C.+Adamson&title=A+phase+I+study+of+17-allylaminogeldanamycin+in+relapsed%2Frefractory+pediatric+patients+with+solid+tumors%3A+a+children%E2%80%99s+oncology+group+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">A phase I study of 17-allylaminogeldanamycin in relapsed/refractory pediatric patients with solid tumors: a children's oncology group Study</span></div><div class="casAuthors">Weigel, Brenda J.; Blaney, Susan M.; Reid, Joel M.; Safgren, Stephanie L.; Bagatell, Rochelle; Kersey, John; Neglia, Joseph P.; Ivy, S. Percy; Ingle, Ashish M.; Whitesell, Luke; Gilbertson, Richard J.; Krailo, Mark; Ames, Matthew; Adamson, Peter C.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1789-1793</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">To det. the recommended phase 2 dose, dose-limiting toxicities (DLT), pharmacokinetic profile, and pharmacodynamics of the heat shock protein (Hsp) 90 inhibitor, 17-allylaminogeldanamycin (17-AAG).  17-AAG was administered as a 60-min infusion, on days 1, 4, 8, and 11 of a 21-day cycle at dose levels of 150, 200, 270, and 360 mg/m2/dose.  Pharmacokinetic studies and evaluations for Hsp72 and Akt levels in peripheral blood mononuclear cells were done during the first course of therapy.  Seventeen patients (7 males), median 7 years of age (range, 1-19 years), were enrolled using a std. dose escalation scheme.  No DLTs were obsd.  Although there were no objective responses, three patients remain on therapy at 6+, 7+, and 9+ months with stable disease.  One patient with hepatoblastoma had a redn. in α-fetoprotein and stable disease over three cycles.  At 270 mg/m2/dose, the Cmax and areas under the plasma concn.-time curves of 17-AAG were 5,303 ± 1,591 ng/mL and 13,656 ± 4,757 ng/mL h, resp., similar to the exposure in adults.  The mean terminal half-life for 17-AAG was 3.24 ± 0.80 h.  Induction of Hsp72, a surrogate marker for inhibition of Hsp90, was detected at the 270 mg/m2 dose level.  Drug exposures consistent with those required for anticancer activity in preclin. models were achieved without DLT.  Evidence for drug-induced modulation of Hsp90 systemically was also detected.  The recommended phase II dose of 17-AAG is 360 mg/m2/d.  Non-DMSO-contg. formulations may improve acceptance of this drug by children and their families.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5bX_5e9xYaLVg90H21EOLACvtfcHk0liq9CEHCqk8Sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXivV2gtLw%253D&md5=993461ceb86c7e6fa3c759a482eea16e</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-2270&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-2270%26sid%3Dliteratum%253Aachs%26aulast%3DWeigel%26aufirst%3DB.%2BJ.%26aulast%3DBlaney%26aufirst%3DS.%2BM.%26aulast%3DReid%26aufirst%3DJ.%2BM.%26aulast%3DSafgren%26aufirst%3DS.%2BL.%26aulast%3DBagatell%26aufirst%3DR.%26aulast%3DKersey%26aufirst%3DJ.%26aulast%3DNeglia%26aufirst%3DJ.%2BP.%26aulast%3DIvy%26aufirst%3DS.%2BP.%26aulast%3DIngle%26aufirst%3DA.%2BM.%26aulast%3DWhitesell%26aufirst%3DL.%26aulast%3DGilbertson%26aufirst%3DR.%2BJ.%26aulast%3DKrailo%26aufirst%3DM.%26aulast%3DAmes%26aufirst%3DM.%26aulast%3DAdamson%26aufirst%3DP.%2BC.%26atitle%3DA%2520phase%2520I%2520study%2520of%252017-allylaminogeldanamycin%2520in%2520relapsed%252Frefractory%2520pediatric%2520patients%2520with%2520solid%2520tumors%253A%2520a%2520children%25E2%2580%2599s%2520oncology%2520group%2520study%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D1789%26epage%3D1793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">McDonald, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K.</span><span> </span><span class="NLM_article-title">Inhibitors of the HSP90 molecular chaperone: attacking the master regulator in cancer</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1091</span><span class="NLM_x">–</span> <span class="NLM_lpage">1107</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm701018h&amp;key=10.2174%2F156802606777812004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm701018h&amp;key=16842148" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm701018h&amp;key=1%3ACAS%3A528%3ADC%252BD28Xpt1ejt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=1091-1107&author=E.+McDonaldauthor=P.+Workmanauthor=K.+Jones&title=Inhibitors+of+the+HSP90+molecular+chaperone%3A+attacking+the+master+regulator+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of the HSP90 molecular chaperone: attacking the master regulator in cancer</span></div><div class="casAuthors">McDonald, Edward; Workman, Paul; Jones, Keith</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1091-1107</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The heat shock protein 90 (HSP90) chaperones represent some 1-2% of all cellular protein and are key players in protein quality control in cells.  They are over expressed in many human cancers and the fact that many oncogenic proteins are clients has prompted much recent research on HSP90 inhibitors as new cancer therapeutics.  A brief introduction is followed by a detailed review of the various classes of inhibitors, both natural product-based and synthetic, that have emerged over the last decade.  The natural products geldanamycin, radicicol and novobiocin have provided the start points for new drugs in this area and their medicinal chem. is reviewed, including the exciting recent results emerging from clin. trials using geldanamycin analogs.  The detailed understanding of the binding mode of these compds. to HSP90 has been significantly enhanced by x-ray crystallog. of HSP90 constructs co-crystd. with various ligands.  Efforts to replace the natural product inhibitors with more drug-like synthetic compds. have mushroomed over the last 4 years.  The purines and the 3,4-diarylpyrazoles have proven to be the most successful and their medicinal chem. is reviewed with particular emphasis on structure-based design.  Protein/ligand co-crystal structures have shown that conserved water mols. in the active site are a vital part of the hydrogen-bonding network established on binding both natural product and synthetic inhibitors.  Medicinal chemists have used this information to develop high affinity lead compds.  Recent research provides the platform for exciting developments in the area of HSP90 inhibition over the next few years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZvK2PleGilLVg90H21EOLACvtfcHk0lh1hCsYfKoC6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xpt1ejt7s%253D&md5=76ebc6e48e0b91a5a9dceba18f7c38f4</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.2174%2F156802606777812004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802606777812004%26sid%3Dliteratum%253Aachs%26aulast%3DMcDonald%26aufirst%3DE.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DJones%26aufirst%3DK.%26atitle%3DInhibitors%2520of%2520the%2520HSP90%2520molecular%2520chaperone%253A%2520attacking%2520the%2520master%2520regulator%2520in%2520cancer%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D1091%26epage%3D1107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Powers, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">Targeting of multiple signalling pathways by heat shock protein 90 molecular chaperone inhibitors</span> <span class="citation_source-journal">Endocr. Relat. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">S125</span><span class="NLM_x">–</span> <span class="NLM_lpage">S135</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=S125-S135&author=M.+V.+Powersauthor=P.+Workman&title=Targeting+of+multiple+signalling+pathways+by+heat+shock+protein+90+molecular+chaperone+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPowers%26aufirst%3DM.%2BV.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DTargeting%2520of%2520multiple%2520signalling%2520pathways%2520by%2520heat%2520shock%2520protein%252090%2520molecular%2520chaperone%2520inhibitors%26jtitle%3DEndocr.%2520Relat.%2520Cancer%26date%3D2006%26volume%3D13%26spage%3DS125%26epage%3DS135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Chiosis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldas, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solit, D.</span><span> </span><span class="NLM_article-title">Heat shock protein-90 inhibitors: a chronicle from geldanamycin to today’s agents</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">534</span><span class="NLM_x">–</span> <span class="NLM_lpage">541</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=534-541&author=G.+Chiosisauthor=L.+E.+Caldasauthor=D.+Solit&title=Heat+shock+protein-90+inhibitors%3A+a+chronicle+from+geldanamycin+to+today%E2%80%99s+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChiosis%26aufirst%3DG.%26aulast%3DCaldas%26aufirst%3DL.%2BE.%26aulast%3DSolit%26aufirst%3DD.%26atitle%3DHeat%2520shock%2520protein-90%2520inhibitors%253A%2520a%2520chronicle%2520from%2520geldanamycin%2520to%2520today%25E2%2580%2599s%2520agents%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2006%26volume%3D7%26spage%3D534%26epage%3D541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neckers, L.</span><span> </span><span class="NLM_article-title">Targeting the molecular chaperone heat shock protein 90 provides a multifaceted effect on diverse cell signaling Pathways of cancer cells</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1625</span><span class="NLM_x">–</span> <span class="NLM_lpage">1629</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm701018h&amp;key=10.1158%2F1078-0432.CCR-06-2966" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm701018h&amp;key=17363512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm701018h&amp;key=1%3ACAS%3A528%3ADC%252BD2sXivV2gsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=1625-1629&author=W.+Xuauthor=L.+Neckers&title=Targeting+the+molecular+chaperone+heat+shock+protein+90+provides+a+multifaceted+effect+on+diverse+cell+signaling+Pathways+of+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the Molecular Chaperone Heat Shock Protein 90 Provides a Multifaceted Effect on Diverse Cell Signaling Pathways of Cancer Cells</span></div><div class="casAuthors">Xu, Wanping; Neckers, Len</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1625-1629</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review with commentary on the title research of Bagatell et al., Ramanathan et al., Solit et al., and Weigel et al. (2007).  Heat shock protein 90 (Hsp90) is a mol. chaperone required for the stability and function of several conditionally activated and/or expressed signaling proteins as well as multiple mutated, chimeric, and/or overexpressed signaling proteins, which promote cancer cell growth and/or survival.  By interacting specifically with a single mol. target, Hsp90 inhibitors cause the eventual inactivation, destabilization, and degrdn. of numerous chaperone-dependent client proteins, and these drugs have shown promising antitumor activity in preclin. model systems.  Hsp90 inhibitors are unique in that, although they are directed toward a specific mol. target, they simultaneously inhibit multiple signaling pathways that frequently interact to promote cancer cell survival.  Several Hsp90 inhibitors, including the benzoquinone ansamycin 17-allylamino-17-demethoxygeldanamycin, are currently undergoing clin. evaluation.  Four phase 1 single-agent studies of 17-allylamino-17-demethoxygeldanamycin, two pediatric and two adult trials, are reviewed.  These studies highlight both the promise and the difficulty of successfully developing such molecularly targeted agents for the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouGXcBY2T52LVg90H21EOLACvtfcHk0lh1hCsYfKoC6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXivV2gsbc%253D&md5=b2adf96c4efbd13dab1056035fb704d4</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-2966&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-2966%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DW.%26aulast%3DNeckers%26aufirst%3DL.%26atitle%3DTargeting%2520the%2520molecular%2520chaperone%2520heat%2520shock%2520protein%252090%2520provides%2520a%2520multifaceted%2520effect%2520on%2520diverse%2520cell%2520signaling%2520Pathways%2520of%2520cancer%2520cells%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D1625%26epage%3D1629" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Egorin, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolff, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callery, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musser, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eiseman, J. L.</span><span> </span><span class="NLM_article-title">Metabolism of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) by murine and human hepatic preparations</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">2385</span><span class="NLM_x">–</span> <span class="NLM_lpage">2396</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1998&pages=2385-2396&author=M.+J.+Egorinauthor=D.+M.+Rosenauthor=J.+H.+Wolffauthor=P.+S.+Calleryauthor=S.+M.+Musserauthor=J.+L.+Eiseman&title=Metabolism+of+17-%28allylamino%29-17-demethoxygeldanamycin+%28NSC+330507%29+by+murine+and+human+hepatic+preparations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEgorin%26aufirst%3DM.%2BJ.%26aulast%3DRosen%26aufirst%3DD.%2BM.%26aulast%3DWolff%26aufirst%3DJ.%2BH.%26aulast%3DCallery%26aufirst%3DP.%2BS.%26aulast%3DMusser%26aufirst%3DS.%2BM.%26aulast%3DEiseman%26aufirst%3DJ.%2BL.%26atitle%3DMetabolism%2520of%252017-%2528allylamino%2529-17-demethoxygeldanamycin%2520%2528NSC%2520330507%2529%2520by%2520murine%2520and%2520human%2520hepatic%2520preparations%26jtitle%3DCancer%2520Res.%26date%3D1998%26volume%3D58%26spage%3D2385%26epage%3D2396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Kelland, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">DT-Diaphorase expression and tumor cell sensitivity to 17-allylamino, 17-demethoxygeldanamycin, an inhibitor of heat shock protein 90</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">1940</span><span class="NLM_x">–</span> <span class="NLM_lpage">1949</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm701018h&amp;key=10.1093%2Fjnci%2F91.22.1940" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm701018h&amp;key=10564678" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm701018h&amp;key=1%3ACAS%3A528%3ADyaK1MXotVaitr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1999&pages=1940-1949&author=L.+R.+Kellandauthor=S.+Y.+Sharpauthor=P.+M.+Rogersauthor=T.+G.+Myersauthor=P.+Workman&title=DT-Diaphorase+expression+and+tumor+cell+sensitivity+to+17-allylamino%2C+17-demethoxygeldanamycin%2C+an+inhibitor+of+heat+shock+protein+90"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">DT-diaphorase expression and tumor cell sensitivity to 17-allylamino-17-demethoxygeldanamycin, an inhibitor of heat shock protein 90</span></div><div class="casAuthors">Kelland, Lloyd R.; Sharp, Swee Y.; Rogers, Paul M.; Myers, Timothy G.; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">1940-1949</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background: To our knowledge, 17-allylamino-17-demethoxygeldanamycin (17AAG) is the first inhibitor of heat shock protein 90 (Hsp90) to enter a phase I clin. trial in cancer.  Inhibition of Hsp90, a chaperone protein (a protein that helps other proteins avoid misfolding pathways that produce inactive or aggregated states), leads to depletion of important oncogenic proteins, including Raf-1 and mutant p53 (also known as TP53).  Given its ansamycin benzoquinone structure, we questioned whether the antitumor activity of 17AAG was affected by expression of the NQO1 gene, which encodes the quinone-metabolizing enzyme DT-diaphorase.  Methods: The antitumor activity of 17AAG and other Hsp90 inhibitors was detd. by use of a sulforhodamine B-based cell growth inhibition assay in culture and by the arrest of xenograft tumor growth in nude mice.  DT-diaphorase activity was detd. by use of a spectrophotometric assay, and protein expression was detd. by western immunoblotting.  Results: In two independent in vitro human tumor cell panels, we obsd. a pos. relation between DT-diaphorase expression level and growth inhibition by 17AAG.  Stable, high-level expression of the active NQO1 gene transfected into the DT-diaphorase-deficient (by NQO1 mutation) BE human colon carcinoma cell line resulted in a 32-fold increase in 17AAG growth-inhibition activity.  Increased sensitivity to 17AAG in the transfected cell line was also confirmed in xenografts.  The extent of depletion of Raf-1 and mutant p53 protein confirmed that the Hsp90 inhibition mechanism was maintained in cells with high and low levels of DT-diaphorase.  17AAG was shown to be a substrate for purified human DT-diaphorase.  Conclusion: These results suggest that the antitumor activity and possibly the toxicol. properties of 17AAG in humans may be influenced by the expression of DT-diaphorase.  Careful monitoring for NQO1 polymorphism and the level of tumor DT-diaphorase activity is therefore recommended in clin. trials with 17AAG.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5zBsj7Xagm7Vg90H21EOLACvtfcHk0lh1hCsYfKoC6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXotVaitr8%253D&md5=508d5f614ce715ae495263171b286bff</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F91.22.1940&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F91.22.1940%26sid%3Dliteratum%253Aachs%26aulast%3DKelland%26aufirst%3DL.%2BR.%26aulast%3DSharp%26aufirst%3DS.%2BY.%26aulast%3DRogers%26aufirst%3DP.%2BM.%26aulast%3DMyers%26aufirst%3DT.%2BG.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DDT-Diaphorase%2520expression%2520and%2520tumor%2520cell%2520sensitivity%2520to%252017-allylamino%252C%252017-demethoxygeldanamycin%252C%2520an%2520inhibitor%2520of%2520heat%2520shock%2520protein%252090%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D1999%26volume%3D91%26spage%3D1940%26epage%3D1949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Meli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennati, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daidone, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plescia, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toba, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altieri, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaffaroni, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colombo, G.</span><span> </span><span class="NLM_article-title">Small-molecule targeting of heat shock protein 90 chaperone function: rational identification of a new anticancer lead</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7721</span><span class="NLM_x">–</span> <span class="NLM_lpage">7730</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060836y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7721-7730&author=M.+Meliauthor=M.+Pennatiauthor=M.+Curtoauthor=M.+G.+Daidoneauthor=J.+Plesciaauthor=S.+Tobaauthor=D.+C.+Altieriauthor=N.+Zaffaroniauthor=G.+Colombo&title=Small-molecule+targeting+of+heat+shock+protein+90+chaperone+function%3A+rational+identification+of+a+new+anticancer+lead"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm060836y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060836y%26sid%3Dliteratum%253Aachs%26aulast%3DMeli%26aufirst%3DM.%26aulast%3DPennati%26aufirst%3DM.%26aulast%3DCurto%26aufirst%3DM.%26aulast%3DDaidone%26aufirst%3DM.%2BG.%26aulast%3DPlescia%26aufirst%3DJ.%26aulast%3DToba%26aufirst%3DS.%26aulast%3DAltieri%26aufirst%3DD.%2BC.%26aulast%3DZaffaroni%26aufirst%3DN.%26aulast%3DColombo%26aufirst%3DG.%26atitle%3DSmall-molecule%2520targeting%2520of%2520heat%2520shock%2520protein%252090%2520chaperone%2520function%253A%2520rational%2520identification%2520of%2520a%2520new%2520anticancer%2520lead%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7721%26epage%3D7730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Kaur, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belotti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burger, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher-Nielson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borsotti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riccardi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thillainathan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollingshead, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sausville, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giavazzi, R.</span><span> </span><span class="NLM_article-title">Antiangiogenic properties of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin: an orally bioavailable heat shock protein 90 modulator</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">4813</span><span class="NLM_x">–</span> <span class="NLM_lpage">4821</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm701018h&amp;key=10.1158%2F1078-0432.CCR-03-0795" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm701018h&amp;key=15269157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm701018h&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlvVegs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=4813-4821&author=G.+Kaurauthor=D.+Belottiauthor=A.+M.+Burgerauthor=K.+Fisher-Nielsonauthor=P.+Borsottiauthor=E.+Riccardiauthor=J.+Thillainathanauthor=M.+Hollingsheadauthor=E.+A.+Sausvilleauthor=R.+Giavazzi&title=Antiangiogenic+properties+of+17-%28dimethylaminoethylamino%29-17-demethoxygeldanamycin%3A+an+orally+bioavailable+heat+shock+protein+90+modulator"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Antiangiogenic properties of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin: an orally bioavailable heat shock protein 90 modulator</span></div><div class="casAuthors">Kaur, Gurmeet; Belotti, Dorina; Burger, Angelika M.; Fisher-Nielson, Kirsten; Borsotti, Patrizia; Riccardi, Elena; Thillainathan, Jagada; Hollingshead, Melinda; Sausville, Edward A.; Giavazzi, Raffaella</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4813-4821</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The purpose of this study was to investigate the antiangiogenic properties of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG; NSC707545), a water-sol. benzoquinone ansamycin.  The activity of 17-DMAG, in vivo, was evaluated for inhibition of fibroblast growth factor (FGF)-2-induced angiogenesis in s.c. implanted Matrigel in mice.  In vitro, the activity of 17-DMAG on endothelial cells (human umbilical vein endothelial cells; HUVEC) was tested in FGF-2; and vascular endothelial growth factor (VEGF)-induced proliferation and apoptosis, motility, and extracellular matrix invasion; and on the alignment of capillary like structures in Matrigel.  The protein level of heat shock protein (Hsp)90 and client proteins was examd. by Western blot in FGF-2 and VEGF-stimulated HUVEC.  Daily oral administration of 17-DMAG affected the angiogenic response in Matrigel in a dose-dependent manner.  The Hb content in the Matrigel implants was significantly inhibited, and the histol. anal. confirmed a decrease of CD31+ endothelial cells and of structures organized in cord and erythrocyte-contg. vessels.  In vitro, the compd. inhibited dose-dependently the migration and the extracellular matrix-invasiveness of HUVEC and their capacity to form capillary like structures in Matrigel. 17-DMAG treatment also inhibited FGF-2 and VEGF-induced HUVEC proliferation and resulted in apoptosis.  Accordingly, the expression of Hsp90 direct client proteins (pAkt and c-Raf-1) or their downstream substrates including pERK was also affected. 17-DMAG consistently increased the expression of Hsp70.  Throughout the study similar results were obtained with 17-allylamino-17-demethoxygeldanamycin (17-AAG; NSC330507), the analog compd. currently undergoing clin. trials.  We show that the Hsp90 targeting agents 17-DMAG and 17-AAG inhibit angiogenesis.  The strong effects on endothelial cell functions, in vitro, indicate that the antiangiogenic activity of 17-DMAG/17-AAG could also be due to a direct effect on endothelial cells.  The oral bioavailability of 17-DMAG might be of advantage in investigating the potential of this compd. in clin. trials with antiangiogenic as well as antiproliferative endpoints.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbGsLTxbCrQ7Vg90H21EOLACvtfcHk0lg2KaUG_MlXGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlvVegs7s%253D&md5=e78331697485d2c1948adec2d4f124e6</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-03-0795&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-03-0795%26sid%3Dliteratum%253Aachs%26aulast%3DKaur%26aufirst%3DG.%26aulast%3DBelotti%26aufirst%3DD.%26aulast%3DBurger%26aufirst%3DA.%2BM.%26aulast%3DFisher-Nielson%26aufirst%3DK.%26aulast%3DBorsotti%26aufirst%3DP.%26aulast%3DRiccardi%26aufirst%3DE.%26aulast%3DThillainathan%26aufirst%3DJ.%26aulast%3DHollingshead%26aufirst%3DM.%26aulast%3DSausville%26aufirst%3DE.%2BA.%26aulast%3DGiavazzi%26aufirst%3DR.%26atitle%3DAntiangiogenic%2520properties%2520of%252017-%2528dimethylaminoethylamino%2529-17-demethoxygeldanamycin%253A%2520an%2520orally%2520bioavailable%2520heat%2520shock%2520protein%252090%2520modulator%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2004%26volume%3D10%26spage%3D4813%26epage%3D4821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Ge, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Normant, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dembski, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Georges, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grenier, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pak, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sydor, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tibbitts, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palombella, V. J.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of hydroquinone derivatives of 17-amino-17-demethoxygeldanamycin as potent, water-soluble inhibitors of Hsp90</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4606</span><span class="NLM_x">–</span> <span class="NLM_lpage">4615</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0603116" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4606-4615&author=J.+Geauthor=E.+Normantauthor=J.+R.+Porterauthor=J.+A.+Aliauthor=M.+S.+Dembskiauthor=Y.+Gaoauthor=A.+T.+Georgesauthor=L.+Grenierauthor=R.+H.+Pakauthor=J.+Pattersonauthor=J.+R.+Sydorauthor=T.+T.+Tibbittsauthor=J.+K.+Tongauthor=J.+Adamsauthor=V.+J.+Palombella&title=Design%2C+synthesis%2C+and+biological+evaluation+of+hydroquinone+derivatives+of+17-amino-17-demethoxygeldanamycin+as+potent%2C+water-soluble+inhibitors+of+Hsp90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm0603116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0603116%26sid%3Dliteratum%253Aachs%26aulast%3DGe%26aufirst%3DJ.%26aulast%3DNormant%26aufirst%3DE.%26aulast%3DPorter%26aufirst%3DJ.%2BR.%26aulast%3DAli%26aufirst%3DJ.%2BA.%26aulast%3DDembski%26aufirst%3DM.%2BS.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DGeorges%26aufirst%3DA.%2BT.%26aulast%3DGrenier%26aufirst%3DL.%26aulast%3DPak%26aufirst%3DR.%2BH.%26aulast%3DPatterson%26aufirst%3DJ.%26aulast%3DSydor%26aufirst%3DJ.%2BR.%26aulast%3DTibbitts%26aufirst%3DT.%2BT.%26aulast%3DTong%26aufirst%3DJ.%2BK.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DPalombella%26aufirst%3DV.%2BJ.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520hydroquinone%2520derivatives%2520of%252017-amino-17-demethoxygeldanamycin%2520as%2520potent%252C%2520water-soluble%2520inhibitors%2520of%2520Hsp90%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4606%26epage%3D4615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Sydor, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Normant, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pien, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ge, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grenier, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pak, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dembski, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penders, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pink, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodward, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grayzel, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palombella, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, J. K.</span><span> </span><span class="NLM_article-title">Development of 17-allylamino-17-demethoxygeldanamycin hydroquinone hydrochloride (IPI-504), an anti-cancer agent directed against Hsp90</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">17408</span><span class="NLM_x">–</span> <span class="NLM_lpage">17413</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=17408-17413&author=J.+R.+Sydorauthor=E.+Normantauthor=C.+S.+Pienauthor=J.+R.+Porterauthor=J.+Geauthor=L.+Grenierauthor=R.+H.+Pakauthor=J.+A.+Aliauthor=M.+S.+Dembskiauthor=J.+Hudakauthor=J.+Pattersonauthor=C.+Pendersauthor=M.+Pinkauthor=M.+A.+Readauthor=J.+Sangauthor=C.+Woodwardauthor=Y.+Zhangauthor=D.+S.+Grayzelauthor=J.+Wrightauthor=J.+A.+Barrettauthor=V.+J.+Palombellaauthor=J.+Adamsauthor=J.+K.+Tong&title=Development+of+17-allylamino-17-demethoxygeldanamycin+hydroquinone+hydrochloride+%28IPI-504%29%2C+an+anti-cancer+agent+directed+against+Hsp90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSydor%26aufirst%3DJ.%2BR.%26aulast%3DNormant%26aufirst%3DE.%26aulast%3DPien%26aufirst%3DC.%2BS.%26aulast%3DPorter%26aufirst%3DJ.%2BR.%26aulast%3DGe%26aufirst%3DJ.%26aulast%3DGrenier%26aufirst%3DL.%26aulast%3DPak%26aufirst%3DR.%2BH.%26aulast%3DAli%26aufirst%3DJ.%2BA.%26aulast%3DDembski%26aufirst%3DM.%2BS.%26aulast%3DHudak%26aufirst%3DJ.%26aulast%3DPatterson%26aufirst%3DJ.%26aulast%3DPenders%26aufirst%3DC.%26aulast%3DPink%26aufirst%3DM.%26aulast%3DRead%26aufirst%3DM.%2BA.%26aulast%3DSang%26aufirst%3DJ.%26aulast%3DWoodward%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DGrayzel%26aufirst%3DD.%2BS.%26aulast%3DWright%26aufirst%3DJ.%26aulast%3DBarrett%26aufirst%3DJ.%2BA.%26aulast%3DPalombella%26aufirst%3DV.%2BJ.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DTong%26aufirst%3DJ.%2BK.%26atitle%3DDevelopment%2520of%252017-allylamino-17-demethoxygeldanamycin%2520hydroquinone%2520hydrochloride%2520%2528IPI-504%2529%252C%2520an%2520anti-cancer%2520agent%2520directed%2520against%2520Hsp90%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2006%26volume%3D103%26spage%3D17408%26epage%3D17413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">McDonald, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brough, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">Discovery and development of pyrazole-scaffold Hsp90 inhibitors</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1193</span><span class="NLM_x">–</span> <span class="NLM_lpage">1203</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm701018h&amp;key=10.2174%2F156802606777812086" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm701018h&amp;key=16842156" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm701018h&amp;key=1%3ACAS%3A528%3ADC%252BD28Xpt1ejtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=1193-1203&author=E.+McDonaldauthor=K.+Jonesauthor=P.+A.+Broughauthor=M.+J.+Drysdaleauthor=P.+Workman&title=Discovery+and+development+of+pyrazole-scaffold+Hsp90+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and development of pyrazole-scaffold Hsp90 inhibitors</span></div><div class="casAuthors">McDonald, Edward; Jones, Keith; Brough, Paul A.; Drysdale, Martin J.; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1193-1203</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  This review explains why the chaperone Hsp90 is an exciting protein target for the discovery of new drugs to treat cancer in the clinic, and summarizes the properties of natural product derived inhibitors before relating the discovery and current state of development of synthetic pyrazole compds.  Blockade of Hsp90 results in reduced cellular levels of several proteins implicated in cancer including CDK4, ERBB2 and C-RAF, and causes simultaneous inhibition of cancer cell proliferation in culture and of tumor xenograft growth in vivo.  Hsp90 has an ATPase domain that is necessary for its Hsp chaperone function, and x-ray crystallog. has shown that natural product inhibitors (geldanamycin, radicicol) of Hsp90 function bind to this domain.  High throughput assays focusing on the ATPase activity of Hsp90 were developed and used to discover novel chem. starting points for cancer drug discovery.  The discovery, synthesis and SAR of 3,4-diaryl pyrazoles is described.  X-Ray crystallog. of protein-inhibitor complexes revealed important interactions involving the resorcinol substituent at C-3, and these x-ray structures strongly influenced subsequent medicinal chem. research that has resulted in highly potent inhibitors with sub-micromolar activity in cells.  SAR and x-ray data are summarized for analogs in which the 4-Ph substituent is replaced by amides or piperazine derivs.  Prospects for the pyrazoles as they progress towards clin. development are discussed in relation to current Phase I trials with derivs. of geldanamycin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSrzLa0m0ydrVg90H21EOLACvtfcHk0lgvPlwXm4eWeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xpt1ejtL0%253D&md5=0e97e917c8f045e2be444ab6fb78482d</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.2174%2F156802606777812086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802606777812086%26sid%3Dliteratum%253Aachs%26aulast%3DMcDonald%26aufirst%3DE.%26aulast%3DJones%26aufirst%3DK.%26aulast%3DBrough%26aufirst%3DP.%2BA.%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DDiscovery%2520and%2520development%2520of%2520pyrazole-scaffold%2520Hsp90%2520inhibitors%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D1193%26epage%3D1203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Discovery and development of purine-scaffold Hsp90 inhibitors</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1183</span><span class="NLM_x">–</span> <span class="NLM_lpage">1191</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm701018h&amp;key=10.2174%2F156802606777812013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm701018h&amp;key=16842155" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm701018h&amp;key=1%3ACAS%3A528%3ADC%252BD28Xpt1ejtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=1183-1191&author=G.+Chiosis&title=Discovery+and+development+of+purine-scaffold+Hsp90+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and development of purine-scaffold Hsp90 inhibitors</span></div><div class="casAuthors">Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1183-1191</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Hsp90 allows cancer cells to tolerate the many components of dysregulated pathways in a transformation-specific manner by interacting with several client substrates, such as kinases, hormone receptors and transcription factors that are directly involved in driving multistep malignancy, and also with mutated oncogenic proteins required for the transformed phenotype.  This distinctive broad involvement in maintaining the transformed phenotype has suggested Hsp90 as an important target in cancer therapy.  Discovery of pharmacol. agents that selectively inhibit its function have aided in probing the biol. functions of Hsp90 at the mol. level and in validating it as a novel target for anticancer drug action.  Two natural product derivs., 17-allylamino-17-desmethoxy-geldanamycin (17AAG) and 17-dimethylaminoethylamino-17-desmethoxy-geldanamycin (17DMAG) have further entered clin. trials, proving that Hsp90 may be modulated pharmacol. without causing target related toxicities in humans.  In spite of their usefulness as proof-of-principle compds., the clin. use of these two agents has been encumbered with some limitations due to their structural characteristics and also to less than optimal pharmacol. profiles.  Thus, the identification of Hsp90 inhibitors with improved structural characteristics and better pharmacol. profiles is a major focus of interest in the field.  One such emerging class is the purine-scaffold series.  This review intends to inform the reader on efforts ranging from the discovery to their clin. translation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtpMNMTF3zyLVg90H21EOLACvtfcHk0lgvPlwXm4eWeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xpt1ejtLw%253D&md5=f619bbb69cd7ac43a2112d56e5a904f2</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.2174%2F156802606777812013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802606777812013%26sid%3Dliteratum%253Aachs%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DDiscovery%2520and%2520development%2520of%2520purine-scaffold%2520Hsp90%2520inhibitors%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D1183%26epage%3D1191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Dymock, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">Inhibitors of HSP90 and other chaperones for the treatment of cancer</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">837</span><span class="NLM_x">–</span> <span class="NLM_lpage">847</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm701018h&amp;key=10.1517%2F13543776.14.6.837" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm701018h&amp;key=1%3ACAS%3A528%3ADC%252BD2cXktlyqsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=837-847&author=B.+W.+Dymockauthor=M.+J.+Drysdaleauthor=E.+McDonaldauthor=P.+Workman&title=Inhibitors+of+HSP90+and+other+chaperones+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of HSP90 and other chaperones for the treatment of cancer</span></div><div class="casAuthors">Dymock, Brian W.; Drysdale, Martin J.; McDonald, Edward; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">837-847</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review with refs.  Mol. chaperones are proteins that ensure the appropriate folding, stability and function of other proteins in the cell.  There is increasing evidence that mol. chaperones are not only important in normal cell homeostasis and response to stresses, such as heat shock, but can also be involved in disease pathol.  In particular, HSP90 has emerged as an important potential drug target in oncol.  This is because it is essential for the stability of a long list of client proteins', including ErbB2/human epithelial growth factor receptor (HER)2, Raf-1, Akt/protein kinase B (PKB), Polo-1, Met, mutant p53 and human telomerase reverse transcriptase (hTERT), as well as the estrogen and androgen receptor.  Inhibition of HSP90 leads to depletion of these oncogenic clients by the ubiquitin proteasome pathway, thereby providing a simultaneous combinatorial attack on all of the hallmark phenotypic traits of cancer cells.  Because of the rapid progress made, this review focuses on the patents dealing with the discovery and application of small mol. inhibitors of HSP90, although limited coverage of other applications in the area of HSP90 and addnl. chaperones is also included.  Pioneering work with natural products, namely geldanamycin and related ansamycin antibiotics together with radicicol macrocycle derivs., established the therapeutic potential of inhibiting the essential N-terminal ATPase of HSP90 by competing at the nucleotide binding site.  A geldanamycin analog, 17-(desmethoxy), 17-allylamino geldanamycin (17AAG), is completing Phase I clin. trials with promising initial results.  The use of high-throughput screening and rational design based on X-ray crystal structures of HSP90 has led to the discovery of small mol. HSP90 inhibitors based on purine and pyrazole scaffolds.  The continued progression of these various compd. classes into clin. trials should help to establish proof of concept for inhibition of HSP90 as a viable therapeutic approach for the treatment of cancer and potentially other diseases.  This would in turn validate protein folding as a strategy for drug development and encourage addnl. chaperones to be explored as mol. targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZ19fmQE-bzbVg90H21EOLACvtfcHk0lgvPlwXm4eWeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXktlyqsL8%253D&md5=68f468698084591e41c9c0a337542ca1</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1517%2F13543776.14.6.837&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.14.6.837%26sid%3Dliteratum%253Aachs%26aulast%3DDymock%26aufirst%3DB.%2BW.%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26aulast%3DMcDonald%26aufirst%3DE.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DInhibitors%2520of%2520HSP90%2520and%2520other%2520chaperones%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2004%26volume%3D14%26spage%3D837%26epage%3D847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Neckers, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neckers, K.</span><span> </span><span class="NLM_article-title">Heat-shock protein 90 inhibitors as novel cancer chemotherapeutics—an update</span> <span class="citation_source-journal">Expert. Opin. Emerging Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">137</span><span class="NLM_x">–</span> <span class="NLM_lpage">149</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm701018h&amp;key=10.1517%2F14728214.10.1.137" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm701018h&amp;key=15757409" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm701018h&amp;key=1%3ACAS%3A528%3ADC%252BD2MXislCrt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2005&pages=137-149&author=L.+Neckersauthor=K.+Neckers&title=Heat-shock+protein+90+inhibitors+as+novel+cancer+chemotherapeutics%E2%80%94an+update"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Heat-shock protein 90 inhibitors as novel cancer chemotherapeutics - an update</span></div><div class="casAuthors">Neckers, Len; Neckers, Katharine</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Emerging Drugs</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">137-149</span>CODEN:
                <span class="NLM_cas:coden">EOEDA3</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Heat-shock protein 90 (Hsp90) is a mol. chaperone whose assocn. is required for stability and function of a growing no. of signalling proteins that have been implicated in cancer cell survival, including several mutated proteins that are only found in specific cancers.  Furthermore, a growing body of evidence suggests that cancer cells are particularly dependent on Hsp90 for their growth and survival, and, therefore, are more sensitive to the effects of its inhibition than are non-transformed cells and tissues.  Several chem. distinct Hsp90 inhibitors have shown encouraging antitumor activity in multiple preclin. model systems, and one Hsp90 inhibitor, the benzoquinone ansamycin 17-allylamino, 17-demethoxygeldanamycin, has completed five Phase I clin. trials, with a no. of Phase II trials soon to be underway or in progress.  Other Hsp90 inhibitors are either in Phase I clin. trial or under development.  This update will focus on how the latest developments in Hsp90 biol. may better inform the clin. development of Hsp90 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozi0ii7Nj7IbVg90H21EOLACvtfcHk0lgvPlwXm4eWeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXislCrt7o%253D&md5=91e907d6208cb717cbc3648f3d025dd3</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1517%2F14728214.10.1.137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728214.10.1.137%26sid%3Dliteratum%253Aachs%26aulast%3DNeckers%26aufirst%3DL.%26aulast%3DNeckers%26aufirst%3DK.%26atitle%3DHeat-shock%2520protein%252090%2520inhibitors%2520as%2520novel%2520cancer%2520chemotherapeutics%25E2%2580%2594an%2520update%26jtitle%3DExpert.%2520Opin.%2520Emerging%2520Drugs%26date%3D2005%26volume%3D10%26spage%3D137%26epage%3D149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Janin, Y. L.</span><span> </span><span class="NLM_article-title">Heat shock protein 90 inhibitors. A text book example of medicinal chemistry</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7503</span><span class="NLM_x">–</span> <span class="NLM_lpage">7512</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050759r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7503-7512&author=Y.+L.+Janin&title=Heat+shock+protein+90+inhibitors.+A+text+book+example+of+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm050759r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050759r%26sid%3Dliteratum%253Aachs%26aulast%3DJanin%26aufirst%3DY.%2BL.%26atitle%3DHeat%2520shock%2520protein%252090%2520inhibitors.%2520A%2520text%2520book%2520example%2520of%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7503%26epage%3D7512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Drysdale, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brough, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepfer, J.</span><span> </span><span class="NLM_article-title">Targeting Hsp90 for the treatment of cancer</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">483</span><span class="NLM_x">–</span> <span class="NLM_lpage">495</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm701018h&amp;key=16889231" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm701018h&amp;key=1%3ACAS%3A528%3ADC%252BD28XntVChs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=483-495&author=M.+J.+Drysdaleauthor=P.+A.+Broughauthor=A.+Masseyauthor=M.+R.+Jensenauthor=J.+Schoepfer&title=Targeting+Hsp90+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Hsp90 for the treatment of cancer</span></div><div class="casAuthors">Drysdale, Martin J.; Brough, Paul A.; Massey, Andrew; Jensen, Michael Rugaard; Schoepfer, Joseph</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Drug Discovery & Development</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">483-495</span>CODEN:
                <span class="NLM_cas:coden">CODDFF</span>;
        ISSN:<span class="NLM_cas:issn">1367-6733</span>.
    
            (<span class="NLM_cas:orgname">Thomson Scientific</span>)
        </div><div class="casAbstract">A review.  Heat shock protein (Hsp)90 is a mol. chaperone that is responsible for the correct folding of a large no. of proteins, which allows these proteins to achieve their functional conformation.  Client proteins of Hsp90 include many overexpressed or mutated oncogenes that are known to be crit. for the transformed phenotype obsd. in tumors.  The compds. 17-AAG (Kosan Biosciences Inc/National Cancer Institute) and 17-DMAG (Kosan Biosciences Inc/National Cancer Institute) are Hsp90 inhibitors that are derived from the prototypical ansamycin natural product Hsp90 inhibitor geldanamycin.  These compds. have demonstrated preclin. efficacy in mouse xenograft models, and are now undergoing phase II and I clin. trials, resp.  Preclin. efficacy studies of these compds. are collated and discussed in this review.  More recent disclosures of small-mol. Hsp90 inhibitors include purine and resorcinol analogs, and the first small-mol. Hsp90 compds. showing oral efficacy have been described.  Inhibition of Hsp90 not only results in the degrdn. of client proteins, but also results in the induction of another chaperone, Hsp70.  Hsp70 is known to be anti-apoptotic, and therefore the induction of Hsp70 may ultimately limit the efficacy of Hsp90 inhibitors under certain circumstances.  Histone deacetylase inhibitors have recently been demonstrated to exert some of their effect through modulation of Hsp90 chaperoning activity, and some mechanistic aspects of this control are also discussed herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-VkK7aR3PuLVg90H21EOLACvtfcHk0liFxpQtJFX3xA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntVChs7k%253D&md5=117860d15c90611ea5da8fc356fe814f</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26aulast%3DBrough%26aufirst%3DP.%2BA.%26aulast%3DMassey%26aufirst%3DA.%26aulast%3DJensen%26aufirst%3DM.%2BR.%26aulast%3DSchoepfer%26aufirst%3DJ.%26atitle%3DTargeting%2520Hsp90%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2006%26volume%3D9%26spage%3D483%26epage%3D495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zatorska, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguirre, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llauger, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">She, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Immormino, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gewirth, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Identification of potent water soluble purine-scaffold inhibitors of the heat shock protein 90</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">381</span><span class="NLM_x">–</span> <span class="NLM_lpage">390</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0508078" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm701018h&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1ynsrrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=381-390&author=H.+Heauthor=D.+Zatorskaauthor=J.+Kimauthor=J.+Aguirreauthor=L.+Llaugerauthor=Y.+Sheauthor=N.+Wuauthor=R.+M.+Immorminoauthor=D.+T.+Gewirthauthor=G.+Chiosis&title=Identification+of+potent+water+soluble+purine-scaffold+inhibitors+of+the+heat+shock+protein+90"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Potent Water Soluble Purine-Scaffold Inhibitors of the Heat Shock Protein 90</span></div><div class="casAuthors">He, Huazhong; Zatorska, Danuta; Kim, Joungnam; Aguirre, Julia; Llauger, Laura; She, Yuhong; Wu, Nian; Immormino, Robert M.; Gewirth, Daniel T.; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">381-390</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hsp90 is a chaperone protein that allows cancer cells to tolerate the many components of dysregulated pathways.  Its inactivation may result in targeting multiple mol. alterations and, thus, in reverting the transformed phenotype.  The PU-class, a purine-scaffold Hsp90 inhibitor series, has been reported to be potent and selective against Hsp90 both in vitro and in vivo models of cancer.  Here, a series of this class was synthesized and evaluated as inhibitors of the chaperone.  The structure-activity relationship and selectivity for tumor Hsp90 of compds. within the series is presented.  The study identifies water sol. derivs. (>5 mM in PBS pH 7.4) of nanomolar potency (IC50 ∼ 50 nM) in cellular and animal models of cancer.  Binding affinities of these compds. for Hsp90 correlate well with their biol. activities.  When administered in vivo to mice bearing MDA-MB-468 human breast cancer xenografted tumors, these agents result in pharmacol. relevant concns. and, accordingly, in modulation of Hsp90-client proteins in tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRwHp1Wo_iW7Vg90H21EOLACvtfcHk0liFxpQtJFX3xA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1ynsrrF&md5=3bd02ca5bc0a147e9cffa58968433917</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm0508078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0508078%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DH.%26aulast%3DZatorska%26aufirst%3DD.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DAguirre%26aufirst%3DJ.%26aulast%3DLlauger%26aufirst%3DL.%26aulast%3DShe%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DN.%26aulast%3DImmormino%26aufirst%3DR.%2BM.%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DIdentification%2520of%2520potent%2520water%2520soluble%2520purine-scaffold%2520inhibitors%2520of%2520the%2520heat%2520shock%2520protein%252090%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D381%26epage%3D390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Biamonte, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busch, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karjian, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maldonado, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sensintaffar, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lough, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundgren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timony, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasibhatla, S. R.</span><span> </span><span class="NLM_article-title">Orally active purine-based inhibitors of the heat shock protein 90</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">817</span><span class="NLM_x">–</span> <span class="NLM_lpage">828</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0503087" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=817-828&author=M.+A.+Biamonteauthor=J.+Shiauthor=K.+Hongauthor=D.+C.+Hurstauthor=L.+Zhangauthor=J.+Fanauthor=D.+J.+Buschauthor=P.+L.+Karjianauthor=A.+A.+Maldonadoauthor=J.+L.+Sensintaffarauthor=Y.+C.+Yangauthor=A.+Kamalauthor=R.+E.+Loughauthor=K.+Lundgrenauthor=F.+J.+Burrowsauthor=G.+A.+Timonyauthor=M.+F.+Boehmauthor=S.+R.+Kasibhatla&title=Orally+active+purine-based+inhibitors+of+the+heat+shock+protein+90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm0503087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0503087%26sid%3Dliteratum%253Aachs%26aulast%3DBiamonte%26aufirst%3DM.%2BA.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DHong%26aufirst%3DK.%26aulast%3DHurst%26aufirst%3DD.%2BC.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DBusch%26aufirst%3DD.%2BJ.%26aulast%3DKarjian%26aufirst%3DP.%2BL.%26aulast%3DMaldonado%26aufirst%3DA.%2BA.%26aulast%3DSensintaffar%26aufirst%3DJ.%2BL.%26aulast%3DYang%26aufirst%3DY.%2BC.%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DLough%26aufirst%3DR.%2BE.%26aulast%3DLundgren%26aufirst%3DK.%26aulast%3DBurrows%26aufirst%3DF.%2BJ.%26aulast%3DTimony%26aufirst%3DG.%2BA.%26aulast%3DBoehm%26aufirst%3DM.%2BF.%26aulast%3DKasibhatla%26aufirst%3DS.%2BR.%26atitle%3DOrally%2520active%2520purine-based%2520inhibitors%2520of%2520the%2520heat%2520shock%2520protein%252090%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D817%26epage%3D828" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Kasibhatla, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biamonte, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busch, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karjian, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sensintaffar, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lough, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brekken, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundgren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grecko, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timony, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ran, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansfield, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fritz, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulm, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, M. F.</span><span> </span><span class="NLM_article-title">Rationally designed high-affinity 2-amino-6-halopurine heat shock protein 90 inhibitors that exhibit potent antitumor activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2767</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050752%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2767&author=S.+R.+Kasibhatlaauthor=K.+Hongauthor=M.+A.+Biamonteauthor=D.+J.+Buschauthor=P.+L.+Karjianauthor=J.+L.+Sensintaffarauthor=A.+Kamalauthor=R.+E.+Loughauthor=J.+Brekkenauthor=K.+Lundgrenauthor=R.+Greckoauthor=G.+A.+Timonyauthor=Y.+Ranauthor=R.+Mansfieldauthor=L.+C.+Fritzauthor=E.+Ulmauthor=F.+J.+Burrowsauthor=M.+F.+Boehm&title=Rationally+designed+high-affinity+2-amino-6-halopurine+heat+shock+protein+90+inhibitors+that+exhibit+potent+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm050752%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050752%252B%26sid%3Dliteratum%253Aachs%26aulast%3DKasibhatla%26aufirst%3DS.%2BR.%26aulast%3DHong%26aufirst%3DK.%26aulast%3DBiamonte%26aufirst%3DM.%2BA.%26aulast%3DBusch%26aufirst%3DD.%2BJ.%26aulast%3DKarjian%26aufirst%3DP.%2BL.%26aulast%3DSensintaffar%26aufirst%3DJ.%2BL.%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DLough%26aufirst%3DR.%2BE.%26aulast%3DBrekken%26aufirst%3DJ.%26aulast%3DLundgren%26aufirst%3DK.%26aulast%3DGrecko%26aufirst%3DR.%26aulast%3DTimony%26aufirst%3DG.%2BA.%26aulast%3DRan%26aufirst%3DY.%26aulast%3DMansfield%26aufirst%3DR.%26aulast%3DFritz%26aufirst%3DL.%2BC.%26aulast%3DUlm%26aufirst%3DE.%26aulast%3DBurrows%26aufirst%3DF.%2BJ.%26aulast%3DBoehm%26aufirst%3DM.%2BF.%26atitle%3DRationally%2520designed%2520high-affinity%25202-amino-6-halopurine%2520heat%2520shock%2520protein%252090%2520inhibitors%2520that%2520exhibit%2520potent%2520antitumor%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Cheung, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowlands, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boxall, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloney, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roe, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodromou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearl, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aherne, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">The identification, synthesis, protein crystal structure and in vitro biochemical evaluation of a new 3,4-diarylpyrazole class of Hsp90 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">3338</span><span class="NLM_x">–</span> <span class="NLM_lpage">3343</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=3338-3343&author=K.+M.+Cheungauthor=T.+P.+Matthewsauthor=K.+Jamesauthor=M.+G.+Rowlandsauthor=K.+J.+Boxallauthor=S.+Y.+Sharpauthor=A.+Maloneyauthor=S.+M.+Roeauthor=C.+Prodromouauthor=L.+H.+Pearlauthor=G.+W.+Aherneauthor=E.+McDonaldauthor=P.+Workman&title=The+identification%2C+synthesis%2C+protein+crystal+structure+and+in+vitro+biochemical+evaluation+of+a+new+3%2C4-diarylpyrazole+class+of+Hsp90+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCheung%26aufirst%3DK.%2BM.%26aulast%3DMatthews%26aufirst%3DT.%2BP.%26aulast%3DJames%26aufirst%3DK.%26aulast%3DRowlands%26aufirst%3DM.%2BG.%26aulast%3DBoxall%26aufirst%3DK.%2BJ.%26aulast%3DSharp%26aufirst%3DS.%2BY.%26aulast%3DMaloney%26aufirst%3DA.%26aulast%3DRoe%26aufirst%3DS.%2BM.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26aulast%3DAherne%26aufirst%3DG.%2BW.%26aulast%3DMcDonald%26aufirst%3DE.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DThe%2520identification%252C%2520synthesis%252C%2520protein%2520crystal%2520structure%2520and%2520in%2520vitro%2520biochemical%2520evaluation%2520of%2520a%2520new%25203%252C4-diarylpyrazole%2520class%2520of%2520Hsp90%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D3338%26epage%3D3343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Sharp, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boxall, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowlands, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodromou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roe, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloney, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Box, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanderson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ball, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marais, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearl, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aherne, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">In vitro biological characterization of a novel, synthetic diaryl pyrazole resorcinol class of heat shock protein 90 inhibitors</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">2206</span><span class="NLM_x">–</span> <span class="NLM_lpage">2216</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=2206-2216&author=S.+Y.+Sharpauthor=K.+Boxallauthor=M.+Rowlandsauthor=C.+Prodromouauthor=S.+M.+Roeauthor=A.+Maloneyauthor=M.+Powersauthor=P.+A.+Clarkeauthor=G.+Boxauthor=S.+Sandersonauthor=L.+Pattersonauthor=T.+P.+Matthewsauthor=K.+M.+Cheungauthor=K.+Ballauthor=A.+Hayesauthor=F.+Raynaudauthor=R.+Maraisauthor=L.+Pearlauthor=S.+Ecclesauthor=W.+Aherneauthor=E.+McDonaldauthor=P.+Workman&title=In+vitro+biological+characterization+of+a+novel%2C+synthetic+diaryl+pyrazole+resorcinol+class+of+heat+shock+protein+90+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSharp%26aufirst%3DS.%2BY.%26aulast%3DBoxall%26aufirst%3DK.%26aulast%3DRowlands%26aufirst%3DM.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DRoe%26aufirst%3DS.%2BM.%26aulast%3DMaloney%26aufirst%3DA.%26aulast%3DPowers%26aufirst%3DM.%26aulast%3DClarke%26aufirst%3DP.%2BA.%26aulast%3DBox%26aufirst%3DG.%26aulast%3DSanderson%26aufirst%3DS.%26aulast%3DPatterson%26aufirst%3DL.%26aulast%3DMatthews%26aufirst%3DT.%2BP.%26aulast%3DCheung%26aufirst%3DK.%2BM.%26aulast%3DBall%26aufirst%3DK.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DRaynaud%26aufirst%3DF.%26aulast%3DMarais%26aufirst%3DR.%26aulast%3DPearl%26aufirst%3DL.%26aulast%3DEccles%26aufirst%3DS.%26aulast%3DAherne%26aufirst%3DW.%26aulast%3DMcDonald%26aufirst%3DE.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DIn%2520vitro%2520biological%2520characterization%2520of%2520a%2520novel%252C%2520synthetic%2520diaryl%2520pyrazole%2520resorcinol%2520class%2520of%2520heat%2520shock%2520protein%252090%2520inhibitors%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D2206%26epage%3D2216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Dymock, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barril, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brough, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cansfield, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgenor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roughley, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M. J.</span><span> </span><span class="NLM_article-title">Novel, potent small-molecule inhibitors of the molecular chaperone Hsp90 discovered through structure-based design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">4212</span><span class="NLM_x">–</span> <span class="NLM_lpage">4215</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050355z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm701018h&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkslSnsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=4212-4215&author=B.+W.+Dymockauthor=X.+Barrilauthor=P.+A.+Broughauthor=J.+E.+Cansfieldauthor=A.+Masseyauthor=E.+McDonaldauthor=R.+E.+Hubbardauthor=A.+Surgenorauthor=S.+D.+Roughleyauthor=P.+Webbauthor=P.+Workmanauthor=L.+Wrightauthor=M.+J.+Drysdale&title=Novel%2C+potent+small-molecule+inhibitors+of+the+molecular+chaperone+Hsp90+discovered+through+structure-based+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Novel, Potent Small-Molecule Inhibitors of the Molecular Chaperone Hsp90 Discovered through Structure-Based Design</span></div><div class="casAuthors">Dymock, Brian W.; Barril, Xavier; Brough, Paul A.; Cansfield, Julie E.; Massey, Andrew; McDonald, Edward; Hubbard, Roderick E.; Surgenor, Allan; Roughley, Stephen D.; Webb, Paul; Workman, Paul; Wright, Lisa; Drysdale, Martin J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4212-4215</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The crystal structure of a previously reported screening hit 1 (CCT018159) bound to the N terminal domain of mol. chaperone Hsp90 has been used to design 5-amide analogs.  These exhibit enhanced potency against the target in binding and functional assays with accompanying appropriate cellular pharmacodynamic changes.  Compd. 11 (VER-49009) compares favorably with the clin. evaluated 17-AAG.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZR4ICeTnHxbVg90H21EOLACvtfcHk0lg9ss9xEzu8-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkslSnsbg%253D&md5=3a854d5f6fd1eb0e292292b2a8d22401</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm050355z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050355z%26sid%3Dliteratum%253Aachs%26aulast%3DDymock%26aufirst%3DB.%2BW.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DBrough%26aufirst%3DP.%2BA.%26aulast%3DCansfield%26aufirst%3DJ.%2BE.%26aulast%3DMassey%26aufirst%3DA.%26aulast%3DMcDonald%26aufirst%3DE.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DRoughley%26aufirst%3DS.%2BD.%26aulast%3DWebb%26aufirst%3DP.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DWright%26aufirst%3DL.%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26atitle%3DNovel%252C%2520potent%2520small-molecule%2520inhibitors%2520of%2520the%2520molecular%2520chaperone%2520Hsp90%2520discovered%2520through%2520structure-based%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D4212%26epage%3D4215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Brough, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barril, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beswick, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dymock, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgenor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">3-(5-Chloro-2,4-dihydroxyphenyl)-pyrazole-4-carboxamides as inhibitors of the Hsp90 molecular chaperone</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">5197</span><span class="NLM_x">–</span> <span class="NLM_lpage">5201</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=5197-5201&author=P.+A.+Broughauthor=X.+Barrilauthor=M.+Beswickauthor=B.+W.+Dymockauthor=M.+J.+Drysdaleauthor=L.+Wrightauthor=K.+Grantauthor=A.+Masseyauthor=A.+Surgenorauthor=P.+Workman&title=3-%285-Chloro-2%2C4-dihydroxyphenyl%29-pyrazole-4-carboxamides+as+inhibitors+of+the+Hsp90+molecular+chaperone"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrough%26aufirst%3DP.%2BA.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DBeswick%26aufirst%3DM.%26aulast%3DDymock%26aufirst%3DB.%2BW.%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26aulast%3DWright%26aufirst%3DL.%26aulast%3DGrant%26aufirst%3DK.%26aulast%3DMassey%26aufirst%3DA.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3D3-%25285-Chloro-2%252C4-dihydroxyphenyl%2529-pyrazole-4-carboxamides%2520as%2520inhibitors%2520of%2520the%2520Hsp90%2520molecular%2520chaperone%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D5197%26epage%3D5201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Barril, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beswick, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collier, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dymock, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fink, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgenor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wayne, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L.</span><span> </span><span class="NLM_article-title">4-Amino derivatives of the Hsp90 inhibitor CCT018159</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2543</span><span class="NLM_x">–</span> <span class="NLM_lpage">2548</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=2543-2548&author=X.+Barrilauthor=M.+C.+Beswickauthor=A.+Collierauthor=M.+J.+Drysdaleauthor=B.+W.+Dymockauthor=A.+Finkauthor=K.+Grantauthor=R.+Howesauthor=A.+M.+Jordanauthor=A.+Masseyauthor=A.+Surgenorauthor=J.+Wayneauthor=P.+Workmanauthor=L.+Wright&title=4-Amino+derivatives+of+the+Hsp90+inhibitor+CCT018159"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DBeswick%26aufirst%3DM.%2BC.%26aulast%3DCollier%26aufirst%3DA.%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26aulast%3DDymock%26aufirst%3DB.%2BW.%26aulast%3DFink%26aufirst%3DA.%26aulast%3DGrant%26aufirst%3DK.%26aulast%3DHowes%26aufirst%3DR.%26aulast%3DJordan%26aufirst%3DA.%2BM.%26aulast%3DMassey%26aufirst%3DA.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DWayne%26aufirst%3DJ.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DWright%26aufirst%3DL.%26atitle%3D4-Amino%2520derivatives%2520of%2520the%2520Hsp90%2520inhibitor%2520CCT018159%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D2543%26epage%3D2548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><div class="note"><p class="first last">PDB id codes for <b>5</b><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2BTO">2BTO</a>; for <b>6</b><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2BSM">2BSM</a>; and for <b>7</b><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2BHY">2BHY</a></p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=PDB+id+codes+for+52BTO%3B+for+62BSM%3B+and+for+72BHY."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Sharp, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodromou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boxall, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Box, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalusa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardcastle, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dymock, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brough, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barril, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cansfield, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgenor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foloppe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aherne, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearl, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">Inhibition of the heat shock protein 90 molecular chaperone in vitro and in vivo by novel, synthetic, potent resorcinylic pyrazole/isoxazole amide analogues</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1198</span><span class="NLM_x">–</span> <span class="NLM_lpage">1211</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm701018h&amp;key=10.1158%2F1535-7163.MCT-07-0149" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm701018h&amp;key=17431102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm701018h&amp;key=1%3ACAS%3A528%3ADC%252BD2sXktFanu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=1198-1211&author=S.+Y.+Sharpauthor=C.+Prodromouauthor=K.+Boxallauthor=M.+V.+Powersauthor=J.+L.+Holmesauthor=G.+Boxauthor=T.+P.+Matthewsauthor=K.+M.+Cheungauthor=A.+Kalusaauthor=K.+Jamesauthor=A.+Hayesauthor=A.+Hardcastleauthor=B.+Dymockauthor=P.+A.+Broughauthor=X.+Barrilauthor=J.+E.+Cansfieldauthor=L.+Wrightauthor=A.+Surgenorauthor=N.+Foloppeauthor=R.+E.+Hubbardauthor=W.+Aherneauthor=L.+Pearlauthor=K.+Jonesauthor=E.+McDonaldauthor=F.+Raynaudauthor=S.+Ecclesauthor=M.+Drysdaleauthor=P.+Workman&title=Inhibition+of+the+heat+shock+protein+90+molecular+chaperone+in+vitro+and+in+vivo+by+novel%2C+synthetic%2C+potent+resorcinylic+pyrazole%2Fisoxazole+amide+analogues"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of the heat shock protein 90 molecular chaperone in vitro and in vivo by novel, synthetic, potent resorcinylic pyrazole/isoxazole amide analogues</span></div><div class="casAuthors">Sharp, Swee Y.; Prodromou, Chrisostomos; Boxall, Kathy; Powers, Marissa V.; Holmes, Joanna L.; Box, Gary; Matthews, Thomas P.; Cheung, Kwai-Ming J.; Kalusa, Andrew; James, Karen; Hayes, Angela; Hardcastle, Anthea; Dymock, Brian; Brough, Paul A.; Barril, Xavier; Cansfield, Julie E.; Wright, Lisa; Surgenor, Allan; Foloppe, Nicolas; Hubbard, Roderick E.; Aherne, Wynne; Pearl, Laurence; Jones, Keith; McDonald, Edward; Raynaud, Florence; Eccles, Sue; Drysdale, Martin; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1198-1211</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Although the heat shock protein 90 (HSP90) inhibitor 17-allylamino-17-demethoxygeldanamycin (17-AAG) shows clin. promise, potential limitations encourage development of alternative chemotypes.  We discovered the 3,4-diarylpyrazole resorcinol CCT018159 by high-throughput screening and used structure-based design to generate more potent pyrazole amide analogs, exemplified by VER-49009.  Here, we describe the detailed biol. properties of VER-49009 and the corresponding isoxazole VER-50589.  X-ray crystallog. showed a virtually identical HSP90 binding mode.  However, the dissocn. const. (Kd) of VER-50589 was 4.5±2.2 nmol/L compared with 78.0±10.4 nmol/L for VER-49009, attributable to higher enthalpy for VER-50589 binding.  A competitive binding assay gave a lower IC50 of 21±4 nmol/L for VER-50589 compared with 47±9 nmol/L for VER-49009.  Cellular uptake of VER-50589 was 4-fold greater than for VER-49009.  Mean cellular antiproliferative GI50 values for VER-50589 and VER-49009 for a human cancer cell line panel were 78±15 and 685±119 nmol/L, resp., showing a 9-fold potency gain for the isoxazole.  Unlike 17-AAG, but as with CCT018159, cellular potency of these analogs was independent of NAD(P)H:quinone oxidoreductase 1/DT-diaphorase and P-glycoprotein expression.  Consistent with HSP90 inhibition, VER-50589 and VER-49009 caused induction of HSP72 and HSP27 alongside depletion of client proteins, including C-RAF, B-RAF, and survivin, and the protein arginine methyltransferase PRMT5.  Both caused cell cycle arrest and apoptosis.  Extent and duration of pharmacodynamic changes in an orthotopic human ovarian carcinoma model confirmed the superiority of VER-50589 over VER-49009.  VER-50589 accumulated in HCT116 human colon cancer xenografts at levels above the cellular GI50 for 24 h, resulting in 30% growth inhibition.  The results indicate the therapeutic potential of the resorcinylic pyrazole/isoxazole amide analogs as HSP90 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdCmDXnfwFjrVg90H21EOLACvtfcHk0lgmS-TQyMVB7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXktFanu7Y%253D&md5=58678b76ed7fbda4d21942c69346946c</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-07-0149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-07-0149%26sid%3Dliteratum%253Aachs%26aulast%3DSharp%26aufirst%3DS.%2BY.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DBoxall%26aufirst%3DK.%26aulast%3DPowers%26aufirst%3DM.%2BV.%26aulast%3DHolmes%26aufirst%3DJ.%2BL.%26aulast%3DBox%26aufirst%3DG.%26aulast%3DMatthews%26aufirst%3DT.%2BP.%26aulast%3DCheung%26aufirst%3DK.%2BM.%26aulast%3DKalusa%26aufirst%3DA.%26aulast%3DJames%26aufirst%3DK.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DHardcastle%26aufirst%3DA.%26aulast%3DDymock%26aufirst%3DB.%26aulast%3DBrough%26aufirst%3DP.%2BA.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DCansfield%26aufirst%3DJ.%2BE.%26aulast%3DWright%26aufirst%3DL.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DFoloppe%26aufirst%3DN.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26aulast%3DAherne%26aufirst%3DW.%26aulast%3DPearl%26aufirst%3DL.%26aulast%3DJones%26aufirst%3DK.%26aulast%3DMcDonald%26aufirst%3DE.%26aulast%3DRaynaud%26aufirst%3DF.%26aulast%3DEccles%26aufirst%3DS.%26aulast%3DDrysdale%26aufirst%3DM.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DInhibition%2520of%2520the%2520heat%2520shock%2520protein%252090%2520molecular%2520chaperone%2520in%2520vitro%2520and%2520in%2520vivo%2520by%2520novel%252C%2520synthetic%252C%2520potent%2520resorcinylic%2520pyrazole%252Fisoxazole%2520amide%2520analogues%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2007%26volume%3D6%26spage%3D1198%26epage%3D1211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Kreusch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesley, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, X. J.</span><span> </span><span class="NLM_article-title">Crystal structures of human HSP90alpha-complexed with dihydroxyphenylpyrazoles</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1475</span><span class="NLM_x">–</span> <span class="NLM_lpage">1478</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1475-1478&author=A.+Kreuschauthor=S.+Hanauthor=A.+Brinkerauthor=V.+Zhouauthor=H.+S.+Choiauthor=Y.+Heauthor=S.+A.+Lesleyauthor=J.+Caldwellauthor=X.+J.+Gu&title=Crystal+structures+of+human+HSP90alpha-complexed+with+dihydroxyphenylpyrazoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKreusch%26aufirst%3DA.%26aulast%3DHan%26aufirst%3DS.%26aulast%3DBrinker%26aufirst%3DA.%26aulast%3DZhou%26aufirst%3DV.%26aulast%3DChoi%26aufirst%3DH.%2BS.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DLesley%26aufirst%3DS.%2BA.%26aulast%3DCaldwell%26aufirst%3DJ.%26aulast%3DGu%26aufirst%3DX.%2BJ.%26atitle%3DCrystal%2520structures%2520of%2520human%2520HSP90alpha-complexed%2520with%2520dihydroxyphenylpyrazoles%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D1475%26epage%3D1478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Carpino, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imazumi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Faham, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrer, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foxman, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henklein, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanay, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mugge, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wenschuh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klose, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beyermann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bienert, M.</span><span> </span><span class="NLM_article-title">The uronium/guanidinium peptide coupling reagents: finally the true uronium salts</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">442</span><span class="NLM_x">–</span> <span class="NLM_lpage">445</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2002&pages=442-445&author=L.+A.+Carpinoauthor=H.+Imazumiauthor=A.+El-Fahamauthor=F.+J.+Ferrerauthor=C.+Zhangauthor=Y.+Leeauthor=B.+M.+Foxmanauthor=P.+Henkleinauthor=C.+Hanayauthor=C.+Muggeauthor=H.+Wenschuhauthor=K.+Kloseauthor=M.+Beyermannauthor=M.+Bienert&title=The+uronium%2Fguanidinium+peptide+coupling+reagents%3A+finally+the+true+uronium+salts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarpino%26aufirst%3DL.%2BA.%26aulast%3DImazumi%26aufirst%3DH.%26aulast%3DEl-Faham%26aufirst%3DA.%26aulast%3DFerrer%26aufirst%3DF.%2BJ.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DY.%26aulast%3DFoxman%26aufirst%3DB.%2BM.%26aulast%3DHenklein%26aufirst%3DP.%26aulast%3DHanay%26aufirst%3DC.%26aulast%3DMugge%26aufirst%3DC.%26aulast%3DWenschuh%26aufirst%3DH.%26aulast%3DKlose%26aufirst%3DK.%26aulast%3DBeyermann%26aufirst%3DM.%26aulast%3DBienert%26aufirst%3DM.%26atitle%3DThe%2520uronium%252Fguanidinium%2520peptide%2520coupling%2520reagents%253A%2520finally%2520the%2520true%2520uronium%2520salts%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2002%26volume%3D41%26spage%3D442%26epage%3D445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Wright, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barril, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dymock, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheridan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgenor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beswick, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collier, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fink, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fromont, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aherne, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boxall, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, R. E.</span><span> </span><span class="NLM_article-title">Structure−activity relationships in purine-based inhibitor binding to HSP90 isoforms</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">775</span><span class="NLM_x">–</span> <span class="NLM_lpage">785</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm701018h&amp;key=10.1016%2Fj.chembiol.2004.03.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm701018h&amp;key=15217611" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm701018h&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlt1Sjsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=775-785&author=L.+Wrightauthor=X.+Barrilauthor=B.+Dymockauthor=L.+Sheridanauthor=A.+Surgenorauthor=M.+Beswickauthor=M.+Drysdaleauthor=A.+Collierauthor=A.+Masseyauthor=N.+Daviesauthor=A.+Finkauthor=C.+Fromontauthor=W.+Aherneauthor=K.+Boxallauthor=S.+Sharpauthor=P.+Workmanauthor=R.+E.+Hubbard&title=Structure%E2%88%92activity+relationships+in+purine-based+inhibitor+binding+to+HSP90+isoforms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationships in Purine-Based Inhibitor Binding to HSP90 Isoforms</span></div><div class="casAuthors">Wright, Lisa; Barril, Xavier; Dymock, Brian; Sheridan, Louisa; Surgenor, Allan; Beswick, Mandy; Drysdale, Martin; Collier, Adam; Massey, Andy; Davies, Nick; Fink, Alex; Fromont, Christophe; Aherne, Wynne; Boxall, Kathy; Sharp, Swee; Workman, Paul; Hubbard, Roderick E.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">775-785</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Inhibition of the ATPase activity of the chaperone protein HSP90 is a potential strategy for treatment of cancers.  We have detd. structures of the HSP90α N-terminal domain complexed with the purine-based inhibitor, PU3, and analogs with enhanced potency both in enzyme and cell-based assays.  The compds. induce upregulation of HSP70 and downregulation of the known HSP90 client proteins Raf-1, CDK4, and ErbB2, confirming that the mols. inhibit cell growth by a mechanism dependent on HSP90 inhibition.  We have also detd. the first structure of the N-terminal domain of HSP90β, complexed with PU3.  The structures allow a detailed rationale to be developed for the obsd. affinity of the PU3 class of compds. for HSP90 and also provide a structural framework for design of compds. with improved binding affinity and drug-like properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2Z11Wd4hiXrVg90H21EOLACvtfcHk0lgmS-TQyMVB7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlt1Sjsrs%253D&md5=dd2146dba0f4b3198d5bc7023e645812</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2004.03.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2004.03.033%26sid%3Dliteratum%253Aachs%26aulast%3DWright%26aufirst%3DL.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DDymock%26aufirst%3DB.%26aulast%3DSheridan%26aufirst%3DL.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DBeswick%26aufirst%3DM.%26aulast%3DDrysdale%26aufirst%3DM.%26aulast%3DCollier%26aufirst%3DA.%26aulast%3DMassey%26aufirst%3DA.%26aulast%3DDavies%26aufirst%3DN.%26aulast%3DFink%26aufirst%3DA.%26aulast%3DFromont%26aufirst%3DC.%26aulast%3DAherne%26aufirst%3DW.%26aulast%3DBoxall%26aufirst%3DK.%26aulast%3DSharp%26aufirst%3DS.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26atitle%3DStructure%25E2%2588%2592activity%2520relationships%2520in%2520purine-based%2520inhibitor%2520binding%2520to%2520HSP90%2520isoforms%26jtitle%3DChem.%2520Biol.%26date%3D2004%26volume%3D11%26spage%3D775%26epage%3D785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Mitchell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doecke, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hay, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koenig, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wirth, D. D.</span><span> </span><span class="NLM_article-title"><i>ortho</i>-Hydroxy assisted deoxygenation of phenones. Regiochemical control in the synthesis of monoprotected resorcinols and related polyphenolic hydroxyl systems</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">5335</span><span class="NLM_x">–</span> <span class="NLM_lpage">5338</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1995&pages=5335-5338&author=D.+Mitchellauthor=C.+W.+Doeckeauthor=L.+A.+Hayauthor=T.+M.+Koenigauthor=D.+D.+Wirth&title=ortho-Hydroxy+assisted+deoxygenation+of+phenones.+Regiochemical+control+in+the+synthesis+of+monoprotected+resorcinols+and+related+polyphenolic+hydroxyl+systems"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMitchell%26aufirst%3DD.%26aulast%3DDoecke%26aufirst%3DC.%2BW.%26aulast%3DHay%26aufirst%3DL.%2BA.%26aulast%3DKoenig%26aufirst%3DT.%2BM.%26aulast%3DWirth%26aufirst%3DD.%2BD.%26atitle%3Dortho-Hydroxy%2520assisted%2520deoxygenation%2520of%2520phenones.%2520Regiochemical%2520control%2520in%2520the%2520synthesis%2520of%2520monoprotected%2520resorcinols%2520and%2520related%2520polyphenolic%2520hydroxyl%2520systems%26jtitle%3DTetrahedron%2520Lett.%26date%3D1995%26volume%3D36%26spage%3D5335%26epage%3D5338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><div class="note"><p class="first last">Atomic coordinates for <b>40f</b> have been deposited with the Protein Data Bank at Rutgers University;</p></div><a href="http://rcsb.rutgers.edu/pdb/index.html" class="extLink">http://rcsb.rutgers.edu/pdb/index.html</a>; PDB code <span class="NLM_ext-link">2VCI</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Atomic+coordinates+for+40f+have+been+deposited+with+the+Protein+Data+Bank+at+Rutgers+University%3Bhttp%3A%2F%2Frcsb.rutgers.edu%2Fpdb%2Findex.html%3B+PDB+code+2VCI."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><div class="note"><p class="first last">Compound <b>30d</b> binding mode was established also and shown to be similar to that of <b>6</b> and <b>40f</b>. Further details are in <a class="ref internalNav" href="#si1" aria-label="supporting information">supporting information</a>. PDB code for <b>30d</b><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2VCJ">2VCJ</a></p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Compound+30d+binding+mode+was+established+also+and+shown+to+be+similar+to+that+of+6+and+40f.+Further+details+are+in+supporting+information.+PDB+code+for+30d2VCJ."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Smith, N. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nutley, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henley, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dymock, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">Preclinical pharmacokinetics and metabolism of a novel diaryl pyrazole resorcinol series of heat shock protein 90 inhibitors</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1628</span><span class="NLM_x">–</span> <span class="NLM_lpage">1637</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm701018h&amp;key=10.1158%2F1535-7163.MCT-06-0041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm701018h&amp;key=16818523" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm701018h&amp;key=1%3ACAS%3A528%3ADC%252BD28XmsVamsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=1628-1637&author=N.+F.+Smithauthor=A.+Hayesauthor=K.+Jamesauthor=B.+P.+Nutleyauthor=E.+McDonaldauthor=A.+Henleyauthor=B.+Dymockauthor=M.+J.+Drysdaleauthor=F.+I.+Raynaudauthor=P.+Workman&title=Preclinical+pharmacokinetics+and+metabolism+of+a+novel+diaryl+pyrazole+resorcinol+series+of+heat+shock+protein+90+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical pharmacokinetics and metabolism of a novel diaryl pyrazole resorcinol series of heat shock protein 90 inhibitors</span></div><div class="casAuthors">Smith, Nicola F.; Hayes, Angela; James, Karen; Nutley, Bernard P.; McDonald, Edward; Henley, Alan; Dymock, Brian; Drysdale, Martin J.; Raynaud, Florence I.; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1628-1637</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">CCT018159 was recently identified as a novel inhibitor of heat shock protein (Hsp) 90, a promising target for cancer therapy.  Pharmacokinetic and metabolic properties are likely to be important for efficacy and need to be optimized during drug development.  Here, we define the preclin. metab. and pharmacokinetics of CCT018159 and some early derivs.  In addn., we assess in vitro metabolic stability screening and in vivo cassette dosing (simultaneous administration of several compds. to a single animal) as approaches to investigate these compds.  The plasma clearance following individual i.v. administration to mice was rapid (0.128-0.816 L/h), exceeding hepatic blood flow.  For CCT066950 and CCT066952, this could be attributed in part to extensive (>80%) blood cell binding.  Oral bioavailability ranged from 1.8% to 29.6%.  Tissue distribution of CCT066952 was rapid and moderate, and renal excretion of the compds. was minimal (<1% of dose excreted).  Compds. underwent rapid glucuronidation both in vivo and following incubation with mouse liver microsomes.  However, whereas CCT066965 was metabolized to the greatest extent in vitro, this compd. displayed the slowest plasma clearance.  The rank order of the compds. from the highest to lowest area under the curve was the same following discrete and cassette dosing.  Furthermore, pharmacokinetic variables were similar whether the compds. were dosed alone or in combination.  We conclude that the pharmacokinetics of CCT018159 are complex.  Cassette dosing is currently the best option available to assess the pharmacokinetics of this promising series of compds. in relatively high throughput and is now being applied to identify compds. with optimal pharmacokinetic properties during structural analog synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSePVxi9Nx6bVg90H21EOLACvtfcHk0liRNQrG4Id2pA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmsVamsLY%253D&md5=53529a34a7d7e9136a0bf191c0a55104</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-06-0041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-06-0041%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DN.%2BF.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DJames%26aufirst%3DK.%26aulast%3DNutley%26aufirst%3DB.%2BP.%26aulast%3DMcDonald%26aufirst%3DE.%26aulast%3DHenley%26aufirst%3DA.%26aulast%3DDymock%26aufirst%3DB.%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DPreclinical%2520pharmacokinetics%2520and%2520metabolism%2520of%2520a%2520novel%2520diaryl%2520pyrazole%2520resorcinol%2520series%2520of%2520heat%2520shock%2520protein%252090%2520inhibitors%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2006%26volume%3D5%26spage%3D1628%26epage%3D1637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Smith, N. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">The application of cassette dosing for pharmacokinetic screening in small-molecule cancer drug discovery</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">428</span><span class="NLM_x">–</span> <span class="NLM_lpage">440</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm701018h&amp;key=10.1158%2F1535-7163.MCT-06-0324" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Fjm701018h&amp;key=17308044" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm701018h&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvVWkurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=428-440&author=N.+F.+Smithauthor=F.+I.+Raynaudauthor=P.+Workman&title=The+application+of+cassette+dosing+for+pharmacokinetic+screening+in+small-molecule+cancer+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">The application of cassette dosing for pharmacokinetic screening in small-molecule cancer drug discovery</span></div><div class="casAuthors">Smith, Nicola F.; Raynaud, Florence I.; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">428-440</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Pharmacokinetic evaluation is an essential component of drug discovery and should be conducted early in the process so that those compds. with the best chance of success are prioritized and progressed.  However, pharmacokinetic anal. has become a serious bottleneck during the 'hit-to-lead' and lead optimization phases due to the availability of new targets and the large nos. of compds. resulting from advances in synthesis and screening technologies.  Cassette dosing, which involves the simultaneous administration of several compds. to a single animal followed by rapid sample anal. by liq. chromatog./tandem mass spectrometry, was developed to increase the throughput of in vivo pharmacokinetic screening.  Although cassette dosing is advantageous in terms of resources and throughput, there are possible complications assocd. with this approach, such as the potential for compd. interactions.  Following an overview of the cassette dosing literature, this article focuses on the application of the technique in anticancer drug discovery.  Specific examples are discussed, including the evaluation of cassette dosing to assess pharmacokinetic properties in the development of cyclin-dependent kinase and heat shock protein 90 inhibitors.  Subject to crit. anal. and validation in each case, the use of cassette dosing is recommended in appropriate chem. series to enhance the efficiency of drug discovery and reduce animal usage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOlFEDbCmwlbVg90H21EOLACvtfcHk0liRNQrG4Id2pA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvVWkurg%253D&md5=fd68aab19d8735a4ceccf27e4b9928ee</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-06-0324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-06-0324%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DN.%2BF.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DThe%2520application%2520of%2520cassette%2520dosing%2520for%2520pharmacokinetic%2520screening%2520in%2520small-molecule%2520cancer%2520drug%2520discovery%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2007%26volume%3D6%26spage%3D428%26epage%3D440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Eccles, S. A.; Massey, A.; Raynaud, F.; Sharp, S. Y.; Box, G.; Valenti, M.; Patterson, L.; Gowan, S.; Boxall, F.; Aherne, W.; Rowlands, M.; Hayes, A.; Martins, V.; Urban, F.; Boxall, K.; Prodromou, C.; Pearl, L.; James, K.; Matthews, T.; Cheung, K. M.; Kalusa, A.; Jones, K.; McDonald, E.; Barril, X.; Brough, P. A.; Cansfield, J. E.; Dymock, B.; Drysdale, M.; Finch, H.; Howes, R.; Hubbard, R. E.; Surgenor, A.; Webb, P.; Wood, L. M.; Wright, L.; Workman, P.</span><span> </span><span class="NLM_article-title">NVP-AUY922: a novel synthetic resorcinylic isoxazole amide HSP90 inhibitor with potent activity against xenograft tumor growth, angiogenesis and metastasis</span>.  <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span><div class="note"><p class="first last">submitted</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=S.+A.+Eccles&author=A.+Massey&author=F.+Raynaud&author=S.+Y.+Sharp&author=G.+Box&author=M.+Valenti&author=L.+Patterson&author=S.+Gowan&author=F.+Boxall&author=W.+Aherne&author=M.+Rowlands&author=A.+Hayes&author=V.+Martins&author=F.+Urban&author=K.+Boxall&author=C.+Prodromou&author=L.+Pearl&author=K.+James&author=T.+Matthews&author=K.+M.+Cheung&author=A.+Kalusa&author=K.+Jones&author=E.+McDonald&author=X.+Barril&author=P.+A.+Brough&author=J.+E.+Cansfield&author=B.+Dymock&author=M.+Drysdale&author=H.+Finch&author=R.+Howes&author=R.+E.+Hubbard&author=A.+Surgenor&author=P.+Webb&author=L.+M.+Wood&author=L.+Wright&author=P.+Workman&title=NVP-AUY922%3A+a+novel+synthetic+resorcinylic+isoxazole+amide+HSP90+inhibitor+with+potent+activity+against+xenograft+tumor+growth%2C+angiogenesis+and+metastasis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEccles%26aufirst%3DS.%2BA.%26atitle%3DNVP-AUY922%253A%2520a%2520novel%2520synthetic%2520resorcinylic%2520isoxazole%2520amide%2520HSP90%2520inhibitor%2520with%2520potent%2520activity%2520against%2520xenograft%2520tumor%2520growth%252C%2520angiogenesis%2520and%2520metastasis%26jtitle%3DCancer%2520Res.%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Howes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barril, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dymock, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Northfield, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgenor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wayne, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M. J.</span><span> </span><span class="NLM_article-title">A fluorescence polarization assay for inhibitors of Hsp90</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">350</span><span class="NLM_x">, </span> <span class="NLM_fpage">202</span><span class="NLM_x">–</span> <span class="NLM_lpage">213</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2006&pages=202-213&author=R.+Howesauthor=X.+Barrilauthor=B.+W.+Dymockauthor=K.+Grantauthor=C.+J.+Northfieldauthor=A.+G.+Robertsonauthor=A.+Surgenorauthor=J.+Wayneauthor=L.+Wrightauthor=K.+Jamesauthor=T.+Matthewsauthor=K.+M.+Cheungauthor=E.+McDonaldauthor=P.+Workmanauthor=M.+J.+Drysdale&title=A+fluorescence+polarization+assay+for+inhibitors+of+Hsp90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHowes%26aufirst%3DR.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DDymock%26aufirst%3DB.%2BW.%26aulast%3DGrant%26aufirst%3DK.%26aulast%3DNorthfield%26aufirst%3DC.%2BJ.%26aulast%3DRobertson%26aufirst%3DA.%2BG.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DWayne%26aufirst%3DJ.%26aulast%3DWright%26aufirst%3DL.%26aulast%3DJames%26aufirst%3DK.%26aulast%3DMatthews%26aufirst%3DT.%26aulast%3DCheung%26aufirst%3DK.%2BM.%26aulast%3DMcDonald%26aufirst%3DE.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26atitle%3DA%2520fluorescence%2520polarization%2520assay%2520for%2520inhibitors%2520of%2520Hsp90%26jtitle%3DAnal.%2520Biochem.%26date%3D2006%26volume%3D350%26spage%3D202%26epage%3D213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Twentyman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balkwill, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balmain, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaplin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Double, J.</span><span> </span><span class="NLM_article-title">United Kingdom Co-ordinating Committee on Cancer research guidelines for the welfare of animals in experimental neoplasia, 2nd ed</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">10</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm701018h&amp;key=10.1038%2Fbjc.1998.1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=1998&pages=1-10&author=P.+Workmanauthor=P.+Twentymanauthor=F.+Balkwillauthor=A.+Balmainauthor=C.+Chaplinauthor=J.+Double&title=United+Kingdom+Co-ordinating+Committee+on+Cancer+research+guidelines+for+the+welfare+of+animals+in+experimental+neoplasia%2C+2nd+ed"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1038%2Fbjc.1998.1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.1998.1%26sid%3Dliteratum%253Aachs%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DTwentyman%26aufirst%3DP.%26aulast%3DBalkwill%26aufirst%3DF.%26aulast%3DBalmain%26aufirst%3DA.%26aulast%3DChaplin%26aufirst%3DC.%26aulast%3DDouble%26aufirst%3DJ.%26atitle%3DUnited%2520Kingdom%2520Co-ordinating%2520Committee%2520on%2520Cancer%2520research%2520guidelines%2520for%2520the%2520welfare%2520of%2520animals%2520in%2520experimental%2520neoplasia%252C%25202nd%2520ed%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D1998%26volume%3D77%26spage%3D1%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Drysdale, M. J.; Dymock, B. W.; Finch, H.; Webb, P.; McDonald, E.; James, K. E.; Cheung, K.-M.; Mathews, T. P.</span><span> </span><span class="NLM_article-title">Preparation of isoxazoles as inhibitors of heat shock proteins</span>. PCT International Application WO04072051,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=M.+J.+Drysdale&author=B.+W.+Dymock&author=H.+Finch&author=P.+Webb&author=E.+McDonald&author=K.+E.+James&author=K.-M.+Cheung&author=T.+P.+Mathews&title=Preparation+of+isoxazoles+as+inhibitors+of+heat+shock+proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26atitle%3DPreparation%2520of%2520isoxazoles%2520as%2520inhibitors%2520of%2520heat%2520shock%2520proteins%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2BTO" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2BTO','PDB','2BTO'); return false;">PDB: 2BTO</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2BSM" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2BSM','PDB','2BSM'); return false;">PDB: 2BSM</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2BHY" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2BHY','PDB','2BHY'); return false;">PDB: 2BHY</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2VCI" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2VCI','PDB','2VCI'); return false;">PDB: 2VCI</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2VCJ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2VCJ','PDB','2VCJ'); return false;">PDB: 2VCJ</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i99"><a href="/doi/suppl/10.1021/jm701018h">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_15853"></div></div></div></div></div><hr /></hr><p class="last">Experimental procedures for the FP assay and synthesis of the FP assay probe. Methods and parameters relating to X-ray crystallography and protein production are also provided as are graphical representations of PK cassette dosing results for cassette 3. Full chemistry experimental procedures and characterization data are presented in this section. This information is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm701018h/suppl_file/jm701018h-file001.pdf">jm701018h-file001.pdf (3.29 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm701018h&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2008.51.issue-2%3Barticle%3Aarticle%3A10.1021%2Fjm701018h%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm701018h" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67990ea899421228","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
